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Abstract
Evidence is needed to inform dietary strategies to promote a healthy weight and reduce 
cardiovascular risk. Dietary protein (P) may influence both energy intake (El) and energy 
expenditure (EE). To determine the relationships between appetite control, body mass 
regulation and protein from different animal and vegetable sources, healthy lean subjects 
were studied in tightly controlled experiments.
In a 5-way crossover study, 28 subjects aged 19-68 years consumed 2.5 MJ high-protein 
preload meals (33% energy from protein(P), 34% fat(F), 33% carbohydrate(C)) rich in 
meat, dairy, nuts and legumes, soy, or control (15%P, 34%F, 51%C), followed by test 
meals 180 min later. Appetite control mechanisms before, during and for 5 hours after 
eating, were assessed from analysis of serial blood samples and other physiological 
measurements. Mean El was lower after soy (4.1±0.4 MJ) than control (4.6±0.4 MJ), meat 
(4.7±0.4 MJ), dairy (4.6±0.4 MJ) or nuts/legumes (5.0±0.5 MJ) jpreloads. Gastric 
emptying was slower and hunger decreased after soy, and after nuts/legumes, satiation 
increased and hunger reduced. Blood glucose and insulin excursions were significantly 
lower after the nuts/legumes and soy meals.
Similar parameters, plus urinary nitrogen, El and EE were measured in 10 adults during 3 
five-day residential experiments. On days 1-3, they ate ad libitum diets providing 10%, 
15%, or 25% protein, 30% fat and the remainder as carbohydrate. El was fixed at 
maintenance requirements on day 4 and EE was measured by calorimeter. El was lower 
during the 25%P (8.1±1.0 MJ/d) than the 15%P diet (8.7±1.0 MJ/d) with higher fullness 
scores, flatter glucose curves and higher pancreatic polypeptide concentration. EE was
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similar but fat oxidation was higher on the 25%P diet.
Higher dietary protein promotes energy balance, through decreased energy intake and 
increased fat oxidation, improves metabolic risk factors, and may be useful to prevent 
weight gain and related metabolic diseases.
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m metres
MC3 Melanocortin receptor 3
MC4 Melanocortin receptor 4
mg Milligram
MJ Megajoules
ml millilitres
mm millimetres
MRI Magnetic Resonance Imaging
MUP Methyl umbelliferyl phosphate
N Nitrogen
NAD Nicotinamide adenine dinucleotide
NADH Nicotinamide adenine dinucleotide (reduced form)
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NBL Nutritional Biochemistry Laboratory
NEFA Non-esterified fatty acids
NHANES National Health and Nutrition Examination Survey
NPY Neuropeptide Y
NS Not significant
NST Nucleus tractus solitarius
O2 Oxygen consumption
OXM Oxyntomodulin
P Protein
P:E Protein to energy ratio
PDR Percentage dose recovered
POD Peroxidase
POMC Pro-opiomelanocortin
PP Pancreatic polypeptide
PVN Paraventricular nucleus
PYY Peptide tyrosine tyrosine
REE Resting energy expenditure
Rmax Maximum rate of label excretion
RMR Resting metabolic rate
S Snack
SA Streptoavidin
SD Standard deviation
SEM Standard error of the mean
SMR Sleeping metabolic rate
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tl/2  Half excretion time
TEE Total energy expenditure
TFEQ Three-Factor Eating Questionnaire
tasc Ascension time
tlag Lag time
tlat Latency time
TMB Tetramethylbenzidine
UK United Kingdom
UKPDS United Kingdom prospective diabetes study
UN Urinary nitrogen
USA United States of America
VAS Visual analogue scale
WHO World Heath Organisation
WHR Waist-hip ratio
y year
Y 1 Y 1 receptors
Y5 Y5 receptors
Chapter 1 Introduction
1.1 Energy regulation and body mass
The long-term balance between energy intake and energy expenditure determines body 
mass (Figure 1.1.1). An individual remains in energy balance if energy intake equals 
energy expenditure, and therefore body energy stores and body mass remain stable. 
Energy intake comprises the protein, fat, carbohydrate and alcohol that are consumed as 
food and drink, while energy output is determined by basal metabolic rate, thermogenesis 
(induced by diet or cold exposure), physical activity and urinary and faecal losses.
For the most part, body mass is highly regulated through complex homeostatic 
mechanisms. A change that disturbs energy homeostasis initiates alterations in energy 
intake or expenditure to return energy balance to baseline (Schwartz et al., 2000). 
However, an individual’s environment modulates eating behaviour which may disrupt 
these innate control mechanisms. An alteration in energy balance may lead to a positive 
energy balance, where energy intake exceeds energy expenditure and body energy stores 
increase, or a negative energy balance, where intake is less than expenditure and energy 
stores decrease.
Figure 1.1.1 The energy balance equation
Energy balance =  Energy intake +  Energy expenditure
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1.1.1 Regulation of energy intake
Appetite is described as the internal motivation that leads a person to look for food, to 
select it and to eat it (de Graaf et al., 2004). The act of eating results from the interaction 
between physiological and psychological factors and adaptation to the environment. 
Appetite is therefore characterised by motivation to eat (or the sensation of hunger), 
energy and nutrient intake, and the timing and size of meals and snacks. When satiation 
develops during a meal, eating is terminated and the satiety that results determines the 
period until the next meal. During and after a meal, receptors in the wall of the stomach 
and gastrointestinal tract, and the rate of gastric filling and emptying, interact with 
receptors in the central nervous system to regulate hunger and satiation. The presence of 
food and of nutrients absorbed from the gastrointestinal tract stimulates the secretion of 
hormones and peptides that are involved in satiation, satiety and the development of 
hunger. Excess energy consumed is stored, in the short term as glycogen and 
subsequently as triacyl glycerols predominantly in adipocytes (but also in muscle and 
liver). Signals from adipose tissue provide a feedback system to influence hunger and 
satiety and provide a longer-term control mechanism for energy regulation.
1.1.1.1 The role o f satiation and satiety in energy intake
Total daily energy intake results from a number of eating episodes that differ in size, 
content and interval and are eaten throughout a 24-hour period, mostly during the 
daytime. Physiologically, food intake is regulated by two main mechanisms. Satiation 
develops during an eating episode and terminates eating and therefore determines the 
amount of food consumed. Satiety is defined as the inhibition of the sensation o f hunger 
after consuming food that prevents further eating in the post-prandial period. As satiety
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reduces, hunger increases and determines when the next eating episode occurs, though in 
the modem world habit, social behaviour and other factors complicate this relationship.
Satiety and satiation are modulated by macronutrient composition, energy density, 
physical structure and sensory qualities of the food recently eaten. Blundell’s satiety 
cascade provides a framework for identifying the physiological mechanisms that mediate 
satiety and satiation during and after eating (Blundell, 1999). As illustrated in the lower 
part of Figure 1.1.2 four main processes determine satiety: sensory, cognitive, pre- 
absorptive and post-absorptive processes.
Sensory signals induced by the senses of sight and smell with contributions from the 
taste, temperature and texture of foods, determine how palatable a food is and, in the 
absence of physical or social limitations on its availability, how much is consumed. 
Anticipating ingestion of food may induce physiological signals before the food has been 
ingested with secretion of gastric hormones in response to stimulation of the cerebral 
cortex of the brain, as illustrated in the cephalic phase in the Figure 1.1.2. Cognitive 
processes to initiate or terminate eating involve an individual’s voluntary control of 
eating, an understanding of the properties of the food consumed, and the social context of 
the meal. By controlling food availability and the eating environment, the experiments 
described in this thesis were designed to exclude the effects of cognitive processes and 
study the physiological factors involved in isolation.
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F ig u re  1 .1.2 B lu n d e ll’s S a tie ty  C a sc a d e
The four processes (sensory, cognitive, pre-absorptive and post-absorptive) that regulate satiation and satiety 
through interactions with the gut, central nervous system and metabolic processes. Abbreviations: NST 
(nucleus tractus solitarius), PVN (paraventricular nucleus), GLP-1 (glucagon-like peptide 1), CCK 
(cholecystokinin), FFA (free fatty acids), AA (amino acids). (From Blundell 1999)
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Pre-absorptive processes occur in the gastrointestinal tract before nutrients are absorbed. 
Firstly, gastric filling and distension occurs when food enters the stomach. Vagal 
mechanoreceptors in the stomach wall are stimulated and contribute to the early phase of 
satiety (Cummings & Overduin, 2007). Once food has reached the stomach and intestine, 
cells in the intestinal wall are stimulated to secrete hormones that reduce food intake 
(such as cholecystokinin (CCK), glucagon-like peptide 1 (GLP-1) and peptide tyrosine 
tyrosine (PYY), and pancreatic polypeptide (PP) from the pancreas) and inhibit the
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secretion of hormones that stimulate eating (such as ghrelin). Glucose, fatty acids, and 
amino acids released by the digestion of food stimulate vagal chemoreceptors in the 
intestinal wall that additionally promote satiety.
Post-absorptive processes that regulate satiety occur mainly from the metabolism of 
macronutrients. The rise in blood glucose after carbohydrate digestion and absorption 
stimulates satiety while a fall in blood glucose stimulates hunger (de Graaf et al., 2004). 
Fatty acids, resulting from the digestion of fat, and amino acids, produced with the 
digestion of protein, appear to regulate hunger indirectly. When these nutrients enter the 
bloodstream secretion of hormones such as leptin and insulin increases, and have both 
immediate and long-term effects on satiety regulation (Badman & Flier, 2005).
1.1.1.2 The role o f the central nervous system in energy intake
The central nervous system (CNS), responds to and determines immediate and long-term 
energy balance by integrating neural, endocrine and metabolic signals to produce 
behavioural, autonomic and endocrine responses (Spiegelman & Flier, 2001) (Badman & 
Flier, 2005). This complex system is illustrated in Figure 1.1.3.
One of the first signals to reach the CNS is from the nutrient and stretch receptors in the 
gastrointestinal tract during the pre-absorptive phase of satiety. Signals are transmitted 
through the vagus nerve to the nucleus tractus solitarius (see Figure 1.1.2) in the 
hindbrain and influence meal timing and size and therefore short-term energy balance 
(Badman & Flier, 2005).
In the subsequent pre-absorptive and post-absorptive phases following a meal the
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hypothalamus has a central role in energy balance. The two main areas in the 
hypothalamus involved in energy regulation are the arcuate nucleus and the 
paraventricular nucleus. Stimulation of pathways in the arcuate nucleus inhibits eating, 
while stimulation of pathways in the paraventricular nucleus increase eating. In the rat, 
inactivating the pathways that inhibit eating by experimental lesions in the ventromedial 
and arcuate nuclei of the hypothalamus produce hyperphagia and eventually obesity. 
Conversely, lesions in the paraventricular nucleus in the lateral hypothalamus (where 
pathways increase feeding) cause aphagia and weight loss (Elmquist et al., 1999).
Neurons in the arcuate nucleus secrete specific peptides which act on second order 
neurons in the paraventricular nucleus to suppress or stimulate eating. Appetite inhibiting 
neurons in the arcuate nucleus contain pro-opoimelanocortin (POMC) peptides (such as a 
melanocyte stimulating hormone (aMSH)) and cocaine-and amphetamine-stimulated 
transcript peptide (CART) (Figure 1.1.3). aMSH acts on melanocortin 3 and 
melanocortin 4 receptors to suppress feeding activity. Appetite stimulating neurons are 
also present in the arcuate nucleus. They secrete neuropeptide Y (NPY) and agouti- 
related peptide (AgRP). NPY acts on Y1 and Y5 receptors and AgRP inhibits 
melanocortin receptor activity in the paraventricular nucleus to increase food intake. NPY 
also inhibits the effect of POMC neurons to further stimulate eating (Badman & Flier,
2005).
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Figure 1.1.3 Central nervous system regulation of satiety
(Badman and Flier 2005). A representation of the effect of peripheral signals and their receptors that act on 
the hypothalamus and hindbrain to modulate eating behaviour. POMC (pro-opiomelanocortin), aMSH (a 
melanocyte-stimulating hormone), MC3 and MC4 (melanocortin receptors), CART (cocaine-and 
amphetamine-stimulated transcript peptide), NPY (neuropeptide Y), Y1 and Y5 (Y receptors), AgRP 
(agouti-related peptide), PYY (peptide YY), PP (pancreatic polypeptide), GLP-1 (glucagon-like peptide 1),
OXM (oxyntomodulin), , direct stimulatory;    direct inhibitory; , indirect pathways. R means
receptor.
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Peripheral signals, primarily from the gut and adipose tissue, are able to cross the blood 
brain barrier to interact with the neurons in the hypothalamus. Gut hormones, particularly 
PYY, inhibit the action of NPY thereby reducing feeding. Adiposity signals, leptin and 
insulin, also inhibit NPY to prevent the stimulation of eating, while leptin also acts 
directly on the POMC neurons to inhibit food intake. The gut hormone ghrelin, is the 
main promoter of eating by stimulating NPY-secreting neurons, and therefore acts as a 
signal to initiate food intake.
1.1.1.3 The role o f the gastrointestinal tract in energy intake
1.1.1.3.1 Gastric filling and emptying
The sense organs that detect gastric filling, and the rate of gastric emptying are important 
in the initial regulation of eating and the subsequent release of the hormones that 
influence satiety and energy balance. The stomach wall contains a large number of 
mechanoreceptors which sense the stretch arising from increased volume of the stomach 
after food has been ingested. Signals from these receptors are relayed to the brain by 
vagal and spinal sensory nerves and contribute to satiation during a meal (Cummings & 
Overduin, 2007). The initial gastric distension during a meal may also contribute to the 
release of gastrointestinal hormones in the upper and lower intestines which, as well as 
coordinating digestion, influence meal satiation and post-prandial satiety.
The rate of gastric emptying during and after a meal contributes to appetite and food 
intake. The volume and weight of a meal, its physical form (liquid or solid), composition 
and energy content all influence gastric emptying (Jackson et al., 2004). Delayed gastric
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emptying enhances both short-term satiation and between meal satiety. When food 
remains in the stomach for a longer period the activated stretch receptors prolong the 
stimulus to the brain which inhibits further eating. Additionally a slower rate of gastric 
emptying prolongs post-prandial secretion of gastrointestinal hormones, increasing post­
meal satiety. Intestinal signals further enhance the satiating effect by delaying gastric 
emptying (Cummings & Overduin, 2007).
1.1.1.3.2 Gastrointestinal hormones
The gut-brain axis is an important link between food intake and appetite regulation. 
Satiety and body energy store signals, processed in the brain, alter food intake in a 
manner intended to maintain energy homeostasis. Hormones are secreted from 
enteroendocrine cells along the entire length of the gastrointestinal tract and, by 
interacting with neurons bearing appropriate receptors in the brain, produce signals which 
act as meal initiators and terminators, as summarized in Figure 1.1.4 (Chaudhri et al.,
2008).
1.1.1.3.3 Cholecystokinin
Cholecystokinin (CCK) is produced by enteroendocrine I cells in the duodenal and 
jejunal mucosa. It is rapidly released in response to nutrients in the gut, particularly lipids 
and proteins (Wynne et a l, 2004). CCK acts via the vagal nerve to coordinate post­
prandial gall bladder contraction and pancreatic secretion and controls gastric emptying 
and gut motility (Badman & Flier, 2005). Experimental CCK administration delays 
gastric emptying which may be the main contributor to the effect of CCK on satiety.
37
Infusions of CCK reduce meal size and duration in humans, and when the action of C CK 
is experimentally blocked in rodents weight gain occurs (W ynne et al., 2004).
Figure 1.1.4 The gastrointestinal tract indicating the locations where gut hormones are released.
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1.1.1.3.4 G lucagon-like peptide 1
Glucagon-like peptide 1 (GLP-1) is cleaved from preproglucagon (Holst, 1999). It is 
released from L-cells in the distal small intestine and colon in response to nutrients, at 
levels in proportion to energy intake (Wynne et al., 2004) and inhibits appetite to reduce 
food intake (Holst, 1999). GLP-1 is an incretin hormone (a hormone that stimulates
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insulin secretion) and regulates glucose-dependent insulin release, inhibits glucagon 
secretion and increases pancreatic B-cell growth (Karhunen et al., 2008). Circulating 
levels rise after food intake, particularly after a glucose load. An interesting feature of 
GLP-1 is that levels increase shortly after a meal, prior to nutrient contact with the distal 
intestine. GLP-1 secretion is also stimulated via indirect neurohormonal mechanisms in 
response to nutrients, particularly carbohydrates and fats, in the duodenum. Additionally, 
GLP-1 plays an important role in the ‘ileal brake’, a mechanism regulating the flow of 
nutrients from the stomach into the small intestine, to slow gastric motility and gastric 
emptying, thereby increasing satiety shortly after a meal (Cummings & Overduin, 2007).
Exogenous GLP-1 reduces energy intake in a dose-dependent manner (Verdich et al., 
2001) and stimulates glucose-induced insulin secretion, reduces glucagon levels and 
slows gastric motility (Kreymann et al., 1987). In type 2 diabetes, GLP-1 infusions 
normalise glucose and enhance weight loss with a possible improvement in insulin 
sensitivity and pancreatic beta cell function (Heine et al., 2005). The limiting factor in the 
therapeutic use of GLP-1, or its receptor agonists, is that it is rapidly inactivated by the 
enzyme dipeptidyl peptidase IV (DPP-IV). However with the development of long-acting 
GLP-1 analogues and DPP-IV inhibitors these agents are now in widespread use for the 
treatment of type 2 diabetes, and some GLP-1 analogues are being tested as treatments 
for obesity.
1.1.1.3.5 Peptide YY
Peptide YY (PYY), a 36-amino acid peptide, is secreted from L cells in the lower 
intestine, many of which co-express GLP-1 (Adrian et al., 1985). It is secreted post-
39
prandially in proportion to the energy load, particularly in response to lipid ingestion. As 
with GLP-1, PYY secretion occurs soon after a meal in response to neural stimulation in 
the duodenum and subsequently by direct nutrient stimulation in the lower intestine. 
PYY, along with NPY, is part of the pancreatic polypeptide-fold protein family which 
interact with neuropeptide Y receptors (of which there are 5 known receptors labelled Y 1 
to Y5) and couple to inhibitory G proteins (Cummings & Overduin, 2007). PYY exists in 
an intact form, PYY(l-36) and as PYY(3-36) where the N-terminal tyrosine-proline 
dipeptide has been cleaved by DPPIV (Grandt et al., 1994). PYY(3-36) binds to
neuropeptide Y2 receptors in the hypothalamus where it inhibits NPY neurons, reduces 
the NPY-induced inhibition of POMC neurons, and stimulates signals that decrease food 
intake. PYY also delays gastric emptying.
The intact PYY(l-36) peptide does not appear to modulate appetite or energy intake 
(Sloth et al., 2006) but infusions of the cleaved form, PYY(3-36), to match post-prandial 
levels, decrease food intake and body weight in rodents and reduce appetite and energy 
intake in healthy human subjects (Batterham et al., 2002). PYY(3-36) has been shown to 
increase diet-induced thermogenesis, post-prandial blood insulin and glucose 
concentrations and free fatty acid secretion, possibly due to increased lipolysis (Sloth et 
al., 2006). PYY may be the key mediator of the satiating effects of protein (Batterham et 
al., 2006).
1.1.1.3.6 Pancreatic polypeptide
Pancreatic polypeptide (PP) belongs to the same PP-fold peptide family that includes 
neuropeptide Y (NPY) and PYY. PP is secreted primarily by the endocrine cells of the
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pancreas with some secretion in the exocrine pancreas, colon and rectum (Karhunen et 
al., 2008). Secretion of PP is controlled by the parasympathetic nervous system and is 
regulated by food intake and by an intrinsic circadian rhythm (Stanley et al., 2004). Food 
intake stimulates a biphasic release of PP in proportion to energy intake, and levels may 
remain elevated for up to 6 hours post-prandially (Adrian et al., 1976). An increase in PP 
concentration has also been observed following adrenergic stimulation due to exercise or 
hypoglycaemia. In addition, sham feeding or gastric distension by water ingestion 
stimulate PP secretion (Witteman et al., 1994), (Karhunen et al., 2008).
Peripherally administered physiological doses of PP in mice produce a rapid, prolonged 
reduction in food intake, acting within 20 minutes and persisting for 24 h (Asakawa et al.,
2006) (Asakawa et al., 2003). Additionally, transgenic mice overexpressing PP are lean, 
have reduced food intake and reduced gastric emptying (Ueno et al., 1999). There 
appears to be a similar effect in humans. PP infusions provided to 10 healthy volunteers 
reduced appetite and energy intake at a lunch two hours post-infusion, with a sustained 
effect that reduced the 24 h energy intake by 25% (Batterham et al., 2003).
1.1.1.3.7 Ghrelin
The orexigenic hormone ghrelin is an acylated 28-amino acid agonist of the growth 
hormone secretagogue receptor formed by the cleavage of preproghrelin (Kojima et al., 
1999). It is released primarily from cells in the fundus of the stomach and the proximal 
small intestine in response to circulating and nutritional signals, in proportion to energy 
intake, and activates the orexigenic neurons expressing NPY in the hypothalamus. 
(Wynne et al., 2004). Plasma concentrations of ghrelin rise before a meal and fall to a
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trough within one hour after eating (Cummings et al., 2001), suggesting a role in 
initiation of eating. Ghrelin further stimulates eating by increasing gastric motility and 
decreasing insulin secretion.
Exogenous ghrelin stimulates food intake in rats (Tschop et al., 2000) (Nakazato et al., 
2001) and humans (Wren et al., 2001) and reduces the time between meals to further 
increase energy intake. Ghrelin levels are lower in obesity (Tschop et al., 2001) and rise 
after weight loss (Cummings et al., 2002) possibly acting as an adaptive mechanism to 
restrict diet-induced weight loss. Cummings et al (Cummings et al., 2002) found ghrelin 
levels were 77% lower in patients after gastric bypass surgery (when the gastric fundus is 
by-passed) than in lean control subjects, suggesting that lack of ghrelin secretion after 
surgery contributes to weight loss. Reports of the long-term outcomes of gastric bypass 
surgery have not consistently shown a decrease in ghrelin, possibly due to the type of 
operation performed and whether ghrelin levels were measured during the weight loss 
phase or at a stable weight (Williams & Cummings, 2005). It is apparent that ghrelin has 
a role in energy balance though its exact association with dietary intake and weight 
regulation requires clarification.
1.1.1.4 The role o f adiposity signals in energy intake
Insulin is released from the pancreatic beta cells in response to blood glucose levels and 
contributes to short-term control of food intake and long-term energy regulation. It acts 
through the insulin receptor to remove glucose from the blood into muscle and other 
tissues and suppress glucose secretion from the liver.
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Insulin receptors are also expressed in the hypothalamus where the presence of insulin 
reduces food intake and increases energy expenditure (Plum et al., 2005). Insulin 
circulates in the blood in proportion to body fat (Schwartz et al., 2000) and enters the 
brain in proportion to plasma levels. The presence and action of insulin in the central 
nervous system is therefore dependent on adiposity and provides a key feedback signal in 
body weight regulation (Woods et al., 2006). With weight gain, insulin sensitivity is 
reduced, necessitating increased insulin release to maintain glucose homeostasis. More 
insulin reaches the hypothalamus to signal a reduction in food intake and limit further 
weight gain. Conversely, in uncontrolled Type 1 diabetes mellitus, a deficiency of insulin 
causes hyperphagia. However, as insulin is required for fat deposition (and leptin 
synthesis in adipocytes) weight gain does not occur in a state of insulin deficiency, as 
excess glucose is secreted in the urine.
Circulating levels of leptin, a hormone secreted predominantly by adipocytes, are roughly 
in proportion to body fat, but there is much unexplained inter-individual variation 
(Considine et al., 1996). Like insulin, leptin enters the central nervous system to interact 
with leptin receptors in the hypothalamus and regulate food intake and energy 
expenditure (Friedman & Halaas, 1998; Schwartz et al., 2000). Leptin is the dominant 
adiposity signal in the central nervous system and has an important role in energy 
homeostasis (Badman & Flier, 2005). Centrally administered leptin reduces food intake 
and increases energy expenditure leading to loss of adipose tissue (Halaas et al., 1995) 
(Friedman & Halaas, 1998). Leptin levels are reduced with food restriction and starvation 
which leads to an increase in appetite and a reduction in energy expenditure. During 
starvation or in the absence of leptin, reproduction and growth are inhibited, further
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reducing energy expenditure (Spiegelman & Flier, 2001). Examining leptin deficient 
mice and the small number of leptin-deficient humans illustrates the function of leptin 
most effectively. Individuals with a mutation in the leptin gene, which disrupts the 
production of leptin, have very low levels of active leptin and have continual hyperphagia 
from a young age which quickly leads to severe obesity (Zhang et al., 1994; Montague et 
al., 1997) that is corrected by administering leptin (Halaas et al., 1995; Farooqi et al.,
1999). In obese humans without leptin deficiency, leptin levels continue to rise in 
proportion to body fat, but appetite is not suppressed and fat mass increases (Considine et 
al., 1996). This situation suggests a reduction in leptin sensitivity from defective 
transport to the CNS or impaired intracellular signalling (Badman & Flier, 2005).
The stomach wall produces small amounts of leptin and, while its role is unclear, gastric 
leptin may also play a role in short-term energy regulation (Meier & Gressner, 2004). 
Like ghrelin, the release of gastric leptin may occur in response to post-prandial insulin 
levels (Obici et al., 2001). Intraperitoneal injection of leptin in rats reduces meal size and 
terminates eating (French & Castiglione, 2002). When leptin was replaced in a patient 
with congenital leptin deficiency, energy intake reduced significantly within seven days, 
suggesting an acute affect of leptin on energy intake despite the presence of similar 
adipose tissue mass (Farooqi et al., 1999).
1.1.2 Regulation of energy expenditure
Energy expenditure is measured as the amount of heat released by the body (Das & 
Roberts, 2001). There are three main components of energy expenditure: basal metabolic 
rate (BMR) or resting metabolic rate (RMR), thermogenesis, and energy expenditure for
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physical activity and arousal (EEPAA). Together these components reflect 24-hour total 
energy expenditure (TEE).
BMR is the rate of energy expenditure while lying in bed at rest, 12-14 hours after the 
last meal. It can account for 60-70% of TEE depending on an individual’s level of 
physical activity. BMR is correlated with fat-free mass so increasing muscle mass 
increases BMR and may provide a mechanism to increase TEE. It is noteworthy that 
BMR is higher in the obese because of an increase in fat-free mass as well as fat mass 
(Prentice et al., 1986). This finding negated earlier theories that obesity is caused by a 
low BMR (Schutz et al., 1984). BMR decreases with age (Roberts et al., 1995) and is 
lower in women (Ferraro et al., 1992), with small fluctuations in BMR throughout the 
menstrual cycle (Davidsen et al., 2007).
Thermogenesis is the process of heat production and occurs after eating, exercise, or in 
response to stimuli such as cold. In humans, the largest component is the energy 
expended with ingestion, absorption, transport, storage and utilization of food, diet- 
induced thermogenesis (DIT) (Das & Roberts, 2001). It is composed of energy used in 
the processing and storage of ingested nutrients, and increased activity of the sympathetic 
nervous system from the sensory and metabolic stimulation of food. DIT is proportional 
to the size of the meal consumed and accounts for 7-13% of energy expenditure (Schutz 
et al., 1984).
EEPAA is the energy expenditure which occurs during physical activity and arousal. As a 
proportion of TEE it typically varies from 30% in sedentary individuals up to 70% in
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highly active individuals. Measuring EEPAA is technically more difficult than the other 
components of TEE as there is a large variability in energy expended during occupational 
activity, leisure activity, and residual arousal and non-specific activity such as fidgeting. 
EEPAA is however a modifiable component of EE, whereas the other components reflect 
basic physiological processes.
Recent evidence has identified the presence of brown adipose tissue in humans which 
persists beyond the newborn period and may be important in cold-induced thermogenesis 
and potentially in the development of obesity (Virtanen et al., 2009). Nuclear medicine 
scans, to investigate tumour metastasis, demonstrated brown adipose tissue in adult 
humans, particularly in cold conditions (Nedergaard et al., 2007). In 10 lean and 14 obese 
subjects, brown adipose tissue was found to be present during cold exposure in all but 
one subject, but not under thermoneutral conditions (van Marken Lichtenbelt et al.,
2009). Tissue activity was reduced in overweight and obese men and was associated with 
a decrease in basal metabolic rate. An inverse association between the amount of active 
brown adipose tissue and body mass suggests a potential role in adult human metabolism 
that is currently being investigated (Cypess et al., 2009).
24 h TEE is a reflection of net EE and may be measured either under controlled 
conditions in a calorimeter, or in free-living individuals using doubly-labelled water. 
These techniques and others that have been used to measure the components of TEE are 
discussed in Chapter 2.
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1.2 Consequences of poor energy regulation
The physiological factors discussed above are designed to tightly control energy balance 
and maintain body mass in the long term. Remarkably, this balance is usually achieved 
and body mass remains stable. However, a sustained small imbalance between energy 
intake and energy expenditure can produce a substantial change in body mass. For every 
1% (approximately 100 kJ/day) increase in energy intake relative to energy expenditure 
body mass increases by approximately 15kg/decade (Das & Roberts, 2001). Imbalances 
in energy regulation lead to the most common public health nutrition problems today; 
ovemutrition and undernutrition. In the economically developed world, and increasingly 
in low and middle-income countries, overnutrition, leading to obesity, is a considerable 
and increasing problem. The diseases associated with obesity are a major cause of 
morbidity and premature mortality, with high health care costs (Seidell, 2000). This 
thesis focuses exclusively on the consequences of positive energy balance and 
investigates the potential for changes in diet composition to maintain balance and prevent 
the development of obesity.
1.2.1 Obesity
In England and Wales, mean Body Mass Index (BMI) has increased steadily during the 
last 50 years and obesity (BMI>30 kg/m2) has trebled since the 1980s. In 2008 24.5% of 
UK adults were obese and 61.4% overweight (BMI>25 kg/m2) (NHS, 2009). Similar 
increases in the prevalence of obesity have been seen in Europe (Seidell, 2000). The 
United States National Health and Nutrition Examination Survey (NHANES) identified 
33.8% of adults as obese and 68% as overweight in 2007-2008 (Flegal et al.). With one 
billion people worldwide overweight and more than 300 million obese the World Health
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Organisation has described the problem as a "worldwide epidemic" (WHO, 2003). Of 
increasing concern is the development of obesity at an earlier age, particularly the 
increasing worldwide prevalence of obesity in children (Lobstein et al., 2004).
Overweight or obesity occurs when energy intake exceeds energy output and excess 
energy is stored as tri acyl glycerol in adipose tissue. Although physiological regulators 
maintain energy balance, the increasing prevalence of obesity suggests that they are 
readily overwhelmed by environmental factors. As the prevalence of overweight and 
obesity increases, the need to identify environmental influences, such as dietary factors, 
to prevent weight gain or promote weight loss has become increasingly important.
1.2.1.1 Definition and Measurement
To define obesity, the World Health Organisation recommends a classification system 
based on Body Mass Index (BMI) (WHO, 2000), calculated as body mass in kilograms 
divided by height in metres, squared (BMI = kg/m2). An adult with a BMI of 18.5 -  24.9 
kg/m2 is within the normal range, 25.0 to 29.9 kg/m2 is overweight and over 30 kg/m2 is 
classified as obese. The classification relates to the progressive increase in risk of 
morbidity and mortality from diseases such as type 2 diabetes, hypertension and coronary 
artery disease associated with an elevated BMI (WHO, 2000; Yusuf et al., 2005).
It is recognised that the measure of BMI is not a reliable measure of fatness for 
individuals. It is a useful surveillance tool to estimate the prevalence of obesity but does 
not allow for differences in body composition or adipose tissue distribution between 
different races or by gender, and may not indicate the same health risks for different
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individuals and populations. Awareness of a group of ‘metabolically normal’ obese, in 
whom BMI is elevated but metabolic profile and risk factors for metabolic disease remain 
normal, has emphasised the need to identify alternative methods for assessing overweight 
(Karelis et al., 2004).
The presence of excess adipose tissue is an indicator of risk for metabolic disease 
especially if fat is stored intra-abdominally. Measurement of waist circumference is a 
simple method of estimating abdominal adipose tissue. The WHO defined limits for waist 
circumference, which indicate a substantially increased risk of metabolic complications, 
are 102 cm for men and 88 cm for women (WHO, 2000). Higher values have been 
associated with hyperlipidaemia, impaired glucose metabolism, hypertension, endothelial 
dysfunction, elevated inflammatory profile and prothrombotic susceptibility (Despres et 
al., 2001) (Yusuf et al., 2005). The International Diabetes Federation has redefined 
central obesity as > 94 cm for men and > 80 cm for women and introduced ethnic- 
specific waist circumference cut-offs to recognise the increased risk for metabolic 
disorders with enlarged abdominal fat, and therefore higher waist circumference, and the 
increasing susceptibility of some ethnic groups to the deposition of abdominal adipose 
tissue (Alberti et al., 2005) (IDF, 2005).
A further marker of adiposity, an increased waist-to-hip ratio (waist circumference as a 
fraction of hip circumference), is defined as >1.0 in men and >0.85 in women (WHO,
2000). Despite debate over whether this ratio is as reliable an indicator of abdominal 
adiposity as waist circumference alone (Despres et al., 2001) a high waist-to-hip ratio is 
associated with obesity-related diseases and increasing cardiovascular risk (Yusuf et al.,
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2005). Including a measure of hip circumference may provide information about gluteal 
muscle mass and estimate total skeletal muscle mass. In support of measuring both waist 
and hip circumference, Heitmann et al (2004) demonstrated that a large hip 
circumference, relative to waist and BMI, protects women against cardiovascular disease 
and coronary heart disease (Heitmann et al., 2004). Measuring a ratio of waist to hip 
circumference therefore integrates the increased risk from a large waist (reflecting intra­
abdominal fat) with the reduced risk of increased hip size (due to increased lean tissue).
Imaging techniques have been used to measure intra-abdominal adipose tissue more 
accurately. Computed tomography (CT) provides the gold standard to distinguish intra­
abdominal from subcutaneous adipose tissue but the radiation exposure during a scan 
limits its widespread use. Dual-energy X-ray absorptiometry (DXA) and Magnetic 
Resonance Imaging (MRI) do not require radiation and are becoming increasingly useful 
to measure visceral adipose tissue (Clasey et al., 1999; Bertin et al., 2000; Gomi et al., 
2005) (Browning et al., 2010). These techniques are discussed in detail in Chapter 2.
1.2.2 Obesity-related diseases
Concern regarding the increasing prevalence of overweight and obesity has arisen 
because of the association with a number of risk factors for cardiovascular disease and 
chronic diseases including dyslipidaemia, hypertension, type 2 diabetes, coronary artery 
disease, obstructive sleep apnoea, gallbladder disease, osteoarthritis, breast, endometrial 
and colon cancers, and fertility problems (WHO 1998) (James et al., 2006). Most notably 
the relative risk for developing type 2 diabetes increases exponentially with an increase in 
BMI (Figure 1.2.1) (Colditz et al., 1995) (Chan et al., 1994).
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Figure 1.2.1 Body mass index and relative risk for developing type 2 diabetes 
modified from Colditz et al., 1995 and Chan et al., 1994
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Additionally, BMI is a strong predictor of mortality. In a prospective study of 900 000 
adults mortality was lowest at a BMI of 22.5-25 kg/m2. Each 5 kg/m2 increase in BMI 
above this range was associated with 30% higher overall mortality, a 40% increase in 
mortality from stroke and vascular disease (particularly due to heart failure and 
hypertension), a 120% increase in diabetes mortality, 60% increase in renal disease 
mortality, 80% increase in liver disease mortality, 10% increase in neoplastic mortality 
and 20% increase in mortality from respiratory disease. At a BMI of 30-35 kg/m2, median 
survival is reduced by 2-4 years, and at a BMI of 40-45 kg/m2 it is reduced by 8-10 years, 
comparable to the effects of smoking (Whitlock et al., 2009).
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Energy regulation and the prevention of excess gain in body mass is critical to decrease 
morbidity and mortality related to obesity. In addition, identification of those at specific 
risk of disease is important in order to attempt to reduce the development of diabetes and 
cardiovascular disease.
1.2.2.1 The metabolic syndrome
The metabolic syndrome is a cluster of features which are associated with an increase in 
the risk of cardiovascular and metabolic disease (particularly type 2 diabetes) and may be 
the first indicator of developing weight-related morbidity. The syndrome includes 
abnormalities of blood lipids, blood pressure and blood glucose metabolism with obesity, 
particularly abdominal obesity, now being recognised as a key factor.
The prevalence of the metabolic syndrome varies with age and ethnicity and is increasing 
(Eckel et al., 2005). Prevalence in the USA was reported as 24% in 2003 (Ford & Giles, 
2003) with higher rates in older age groups (44% aged 60-69 y) and amongst minority 
ethnic groups. As increasing rates are being seen in all ages it is important to identify the 
syndrome accurately to be able to identify those most at risk of developing later disease 
and determine appropriate preventative strategies.
A World Health Organisation consultation proposed a set of criteria to define the 
metabolic syndrome in 1999 as the presence of insulin resistance together with at least 
two of: raised blood pressure, hypertriglyceridaemia and/or low HDL-cholesterol, obesity 
(as measured by waist/hip ratio or body-mass index), and microalbuminuria. In 2001, the 
National Cholesterol Education Program Expert Panel on Detection, Evaluation, and
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Treatment of High Cholesterol in Adults (ATP III) defined the metabolic syndrome with 
a focus on cardiovascular risk (NHLBI, 2001). Three or more features of central obesity, 
hypertriglyceridaemia, low HDL cholesterol, hypertension, and elevated fasting plasma 
glucose defined the metabolic syndrome. A comparison of these two main definitions of 
the metabolic syndrome identified that, although the prevalence for the whole population 
is similar using either definition, 15-20% of people would be classified differently 
depending upon the criteria used (Ford & Giles, 2003).
A call for a unified definition of the metabolic syndrome led the International Diabetes 
Federation (IDF) to propose a new definition in 2004 that would reduce confusion and 
allow greater comparability between studies (Alberti et al., 2005; Eckel et al., 2005; IDF, 
2005). In this new definition, central obesity is essential for determining the metabolic 
syndrome because of the strength of the evidence linking waist circumference with 
cardiovascular disease and the other metabolic syndrome components (Alberti et al., 
2005) and the likelihood that central obesity is an early step in the aetiology of the 
metabolic syndrome. Changes in features of the metabolic syndrome over 4.5 years in a 
prospective cohort identified obesity to be the central feature of the syndrome and 
suggested the importance of obesity in the aetiology of the metabolic syndrome (Maison 
et al., 2001). While the cluster of features of the metabolic syndrome predict 
cardiovascular disease and type 2 diabetes (Isomaa et al., 2001; Laaksonen et al., 2002; 
Lakka et al., 2002; Hu et al., 2004) the importance of the link between waist 
circumference and cardiovascular disease (Eckel et al., 2005) has led to the IDF requiring 
the presence of central obesity in order for diagnosis of the metabolic syndrome. The 
criteria for the IDF definition of the metabolic syndrome are shown in Table 1.2.1.
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T a b le  1 .2.1 C r i t e r i a  fo r  th e  d iag n o s is  o f  th e  m e ta b o lic  s y n d ro m e  a c c o rd in g  to  th e  ID F  d e f in it io n
Central obesity
Waist circumference
> 94 cm for Europid men
> 80 cm for Europid women
ethnicity specific values 
for other groups
Plus any two of:
Raised triglycerides > 150 mg/dL (1-7 mmol/L)
or specific treatment for 
this lipid abnormality
Reduced HDL- 
cholesterol
< 40 mg/dL (103 mmol/L) men
< 50 mg/dL (1-29 mmol/L) women
or specific treatment for 
this lipid abnormality
Raised blood 
pressure
Systolic > 130  mm Hg 
or
Diastolic > 85 mm Hg
or treatment of 
previously diagnosed 
hypertension
Raised fasting 
plasma glucose
>100 mg/dL (5-6 mmol/L)
or previously diagnosed 
type 2 diabetes
Preventing and managing obesity therefore appear to be critical to reduce the incidence of 
diseases that arise from longstanding features of the metabolic syndrome. In the obese, 
components of the syndrome must be identified and managed.
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7.2.2.2 Glucose and insulin metabolism
In healthy subjects, glucose levels are maintained between tight limits. After a meal 
insulin release from the pancreatic beta cells regulates glucose uptake from the blood to 
peripheral tissues. Insulin also inhibits gluconeogenesis and glycogenolysis in the liver to 
prevent glucose production in the post-prandial period. Dysfunction of beta cells and 
insulin resistance, leading to dysregulation of glucose, may occur early in the 
development of metabolic disease, and elevated glucose levels, particularly post- 
prandially, have been associated with an increase in cardiovascular risk, oxidative stress, 
endothelial dysfunction, a pro-inflammatory response and hypercoagulability (Ceriello, 
2005; Tushuizen et al., 2005).
For this reason hyperglycaemia was a key feature of the WHO diagnostic criteria for the 
metabolic syndrome (Alberti & Zimmet, 1998) and remains an important component. 
Hyperglycaemia predicts type 2 diabetes, the complications of which are a leading cause 
of morbidity and mortality, and is an independent risk factor for cardiovascular disease 
(Ceriello, 2005), (Gerstein, 1997). In the UKPDS a reduction in complications from 
diabetes was shown when glycated haemoglobin (a measure of advanced glycation end- 
products which reflect glucose levels over the preceding 6-8 weeks) was lowered, and 
blood glucose measured 2 hours after a 75 g oral glucose load was seen to be a better 
predictor of all cause mortality than fasting glucose (UKPDS, 1998).
In a similar manner mild hyperglycaemia (within non-diabetes limits) has been associated 
with an elevated risk of cardiovascular disease and is increasingly being recognised as an 
important risk for developing metabolic disease. The DECODE study group identified the
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importance of post-prandial hyperglycaemia in 18,048 men and 7,316 women from 13 
prospective European cohort studies. Abnormalities in 2 hour glucose concentration after 
a 75g oral glucose load predict mortality more accurately than fasting glucose, and 
mortality is increased with an elevated 2 hour glucose at any level of fasting glucose 
including those within the normal range (DECODE, 1999). A meta-analysis of 20 studies 
involving more than 95 000 people identified a continuous increase in cardiovascular risk 
with post-prandial hyperglycamia, including normal glucose levels (Coutinho et al., 
1999). Identifying dietary factors that may curtail the rise in post-prandial glucose may 
therefore reduce the risk of cardiovascular disease and mortality.
1.3 Dietary determinants of body mass
The foregoing evidence illustrates the need to attempt to achieve and maintain a healthy 
body mass to prevent the development of obesity, and to reduce metabolic risks to limit 
the burden of disease in those currently obese. This thesis focuses on dietary strategies, as 
they are widely applicable, low in cost, relatively straightforward to implement and 
provide an important foundation for the maintenance of energy balance.
1.3.1 Characteristics of meals and eating patterns
The energy density of foods has an important role in energy regulation and increases in 
dietary energy density are associated with a higher energy intake (Johnson et al., 2009). 
Energy density (kJ/g) is the amount of energy (kJ) in a given weight of food (g). Fat has 
the highest energy content per gram (37kJ/g) (compared with carbohydrate, 16 kJ/g and 
protein which provides 17 kJ/g) so a higher proportion of fat in a meal increases its
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energy density and has been associated with increased total energy intake (Rolls et al., 
2005). Experiments with volunteers show that foods which have a higher energy density 
increase consumption of total energy at the meal while low energy-dense food eaten at 
the start of a meal, such as a salad (Rolls et al., 2004), or water added to a meal (Rolls et 
al., 1999), reduce total energy intake (Rolls et al., 2005).
Portion size is another factor that may predispose to obesity. When larger portions are 
offered in an experimental setting, more food is consumed and individuals do not report 
differences in satiety with increased food intake (Ello-Martin et al., 2005). Moreover, 
there is incomplete compensation in energy intake at subsequent meals after 2 days of 
increased portion size (Ledikwe et al., 2005; Rolls et al., 2006) or when portion sizes 
were increased over 11 days (Rolls et al., 2007). Whether portion size has an effect on 
long-term energy intake remains to be determined.
Frequency of eating has also been linked to weight control but the evidence is 
inconsistent. In observational studies more frequent eating episodes are associated with 
lower body weight, however it is likely that the nature of food consumed at each episode 
is the most important factor in determining the effect of eating episodes on energy 
regulation (Drummond et al., 1996).
The evidence for a relationship between dietary components and obesity is limited by the 
multifactorial nature of eating behaviour and food intake in humans, and confusion 
generated by under-reporting of energy intake which is higher in overweight and obese 
individuals (Livingstone & Black, 2003; Rennie et al., 2005). If total energy intake is
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under-reported, it is assumed that other nutrients are also underestimated so that 
identifying a nutrient-specific role in the development of obesity is difficult. Dietary 
patterns have been explored to investigate whether a broader group of food or nutrients 
may be more closely associated with obesity. Diets high in fat or sugar and low in fibre 
have been associated with obesity, while a change to a diet lower in fat and sugar and 
high in fibre over 10 years resulted in a reduction in BMI in obese women and less 
increase in BMI in lean women (Newby et al., 2006). In children, high fat, low fibre, 
energy dense dietary patterns are associated with an increase in fat mass and linked to 
excess gain in body mass (Johnson et al., 2008).
1.3.2 Macronutrient regulation of energy intake
The macronutrient composition of the diet may have a specific effect on appetite, and 
hence energy intake. Satiety appears to be linked to the ability to store or utilize dietary 
energy and so macronutrients that are tightly regulated have more effect on subsequent 
energy intake and energy balance (Stubbs et al., 1995a; Jebb et al., 1996). There is 
limited ability to store protein, and protein oxidation is closely linked to protein intake 
(Jebb et al., 1996, Shetty, 1994 #568). Conversely, the ability to store fat is large, and 
there appears to be almost no autoregulation between fat intake and fat oxidation, leading 
to fat storage when intake is in excess (Prentice, 1995). Protein and carbohydrate (which 
> also has well regulated substrate oxidation) may therefore exert more control over energy
regulation than fat.
Traditional recommendations for weight control or weight loss promote high- 
carbohydrate, low-fat diets. These diets provide a reciprocal change in the proportion of
58
carbohydrate and fat, while protein remains unchanged. The focus on reducing fat intake 
has developed from short-term experimental studies which have demonstrated that 
increasing the proportion of energy from dietary fat increases hunger and total energy 
intake (Rolls et al., 1994; Stubbs et al., 1995a). Reducing dietary fat (by increasing 
carbohydrate) over six months has been shown to reduce weight gain and increase weight 
loss (Saris et al., 2000; Saris, 2003; Astrup, 2006). A meta-analysis of 16 intervention 
studies identified a 3.2 kg greater weight loss in subjects following a low-fat diet even 
when energy intake was not intentionally restricted (Astrup et al., 2000). The proposed 
mechanism for the weight loss effect is the lower energy density of the fat-reduced diet, 
so that this diet provides more food volume and weight for less energy, and hence greater 
satiating effect than a higher-fat diet. It is has also been proposed that individuals 
susceptible to obesity have an impaired ability to rapidly adjust fat oxidation in response 
to increasing the dietary fat content, therefore a diet lower in fat may be beneficial 
(Astrup, 2006). However, the degree of weight loss demonstrated in this meta-analysis 
does not persist in studies over a longer period. In the Women's Health Initiative Dietary 
Modification Trial, a low-fat, high-carbohydrate diet resulted in weight loss of 2.2 kg in 
the first year, reducing to 0.4 kg after 7.5 years (Howard et al., 2006) although this was 
not statistically different from the control group. However, a clear dose response effect 
between fat reduction and weight loss evident in the post-hoc analysis, strongly suggests 
that the lack of an overall long-term effect is the result of poor compliance.
A recent study investigating the long term (2 year) effect of four diets: low-protein, low- 
fat; high-protein, low-fat; low-protein, high-fat; and high-protein, high-fat in 811 
overweight adults did not demonstrate a difference between diet groups in 2 y weight loss
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or change in waist circumference (Sacks et al., 2009). Limited long-term compliance was 
undoubtedly a factor in the inability of this trial to differentiate between the four diets. 
Attendance at diet counselling sessions was strongly associated with weight loss, 
suggesting that those who followed the prescribed diet were successful at weight loss. 
Dietary goals were only partly achieved, differences in macronutrient intake were small 
and the intended reduction in energy intake was not sustained, making it difficult to draw 
conclusions of the specific impact of macronutrient composition.
In contrast, a similar 2 year study in 322 obese subjects investigated the effect on weight 
loss of three diets: low-fat, low-energy; Mediterranean, low-energy; low-carbohydrate, ad 
libitum’, providing information about diets in a workplace cafeteria rather than relying on 
counselling sessions for dietary instruction. Weight loss was achieved in all three groups, 
with greater reduction in the Mediterranean diet group (4.4 kg) and the low-carbohydrate 
group (4.7 kg) than the low-fat group (2.9 kg) (p<0.001) (Shai et al., 2008).
Traditionally most research has focussed on fat and carbohydrate content while keeping 
the percent of total energy from protein constant. Because the proportion of total energy 
from protein is comparatively low and protein intake over time has remained relatively 
constant there has been an assumption that protein was unlikely to exert significant 
influence over total energy intake. Newer research indicates that increasing the protein 
content at the expense of fat and carbohydrate might offer a way to increase the satiating 
and thermogenic effect of diets, and facilitate weight loss and maintenance. Experimental 
evidence that protein is more satiating than carbohydrate or fat (Poppitt et al., 1998) has 
recently been accompanied by data from clinical trials examining the potential benefit of
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protein in short and long-term energy intake and weight regulation (Raben et al., 2003; 
Weigle et al., 2005). Protein has higher diet-induced thermogenesis and may additionally 
influence weight regulation through effects on energy expenditure (Westerterp-Plantenga 
et al., 1999). A meal high in protein may also help to reduce post-prandial glycaemic 
excursions and so have beneficial effects on metabolic disease risk. There is therefore a 
need for a fundamental understanding of the role of protein in energy metabolism, 
including energy intake, energy expenditure, and metabolic risk and to explore some of 
the underlying mechanisms. The role of dietary protein on these factors is the focus of 
this thesis.
1.4 Protein requirements
Protein requirements are based on estimates of the amount of high-quality egg or milk 
protein (which are completely digestible) required for nitrogen equilibrium. Additional 
allowances for times of increased growth (infants, children, pregnancy, lactation) are 
included in the recommendations and are calculated to ensure adequate weight gain or 
growth, a suitably positive nitrogen balance, and the maintenance of a state of well-being 
(COMA, 1991). The recommended daily intake for protein is presented in Table 1.4.1. In 
a 70 kg male this intake of 53 g protein per day is equivalent to 11% of an 8000 kJ diet. 
The recommendations assume that the dietary protein intake includes sufficient variety of 
protein-containing foods or sufficient high-quality animal protein to provide for 
indispensable amino acid (LAA) requirements. Previous studies in the UK have indicated 
that the average household consumes a diet containing adequate amounts of LAA (Buss & 
Ruck, 1977) and no further recommendations on the type of protein to be consumed were 
considered necessary. If diets contain a considerable amount of unrefined cereal grains
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and vegetables a correction for digestibility of 85% should be applied.
The Committee on Medical Aspects of Food (COMA) recognises that there are a number 
of areas of uncertainty in the recommendations for protein intake. Maintenance needs for 
protein are based on achieving nitrogen equilibrium in nitrogen balance studies. These 
needs equate to about 70 % more than the minimum rates of nitrogen loss in individuals 
fed a protein-free diet. It is not understood why there is such a large discrepancy in this 
excess of requirements over minimum needs, however it is possible that miscellaneous 
losses are not adequately accounted for or calculated correction factors are incorrect. 
Dietary amino acids regulate growth, development and body function and may therefore 
be important in determining protein requirements, particularly in times of rapid growth, 
and may account for the excess of requirements above minimum needs.
The committee however expressed concern over high-protein intakes because of the 
potential for excessive protein to impair renal function. While acknowledging that there 
is little evidence to support this theory in healthy individuals with normal renal function, 
an upper limit of 1.5g protein/kg/d was suggested. In a 70 kg person this fraction equates 
to 105 g protein per day or 22% of an 8000 kJ diet.
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Table 1.4.1 Recommended daily allowance of protein based on recommendations from the 
Committee on Medical Aspects of Food (COMA)
( C O M A ,  1 9 9 1 ) .
Age Weight
kg
Reference Nutrient Intake 
g/d
Infants and children 
0-3 months 5.9 12.5
4-6 months 7.7 12.7
7-9 months 8.8 13.7
10-12 months 9.7 14.9
1-3 years 12.5 14.5
4-6 years 17.8 19.7
7-10 years 28.3 28.3
Males 
11-14 years 43.0 42.1
15-18 years 64.5 55.2
19-50 years 74 55.5
50 + years 71 53.3
Females 
11-14 years 43.8 41.2
15-18 years 55.5 45.4
19-50 years 60.0 45.0
50 + years 62.0 46.5
Pregnancy + 6
Lactation 
0-6 months + 11
6+ months + 8
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The focus of the recommendations is based on maintaining equilibrium or replacing 
losses. There is no consideration as to whether protein may have other functions in the 
regulation of body mass or whether there is an optimal level of protein consumption for 
weight maintenance or glucose metabolism.
1.5 Mechanisms for the effect of protein on energy regulation
1.5.1 Protein and satiety
Protein has the potential to act at all stages of the satiety cascade to reduce immediate and 
subsequent food intake. Satiety measured after high-protein preload meals has been 
demonstrated to be higher than after isoenergetic fat or carbohydrate meals, and in some 
preload studies has been associated with a reduction in energy intake. The importance of 
satiety over a longer period in a free-living environment was illustrated by Weigle et al 
(Weigle et al., 2005). 19 subjects were placed on a weight-maintaining diet (15% protein, 
35% fat, and 50% carbohydrate) for 2 weeks, followed by an isoenergetic diet (30% 
protein, 20% fat, and 50% carbohydrate) for 2 weeks, and an ad libitum diet (30% 
protein, 20% fat, and 50% carbohydrate) for 12 weeks. Satiety was markedly increased 
during the isoenergetic high-protein diet. The enhanced satiety translated into a reduction 
in energy intake once ad libitum consumption of the high protein diet commenced. 
Reduced energy intake was maintained until the end of the 12-week period with a mean 
reduction in energy of 1.8 ± 0.3 MJ/day. This implies that the benefit of increased protein 
in body weight is primarily achieved through appetite control mechanisms.
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1.5.2 Protein and gastric emptying
One mechanism by which protein may regulate energy intake is to slow gastric emptying 
and thereby increase satiation and prolong satiety. Gastric emptying was investigated in 
eight subjects with type 2 diabetes who consumed a soup drink prior to a meal, with the 
soup or meal or neither containing additional whey protein. Gastric emptying was slowest 
when whey was added to the soup drink (Ma et al., 2009). Park et al (2007) (Park et al., 
2007) assessed gastric emptying using scintigraphy after subjects consumed diets 
containing 2.1 MJ additional protein, fat, or carbohydrate, compared to a standard diet, 
over a two week period. No difference in the rate of solid meal emptying was observed 
after a standard labelled egg meal. In two studies, gastric emptying was measured after 
preloads of whey and casein using an oral dose of 1500 mg of paracetomol. Plasma 
paracetamol levels can be measured as a marker of the rate at which the paracetamol and 
preload meal is emptied from the stomach. Hall et al (2003) (Hall et al., 2003), 
demonstrated an initial rapid gastric emptying after casein than whey, but subsequent 
slower gastric emptying after the casein preload. In this study, lower energy intake and 
greater satiety were measured after meals containing whey compared to casein which 
may be accounted for by the initial delay in gastric emptying resulting in increased 
satiety. Bowen et al (2006) (Bowen et al., 2006c) found no difference in gastric emptying 
between whey and casein preloads but gastric emptying was slower after the protein 
preloads than after glucose and lactose preloads. A reduction in energy intake and satiety 
was also present after the protein preloads compared to the glucose preload consistent 
with the theory that delayed gastric emptying increases satiety and reduces subsequent 
energy intake.
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1.5.3 Protein and gastrointestinal hormones
Hormones released from the gastrointestinal tract in response to food or metabolic signals 
have an important role in the regulation of food intake (see section 1.1.1.3). Stimulating 
anorexigenic hormones and inhibiting orexigenic hormones may be a mechanism for the 
increased satiety effects of protein.
1.5.3.1 Ghrelin
When liquid preloads differing in carbohydrate and protein were given to 19 overweight 
subjects, plasma ghrelin levels were suppressed for a longer period after a protein drink 
than after glucose, suggesting reduced action of the orexigenic pathways stimulated by 
ghrelin. Decreased energy intake at a subsequent meal was also seen after the protein 
drink (Bowen et al., 2006b). In contrast measurements of blood ghrelin in 14 subjects 
showed that post-prandial release increased after fat and protein meals, and decreased 
after a high-carbohydrate meal, despite an associated increase in satiety (Erdmann et al.,
2004). Ghrelin concentrations were not suppressed during 24 hours of increased protein 
intake in a calorimeter (Lejeune et al., 2006) or during 16 week weight loss diets (Moran 
et al., 2005) (Weigle et al., 2005) but decreased in proportion to weight loss and fasting 
glucose levels.
Ghrelin concentration is low when insulin levels are high immediately after a meal and it 
is possible that post-prandial insulin levels may mediate an apparent macronutrient effect 
on ghrelin release (Erdmann et al., 2004). However the prolonged suppression of ghrelin 
after a meal occurs when insulin concentration has returned to baseline (Bowen et al., 
2006b) suggesting an effect independent of insulin. The pattern of release of ghrelin in
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response to meals is inconsistent and the interaction with insulin, satiety and long-term 
energy intake requires clarification.
1.53.2 GLP-1
Macronutrient composition appears to influence GLP-1 release and may mediate the 
differences in satiety seen in response to various experimental meals. In 12 lean women 
consuming a high-protein diet (30% of energy as protein) compared to a diet comprising 
10% of energy as protein for four days, higher post-prandial concentrations of GLP-1 
were observed after the high-protein diet. Additionally enhanced satiety was associated 
with the increase in GLP-1 levels. (Lejeune et al., 2006). In contrast, Batterham et al 
found no difference in GLP-1 levels after test meals comprising 65% of energy from 
protein, 64% of energy from fat or 66% of energy from carbohydrate with protein 
comprising 17% of energy in the latter two meals (Batterham et al., 2006). Protein type 
has also been investigated for an effect on GLP-1. When meals containing whey or casein 
protein were provided to human subjects GLP-1 release was 65% higher after 
consumption of whey, the form of protein that was found to be the most satiating (Hall et 
al., 2003).
1.5.3.3 PYY
Batterham et al (Batterham et a l, 2006) have proposed that PYY is a critical factor in 
protein-induced satiety and its role in regulation of body weight. In the crossover study 
described above, high-protein meals produced the greatest increase in PYY in human 
volunteers. It is interesting to note that the test meals chosen contained a proportion of 
protein that exceeded standard intake or conventional ‘high’ protein diets. To further
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investigate the PYY response, mice were fed high (40%) and low (15%) protein meals. 
Post-prandial release of PYY was increased after the high-protein diet and enhanced PYY 
synthesis and secretion was observed after 16 weeks of ad libitum feeding on the high 
protein diet. In a second group of mice the PYY coding region was deleted. These mice 
developed marked obesity which was reversed by exogenous PYY, suggesting the 
importance of PYY in energy homeostasis.
1.5.3.4 CCK
CCK levels have been shown to increase in response to a protein load. Hall et al, 2003 
identified an increase in CCK after whey protein meals compared with casein associated 
with enhanced gastric emptying (Hall et al., 2003). Higher CCK secretion was similarly 
seen after whey in comparison to casein, glucose and lactose and was correlated with 
satiety but not energy intake (Bowen et al., 2006b). CCK may therefore mediate the 
satiating properties of dietary protein but as is seen in other preload studies enhanced 
satiety may not translate into effects on long-term energy regulation.
1.5.3.5 PP
Stimulation of PP has been observed in response to protein meals in adults (Tomita et al., 
1989) due in part to increased circulating levels of amino acids (Schmid et al., 1989). 19 
obese children provided with a low (0.2 g/kg) and high (2.0 g/kg) protein meal 
demonstrated enhanced post-prandial secretion of PP after the high-protein meal (581 
pg/ml) than the low-protein meal (302 pg/ml) (Zipf et al., 1983). Neural and other 
endocrine factors appear to contribute to the release of PP (Karhunen et al., 2008) as is 
evidenced by a higher concentration of blood PP after sham fed meals high in protein
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compared to meals high in carbohydrate (Witteman et al., 1994).
1.5.4 Protein and energy expenditure
Protein may also modulate energy regulation by increasing energy expenditure, so 
favouring weight loss. The success of the Atkins diet (the popular high-protein, low- 
carbohydrate, high-fat diet) has been attributed to weight loss occurring because of a 
‘metabolic advantage’ from the combination of reduced digestible energy, increased diet- 
induced thermogenesis, enhanced macronutrient oxidation, and loss of energy in the form 
of ketones (Atkins, 1998). There is little direct evidence for these effects; however, 
enhanced weight loss in clinical trials of high-protein diets (Samaha et al., 2003) or 
maintenance of weight loss (Westerterp-Plantenga et al., 2004) is reported to occur 
without a measured difference in reported energy intake. This failure to account for 
weight loss through reduced energy intake may be in part due to misreporting of food 
intake, but may also support the theory of enhanced energy expenditure with an increased 
protein to energy ratio.
Protein may influence energy expenditure by increasing one or all of the components of 
24-hour energy expenditure -  basal metabolic rate, diet-induced thermogenesis, and 
activity-induced energy expenditure. Differences in absorption of protein compared with 
other macronutrients, and effects on substrate oxidation may also be factors that affect 
energy balance and therefore weight regulation.
Diet-induced thermogenesis (DIT) was 17% higher after a high-protein meal (32% of 
energy from protein) than after meals rich in fat or carbohydrate (12% of energy from
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protein) (Raben et al., 2003) and repeated elevations in DIT have been observed when a 
high-protein diet is consumed throughout a single day (Westerterp et al., 1999). However 
these effects cannot be clearly linked to an increase in total energy expenditure or 
sleeping metabolic rate over 24 hours (Westerterp et al., 1999) probably because in 
humans DIT is quantitatively a small proportion of total energy expenditure. After 4 days 
following a high-protein diet, healthy overweight subjects showed a significant increase 
in DIT that was associated with a 3% increase in 24 h energy expenditure, suggesting 
adaptation had occurred that further increased energy expenditure (Mikkelsen et al., 
2000; Lejeune et al., 2006). Effects on energy expenditure differed with protein type, 
with increased energy expenditure on diets high in animal versus vegetable protein 
(Mikkelsen et al., 2000).
Changes in energy expenditure may contribute to changes in body mass in people eating 
high-protein diets but are unlikely to account for the difference entirely. Weight lost over 
six months in intervention studies was approximately 4 kg greater in subjects eating the 
high-protein diet than in those eating a diet with adequate protein (Foster et al., 2003; 
Samaha et al., 2003). The absolute difference in total energy expenditure in the above 
studies range from 0.24 MJ/d to 0.49 MJ/d which would produce a 43.7 MJ to 89.2 MJ 
energy deficit over six months. Assuming body mass lost comprises 75-80% as fat and 
20-25% as lean tissue, a deficit of approximately 29 MJ is required to lose 1 kg. 
Therefore 1.35 kg to 2.75 kg over six months could be accounted for by energy 
expenditure based on the difference in 24-hour energy expenditure seen in these studies. 
In longer, community-based interventions, increasing dietary protein has not produced a 
i significant effect on total energy expenditure in subjects with hyperinsulinaemia
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(Luscombe et al., 2003), or on BMR and DIT in subject with type 2 diabetes (Luscombe 
et al., 2002), or on BMR during weight maintenance after weight loss (Westerterp- 
Plantenga et al., 2004).
1.5.4.1 Nutrient absorption
All macronutrients except fibre-rich carbohydrates are well absorbed after ingestion, 
although protein has a lower proportion of digestible energy (91%) compared to fat 
(96%) (Southgate & Durnin, 1970). This difference in absorption is a small percentage 
of total energy consumed so does not produce a clinically significant effect on energy 
balance (Prentice, 1995). For example if protein provides 15% of energy from an 8 
MJ/day intake, total energy comprises 1.2 MJ of protein of which 1.09 MJ (91%) is 
absorbed. Increasing the proportion of energy from protein to 30% results in 2.4 MJ 
intake from protein. With this increase in the proportion of energy from protein, an extra 
0.11 MJ/day would not be absorbed, leading to a 19 MJ deficit over six months. Using 
the above calculation, this decrease in energy intake would result in 0.65kg weight loss in 
six months that could be attributed to lower nutrient absorption. This quantity is 
insufficient to account for more than a fraction of the observed weight loss in clinical 
trials.
1.5.4.2 Substrate oxidation
Substrate oxidation occurs in a clear hierarchy inversely related to the ability of the body 
to store macronutrients (Jebb et al., 1996). Carbohydrate is stored as glycogen and 
because there is limited capacity for glycogen storage oxidation is tightly regulated to 
intake. Similarly, protein has few sites for storage and protein oxidation is also well
71
regulated (Shetty et al., 1994). In contrast, fat is easily stored in adipose tissue and little 
regulation occurs when fat intake alters. Metabolic fuel selection was investigated in 6 
lean men who overate (16.5 MJ/d) or underrate (3.5 MJ/d) for 12 days while confined in 
a whole-body calorimeter. Carbohydrate intake dominated substrate oxidation with tight 
autoregulation such that carbohydrate balance was re-established after 2-4 d of energy 
imbalance, despite large differences in intake. Protein was less well regulated. Oxidation 
of protein increased during overfeeding and decreased during underfeeding but protein 
balance was not achieved during the 12 days of investigations. Conversely, fat oxidation 
occurred in a reciprocal manner to intake, dependent on the need to maintain 
carbohydrate balance. During overfeeding, fat oxidation fell rapidly from baseline in the 
first few days, suppressed by the increase in carbohydrate oxidation. In contrast, fat was 
required to be the major oxidative fuel during underfeeding, and fat oxidation was 
substantially higher than intake throughout (Jebb et al., 1996). The counterregulation of 
fat oxidation, due to the dominance of carbohydrate in the oxidative hierarchy, leads to 
fat storage and weight gain when fat is consumed in excess (Prentice, 1995). Studies to 
date have investigated diets with a standard intake of protein (15% of energy) and the 
effect of altering the proportion of protein on metabolic fuel selection is not known.
1.6 Protein and energy regulation in human studies
The foregoing evidence suggests a number of plausible mechanisms by which protein 
affects energy regulation and body mass. The predominant mechanism is likely to be due 
to an effect on appetite and energy intake, and studies investigating this relationship are 
discussed below. Energy expenditure appears to increase after a protein rich meal, 
however there remains uncertainty about whether this effect persists in the long-term or is
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of sufficient magnitude to make a meaningful difference to energy balance.
1.6.1 Studies of high-protein meals in a preload design
A number of studies have investigated the satiating properties of protein using a preload 
design as summarised in Table 1.6.1. There is a suggestion from these data that when 
comparing macronutrient preloads, high-protein (P) meals reduce hunger and subsequent 
energy intake to a greater degree than isoenergetic high-fat (F) or high-carbohydrate (C) 
meals (Barkeling et al., 1990; Porrini et al., 1995; Poppitt et al., 1998; Vozzo et al., 
2003). For example, a 12% reduction in energy intake was observed 90 min after a 2 MJ 
high-protein preload lunch (60% P, 20% C, 20% F) compared to a high-carbohydrate 
meal (11% P, 68% C, 19% F) (Poppitt et al., 1998), and 4 h after a 2.6 MJ lunch energy 
intake was similarly reduced by 12% with a high-protein meal (43% P, 37% C, 22% F) 
compared to a high-carbohydrate lunch (10% P, 69% C, 22% F) (Barkeling et al., 1990). 
A 12 % difference in energy intake over 7 h of ad libitum eating was observed after a 
high-protein preload yoghurt drink (29% P, 44% C, 24% F) compared to a high- 
carbohydrate drink (14% P, 60% C, 24% F) (Vozzo et al., 2003). Larger effects on 
energy intake have been seen after whole-food meals or liquid preloads when protein 
provided a high-proportion of energy (24% reduction in energy intake with a 71.5% 
protein drink (Latner & Schwartz, 1999), 46% lower energy intake after a 56% protein 
meal (Porrini et al., 1995)). Oesch et al. (2005) found total energy intake (of a preload 
and subsequent test meal) was reduced by 19% with a protein preload (containing 98% 
protein, 912 MJ), compared to a water control, and was reduced by 27% with the addition 
of an intraduodenal infusion of fat (Oesch et al., 2005). The protein preload significantly
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reduced the eating time at the test meal which may have accounted for the reduction in 
energy intake.
Other studies have failed to show an effect on energy intake with differences in preload 
macronutrient composition. Stubbs et al. (1996), provided meals high in protein (59% of 
energy as protein), carbohydrate (61% of energy as carbohydrate) and fat (57% of energy 
as fat) to 6 men resident in a calorimeter in a crossover study (Stubbs et al., 1996). Meals 
were whole foods presented in a similar way to a standard meal and were of similar 
energy density. No difference in energy intake was seen at the following meal or over the 
whole day but hunger scores were lower after the high-protein meal was consumed. 
However the small number of subjects suggests this study may have been statistically 
underpowered. In a similar design Raben et al. (2003) provided 20 lean male and female 
subjects with whole food meals rich in protein, carbohydrate, fat or alcohol with the same 
energy density and fibre (Raben et al., 2003). In the high-protein meal, protein provided 
31.8% of energy, more than twice the recommended proportion of protein but lower than 
that used in other preload studies. The protocol illustrates the difficulty in obtaining a 
higher percentage of energy from protein without using modified food. Neither energy 
intake at a subsequent meal or satiety following the meal differed between the meals. 
However, it is notable in these studies that the meals were of the same energy density 
(Stubbs et al., 1995b, Raben, 2003 #23) and fibre (Raben et al., 2003), perhaps 
suggesting that the impact of protein on satiety is not independent of other dietary factors.
Preload studies therefore suggest that an increase in the proportion of protein enhances 
satiety and, have in some experimental settings, led to a subsequent reduction in energy
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intake at the next meal or over course of day. A possible explanation for the discrepancy 
between macronutrient effects on satiety and subsequent energy intake is the complex 
interaction between behaviour and physiological control of appetite. While innate 
physiological signals may indicate the onset of satiation, they may need to be strong to 
overcome other learnt behaviours such as energy consumed during a meal (Poppitt et al., 
1998).
75
Ta
bl
e 
1.6
.1 
Si
ng
le 
M
ea
l 
Pr
elo
ad
 
St
ud
ie
s
£ 'n
£  &\e ^
co c  CL|C ^*“ * co
CU O52 a  e
kb coJ3
*- oJ3
&
O
"o ^R  « j— <L)
3JSMO
W)c3
C £
u
I  -  £  «
U u u
00 _
00 U.
r-r-
o or-


1.6.2 Protein-rich diets and long term energy regulation
Popular weight loss programmes have in part fuelled the debate regarding the optimal 
level of protein consumption and whether protein intake is important in long-term weight 
regulation. Increasing the proportion of protein is a component of many popular diet 
plans. Perhaps the most prominent of these has been the Atkins diet (Atkins, 1998), 
where the main focus is restricting carbohydrate with fat and protein intake being 
significantly higher than average intakes. Anecdotal reports of enhanced weight loss have 
been attributed to a variety of proposed mechanisms, including effects on energy intake 
and expenditure. The widespread adoption of these diets among people with obesity and 
metabolic disease led to randomised controlled intervention studies aiming to determine 
their efficacy and safety.
When the Atkins diet was adopted by community-based free-living obese subjects with 
either minimal dietary advice (n = 63) (Foster et al., 2003) or regular dietary instruction 
(n = 132) (Samaha et al., 2003), weight loss was greater in the Atkins group after 6 
months (-7.0% ± 0.8 vs. -3.2% ± 0.7 (minimal advice) and -4.5% ± 0.8 vs. 1.44% ± 0.2 
(regular advice) but was not sustained at 12 months (Figure 1.6.1) (Stern et al., 2004). 
The early weight loss was not explained by a reported difference in energy intake 
suggesting either differential mis-reporting of energy intake between groups or an 
intrinsic effect of the diet on energy expenditure. As with other low-carbohydrate diets, 
triglycerides were reduced but there was no other significant difference in risk factors for 
the metabolic syndrome or cardiovascular disease.
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Figure 1.6.1 Community-based free-living studies of low-carbohydrate diets showing weight loss over 
12 months
a) with minimal intervention (Foster et al, 2003) and b) with regular dietary instruction in severely obese 
subjects (Samaha et al, 2003, Stem et al, 2004). Asterisks indicate a significant difference (p<0.05) 
between the groups.
a)
Low carbohydrate diet 
Conventional diet
Months
b)
Dfi
Low carbohydrate diet 
■«— Conventional diet
-10
Months
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A recent systematic review demonstrated that low-carbohydrate Atkins-type diets (and 
hence high protein diets) were more effective at reducing weight and improving 
cardiovascular disease risk (assessed by favourable effects on high-density lipoprotein 
cholesterol, triacylglycerols and systolic blood pressure) than low fat, low energy diets 
over 6 months. Additionally, low-carbohydrate, high-protein diets were at least as 
effective than low-fat diets up to 1 year (Hession et al., 2009).
A number of controlled dietary intervention studies have explored the effect of increasing 
the proportion of protein in the diet with modest reductions in fat and carbohydrate rather 
than the very large reduction in carbohydrate seen in Atkins-type diets. In a group of 65 
overweight and obese subjects who were randomly assigned to a high-protein (25% of 
energy as protein), high-carbohydrate (12% of energy as protein) or control group for six 
months, with all food provided by a study supermarket, weight loss was greater in.the 
high-protein group (8.7 kg Cl 7.3-11.9 kg) than the-high carbohydrate group (5.0 kg Cl 
3.6-6.4 kg). Blood triacylglycerols and fatty acids were also reduced in the high-protein 
group (Skov et al., 1999). A similar design was extended to twelve months in 50 
overweight and obese subjects. After 12 months, weight loss was not significantly 
different (high protein 6.2 kg Cl 3.8-8.6, high carbohydrate 4.3 kg Cl 2.2-6.4), but the 
high protein group had a 10% greater reduction in intra-abdominal adipose tissue and 
17% had lost more than 10 kg. None of the control group achieved this degree of weight 
loss (Due et al., 2004). In a second study 100 women were assigned a 5.6 MJ/day high- 
protein (34% of energy from protein) or high-carbohydrate diet (17% of energy from 
protein) for twelve weeks. Weight loss was not significantly higher in the high-protein 
group (7.6 ± 0.4 versus 6.9 ± 0.5 kg). The high-protein diet had a beneficial effect on
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reducing triacylglycerol concentrations and weight loss was associated with similar 
improvements in fasting LDL-cholesterol, HDL-cholesterol, glucose, insulin, free fatty 
acid, and C-reactive protein concentrations in both groups (Noakes et al., 2005). A 
further 12 week ad libitum high-protein diet of 30% protein, 20% fat, and 50% 
carbohydrate produced a significant reduction in energy intake with a 4.9 kg weight loss 
and lower adipose tissue mass (3.7 kg) (Weigle et al., 2005).
The long-term weight maintenance effect of a high-protein diet was investigated in 130 
obese subjects who were assigned a high-protein (30% of energy from protein) or 
conventional (15% of energy from protein) diet for a 4-month period of weight loss 
followed by 8 months of weight maintenance. After 4 months the high-protein group had 
lost 22% more adipose mass than the conventional group although weight loss did not 
differ between the groups. At 12 months, in the group of subjects who had achieved 
greater than 10% weight loss (and were therefore felt to have had better compliance to 
the study diet), the change in weight was greater in the high-protein group (-16.5 kg) than 
in the conventional group (-12.3 kg) and a greater reduction in adipose mass was 
observed. Additionally there were fewer dropouts in the high protein diet group and 
greater reduction in triacyglycerols than the conventional diet (Layman et al., 2009).
In the Diet Obesity and Genes study (DiOGenes), the largest study to date, 773 adults 
who had lost at least 8% of their body weight during a low calorie diet were randomised 
to one of 5 ad libitum dietary interventions to prevent weight regain over 6 months. The 
diets were low protein with low or high glycaemic index or high protein with low or high 
glycaemic index, or a control diet. The diets high in protein or low in glycaemic index
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had lower drop outs than the low protein high glycaemic index group, and weight regain 
was 0.93 kg lower in high protein than low protein diets (Larsen et al., in press).
These studies suggest a beneficial effect of high protein diets on weight loss, and possibly 
on weight maintenance, although to date the maximal effect on body mass occurs at 
around 6 months possibly due to compliance to the study diet. Additionally there appears 
to be beneficial effects on a number of metabolic risk factors, most notably reductions in 
fat mass and tri acyl glycerol levels.
1.7 Protein and metabolic risk
>3?
1.7.1 Effect on nutrient partitioning
Changing the ratio of protein to energy intake has the potential to alter nutrient 
partitioning and therefore body composition. Animal models have shown that increasing 
dietary protein delays weight gain and reduces the proportion of adipose gained (Klaus,
2005). An improvement in body composition with a reduction in the proportion of 
adipose mass has been shown in human studies with additional dietary protein in energy 
restricted diets (Layman et al., 2005), (Layman et al., 2003), during ad libitum eating 
(Westerterp-Plantenga et al., 2004), (Weigle et al., 2005) and is seen in habitual 
consumers of high-protein diets (Merchant et al., 2005) (see also section 4.1.2.1).
Changes in body composition associated with an increase in dietary protein may be due 
to a reduction in adipose mass or sparing of muscle protein, or both. A reduction in post­
prandial insulin after a high-protein meal may promote lipolysis and hence reduce
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adipose mass. Additionally increased dietary protein reduces nitrogen losses associated 
with energy restricted diets and muscle protein synthesis is maintained (Layman et al., 
2003). Adiposity, particularly intra-abdominal adiposity, is associated with an increased 
risk of cardiovascular disease and is essential to the diagnosis of the metabolic syndrome 
(Eckel et al., 2005). Altering the ratio of lean-to-adipose tissue during weight loss or 
weight maintenance may therefore have long-term health benefits.
1.7.2 Glucose and insulin metabolism
The effect of protein on blood levels of glucose and insulin has been investigated to 
explore whether different post-prandial responses may be associated with differences in 
subsequent energy intake. Fluctuating levels of glucose and insulin stimulate hunger, 
particularly when there is a period of hypoglycaemia following a high-glucose peak 
(Bray et al., 1998). An increase in the post-prandial insulin AUC reflects the secretion of 
insulin in response to high post-prandial glucose and has been associated with reduced 
satiety (Holt & Miller, 1995). Stabilising post-prandial glucose and insulin levels could 
therefore lead to a reduction in post-meal hunger and subsequent energy intake. Post­
prandial hyperglycaemia is also an important component of the metabolic syndrome and, 
as discussed previously, is associated with an increase in the development of type 2 
diabetes, cardiovascular disease and mortality.
Raben et al, 2003 (Raben et al., 2003) demonstrated that glucose and insulin curves are 
significantly lower after a high-protein meal than after a carbohydrate-rich meal, and are 
similar to high-fat meal. The effect of high-protein diets on glucose metabolism were 
investigated over a longer period using a five-week crossover design in which eight men
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with untreated type 2 diabetes were provided with a diet high in protein (30% P, 20% C, 
50% F) or a control diet (15% P, 55% C, 30% F). Mean 24 h serum glucose at the end of 
the high-protein diet was 7 mmol/1 compared to llmmol/1 after the control diet. Glycated 
haemoglobin was also reduced after the high-protein diet (Gannon & Nuttall, 2004).
Although post-prandial or mean 24 h glucose is reduced after a high-protein diet 
compared to diets high in carbohydrate, it is difficult to ascertain whether the glucose 
lowering effect is due to an intrinsic property of protein or secondary to the reduction in 
carbohydrate. As current dietary guidelines for people with or without diabetes 
recommend a diet high in carbohydrate, recognising that replacing protein for 
carbohydrate produces beneficial effects on glucose metabolism is perhaps more 
clinically important then the underlying mechanism.
1.7.2.1 Regulators o f glucose homeostasis -  IGF-I, cortisol,
Other metabolic factors influenced by a high-protein weight maintenance diet may 
regulate post-prandial glycaemia, in particular elevations in growth hormone and Insulin 
like growth factor-1 (IGF-I), and urinary cortisol associated with elevated 
adrenocorticotropic hormone (ACTH) (indicating that the increased cortisol release is 
determined by pituitary or hypothalamic action) (Nuttall et al., 2003). IGF-I has emerged 
as an important determinant of glucose homeostasis (Sandhu et al., 2002) and may 
therefore potentially have a role in stabilising post-prandial glucose excursions with 
subsequent effects on appetite. More than 90% of IGFs in the circulation are bound to 
IGF-binding proteins (IGF BPs) mainly IGF BP-3. Circulating IGF-I levels are largely 
determined by genetic factors and age but are also affected by gender, physical activity,
87
diet and nutritional status (Yu & Rohan, 2000). Changes in glucose metabolism, which 
occur during diets differing in protein content, may therefore be partially mediated by 
alterations in IGF-I or its predominant binding protein, IGF-BP3.
1.7.3 Blood lipids
High-protein diets are associated with a reduction in blood triacylglycerols and an 
increase in HDL cholesterol, particularly in the setting of very low-carbohydrate, high- 
fat, and high-protein (Nordmann et al., 2006), (Foster et al., 2003), (Samaha et al., 2003), 
(Stern et al., 2004) (Noakes et al., 2005; Volek et al., 2005). As individuals in these 
studies often lost more weight following the low-carbohydrate diet, it was unclear 
whether reduced body mass was the main cause of any changes in blood lipid levels. In 
118 subjects, randomised to an energy restricted low-carbohydrate diet (4%, 35%, and 
61% of energy as carbohydrate, protein, and fat, respectively) or a low-fat diet 46%, 
24%, and 30% of energy as carbohydrate, protein, and fat, respectively), designed to 
ensure similar weight loss in the two groups over 1 year, subjects in the low-carbohydrate 
group had a greater decrease in blood triacylglycerol and an increase in HDL cholesterol. 
Concerningly an increase in LDL cholesterol was apparent. As high LDL may be 
associated with an increase in cardiovascular disease risk, questions remain regarding the 
safety of a high-protein, low-carbohydrate, low-fat diet. (Brinkworth et al., 2009).
In a comparison between a high-protein diet (30% of energy from protein) and a control 
diet (15% of energy from protein) when both were low in fat (30% of energy from fat), 
130 subjects were randomised to one of the diets for a 4 month period of energy 
restriction followed by 8 months of weight maintenance (Layman et al., 2009). Subjects
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consuming the high-protein diet had favourable reductions in serum triacylglycerol and 
elevations in HDL cholesterol at 4 months and at 12 months. LDL cholesterol was 
elevated at 4 months in the high-protein group but no difference remained between the 
groups at 12 months, suggesting that in the presence of low-fat intake a high-protein diet 
has beneficial effects on blood cholesterol which are not attenuated by the deleterious 
increase in LDL seen in high-fat, high-protein diets. Similar reductions in blood 
triacyglycerols have been reported in previous studies of high-protein, low-fat diets (Skov 
et al., 1999), (Layman et al., 2003).
Triacylglycerols are associated with cardiovascular events (Bansal et al., 2007) 
(Nordestgaard et al., 2007) and the promotion of atherosclerosis, therefore the reduction 
in levels observed in high-protein diets may have positive long-term effects on 
cardiovascular disease. Little is currently known about the effect of increases in the 
proportion of protein on triacylglycerols.
1.7.4 Blood pressure
Blood pressure falls with weight loss; therefore investigating the effect of a particular diet 
when weight change is the primary outcome (as in the majority of trials comparing high 
and low-protein diets) is difficult. A meta-analysis of very low-carbohydrate, high- 
protein, high-fat diets compared with low-fat diets concluded that there was no difference 
between the diets in systolic or diastolic blood pressure after 1 year (Nordmann et al.,
2006). Similarly when high-protein, low-fat diets are compared to low-protein diets blood 
pressure appears to fall as a result of weight loss independent of the diet composition 
(Brinkworth et al., 2009) However, in 60 subjects who followed either an isoenergetic
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high protein (24% of energy from protein) or habitual protein (19% of energy from 
protein) diet for 8 weeks systolic blood pressure was 5 mmHg lower in the high-protein 
group (Hodgson et al., 2006). As high blood pressure is an important risk factor for 
cardiovascular disease this finding may have important implications for the effect of 
protein on metabolic risk.
1.8 Summary
Regulation of body mass is a tightly controlled balance between energy intake and energy 
expenditure. Complex physiological processes initiated after the consumption of a meal 
control the sensations of satiation and satiety to modulate immediate food intake and 
future eating episodes. Energy expenditure may also be altered to maintain energy 
balance. Poor energy regulation is becoming an increasing problem in the developed and 
now the developing world, the predominant concern being a worldwide epidemic of 
obesity and it seems plausible that the strong biological factors that exist to regulate body 
mass may be over-ridden by social, cultural and psychological factors, resulting in energy 
imbalance. Obesity is associated with a wide range of diseases, particularly an increased 
risk of the metabolic syndrome, and a predisposition to type 2 diabetes, cardiovascular 
disease and premature death.
Dietary factors have been intensively studied to identify the specific risk factors for 
obesity and to establish dietary guidelines for maintenance of body mass and 
management of obesity. Dietary strategies to optimise energy balance must not only 
promote weight loss or weight maintenance, but must attempt to reduce obesity-related
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disease. While the type and proportion of fat and carbohydrate have been extensively 
investigated for their role in weight management and disease modification, protein has 
only recently been identified as a potential important regulator of body mass and 
metabolic risk. Current evidence suggests that diets with a high protein to energy ratio 
increase weight loss in the obese, at least in the short-term. There needs to be a clearer 
understanding of the possible mechanisms involved in order to identify whether 
promotion of a diet high in protein is an appropriate method to achieve sustained weight 
loss and thereby reduce the complications associated with overweight and metabolic 
disease.
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1.9 Aims and objectives
The aim of this thesis is to perform a detailed investigation into the relationship between 
dietary protein and body mass regulation. The specific objectives are:
• To consider the effect of protein amount and type on short-term appetite 
control using a classic preload design (Chapter 3).
• To investigate whether there is a dose-dependent relationship between 
protein consumption and energy intake in a medium-term controlled 
intervention study (Chapter 4), and explore in detail the role of protein in 
appetite control mechanisms, metabolic risk factors, and body 
composition.
• To determine the effect of protein on energy expenditure in a short-term 
highly controlled experiment (Chapter 5).
Collectively these data contribute to the evidence base to develop dietary 
recommendations for protein with respect to the prevention and management of obesity 
and associated metabolic diseases.
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2 Chapter 2 Methods
This chapter reports on the methods available for measuring appetite, energy balance, 
body composition and markers of metabolic risk and describes the selection of methods 
used in the studies for this thesis.
2.1 Facilities
The study reported in Chapter 3 in this thesis was performed at the Medical Research 
Council Human Nutrition Research Unit (HNR) and the studies reported in Chapters 4 
and 5 were conducted at HNR and the Wellcome Trust Clinical Research Facility (CRF), 
Cambridge.
HNR has specialist equipment and facilities for performing nutrition research. The 
volunteer suite contains a kitchen where all food was prepared and served and a volunteer 
lounge with facilities for relaxing, watching television, working on the internet and 
performing activities at a desk, such as crafts. A dining area provides screened off areas 
for uninterrupted private eating. Interviews, measurements and procedures were 
conducted in private rooms or cubicles. Cannulations and blood sampling were 
performed in a separate room dedicated to such procedures. A volunteer manager was 
available to help with technical difficulties and two medical practitioners and a first aid 
team were available to assist with complications with the subjects, such as fainting.
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The CRF provides facilities for a wide variety of clinical research activities, and can 
accommodate subjects staying overnight. Two room calorimeters are housed in a separate 
metabolic research area, together with a room for performing DXA scans and BOD POD 
measurements. In the studies described in Chapters 4 and 5, subjects stayed overnight at 
the CRF from the evening prior to day 1 of the study until the morning of day 5.
2.2 Measuring Energy Intake
2.2.1 Habitual dietary patterns
Habitual diet or recent changes in diet may influence energy consumed in an 
experimental period. Likewise, underlying attitudes and eating behaviour, such as 
restrained eating, may affect energy consumption. These factors must be assessed during 
subject selection and prior to an investigation period, and attempts must be made to 
reduce their effect. In the studies reported in this thesis all subjects were asked to not 
make any changes to their habitual diet prior to and during the investigations. In the study 
reported in Chapter 4 subjects were provided with a meal the night prior to 
commencement of the study to standardise baseline hunger as far as possible in order to 
avoid compensatory over-eating on the study day.
2.2.7.7 Identifying subjects who are restrained eaters
Restrained eating occurs when individuals attempt to suppress their appetite and can 
occur in people of any weight. Restrained eaters eat more after a preload meal, in 
comparison to unrestrained eaters who are able to regulate their eating and eat
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appropriately less. Additionally, restrained eaters eat more in a distressing situation than 
when calm (Lowe, 1993). Therefore, ideally restrained eaters should be excluded from 
short-term investigations involving energy intake.
There are two main questionnaires used to assess restrained eating, the Three Factor 
Eating Questionnaire (TFEQ) and the 26 item Eating Attitudes Test (EAT-26). Both have 
been designed to identify eating disorders in a clinical context but have also been used in 
research involving healthy volunteers to distinguish subjects with abnormal eating. 
Stunkard et al. (1985) proposed the TFEQ to investigate the effect of (1) cognitive 
restraint of eating, (2) disinhibition and (3) hunger in eating behaviour, particularly in 
overweight subjects or those with a psychiatric condition (Stunkard & Messick, 1985). 
They argued that disinhibition was equally important as restrained eating in conditions 
such as depression as a risk for weight gain, and high scores on the hunger section of the 
questionnaire predicted binge-eating behaviour in obesity. All three factors were 
therefore important to include in their questionnaire, particularly when assessing subjects 
who were healthy and of normal weight (see Appendix II.2.7).
The Eating Attitudes Test (EAT) was first proposed as a 40 item questionnaire to identify 
symptoms of anorexia nervosa (Garner & Garfinkel, 1979). The abbreviated 26 item 
questionnaire (EAT-26) has now been used extensively, not only in the diagnosis of 
anorexia nervosa, but also to identify normal subjects who show a tendency towards 
restrained eating (Garfinkel & Newman, 2001). Five final behavioural questions are 
aimed at determining the presence of extreme weight-control behaviours and provide an 
estimate of their frequency. It is recognised as a test with good reliability and validity,
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with sensitivity of 88% and specificity of 96% for abnormal eating (Garfinkel & 
Newman, 2001). The EAT-26 is simple to perform and was therefore suitable to use as a 
screening tool in the studies reported in this thesis. Subjects’ obtain scores between 0 and 
3 for each of the 26 questions, with a maximal score for the questionnaire of 78. Subjects 
who score above 20 are considered to need further investigation and were therefore 
excluded from these studies (see Appendix II.2.8).
22.1.2 Habitual Diet
In experimental studies, measuring the subjects’ habitual diet is important to identify 
factors which may alter hunger or fasting blood parameters the following day, such as 
over- or under-consumption, missing meals, or eating fatty or energy-dense meals. A 24 h 
recall of food consumption prior to the investigation day can identify whether the 
subjects’ diet may have been affected by any of these factors, and in a within-subject 
design the diet record may be compared between visits. A 24-h recall was used in the 
study reported in Chapter 3. Subjects were not scheduled for investigation days close to 
celebrations that involved feasting or alcohol and the previous day’s diet recall was able 
to identify any unusual eating behaviour.
In the studies reported in Chapters 4 and 5 subjects recorded their habitual diets by 
writing food diaries, a method that has been used extensively to assess eating patterns in a 
variety of research settings. Although 7-day weighed food diaries provide the most 
reliable measure of habitual diet, they are time-consuming and the accuracy of results 
may suffer from the significant burden required of subjects to weigh and record all food 
consumed. 4-day food diaries that include 2 weekdays and 2 weekend days are an
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acceptable alternative for both researchers and subjects, and household measures provide 
similar values to weighed food (Bingham et al., 1997). At HNR, food diaries have been 
developed that allow space for recording all food consumed throughout the day in 
specific time periods. An estimate of portion size is required for all food consumed, either 
by recording information from the packaging of the food, or by estimating a small, 
medium or large portion with assistance from photographs of a number of different foods 
presented in different portions. Data obtained from the diaries is coded (Price et al., 
1995) and entered into an in-house database based on McCance and Widdowson’s The 
Composition of Foods (FSA, 2002) by experienced coders at HNR. The food menu is 
separated into major food groups and subgroups from which a specific food can be 
selected and the portion size entered. Specific information about the macronutrient and 
micronutrient content of the diet can then be obtained from the details of each food held 
in the database.
2.2.2 Measuring food intake
Energy intake during the studies was measured in the metabolic suite by weighing the 
amount of food provided to subjects, then weighing the amount of food remaining after 
ad libitum consumption. Food consumed could then be converted to nutrients ingested by 
using food composition tables, as described in section 2.2.2.1. All food for the ad libitum 
meals was presented to the subjects in a similar manner. A large quantity of food was 
provided in a serving dish and subjects were able to serve their meal onto a separate 
plate. Subjects were not aware that the food they were consuming was being recorded as 
they were advised that the studies were designed to investigate metabolic responses to 
different foods, such as the response of blood parameters (see section 2.7).
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2.2.2.7 Formulation and preparation o f diets
I designed and prepared all meals provided in these studies, at HNR, using household 
ingredients. The composition of the diets was calculated on a specifically designed 
spreadsheet using data from the McCance and Widdowson tables (FSA, 2002). The 
composition of foods was taken from the tables and entered into the spreadsheet. 
Quantities of ingredients were then adjusted to provide the appropriate macronutrient 
composition. Additional ingredients, such as bran flakes, were added to ensure that 
factors, such as fibre, were kept as constant as possible. Olive oil was added to the 
preload meals in Chapter 3 to balance out the fatty acid profile, given the high 
monounsaturated fat content of the nuts and legumes meal. Egg white or milk powder 
was used where additional protein was required. Low fat dairy products or tofu were used 
when the fat content needed to be lowered while keeping the protein content high. Details 
of additional ingredients and methods used are presented in the chapters describing the 
studies.
All food was informally tested for taste and consistency prior to the studies commencing, 
and cooked meals were weighed to accurately assess energy density. In the studies 
described in Chapters 4 and 5, the water content of the meals was adjusted to keep the 
energy density as constant as possible for the same meal in spite of different 
macronutrient composition.
All ingredients were bought in local shops, in large quantities where possible, to reduce 
the variability of composition that can occur with different batches of produce. If 
possible, the meals were prepared in advance in the kitchen at HNR and stored in the
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freezer. All ingredients were weighed using scales (Sartorius type 1574, GMBH, 
Gottingen, Germany) which measure to an accuracy of 0.01 g up to 400 g and 0.02 g 
between 400 and 800 g. Food was prepared and cooked according to study protocols. 
During the study week, food was defrosted and heated according to standard protocols 
and the temperature of food about to be served was measured with a temperature probe 
(Foodcheck, ETI Ltd, Worthing, Sussex, UK). Food was therefore served hot enough to 
comply with food safety recommendations but did not exceed a safe temperature for 
consumption (65-80 °C). Fresh food was bought the day before or the day of the study 
and prepared the day it was to be consumed.
2.2.3 Measuring nitrogen excretion
Protein intake can also be estimated by measuring 24-h urine nitrogen excretion, a 
reliable biomarker used to calculate nitrogen (and hence protein) intake and oxidation 
rates (Bingham, 2003). 7-day weighed and estimated food diaries show good correlation 
between recorded protein intake and 24-h urine nitrogen excretion (Bingham, 1997) when 
subjects are in nitrogen balance, and there is no accumulation due to growth or repair of 
muscle tissue or loss due to starvation (Bingham, 2003).
In the studies reported in Chapters 4 and 5, urinary nitrogen was measured to verify that 
the experimental diets were modulating nitrogen excretion and to calculate metabolic 
protein oxidation. Subjects were confined to the metabolic suite for 4 days prior to the 
measurement, to ensure they had not experienced any muscle damage, strenuous exercise, 
excess intake or starvation, which may have interfered with the results.
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The reference method for measuring total urinary nitrogen is the Kjeldahl digestion 
method. The sample is decomposed in hot concentrated sulphuric acid to convert organic 
nitrogen to ammonium sulphate and oxidize carbon and hydrogen to carbon dioxide and 
water. Because it is time-consuming and potentially dangerous to laboratory staff, the 
Kjeldahl method has been replaced in many laboratories by the Dumas method, a safe 
and accurate alternative, with results about 1.5% higher than with the Kjeldahl method 
(Thompson et al., 2002). Total nitrogen was determined using this method by the 
Institute of Grassland and Environmental Research, Aberystwyth, Ceredigion, Wales on a 
Leco FP 428 nitrogen determinator (Leco Corporation, Michigan, USA). The analysis 
removes nitrogen by high-temperature combustion and measures it with a thermal 
conductivity detection system. The between-run coefficients of variation were 0.015%.
2.3 Measuring appetite and satiety
Subjective measures of appetite and satiety are critical to understanding the factors that 
influence energy intake and eating behaviour. It has been argued that measurements of 
satiety provide a more reliable indicator of the physiological effects of eating (Flint et al., 
2000) but a relationship between appetite ratings and subsequent energy intake is not 
always present (Raben et al., 1995).
The most commonly used method for assessing subjective appetite sensations are visual 
analogue scale (VAS) scores (Raben et al., 1995). Lines are anchored at each end by 
words expressing the most positive or negative sensations (e.g. not at all hungry/very 
hungry). The lines represent a continuum between these extremes, and subjects mark a
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point on the line which they feel corresponds to their sensation at the time. Scores are 
obtained by measuring the distance from the left end of the line to the mark.
Inter-subject variation accounts for >50% of the variance in VAS, meaning that the 
method is most suitable for within-subject comparisons (Stubbs et al., 2000b). 
Reproducibility is lowest during fasting measurements and higher for post-prandial 
measurements, particularly at 4.5 h after a meal when the role of any outlying ratings is 
reduced (Hint et al., 2000). Reproducible results can be obtained without dietary 
standardisation prior to the test day. The accuracy of detecting small differences in satiety 
has also been estimated. Using a paired design, 18 subjects completing the VAS scores 
are sufficient to detect a 5 mm difference (when using a 100 mm VAS line) in mean 
score for satiety, hunger and fullness measures, with 90% power. The sample size can be 
reduced when the study protocol is more tightly controlled, and increases significantly in 
an unpaired design or when the study design is more variable (Hint et al., 2000). The 
sample sizes in the studies in this thesis are therefore adequate to detect a significant 5 
mm difference in mean score with 80 -  90% power. As the studies were highly controlled 
within-subject repeated measure designs and VAS have been shown to predict meal 
initiation and amount eaten, and be sensitive to alterations in diet composition, 
particularly in an experimental setting (Stubbs et al., 2000b), they are suitable for use in 
the studies reported in this thesis.
VAS scores are obtained by measuring the distance from the left side of the line to the 
subject’s mark. Comparisons can be performed between the score at critical timepoints
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throughout the study, the mean score during time periods, or the AUC of the scores 
plotted against time (section 2.8).
Palatability was also measured in the study reported in Chapter 4. Standardised questions 
were used to identify differences in palatability between meals of a similar appearance 
but with different macronutrient composition in a within-subject design. These questions 
have also been reported to elicit reliable and reproducible answers in previous 
experimental studies and so are appropriate for use in this thesis (Flint et al., 2000).
2.4 Measuring energy expenditure
Energy expenditure is defined as the metabolic energy expended as mechanical work, 
biosynthesis or heat and can be measured using a number of different methods. The most 
precise is measurement by calorimetry involving whole-body measurements in an 
enclosed chamber.
2.4.1 Calorimetry
Direct calorimetry measures energy expenditure as the rate at which heat is lost from the 
body to the environment. Heat loss includes non-evaporative heat losses (radiation, 
convection and conduction) and evaporation of water (Murgatroyd et al., 1993a). Heat 
loss is adjusted by peripheral blood flow and posture but is independent of the metabolic 
processes that produce the heat, so under resting conditions, direct calorimetry is a very 
accurate measurement of energy expenditure. The measurement procedure is technically 
complex and costly and is unable to provide information about the relative contributions
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of different substrates to expenditure of energy. It is rarely used to study energy 
expenditure in humans.
Indirect calorimetry measures energy expenditure as the rate at which heat is produced in 
the body. Heat production is calculated from rates of respiratory gas exchange (oxygen 
consumption and carbon dioxide production) that occurs with oxidation of the major 
substrates: carbohydrate, fat, protein and alcohol. Although indirect calorimetry is 
expensive to perform and requires a considerable degree of expertise, it is technically 
easier than direct calorimetry and is the method of choice for measurements of energy 
expenditure and substrate oxidation (Das & Roberts, 2001).
The two calorimeter chambers used in the studies reported in Chapter 5 have 10.4 m2 
floor area and 24 m3 volume. They are comfortable bed-sitting rooms within the CRF 
with an outside window and a window to the inside research office. The rooms are 
furnished with a bed, armchair, a desk and upright chair, a television, DVD player, 
internet computers and an exercycle. A washbasin and camping toilet is provided. A 
telephone and intercom provide communication to the research staff and the outside 
world. Food enters the room through an air-lock hatch and urine collected in the room is 
passed out through a second hatch. Blood samples are taken by the subject placing their 
arm in a latex sleeve through an air-locked hole in the door.
a
Air within the rooms was circulated at 20 m /min, mixing the subject’s expired air with 
room air to produce uniform room air composition. Air temperature was kept at 23 ± 
0.5°C. Fresh air to ventilate the rooms was introduced at 200L/min and samples of the
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room air were taken at 200 s intervals. Fresh air samples were taken every 20 min, and 
every two hours calibration checks were performed. The moisture content of the samples 
was measured (Dewpoint analyser type 1100 ap, General Eastern, Watertown, MA, 
USA), before analysis of oxygen and carbon dioxide concentrations (paramagnetic 0 2  
analysers types 184 and 1440 and infra-red C 02 analysers type 1510; Servomex, 
Crowborough, UK). Data was logged onto a computer every 5 min and the room 
environment could be checked on the computer screen by the research team.
Oxygen consumption and carbon dioxide production was calculated using the expressions 
of Brown et al (Brown et al., 1984). These equations are based on the principle that for 
any gas at standard temperature and pressure:
Rate of increase of volume of gas inside the chamber 
= rate of volume flow of gas into the chamber 
+ rate of net volume production of gas by the subject 
- rate of volume flow of gas out of the chamber 
Corrections are therefore made for temperature and pressure and moisture content and the 
equations allow for analysis of rapid changes in gaseous exchange between a subject and 
the environment. The duration that subjects spent in the calorimeter was separated into 
specific time periods in order to calculate energy expenditure at rest (basal metabolic 
rate), after meals (diet-induced thermogenesis), during the night (sleeping metabolic 
rate), and for the entire 24-h period.
Calculation of substrate oxidation rates were performed using the expressions of 
Murgatroyd et al (Murgatroyd et al., 1993b), and the values for respiratory quotients and
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energy equivalents of oxygen of Elia and Livesey (Elia & Livesey, 1992). The net 
oxidation of fat, F, and carbohydrate, C, are expressed in terms of oxygen consumption, 
O2 , carbon dioxide production, CO2 , and nitrogen excretion, N:
Fat = [C 02 - R c 0 2 + (Rc - RP)VP k N]FVf(Rf- Rc) (1)
Carbohydrate = [CO2 - Rf O2 + (R f RP)VP k N]/VC(RC -R f )  (2)
where Rf Rc and Rp are the ratios of carbon dioxide production to oxygen consumption
and Vf, Vc, and Vp are the volumes of oxygen consumed per gram oxidized for fat,
carbohydrate and protein respectively. The constant, k, relates protein oxidation to 
nitrogen excretion, the protein oxidation rate being therefore k N. The values for the 
constants used in this study are Rc = 1.0, Rf = 0.71, Rp = 0.835. Vc = 0.746 L/g, V/= 2.01 
L/g, Vp = 0.952 L/g, and k = 6.25 (Elia & Livesey, 1992).
When these values are inserted into the equations the results are:
Fat = -1.7156[C02 - 0 2 + 0.9818.N]
Carbohydrate = 4.6224[C02 - 0.71 0 2  - 0.7437 N]
Protein = 6.25 N
where fat, carbohydrate and protein are measured in grams when oxygen and carbon 
dioxide are in litres and nitrogen is in grams.
2.4.2 Portable indirect calorimetry
Portable measures of energy expenditure use the principles of indirect calorimetry to 
measure the concentration differences of oxygen and carbon dioxide between inspired 
and expired air. A ventilated canopy is placed over the subject’s head. A constant flow of
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air (between 20 and 80 L/min) enters the canopy and expired air is drawn through a 
mixing chamber and passed through sensors that measure O2 and CO2 . Calculations can 
then be performed to measure resting energy expenditure. Due to the small residual air 
volumes (in comparison to a whole-body chamber), measurements of energy expenditure 
using this method may be more precise than classical room calorimetry, although 
measurements can be affected by air quality in the room or by subject movement during 
the measuring period. Measurements are limited to resting energy expenditure (basal 
metabolic rate) due to the requirement that subjects must lie still prior to and during the 
procedure. The cost of performing this procedure is significantly lower than that of 
whole-body calorimetry, and together with the short time frame to complete a 
measurement (20 -  30 min), portable indirect calorimetry provides a useful tool to 
measure resting energy expenditure when whole-body calorimetry is unavailable or 
impractical.
In the study reported in Chapter 5, resting oxygen consumption and carbon dioxide 
production, measured by using a ventilated-hood indirect calorimetry system (GEM 
Nutrition Ltd. Daresbury, Cheshire) was used to calculate resting energy expenditure at 
the start and end of each study week. The results from the first study day were used to 
calculate a predicted total energy expenditure, which provided the basis for the energy 
content of the meals prepared for each subject during the fixed energy intake day in the 
calorimeter. Further details are reported in Chapter 5.
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2.5 Measuring body composition
The variation in body composition between individuals is large, mainly due, in healthy, 
active young subjects, to differences in fat mass. Excess body fat, especially abdominal 
adiposity is an important indicator of the metabolic syndrome and a contributor to the risk 
for metabolic and cardiovascular diseases.
2.5.1 Measuring whole body adiposity
In order to measure whole body adiposity accurately a number of different components of 
body composition can be identified. The simplest model assumes that the body is 
composed of two compartments, fat and fat-free mass. This is the basis for the whole body 
density method, or estimates based on total body water. Total body water can be measured 
by isotopically labelled tracer and, by combining density and body water, it is possible to 
derive a three component model -  water, fat and dry fat free mass. Using techniques such 
as DXA to measure bone mineral allow for further separation of fat-free mass into 
minerals and protein. Body composition can therefore be separated into the four 
compartments: fat mass, total body water, minerals and protein (Jebb & Elia, 1993) 
(Deurenberg & Roubenoff, 2002).
2.5.1.1 Whole-body density
Underwater weighing has been the gold-standard method for measuring body density and 
hence body fat mass (Deurenberg & Roubenoff, 2002). The weight of a subject is 
measured in air and then while fully submerged underwater. The difference between the 
weight in air and the weight underwater calculates the body volume, once residual lung
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volume (measured) and air in the gut (assumed to be 100 ml for a fasted subject) have 
been subtracted (Jebb & Elia, 1993). This technique is very accurate and provides 
reproducible results but is limited by the ability of subjects to tolerate the procedure.
An alternative to measuring body volume underwater is to measure by air displacement. 
In the Bod Pod (Life Measurements, Inc, Concord, CA) body volume is measured in a 
sealed machine containing two chambers, separated by a diaphragm, with a known 
volume of air. The subject sits in the front chamber with the door closed and the change 
in pressure between the front and rear chambers is measured, from which the body 
volume is calculated. A predicted lung volume is used to calculate body density using the 
formula:
Body density = Mass/V£raw + 0.40 -  SAA + 40% Vtg
where V£raw = raw body volume, SAA = surface area artifact and Vtg = thoracic gas 
volume (Ball & Altena, 2004). Good agreement has been found between underwater 
weighing and air displacement, with air displacement being better accepted by subjects 
(Deurenberg & Roubenoff, 2002).
Both methods assume that the body is composed of two compartments, fat and fat-free 
mass, each with a constant density, 0.9 kg/L for fat and 1.1 kg/L for fat-free mass. 
Density is measured as the mass of the body in air divided by the volume of body tissues 
(Jebb & Elia, 1993). Once the density of the body has been determined the proportion of 
fat in the body can be calculated using Siri’s equation:
% fat = [495/body density] -  450] * 100
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Fat and fat-free mass were measured in the studies reported in Chapters 4 and 5 by the 
Bod Pod, as the most tolerable procedure to measure whole body density. A standard 
protocol was followed for each measurement. The Bod Pod was turned on and warmed 
up for 30 min, then calibrated using a 50 L cylinder. An auto run was performed to 
ensure the accuracy of the machine following calibration. Subjects were fasted and tested 
immediately after resting (after the measurement of BMR by the GEM portable 
calorimeter). Subjects were dressed in tight fitting swimwear or underwear and a lycra 
swimming cap, and all jewellery and watches were removed. Subjects entered the Bod 
Pod and were asked to sit quietly without leaning against the back wall to prevent air 
trapping. They were shown a green button which illuminates when the door is held closed 
by the magnetic latches and can be used in an emergency to release the door. Two 
measurements of body volume were taken and a third measurement was performed if the 
first two differed by more than 150 ml. Subjects were seated in the Bod Pod for 
approximately 5 min while the measurements took place. Once completed the door was 
opened and the subjects able to leave.
2.5.7.2 Dual energy x-ray absorptiometry
Dual energy X-ray absorptiometry (DXA) measures three components of the body, fat 
mass, lean mass and bone mineral (Jebb & Elia, 1993). The body is scanned with X-rays 
at two distinct levels of energy (40 keV and 70 keV) (Pietrobelli et al., 1996). The 
differential attenuation of the tissues for these two levels of radiation depends on its 
chemical composition. Software in the DXA scanning machines uses specific algorithms 
to distinguish bone mineral from soft tissue, and subsequently divides soft tissue into fat 
and lean tissue. Identification of fat mass, lean mass and bone mineral are therefore
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possible in different areas of the body, legs, trunk, spine, femur and arms, but DXA 
scanning cannot differentiate subcutaneous adipose tissue from internal adipose tissue 
depots (Deurenberg & Roubenoff, 2002).
DXA scanning involves only a small amount of radiation, particularly as newer 
technology reduces scanning time. For the whole-body scans used in this thesis, the 
radiation dose per scan was <0.4 pSv which is equivalent to less than one sixth of the 
background radiation dose received in one day.
A limitation in the use of DXA scanning is that attenuation of the X-rays depends on the 
thickness of the tissue, so that correction for body size must be made. Subjects must also 
fit within the scanning area which may be difficult for the exceptionally tall or obese. 
Some parts of the body of such subjects are left out of the scanning image; the 
calculations must be adjusted for these omissions (Jebb & Elia, 1993) (Deurenberg & 
Roubenoff, 2002). However, as subjects just need to lie still on the scanning bed, 
reproducibility of DXA is very high (between 0.5% to 2%).
In this thesis subjects were scanned using a Lunar Prodigy Advance (GE Medical 
Systems LTD, UK). Standard DXA quality control and calibration measures were 
performed prior to each testing session. Subjects were scanned in the fasted state after the 
Bod Pod measurements. Subjects were asked to remove shoes and all metal objects such 
as watches and jewellery. Subjects were then asked to lie on the DXA scanner table and 
were positioned accurately for the scanning beam and to ensure that the position was the 
same for every scan. When the scan started, the scanning arm moved over the subject to
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obtain readings for the attenuation of tissue. Subjects were asked to lie still, while 
breathing normally. Scanning took 5 to 10 minutes and the scan was analysed to 
determine fat mass, lean mass and bone mass.
2.5.2 Measuring abdominal adiposity
Imaging techniques enable an accurate assessment of individual organs, location and 
quantity of adipose tissue, and detailed imaging of muscle mass.
Computed tomography (CT) has provided the gold standard in imaging techniques, 
particularly to distinguish visceral fat from subcutaneous fat. During CT scanning, a 
source of X-rays rotates around the part of the body to be examined. Photodetectors on the 
opposite side of the source of X-rays detect the attenuation of the X-rays after they have 
passed through the body. Images of the tissues present in each cross-sectional slice are 
then generated. CT scanning is very accurate, with an error of about 1%, and the scan is 
relatively fast. However, the cost, the need for the output to be read by a trained 
radiologist, and the significant level of radiation exposure during a scan limits its 
widespread use (Deurenberg & Roubenoff, 2002).
Magnetic resonance imaging (MRI) does not involve radiation and is becoming 
increasingly used to accurately measure visceral fat (Gomi et al., 2005). A subject enters a 
cylindrical chamber which contains a strong magnetic field. Nuclei with intrinsic 
magnetic properties align themselves in the direction of the magnetic field when a radio­
frequency wave is passed through the body. When the radiowave is turned off the nuclei 
relax and emit energy that they had absorbed (Jebb & Elia, 1993). The signals emitted are
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used to generate an image of each cross-section, and accurate information about the 
tissues present at each slice is obtained. M RI scanning is more expensive than CT 
scanning and the time taken to complete a scan is considerably longer, making MRI 
impractical for general use.
Recently a new instrument has been developed to measure body composition. Quantitative 
magnetic resonance (QMR), EchoMRI uses similar principles to MRI. The differences in 
nuclear magnetic resonance properties of hydrogen atoms are used to determine fat mass, 
lean mass and free water. Precision has been reported to be as small as 0.25 -  0.5 kg and 
as a scan can be performed in less than 3 minutes this method may become the new 
standard for measuring differences in fat and lean mass (Napolitano et al., 2008).
The above methods are expensive and time-consuming, and in the case of CT scanning 
involve a significant degree of radiation exposure. A useful proxy to indicate abdominal 
adiposity is to measure waist circumference (Lean et al., 1995) (Browning et al., 2010). 
A measurement at the mid-point between the lower rib and the superior border of the iliac 
crest measures waist circumference to the nearest 0.5 cm. Measurements are complicated 
by differences in investigator technique, and the bony ‘landmarks’ being difficult to 
locate, particularly in the obese.
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2.6 Assessing metabolic risk
2.6.1 Body mass, height and BMI
All measurements were made after an overnight fast.
Weight was measured to the nearest 0.1 kg using Seca digital scales (Seca GB, 
Birmingham, UK), with subjects wearing light indoor clothing, and no shoes. Height was 
measured to the nearest 0.1 cm using a wall-mounted Seca measuring rod (Seca GB, 
Birmingham, UK). Subjects stood upright without shoes, with knees and back straight. 
Repeated measurements of height and weight over the course of the study were made 
using the same scales and measuring rod on each occasion.
Body mass index (BMI) was calculated by the following equation:
BMi = WeightM
Height (m)
2.6.2 Blood pressure
Blood pressure was measured using an automated Dinamap blood pressure monitor 
(Critikon, Dinamap PRO200 monitor, Tampa, FL, USA). Subjects were rested in the 
seated position for 5 minutes and three measurements were taken at 2 min intervals. The 
first measurement was discarded and a mean was calculated for the second and third 
readings.
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2.6.3 Blood markers of satiety and metabolic risk
Blood markers of satiety and metabolic risk, indicating presence or future risk of the 
metabolic syndrome, were recorded from venous blood samples during the studies 
reported in this thesis. In the study reported in Chapter 3, glucose, insulin, and non- 
esterified fatty acids (NEFA) concentrations were measured from fasting and post­
prandial blood samples, while in the studies in Chapter 4 and 5, fasting blood samples 
were taken for measurement of glucose, insulin, total cholesterol, triacyl glycerol, LDL 
cholesterol, HDL cholesterol, and high sensitivity C-reactive protein (hsCRP), and post­
prandial samples for measurement of glucose, insulin, ghrelin, GLP-1, PYY, PP, insulin­
like growth factor 1 (IGF-I) and insulin-like growth factor binding protein 3 (IGF-BP3).
Fasting blood samples were taken after an overnight fast during which time subjects were 
allowed to only drink water. Post-prandial samples were taken at specific timepoints as 
detailed in the protocol for each study. Samples were taken though an 18 or 20 gauge 
intravenous cannula (Vygon biovalve cannula, Laboratory Pharmaceutiques, Ecouven, 
France) inserted into a large vein in the antecubital fossa or the forearm. After insertion, 
the first blood samples were taken and the cannula was flushed with 5 -  10 ml of normal 
saline. The cannula was secured and subjects were asked to avoiding bending their arm if 
the cannula crossed the elbow joint. At each blood-sampling timepoint, 2 ml was 
removed and discarded prior to taking the sample. The cannula was then flushed with 
normal saline. If problems occurred with sampling 0.5 ml of heparin (Canusal heparin 
sodium (mucous) BP. 100 units/ml, CP Pharmaceuticals Ltd, Wrexham, UK) was flushed 
into the cannula and left until the next sampling period.
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Samples were aliquotted into monovettes (Sarstedt, Leicester, UK), which were pre­
treated with lithium heparin, fluoride, citrate, aprotinin, or a serum gel clotting activator 
as required. Samples were immediately placed on ice, with serum samples being allowed 
to coagulate first. All samples were centrifuged for 20 min at 3000 rpm at 4 °C within 1 
hour of collection. Plasma and serum samples were then aliquotted into pre-labelled 2 ml 
microtubes (Sarstedt Ltd., Leicester, UK) and stored at -80  °C until analysis.
All human samples collected during this study were processed at HNR or at the CRF, in a 
sample-processing laboratory equipped with centrifuges, class II safety cabinets and a 
urine processing cabinet.
The assays used and methods of analysis are described below. One limitation of these 
analyses is that many of the data were close to the limit of detection, defined as the 
lowest quantity of a substance that can be distinguished from the absence of that 
substance. This limit may however be lower than the limit of quantification, the level 
where the analysis precision allows for reasonable detection of the difference between 
two different values. The values close to the limit of detection may have occurred 
because samples were taken from healthy subjects with subtle changes in conditions 
which produced relatively small changes in blood analytes.
2.6.3.1 Glucose
Plasma samples were collected in monovettes pre-treated with fluoride (Starstedt, 
Leicester, UK). Samples were analysed by the Nutritional Biochemistry Laboratory 
(NBL) at HNR on the Siemens ARx clinical chemistry system (Frimley, Camberley,
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Surrey GU16 8QD). The method is an adaptation of the hexokinase-glucose-6-phosphate 
dehydrogenase method which is the generally accepted reference method for measuring 
glucose. Hexokinase (HK) catalyzes the phosphorylation of glucose in the presence of 
adenosine-5’-triphosphate (ATP) and magnesium to form glucose-6-phosphate (G-6-P) 
and adenosinediphosphate (ADP). G-6-P is then oxidized by glucose-6-phosphate 
dehydrogenase (G-6-PDH) in the presence of nicotinamide adenine dinucleotide (NAD) 
to produce 6-phosphogluconate and NADH. One mole of NAD is reduced to one mole of 
NADH for each mole of glucose present. The absorbance due to NADH (and thus the 
glucose concentration) is determined by photometry using a bichromatic (light at 
wavelengths 340 and 383 nm) endpoint technique.
All reagents, standards and consumables were those recommended and supplied by the 
manufacturer. The assay range was 0 - 27.8 mmol/1 and between run coefficients of 
variation were 2.6% at 3.24 mmol/1, 2.8% at 6.73mmol/l and 2.3% at 19.84 mmol/1.
2.6.3.2 Continuous glucose monitoring
In the studies reported in Chapters 4 and 5 interstitial glucose was measured over two 24 
h periods. Although changes in interstitial glucose lag behind those of blood glucose, the 
frequency of measurement (at 5 min intervals) allows for a more detailed investigation of 
glucose metabolism in response to changes in diet composition throughout the day.
When fitted with the continuous glucose monitoring system (CGMS (Gold) Continuous 
Glucose Monitoring System, Medtronic, UK) subjects were given full training in how to 
operate it. The sensor was inserted according to the manufacturer’s instructions, using the 
insertion device provided, and employing sterile technique. The insertion site was
116
selected as an area with adequate subcutaneous fat, most frequently the lower abdomen, 
avoiding the belt/waistline or other areas where clothing could rub or constrict, the 5 cm 
area around the navel, and any scarred or atrophied tissue. Subjects were instructed in 
how to take a finger-prick blood glucose reading using the Accu-chek Advantage system 
(Roche Diagnostics Limited, Lewes, UK). A lancet is inserted into a pen device and with 
the device held firmly against the skin a button is pressed to release the lancet and prick 
the skin. When a small drop of blood is obtained it is held up to a testing strip that has 
been inserted into the meter. Blood is automatically drawn up into the test strip and the 
meter begins to analyse the glucose measurement. Subjects were instructed in how to 
enter readings into the CGMS monitor and asked to enter 4 readings per day for 
calibration of the monitor, at any time excluding the half hour following eating. Subjects 
were also instructed in how to enter ‘events’ (i.e. food, exercise), and possible reasons for 
and what to do if the monitor alarmed. Subjects were given a simple instruction leaflet 
(Appendix II.2.10) and provided with 24-hour phone numbers for contacting both the 
chief investigator and a representative from Medtronic in case of difficulties.
2.6.33 Insulin
Plasma samples were collected in monovettes pre-treated with lithium heparin (Starstedt, 
Leicester, UK). Samples were analysed by the Clinical Biochemistry Department at 
Addenbrooke’s Hospital, Cambridge, UK, on a 1235 AutoDELFIA automatic 
immunoassay system using a two-step time resolved fluorometric assay (Kit No. B080- 
101). All reagents, standards and consumables were those recommended by the 
manufacturer. The calibrators were referenced to WHO 1st IRP 66/304.
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Cross-reactivity with intact pro-insulin is < 0.5 % at 2736 pmol/1, 32-33 split pro-insulin 
1% at 2800 pmol/1, C-peptide <0.1% at 5280 pmol/1. The limit of detection is 1.3 pmol/1, 
and the assay range without dilution is approximately 1100 pmol/1. Between batch 
coefficients of variation were 3.1% at 29 pmol/1, 2.1% at 79.4 pmol/1, 1.9% at 277 pmol/1 
& 2.0% at 705 pmol/1 (n = 174).
2.6.3.4 Ghrelin
Plasma samples were collected in monovettes pre-treated with EDTA 
(ethylenediaminetetraacetic acid) as an anticoagulant and aprotinin as an enzyme 
inhibitor (Starstedt, Leicester, UK). Samples were acidified prior to analysis at the 
Centre for Diabetes and Endocrinology, University College London. Active ghrelin was 
measured by Sandwich ELISA, which involves capture of the active form of human 
ghrelin molecules in the sample by anti-human ghrelin IgG and the simultaneous binding 
of a second antibody to ghrelin. Unbound material is washed away and the bound enzyme 
is conjugated with horseradish peroxidase. The activity of the antibody-enzyme conjugate 
is measured spectrophotometrically by increased absorbency at 450 nm. Since the 
increase in absorbency is directly proportional to the amount of captured active human 
ghrelin in the sample, the concentration of active ghrelin can be derived from a reference 
curve generated in the same assay with reference standards of known concentrations of 
human ghrelin. All reagents, standards and consumables were those recommended by the 
manufacturer.
Sensitivity of the assay at the 95% confidence limit was 25 pg/ml and the inter-assay 
coefficients of variation were 3.6% at 65.2 pg/ml and 9.3% at 397 pg/ml.
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2.6.3.5 Glucagon-like peptide-1 (GLP-1)
Plasma samples were collected in monovettes pre-treated with EDTA 
(ethylenediaminetetraacetic acid) as an anticoagulant and aprotinin as an enzyme 
inhibitor (Starstedt, Leicester, UK). Samples were analysed at the Centre for Diabetes 
and Endocrinology, University College London. Active GLP-1, (7-36 and 7-37 amides) 
was measured by an ELISA assay which captures active GLP-1 from the sample by a 
monoclonal antibody, immobilized in the wells of a microwell plate, that binds 
specifically to the N-terminal region of the active GLP-1 molecule. Unbound material is 
removed and added anti GLP-1 alkaline phosphatase conjugates to the immobilised GLP- 
1. The bound conjugate is detected by adding MUP (methyl umbelliferyl phosphate) 
which in the presence of alkaline phosphatase forms the fluorescent product 
umbelliferone. Since the amount of fluorescence generated is directly proportional to the 
concentration of active GLP-1 in the sample, the concentration of active GLP-1 can be 
derived from a reference curve generated in the same assay with reference standards of 
known concentrations of active GLP-1. All reagents, standards and consumables were 
those recommended by the manufacturer.
Sensitivity of the assay at the 95% confidence limit was 2.0 pM and the inter-assay 
coefficients of variation were 13% at 4 pM and <1% at 76 pM.
2.6.3.6 Peptide tyrosine tyrosine (PYY)
Plasma samples were collected in monovettes pre-treated with EDTA 
(ethylenediaminetetraacetic acid) as an anticoagulant and aprotinin as an enzyme 
inhibitor (Starstedt, Leicester, UK). Samples were analysed at the Centre for Diabetes
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and Endocrinology, University College London. Total PYY was measured by an enzyme 
immunoassay using an antibody to PYY and a labelled antigen. Horse radish peroxidase 
(HRP) labelled streptoavidin (SA) is added to form HRP labelled streptoavidin-
biotinylated anti gen-anti body complex. HRP enzyme activity is determined by 3,3’,5,5’-
Tetramethylbenzidine (TMB) and the concentration of human PYY is calculated. All 
reagents, standards and consumables were those recommended by the manufacturer.
Sensitivity of the assay at the 95% confidence limit was 1.4 pg/ml and the inter -assay 
coefficients of variation were 5.45-10.26%
2.6.3.7 Pancreatic polypeptide (PP)
Plasma samples were collected in monovettes pre-treated with lithium heparin (Starstedt, 
Leicester, UK). Samples were analysed at the Centre for Diabetes and Endocrinology, 
University College London. PP was measured by an ELISA assay by adding the samples 
to anti-human PP polyclonal antibody and then adding a second antibody to the bound 
sample. Added horseradish peroxidase conjugates to the bound antibodies and the 
enzyme activity is measured by quantifying the antibody-enzyme conjugate 
spectrophotometrically by the increased absorbency at 450 nm. Since the increase in 
absorbency is directly proportional to the amount of captured human PP in the sample, 
the latter can be derived from a reference curve generated in the same assay with 
reference standards of known concentrations of human PP. All reagents, standards and 
consumables were those recommended by the manufacturer.
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Sensitivity of the assay at the 95% confidence limit was 12.3 pg/ml and the inter-assay 
coefficients of variation were 9.8% at 103 pg/ml and 4.9% at 128 pg/ml.
2.6.3.8 Non-esterified fatty acids (NEFA)
Plasma samples were collected in monovettes pre-treated with lithium heparin (Starstedt, 
Leicester, UK). Samples were analysed by the NBL at HNR using the Cobas FARA 
(Roche Diagnostic Ltd., Lewes, UK) using Roche reagents. The assay uses a standard 
enzymatic method based on acyl-CoA synthetase, acyl-CoA oxidase and peroxidase 
reactions. The between run total coefficients of variation were 3.1% at 1574.17 |imol/l, 
and 4.0% at 630.4 pmol/1.
2.6.3.9 High-sensitivity C reactive protein (HsCRP)
Serum samples were collected in monovettes pre-treated with a serum gel clotting factor 
(Starstedt, Leicester, UK). Samples were analysed by the NBL at HNR using the Siemens 
BN ProSpec (Siemens, Frimley, Camberley, Surrey GU16 8QD). Polystyrene particles 
coated with monoclonal antibodies specific to human CRP are aggregated when mixed 
with samples containing CRP. These aggregates scatter a beam of light passed through 
the sample. The intensity of the scattered light is proportional to the concentration of the 
relevant protein in the sample. The result is evaluated by comparison with a standard of 
known concentration.
The sensitivity of the assay was 0.175 mg/1 and the between-run coefficients of variation 
were 3.1% at 0.69 mg/1, and 3.5% at 49.5 mg/1.
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2.6.3.10 Total Cholesterol
Serum samples were collected in monovettes pre-treated with a serum gel clotting factor 
(Starstedt, Leicester, UK). Samples were analysed by the NBL at HNR using the 
Dimension Xpand Clinical Chemistry Analyser (Siemens, Frimley, Camberley, Surrey 
GU16 8QD).
Cholesterol esterase catalyses the hydrolysis of cholesterol esters to produce free 
cholesterol which, along with pre-existing free cholesterol, is oxidized in a reaction 
catalysed by cholesterol oxidase to form cholest-4-en-3-one and hydrogen peroxide. In 
the presence of horseradish peroxidase, the hydrogen peroxidase formed is used to 
oxidize N,N-diethylaniline-HCL/aminoantipyrine to produce a chromophore. The 
absorbance of this chromophore is proportional to the total cholesterol concentration and 
is measured using a polychromatic endpoint technique.
The assay range is 1.3-15.5 mmol/1 and between-run total coefficients of variation were 
3.8% at 2.41 mmol/1, 2.5% at 4.05 mmol/1 and 1.6% at 6.43 mmol/1.
Samples with higher apparent concentrations were re-assayed following dilution in 
purified water. Samples with apparent concentrations below the assay range were diluted 
1:1 in a high concentration QC material, re-assayed and if confirmed reported as <1.3 
mmol/1.
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2.6.3.11 Triacylglycerols
Serum samples were collected in monovettes pre-treated with a serum gel clotting factor 
(Starstedt, Leicester, UK). Samples were analysed by the NBL at HNR using the 
Dimension Xpand Clinical Chemistry Analyser (Siemens, Frimley, Camberley, Surrey 
GU16 8QD).
An enzymatic assay was used to measure the serum or plasma concentrations of 
triacyl glycerol. The samples are incubated with lipoprotein lipase (LPL) that converts 
triacylglycerols into glycerol and fatty acids. Glycerol kinase (GK) catalyzes the 
phosphorylation of glycerol by adenosine-5-triphosphate (ATP) to glycerol-3-phosphate. 
Glycerol-3-phosphate-oxidase oxidizes glycerol-3-phosphate to dihydroxyacetone 
phosphate and hydrogen peroxide (H2O2). The catalytic action of peroxidase (POD) 
forms quinoneimine from H2O2 , aminoantipyrine and 4-chlorophenol. The change in 
absorbance due to the formation of quinoneimine is directly proportional to the total 
amount of glycerol and its precursors in the sample and is measured by photometry using 
a bichromatic (510, 700nm) endpoint technique.
The assay range is 0.17 -  11.3 mmol/1 and between run coefficients of variation were 
7.0% at 0.847 mmol/1, 5.9% at 1.315 mmol/1, and 3.6% at 2.111 mmol/1.
2.6.3.12 High-density lipoprotein (HDL)
Serum samples were collected in monovettes pre-treated with a serum gel clotting factor 
(Starstedt, Leicester, UK). Samples were analysed by the NBL at HNR using the
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Dimension Xpand Clinical Chemistry Analyser (Siemens, Frimley, Camberley, Surrey 
GU16 8QD).
The automated HDL assay is a homogeneous method for directly measuring HDL 
cholesterol levels without the need for off-line pre-treatment or centrifugation steps. The 
reference method for the quantitation of HDL cholesterol combines ultracentrifugation 
and chemical precipitation to separate HDL from other lipoproteins, followed by 
cholesterol measurement using the Abell-Kendall assay. This method is too time 
consuming and labour intensive for use in routine analysis. Therefore most laboratories 
use an alternative method involving selective precipitation and removal of LDL and 
VLDL, followed by the enzymatic assay of HDL cholesterol in the supernatant fraction. 
A specific detergent selectively solubilises HDL and a standard enzymatic assay based on 
cholesterol oxidase and peroxidase reactions is used.
The assay range is 0.26 - 3.89 mmol/1 and between run coefficients of variation were 
7.5% at 0.93 mmol/1, 5.2% at 1.58 mmol/1, and 3.6% at 2.03 mmol/1.
2.6.3.13 Low-density lipoprotein (LDL)
LDL cholesterol was calculated from values for total cholesterol, HDL cholesterol and 
triacylglycerols using Friedewald’s formula (Friedewald et al., 1972):
LDL cholesterol = [Total cholesterol] - [HDL- cholesterol] - ([triacylglycerol]/2.2)
LDL cannot be calculated if the triacylglycerols are > 4.52 mmol/1.
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2.6.3.14 Insulin-like growth factor-1 (IGF-I)
Serum samples were collected in monovettes pre-treated with a serum gel clotting factor 
(Starstedt, Leicester, UK). Samples were analysed by the Nutrition Bone Health
Laboratory at HNR using the Immulite 1000 system.
Immulite 1000 IGF-I is a solid phase, enzyme-labelled chemiluminescent immunometric 
assay, which has 60 min incubation cycle. Because of the presence of acid-labile 
components and binding proteins, samples are pre-treated with acid to release IGF-I.
The sensitivity of the assay was 20ng/m l and the intra-assay coefficients of variation 
were 6.1% at 49 ng/ml and 5.8% at 955 ng/ml.
2.6.3.15 Insulin-like growth factor binding protein 3 (IGF-BP3)
Serum samples were collected in monovettes pre-treated with a serum gel clotting factor 
(Starstedt, Leicester, UK). Samples were analysed by the Nutrition Bone Health
Laboratory at HNR using the Immulite 1000 system.
Immulite 1000 IGFBP-3 is a solid phase, enzyme-labelled chemiluminescent
immunometric assay, which has 30 min incubation cycle.
The sensitivity of the assay was 0.1 pg/mX and the intra-assay coefficients of variation 
were 9.1% at 0.55 pglmX and 8.5% at 7.8 pglmX.
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2.7 Nature of the research
These studies were performed according to the British Sociological Association 
recommendations for covert research (BSO, 2002). Subjects were informed that they 
were participating in studies to investigate the ‘Metabolic response to different meal 
types’ for the study reported in Chapter 3 (see Appendix 1.2.1) and investigating ‘Diet 
and energy metabolism’ for the studies reported in Chapters 4 and 5 (see Appendix 
■II.2.1). As energy intake, one of the main outcome measures in these studies, was 
dependent on the subjects’ ad libitum food consumption, it was important that subjects 
were not aware that their food intake was being recorded. By attempting to focus on other 
aspects of the study, such as blood sample analysis, rather than energy intake, the 
physiological effect of the diets could more precisely be measured independent of 
psychosocial and environmental eating triggers. The use of covert research is recognised 
to present ethical and legal issues in conducting research, particularly with the ability of 
subjects to provide informed consent. It is, however, acknowledged that difficulties arise 
in research when participants change their behaviour because they know what is being 
studied, and in this situation covert research is justified.
2.8 Statistical analysis
All statistical analyses were carried out using Microsoft Excel 2000 (Microsoft 
Corporation, USA) and Stata version 9.1 (StataCorp LP, Texas, USA). Normality of 
distribution of variables was checked using quantile plots, and data were transformed to 
achieve normality where necessary. Endpoint outcome measures were compared within- 
person using a random effects model for continuous normal data. Subjects were the only
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random effect; to make the analysis within-subject, the fixed effects were the type of 
protein (in Chapter 3) and percentage of protein (in Chapters 4 and 5). Additionally, in 
chapter 4, a number of exploratory secondary outcomes were measured. Graphs of 
endpoints were examined by randomisation group to give an indication of any differing 
effects by treatment order.
The area under the curve (AUC) was calculated for a post-prandial blood tests and visual 
analogue scales. The AUC is obtained by applying the trapezoid rule: two adjacent scores 
are added together and divided by the time between when the scores were recorded. The 
values for each pair of scores are then added together to obtain the total AUC.
As post-prandial glucose levels can fall below the baseline several methods have been 
used to calculate the AUC of glucose (Figure 2.8.1) with little consensus about the ideal 
method (Brouns, 2005). Method 1 (Figure 2.8.1(a)) calculates the total AUC down to a 
blood concentration of 0. Since the area above the baseline is only a small proportion of 
total AUC, this method is less sensitive for distinguishing differences in glucose 
excursions from baseline. Methods 2 - 5  calculate the AUC from fasting to the first return 
to baseline and then calculate the area under the baseline curve in a number of different 
ways: by not calculating blood glucose values after the first return to baseline (method 2, 
Figure 2.8.1(b)), by only calculating values greater than the baseline levels (method 3 
Figure 2.8.1(c)), by using the lowest glucose concentration, rather than the fasting 
concentration as the baseline (method 4 Figure 2.8.1(d)), or by subtracting the area below 
the baseline from the AUC above the baseline (method 5 Figure 2.8.1(e)). Although the 
Food and Agriculture Organization (1998) recommend the use of method 3 to measure 
glycaemic index (Brouns, 2005) this method is not necessarily ideal for investigating
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glucose excursions after mixed meals. Glucose concentrations falling below the baseline 
may be associated with increased hunger and a subsequent increase in energy intake. A 
flatter profile may therefore be more beneficial when assessing the effect of food on post­
prandial glucose levels. In order to include the whole area of the glucose curve and to 
identify whether any differences were obtained when the area below baseline was 
subtracted from the total area, the AUC of all glucose curves in this thesis were calculated 
using methods 1 and 5.
Figure 2.8.1 Different methods to determine area under the curve (AUC)
(a) Total AUC, method 1; (b) incremental AUCcut, method 2; (c) incremental AUC, method 3; (d), 
incremental AUCmin, method 4; (e) net incremental AUC, method 5. From (Brouns, 2005).
128
3 Chapter 3 The effect of protein type on short­
term appetite and energy intake
3.1 Introduction
Protein, fat and carbohydrate exert differential effects on appetite and satiety, as 
discussed in Chapter 1. Increasing fat in the diet results in less suppression of hunger and 
greater energy intake. Dietary recommendations to reduce energy intake have therefore 
concentrated on reducing fat by increasing carbohydrate. However, protein appears to 
produce the greatest satiety and may enhance weight regulation. There has been relatively 
little attention given to the type of protein and, as different protein sources are associated 
with very different dietary patterns, it is important to refine the basic evidence linking 
protein to post-prandial satiety to inform dietary recommendations and public health 
strategies.
3.1.1 Methodological approaches
The challenge presented when investigating complex physiological processes, such as 
appetite and satiety, that are influenced to a large extent by the environment, is whether 
to replicate habitual conditions as closely as possible, or to provide a high level of control 
and focus specifically on a few physiological factors. Dietary surveys can ascertain 
habitual diet in free-living subjects and, when compared to body mass, provide an
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indicator of the effect of diet patterns on energy intake. Inferences about the satiety 
effects of a particular diet can then be made. Surveys provide valuable information about 
dietary effects in large populations but dietary reporting can be imprecise and 
complicated by confounding factors, limiting their use in small studies.
Questionnaires to assess appetite have been used in long-term intervention studies where 
the diet is well-controlled (by providing some or all of the study diet) or closely followed 
(such as through regular diet counselling sessions). The information obtained reflects 
satiety in an habitual living environment with moderate control over the diet being 
consumed, but imprecision and uncertainty about the exact diet and activity of the 
subjects remain.
Experimental research has frequently used preload studies to investigate the effect of 
single meals on hunger and satiety. A preload meal of fixed-energy content is provided to 
subjects, usually after a period of fasting, and subjects are required to consume the entire 
meal. Measurements of components of satiety follow, and may include visual analogue 
scales (as discussed in Chapter 2) and blood tests. After a fixed period of time, a second 
test meal is provided, usually an ad libitum buffet style meal in which the energy content 
of all the dishes is known. Subjects select the quantity of food they wish and are asked to 
eat until they feel comfortably full. The food selected is weighed before and after the 
meal to determine the weight of the food consumed, from which the energy of food 
ingested can be calculated. This objective measure of energy intake is taken as an index 
of ‘hunger’ or as a measure of the satiation induced by the preceding meal.
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Preload studies are highly controlled and therefore provide a valuable tool to investigate 
post-prandial properties of food. However, the experimental nature of the study design, 
with meals eaten and measurements performed in a metabolic suite, limit the translation 
of preload studies to a free-living eating environment.
Preload studies have been used to investigate the effect of macronutrients on satiety and 
energy intake (e.g. (Stubbs et al., 1996), (Poppitt et al., 1998), and the properties of 
macronutrients such as the glycaemic index of carbohydrates (Warren et al., 2003) and 
fatty acid composition of food (Westerterp-Plantenga, 2004), (Hint et al., 2003). Only a 
few studies have investigated the effect of protein type on satiety and energy intake.
Comparisons between preload studies are difficult because of variations in subject 
characteristics and study design. Studies may be performed on lean or obese subjects. 
Bowen et al (2006) argue that strategies to optimise satiety are most applicable to 
overweight subjects as a means of improving compliance with energy restricted diets 
(Bowen et al., 2006c), however studies of only the overweight or obese may not be 
relevant to a lean population or for the prevention of overweight and obesity. Preload 
meals may be provided as a standard meal with normal household ingredients (Stubbs et 
al., 1996), or as a modified food (Vozzo et al., 2003), often in liquid form (Bowen et al., 
2006c). A modified food produces a more accurate study meal because of inherent 
variations in the production and processing of standard food ingredients. Variability in 
meals due to differences in composition, such as palatability, fibre content, and energy 
density can be more precisely controlled when using modified foods. Visual appearance 
of study meals can be more comparable and differences in the composition of the meal
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are often indistinguishable to subjects (Latner & Schwartz, 1999). Modified food 
preloads are frequently presented as a liquid which does not represent the typical form in 
which food is generally consumed, so results from these studies cannot easily be related 
to a normal eating environment. Providing a preload meal in liquid form may also alter 
measurements of glucose, insulin, satiety hormones and gastric emptying due to 
interactions between the meal and receptors in the gastrointestinal tract (Bowen et al., 
2006c).
The percentage of energy provided from each macronutrient differs between studies and 
may be very different from a standard diet. For high-protein meals, the percentage of 
energy from protein is often higher than is possible to achieve with standard meals, nor 
appropriate on a long-term basis. For example Latner and Schwartz (1999) compared a 
meal containing 71.5% of energy from protein to a meal comprised of 99% of energy 
from carbohydrate (Latner & Schwartz, 1999). The total energy provided at a preload 
meal also differs. Macronutrient influences on energy intake appear to be dependent on 
meal size; a change in energy intake is more likely if more than 1 MJ of the 
macronutrient is provided (Stubbs et al., 1996; Poppitt et al., 1998) suggesting a possible 
critical threshold required to influence satiety. A high-energy preload meal may saturate 
effects on satiety and blood parameters and reduce any effect between meals (Lang et al., 
1998; Lang et al., 1999) while a low-energy preload may not alter satiety sufficiently to 
produce detectable effects on subsequent energy intake (Porrini et al., 1997).
The timing and nature of the test meal may determine whether a preload influences 
subsequent energy intake. A longer period between the preload and the test meal may
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more accurately reflect the effect of the preload on energy intake (Raben et al., 2003), 
while providing the preload and the test meals at habitual eating times replicates usual 
meals and translates more reliably to habitual eating conditions (Stubbs et al., 1996). 
Anderson et al demonstrated an increase in consumption of food at a test meal when the 
experiment was performed later in the morning (0830 versus 1 lOOh) (Anderson et al., 
2004). The sensitive moment in time to offer a test meal has been determined by the latest 
time point after a preload meal where the measured parameters remain significantly 
different {Veldhorst, 2009 #972} {Veldhorst, 2009 #1063}.
Increasing the variety of foods presented at the test meal stimulates food intake (Rolls et 
al., 1981; Stubbs et al., 2001) and there is potential for this effect to exceed the satiating 
effect of the preload meal (Lang et al., 1999).
Some studies do not provide a test meal but concentrate on measurements of satiety 
through visual analogue scales or post-prandial blood glucose and insulin levels after the 
preload meal (Nuttall & Gannon, 1990), but no information about energy intake. A 
further limitation of many preload studies is the lack of a control meal (Barkeling et al., 
1990; Poppitt et al., 1998; Latner & Schwartz, 1999) that replicates the composition of 
subjects’ habitual diet.
3.1.2 Studies of protein type in a preload design
In Chapter 1 studies with preload meals comparing protein, fat, and carbohydrate were 
described, and demonstrated that an increase in the proportion of protein in a meal 
increases satiety and, in some settings, leads to a subsequent reduction in energy intake.
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Just as the impact of carbohydrate or fat may vary with the characteristics of the food, 
e.g. glycaemic index or fibre content of carbohydrate, or fatty acid composition of fat, so 
the amino acid profile of protein or other characteristics of different protein sources may 
have a differential impact on appetite, and protein type should therefore be considered in 
more detail. In mixed macronutrient preload studies, protein is usually meat-based or a 
mixture of proteins from different sources. Comparisons between types of protein are 
limited and inconclusive. Few studies have provided whole-food meals to measure satiety 
or energy intake with different sources of protein, with most opting for modified forms of 
protein meals or drinks. Preload studies investigating the effect of different protein type 
on energy intake and satiety are presented in Table 3.1.1.
Williamson et al (2006) compared pasta meals containing chicken, mycoprotein or tofu 
with 17% of energy provided by protein (Williamson et al., 2006). The meals were 
controlled for energy density but fibre was higher in the mycoprotein meal than in the 
other two. Energy intake was significantly reduced after the mycoprotein and tofu meals 
(12.3% and 14.5% reduction respectively) compared to the chicken meal, with no 
compensation for this reduction at a subsequent meal four hours later. No difference was 
seen in the visual analogue ratings for hunger and fullness between these meals despite 
the difference in energy intake. Energy intake had previously been found to be 24% 
lower throughout the day after a meal containing mycoprotein, than a meal containing 
chicken, and 16.5% lower the following day, using self-reported weighed food diaries 
(Turnbull et al., 1993). A reduction in visual analogue ratings for prospective food 
consumption and desire to eat was seen three hours after the study meal. In this study it 
was proposed that reductions in energy intake and increased satiety sensations after
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mycoprotein consumption compared to chicken may have been due to the higher fibre 
content of mycoprotein, as fibre has been shown to enhance satiety in other preload 
studies (Hulshof et al., 1993; Delargy et al., 1997).
Modified forms of protein incorporated into soup or drinks have shown a reduction in 
energy intake at a test meal 90 minutes following whey compared to casein (Hall et al., 
2003). In contrast another study demonstrated no difference in energy intake after whey 
and casein liquid preloads (Bowen et al., 2006c) possibly due to the smaller energy 
content of the meal (1 MJ) and a longer time to the preload meal (180 min). Lang et al, 
1998, showed no difference between egg white, cow milk, pig gelatine, soy protein, pea 
protein, or wheat protein in energy intake at an ad libitum dinner eight hours after a test 
meal with a high-protein 5.2 MJ preload (Lang et al., 1998), or when the energy content 
of the preload was reduced (3.6 MJ) (Lang et al., 1999).
Subjective measures of satiety have produced conflicting results, perhaps reflecting their 
lower precision relative to objective measures of El. When 50 g of beef, chicken or fish 
were provided to 6 lean men, satiety ratings were greater after fish than other protein 
sources (Uhe et al., 1992). Uniquely, in this study subjects consumed only the protein 
source rather than a whole meal; therefore the appearance of the meals was very 
different. Longer satiety and less hunger were demonstrated after gelatine compared to 
casein in a 3.6 MJ meal (Lang et al., 1999), but not in a 5.2 MJ meal (Lang et al., 1998) 
perhaps due to a saturation effect of the higher energy meal. Hall et al (2003) measured 
energy intake and satiety in two studies with the same whey or casein preload and 
observed greater satiety after whey only in the second study, attributed to a difference in
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study population (Hall et al., 2003). Bowen et al (2006) demonstrated no differences in 
satiety scores between whey and casein after a 1 MJ liquid preload. However, this 
experiment was performed in overweight subjects who may have different responses to 
satiety scores irrespective of the preload provided (Bowen et al., 2006a).
An increase in the post-prandial insulin area under the curve (AUC) has been seen after 
soy compared to gelatine (Lang et al., 1999) and after cottage cheese compared to egg 
white, but the associated reduction in plasma glucose was not significant (Nuttall & 
Gannon, 1990). In contrast, no differences in glucose or insulin levels were demonstrated 
after protein loads of beef, chicken or fish (Uhe et al., 1992) or when comparing whey 
and casein (Hall et al., 2003, Bowen, 2006 #749)}. The effect of protein type on plasma 
glucose and insulin therefore remains to be determined.
Altering gastric emptying is one mechanism by which protein may influence appetite. 
Park et al (2007) assessed gastric emptying using scintigraphy after subjects consumed 
diets high in protein (energy from: 36%P, 40%C, 24%F), fat (energy from: 16%P, 40%C, 
44%F), or carbohydrate (energy from: 16%P, 60%C, 24%F), compared to a standard diet 
(energy from: 20%P, 50%C, 30%F), over a two week period (Park et al., 2007). No 
difference in the rate of gastric emptying of the solid meal was observed after a standard 
labelled-egg meal. In two studies whey and casein preloads were investigated using 
plasma paracetomol levels as a marker of the rate of gastric emptying. Hall et al (2003) 
demonstrated an initial rapid gastric emptying after a meal of casein, then a subsequent 
slower rate than after eating whey (Hall et al., 2003) with lower energy intake and greater 
satiety measured after whey compared to casein, suggesting that the initial slower gastric
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emptying after the whey meal reduced energy intake. Bowen et al (2006) found no 
difference in gastric emptying between whey and casein but gastric emptying was slower 
after these protein preloads than after glucose and lactose preloads (Bowen et al., 2006c). 
A reduction in energy intake and satiety was also present after the protein preloads 
compared to the glucose preload implying that altering the rate of gastric emptying may 
be an important mechanism in the relationship between protein and satiety.
Additionally, protein type may influence appetite and energy intake through post-prandial 
secretion of gastrointestinal hormones. Ghrelin secretion is reported to increase after meat 
protein and decrease after consumption of dairy proteins (Karhunen et al., 2008). In 9 
lean subjects provided with casein or whey protein liquid preloads GLP-1 secretion was 
65% higher after the whey protein than casein, and a corresponding greater satiety after 
whey was observed (Hall et al., 2003) suggesting that gastrointestinal digestion and 
absorption of different types of protein is important for their subsequent satiety effect. 
Secretion of PYY and PP after meals of different protein type is not known, however as 
protein appears to stimulate PYY (Batterham et al., 2006) and PP (Tomita et al., 1989) 
release it is possible that protein type has a role in differential secretion of these 
hormones and the subsequent satiety effects.
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3.1.3 Influence of protein type on energy balance and metabolic risk
In addition to putative effects on energy intake, there is emerging evidence that specific 
types of protein may exert differential effects on glucose control, insulin resistance and 
cardiovascular risk factors.
3.1.3.1 Nuts
Nuts provide energy, protein, fibre, essential fatty acids and certain vitamins and
minerals, and are an important diet component in many different cultures. Many are,
however, energy dense and high in fat. As evidence has emerged about the cardiovascular
benefits of eating nuts there has been concern that weight gain may be a detrimental side
effect. In fact, the data to date suggest a beneficial effect on body mass of people eating
nuts. Epidemiological data indicate that frequent nut consumption is associated with no
change or reduction in body mass (Fraser et al., 1992; Hu et al., 1998; Sabate, 2003).
Intervention studies have investigated the effect on body mass by providing a supplement
of nuts without other dietary advice. Over six months, a 1340 kJ daily supplement of
almonds produced no change in body mass but a substantial change in fatty acid intake
(which may contribute to the cardiovascular benefits of nuts) (Fraser et al., 2002a)
(Fraser et al., 2002b). In a 12-month crossover study a 6-month, 965 kJ daily walnut
supplement produced a much lower than expected weight gain for the higher energy
intake. Hollis and Mattes (2007) (Hollis & Mattes, 2007) provided a 1440 kJ almond
supplement to twenty overweight women for 10 weeks. No change in body mass or body
composition was reported and energy intake did not increase, suggesting a satiating effect
during the almond supplementation. The subsequent dietary compensation accounted for
74% of the energy contributed by the almonds. Resting metabolic rate and total energy
expenditure, measured by doubly labelled water, did not differ in subjects eating more
143
almonds. There was, however, a significant decrease in the digestibility coefficient of the 
diet, measured by faecal energy content, which accounted for a further 7% of the energy 
contributed by the almonds.
During weight loss with a low-calorie liquid diet supplemented with almonds or complex 
carbohydrates in 65 subjects Wien et al (2003) demonstrated a greater, more sustained 
weight loss in the almond-eating group over 24 weeks with a significantly lower waist 
circumference and fat mass than the carbohydrate group despite similar energy 
consumption in the two groups (Wien et al., 2003).
Diets rich in nuts have additionally been associated with a lower risk of cardiovascular 
disease. There is now strong epidemiological evidence from the Adventist Health Study 
(Fraser et al., 1992), the Nurses’ Health Study (Hu et al., 1998), the Physicians’ Health 
Study (Albert et al., 2002), and the Iowa Women’s Health Study (Ellsworth et al., 2001) 
that frequent consumption of nuts lowers the risk of fatal and non-fatal coronary heart 
disease. Several intervention studies have shown that nuts improve lipid profiles with 
normal and hypercholesterolemia (Sabate et al., 1993), (Rajaram et al., 2001), (Lovejoy 
et al., 2002), (Sabate et al., 2003), (Garg et al., 2003), (Sheridan et al., 2007). Proposed 
mechanisms for the beneficial effect of nuts on cardiovascular disease have been related 
to an increase in unsaturated fatty acid consumption, increased fibre, reductions in 
glycaemic index, increased vitamin E and magnesium and the role of arginine in 
increasing nitric oxide-stimulated vasodilatation (Rajaram & Sabate, 2007) (Hu et al., 
1998; Jiang et al., 2002).
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When investigating the risk of developing type 2 diabetes, nut consumption may also be 
beneficial. A prospective cohort study of 83,818 women in the Nurses’ Health Study, 
followed for 16 years, found an inverse association with frequency of nut consumption 
and risk for developing type 2 diabetes, with a 30 % lower risk in those who consumed 
nuts five or more times a week (Jiang et al., 2002). In established type 2 diabetes there is 
some evidence that nut supplementation improves glucose metabolism, with a greater 
reduction in fasting insulin and requirement for diabetes medication (Wien et al., 2003). 
Lower post-prandial glucose and insulin curves and reduced post-prandial oxidative 
damage have been seen following a nut preload, compared to a meal of rice or potatoes 
with added butter and cheese to match macronutrient composition (Jenkins et al., 2006).
3.1.3.2 Dairy products
The effect of dairy products on body mass remains controversial as dairy products may 
be high in fat, particularly saturated fat, which can be detrimental to weight regulation 
and cardiovascular disease risk, but have, in some observational studies, contributed to 
loss of body mass in the overweight and obese (Zemel, 2005). Epidemiological studies 
describe inconsistent relationships between intake of dairy products and weight. No effect 
of dairy or calcium intake on body weight or weight change was seen over 12 years in the 
Health Professionals Study despite those in the highest quintile of calcium intake being 
more physically active (Rajpathak et al., 2006). Moreover, men with the largest increase 
in high-fat dairy products over the study period gained significantly more weight than 
men who decreased their intake. In a similar-sized longitudinal study of 19,352 Swedish 
women BMI was higher in subjects with a low intake of whole milk and sour milk, 
cheese and butter, but lower in subjects with a low intake of low-fat milk and sour milk
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(Rosell et al., 2006). Women who maintained a higher intake of dairy products had a 
lower risk of gaining weight over the mean 8.8 y follow-up than women who decreased 
their intake. Conversely an association between cheese intake and a higher BMI was seen 
in 2064 individuals in the Hoorn Study (Snijder et al., 2007). In a comparison of two 
high-protein weight loss diets, one high in dairy protein and the other a mixed protein 
diet, there was no difference in weight loss between the two groups, or any difference in 
other metabolic parameters (Bowen et al., 2005). A recent opinion by the European Food 
Safety Authority (EFSA) concluded that a cause and effect relationship is not established 
between the daily consumption of dairy foods (milk, cheese and yoghurt) and a healthy 
body weight in children and adolescents, due to a lack of intervention studies to examine 
a causal relationship. Additionally there is insufficient data to establish a specific level or 
frequency of consumption of dairy foods associated with any specific effect on body 
weight (EFSA, 2008).
The putative benefit of dairy products is thought to be increased calcium intake, with 
possible additional benefits of milk proteins. Increased calcium intake down-regulates 
parathyroid hormone and 25-dihydroxy vitamin D [l,25-(OH2)D] and therefore reduces 
intracellular calcium. Lower intracellular calcium stimulates lipolysis and inhibits 
lipogenesis in adipocytes, thereby reducing fat mass (Zemel, 2002). In addition, 
decreased intracellular calcium concentrations may reduce blood pressure by lowering 
vascular smooth muscle tone and peripheral vascular resistance. Some milk proteins 
inhibit angiotensin-converting enzyme (ACE) activity, which may explain the 
antihypertensive effect, and may contribute to regulation of adipocyte lipogenesis 
(Shahar et al., 2007).
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The potential effect of dairy calcium on body mass has been investigated in intervention 
studies, although often in the context of energy restriction. Adding two portions of 
yoghurt to the diet of obese African-Americans over 1 y resulted in a reduction in body 
weight of 4.9 kg. Subsequently 32 obese adults were randomised to a 2000 kJ/d deficit 
weight loss diet for 6 months with standard dietary advice, a high-calcium diet, or a high- 
dairy diet. Those in the high-dairy group reduced body mass, fat mass and waist 
circumference significantly more than the high-calcium group, who reduced these 
parameters more than the standard diet group (Zemel et al., 2004). Therefore, the 
beneficial effects appear greatest when dairy products are consumed in entirety, although 
calcium supplementation may also influence body mass loss.
An effect of high calcium on body mass has not been consistently observed. In a 
comparison of two high-protein weight loss diets, one high in dairy protein and the other 
a mixed protein diet, there was no difference in weight loss between the two groups, or 
any difference in other metabolic parameters (Bowen et al., 2005). Similarly, in 54 obese 
men assigned an energy restricted diet high (1200mg/d) or low (500 mg/d) in dairy 
calcium, no difference in weight loss was demonstrated between the diets (Harvey-Berino 
et al., 2005). When the calcium was supplied in tablet form, a 1000 mg/d calcium 
supplementation compared with placebo in 100 women did not produce a difference in 
change in body mass or fat mass (Shapses et al., 2004). Recently, additional dairy 
calcium enhanced weight loss in 259 overweight people with type 2 diabetes (Shahar et 
al., 2007). A possible explanation for weight loss is due to increased fat loss in faeces. A 
short-term increase in dairy calcium did not alter 24-h energy expenditure but increased 
faecal fat and energy elimination by 350 kJ/day (Jacobsen et al., 2005).
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A beneficial effect of eating dairy products on features of the metabolic syndrome and 
cardiovascular disease is less controversial. The 10-year longitudinal Coronary Artery 
Risk Development in Young Adults (CARDLA) study showed an inverse association 
between dairy intake and development of features of the metabolic syndrome in 
overweight subjects, with a reduction in development of obesity, abnormal glucose 
homeostasis, elevated blood pressure and dyslipidaemia (Pereira et al., 2002). An 
association between a high consumption of low-fat dairy products and a lower risk for 
developing type 2 diabetes was also seen in the Health Professionals Study (each serving- 
per-day increase in total dairy intake was associated with a 9% lower risk for type 2 
diabetes) independent of body weight (Choi et al., 2005). A 24-week high-dairy weight 
loss diet improved glucose tolerance in overweight subjects compared to high-calcium or 
standard diets and modestly improved systolic blood pressure (Zemel et al., 2004). An 
association between dairy and a decrease in blood pressure (Snijder et al., 2007) and the 
diagnosis of the metabolic syndrome (Lutsey et al., 2008) has also been reported.
3.1.3.3 Soy
Most research investigating the effect of protein type on body mass and metabolic 
parameters has focused on animal rather than vegetable sources of protein such as soy. 
Studies of diets rich in soy protein have predominantly investigated serum lipids and 
other markers of metabolic risk, rather than a specific effect on weight regulation. A soy 
based energy-restricted diet in 30 obese adults who consumed either soy protein as the 
only protein source or a traditional diet of animal and plant protein for 8 weeks produced 
a similar degree of weight loss (Liao et al., 2007) and significantly reduced LDL 
cholesterol concentration, but not waist circumference or blood pressure. Similarly, 47
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overweight women, provided with either dietary counselling alone or with soy protein 
products as their main source of protein in addition to dietary counselling, over 12 weeks, 
showed no difference in weight loss, change in fat mass, waist circumference, lipid, 
glucose or insulin concentrations (St-Onge et al., 2007). Soy milk and skimmed cows’ 
milk added to an energy restricted diet, in a small study of 14 overweight women, 
produced the same degree of weight loss and loss of fat mass (Lukaszuk et al., 2007). In a 
study designed to investigate the hormonal effects of soy food and a low-fat diet, 57 
women were randomised to a very low-fat diet, a control diet or a control diet 
supplemented with soy-based foods. Subjects were not counselled to lose weight but 
small, equal amounts of weight were lost in each group over 8 weeks (Wu et al., 2005). 
In one of the only studies to show an effect of soy products on weight loss Diebert et al, 
2004, randomised 90 overweight subjects to receive lifestyle education, or a high-soy- 
protein diet with or without a physical activity programme for 6 months (Deibert et al., 
2004). Subjects in the high-soy-protein groups lost significantly more weight and had a 
greater loss of fat mass than the lifestyle education group, possibly due in part to the soy 
group being provided with a more prescriptive energy-restricted diet (and soy-based meal 
replacements) than those provided counselling alone.
The beneficial effect of soy on cholesterol is clearer. A meta-analysis in 1995 concluded 
that soy protein consumption reduced total and LDL-cholesterol by 9% and 13% 
respectively (Anderson et al., 1995). 34 of the 38 studies analysed showed a reduction in 
cholesterol and, in those studies that did not, subjects had low baseline cholesterol. These 
findings formed the basis of a health claim approved by the Food and Drug 
Administration (FDA) that ‘soy protein included in a diet low in saturated fat and
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cholesterol may reduce the risk of CHD by lowering blood cholesterol levels’ 
(http://vm.cfsan.fda.gov/~lrd/fr991026.html). This claim recommends consumption of 25 
g soy protein per day, as part of a low-saturated-fat, low-cholesterol diet, to help reduce 
risk of coronary heart disease. The mechanism for reduction in cholesterol levels is 
unclear but may be due to the oestrogenic effects of soy proteins which contain 
isoflavones and phytoestrogens (Anderson et al., 1995). A further meta-analysis 
investigated the effect of soy protein containing isoflavones (Zhan & Ho, 2005). After 
analysis of 23 trials, soy protein was associated with significant decreases in serum total 
cholesterol (by 3.77%), LDL cholesterol (by 5.25%), and tri acyl glycerols (by 7.27%) and 
significant increases in serum HDL cholesterol (by 3.03%). The change in cholesterol 
was dependent on the baseline cholesterol concentration. Reduced cardiovascular disease 
with an increase in soy intake is primarily attributable to an improvement in lipid 
profiles, however other possible mechanisms of a soy diet are reducing blood pressure 
and lowering glucose concentrations.
Yang et al (2005) investigated the effect of soy on blood pressure in a large longitudinal 
study. Women aged 40 -  70 y who consumed more than the 25g per day FDA 
recommendation had a significantly lower systolic and diastolic blood pressure than 
women who consumed less (Yang et al., 2005). They proposed that soy isoflavones 
reduce oxidative stress and inflammation and may stimulate the production of nitric oxide 
to enhance vasodilatation and hence reduce blood pressure.
Using the method to determine glycaemic index (FAO/WHO, 1998) 6 commercial 
products rich in soy (2 chocolate soy bars, soy spaghetti, 2 chocolate soy shakes and soy
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protein chips) were tested against the glucose reference in 10 subjects to investigate the 
glucose and insulin response to soy food (Blair et al., 2006). Subjects had significantly 
lower glucose and insulin excursions after consuming the test foods in comparison to 
glucose. Aall but one of the 6 foods tested (the soy protein chips) had a glycaemic index 
below 55. In a comparison of cod, cows’ milk and soy protein, von Post-Skagegard 
(2006), demonstrated a significantly lower area under the glucose curve in subjects 
consuming a soy protein meal than after cod protein, and a similar glucose response to 
milk. Insulin levels were lower after the soy than milk diets but higher than after cod (von 
Post-Skagegard et al., 2006).
3.1.4 Summary
Evidence from preload studies suggests that protein may be more satiating than other 
macronutrients but less is known about the relative effects of different types of protein. 
Certain types of protein are associated with improvements in metabolic risk factors and 
possibly regulation of body mass. Possible mechanisms include differences in post­
prandial metabolism, which may modulate both metabolic risk and, through feedback 
loops to appetite, body mass control. This study investigates, in a preload design, whether 
incorporating different protein types into a moderately high-protein meal differentially 
alters appetite and subsequent energy intake.
3.1.5 Objective
The primary objective of this study was to determine whether isoenergetic high-protein 
preloads (33% of energy from protein), based on meat, dairy, nuts and legumes, or soy or
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a preload of standard composition (15% of energy from protein), exert differential effects 
on satiety and subsequent energy intake.
The secondary objective was to make a preliminary investigation of the post-prandial 
metabolic (glucose, insulin and fatty acids), and gastric (gastric emptying) response to 
different protein sources and in comparison to a control treatment, as potentially 
important variables to explain the differences in appetite control and weight regulation 
associated with different foods.
3.2 Methods
This experiment was performed at MRC Human Nutrition Research (HNR) between July 
2005 and May 2006. The study was approved by Peterborough & Fenland Local 
Research Ethics Committee in June 2005 (Ref: 05/Q0106/37).
3.2.1 Subjects
3.2.1.1 Sample size
Prior estimates of effect size and the likely standard deviation were limited by a scarcity 
of studies using a crossover design to test various preload meals with an isoenergetic 
control. Accordingly, the sample size calculation was based on Warren et al (2003) in 
which 37 subjects were given low or high-glycaemic index breakfasts, or a control 
breakfast, in a cross-over trial (Warren et al., 2003). The effect size was based on a mean
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difference in energy intake of 10%. To detect an effect of this magnitude at a significance 
level of 0.05 and power of 80%, a sample size of 30 subjects was required.
3.2.1.2 Recruitment
Subjects were recruited from the general population in a number of different ways. A 
search was performed on the HNR volunteer database. This database contains basic 
anthropometric and medical information about volunteers interested in research to allow 
selection of potentially suitable subjects. A letter, approved by the ethics committee 
(Appendix 1.2.4), was sent to all lean healthy subjects inviting them to participate in the 
study. An advertisement (Appendix 1.2.6) was placed on a graduate university student 
email newsletter. Advertisements were also placed in local libraries, doctors’ surgeries 
and supermarkets. Information sheets were distributed through unit-wide information 
stands at Cambridge Science week, at local shopping malls, and at HNR volunteer open 
evenings. Information sheets and advertisements were also placed in the volunteer suite 
lounge for subjects who were participating in other research in the unit.
Potential subjects contacted the chief investigator to discuss the study in more detail. 
Those wishing to participate completed a brief telephone-screening questionnaire (see 
Appendix 1.2.3) to determine eligibility. Subjects were then invited to HNR. Written 
informed consent was obtained. A brief questionnaire enquired about dieting history, 
guilt associated with food, and not eating when hungry, to exclude restrained eaters. 
Body mass, height and blood pressure were measured according to the methods described 
in Chapter 2. Body mass index was calculated to ensure eligibility.
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The general practitioners of all eligible subjects wishing to participate in the study were 
informed (see Appendix 1.2.5). They were asked to contact the chief investigator if there 
was any medical reason that would prevent participation in the study. All clinically 
relevant results were reported back to the GP with the consent of the subject.
3.2.1.3 Eligibility
i
Eligible subjects were aged between 18 and 70 years. They were lean (BMI 18-25 
kg/m2), non-smokers and took no medications or had any medical conditions that 
excluded them from participating. They were willing to eat all the study meals and did 
not report any unusual or restrictive eating habits.
Subjects were excluded if they had acute or chronic medical conditions or were taking 
medications that would interfere with satiety, gastrointestinal function, or glucose 
metabolism. The oral contraceptive pill and hormone replacement therapy were allowed 
if continuous use had been for three months or longer. Subjects were also excluded if 
they were pregnant, lactating or planning to conceive, and those unable to eat all of the 
study foods (because of dietary preference, food allergy or intolerance).
Subjects were asked not to alter lifestyle factors for the duration of the study visits, to 
continue their usual diet and exercise regime and to not start or stop taking any dietary 
supplements four weeks prior to participation in the study or for the duration of the study. 
Pre-menopausal women were studied during the same phase of their menstrual cycle as 
changes in energy balance occur during the cycle, particularly an increase in energy
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intake and body mass in the pre-menstrual (late luteal) phase (Buffenstein et al., 1995) 
(Davidsen et al., 2007).
3.2.2 Study Design
The study was a five period randomised crossover of four preload meals high in protein 
and a control preload of standard protein. The predominant protein source in the high- 
protein preloads was from meat, dairy, nuts and legumes, and soy. The preload meal was 
labelled with [ l - 13C]-Octanoic acid in order to measure gastric emptying. Subjects visited 
HNR to consume each of the five preload meals. At baseline and after the preload meal 
measurements were taken of satiety, gastric emptying and metabolic responses to the 
preload. An ad libitum test meal was served three hours after the preload and the energy 
of the food consumed was calculated.
Subjects attended HNR on five separate occasions in random order, with at least one 
week between visits, on each occasion after a 12 h fast. Random allocation to each visit 
was performed using random number tables. Subjects had maintained their usual diet and 
exercise regime and had not consumed alcohol for 24 h prior to their visit. Study visits 
were scheduled away from celebrations and social engagements to prevent the study day 
being affected by unaccustomed eating or sleeping the previous day. Transport to HNR 
was by car or taxi to avoid vigorous exercise on the subject’s investigation days.
Participants were advised that they were participating in a study to investigate the effect 
of different meal types on the metabolic response to eating. The covert nature of the study 
outcome was designed to ensure that subjects did not change their eating behaviour
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because of knowing what was being studied and was conducted according to British 
Sociological Association 2002 guidelines on the use of covert research in such 
circumstances (http://www.socresonline.org.uk/info/ethguide.html).
The protocol for each investigation day is presented in Table 3.2.1. On arrival at HNR 
subjects were interviewed to ensure that were fasted, had not had any recent illnesses or 
taken any medication to exclude them from the study. They recalled their diet from the 
previous 24 h and indicated whether it diverted from their habitual diet. Body mass, 
height and blood pressure were recorded at the initial visit and body mass was measured 
at subsequent visits according to the method in Chapter 2. An intravenous cannula was 
inserted (see Chapter 2 for details). A breath test was taken 12 minutes prior to the 
preload meal and just before the preload meal was served. Three baseline blood samples 
were taken through the intravenous cannula 10, 5 and 1 minute before the preload meal. 
Visual analogue scales for appetite were completed 10 and 1 minute before the preload. 
The preload meal was served in private cubicles in the volunteer suite lounge. Subjects 
were asked to consume the entire meal within 15 minutes. They were allowed water to 
drink during the preload and throughout the study day.
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T a b le  3 .2 .1  S u m m a ry  o f  e x p e r im e n ta l  d es ig n  o f  in v e s tig a tio n  d a y s
Time (min) Blood Sample Breath Test Visual Analogue Scale
-30 Weight measured 
Questionnaire completed 
IV cannula inserted
-12 X
-10 X X
-5 X
-1 X X X
0 Preload Meal
12 X
24 X -
30 X X
36 X
48 X
60 . X X X
72 X
84 X
90 X X
96 X
108 X
120 X X X
132 X *
144 X
150 X X
156 X
160
168
180 X X X
Test Meal
192 X
204 X
210 X
216 X
228 X
240 X X
252 X
264 X
276 X
288 X
300 X X
312 X
324 X
336 X
348 X
360 X
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Breath samples continued after the preload at 12-minute intervals for six hours. Subjects 
were given a timer set to alarm every 12 minutes and a rack of labelled tubes to blow 
into. Visual analogue scales were taken at 30-minute intervals for 5 hours. Blood samples 
were taken every 30 minutes until the last sample at 180 minutes. At this time the cannula 
was removed and the ad libitum test lunch was served. The lunch was eaten in private, 
without interruption, and subjects were allowed 30 minutes for their meal. Subjects were 
asked to eat until they felt comfortably full. A palatability questionnaire was completed 
after the preload meal and the test meal.
3.2.2.1 Meals
Subjects consumed all preloads in random order on their five study visits. The 
composition of the five preload meals, one of standard protein and four of high-protein 
was calculated using UK food databases (McCance and Widdowson tables) (FSA, 2002) 
as described in Chapter 2. A summary of the meals is presented in Table 3.2.2 and details 
are shown in Appendix 1.1.
All preloads provided 2.5 MJ metabolisable energy. The standard protein preload was the 
control and contained 15% of energy from protein, 34% from fat, and 51% from 
carbohydrate. Protein sources were meat and vegetables designed to resemble usual 
protein consumption. The four high-protein preload meals were composed of 33% 
protein, 34% fat and 33% carbohydrate. Fat was held constant to minimize the impact of 
manipulations on energy density. However it was not possible to ensure all relevant 
dietary factors were standardised given the inherent differences in different sources of 
protein, for example with respect to fibre. In order to test the effect of the different
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protein types, the preloads were designed so that the predominant protein was the type 
being tested. The four protein types were meat, dairy, soy and a nuts and legumes mix. 
During recipe testing it became apparent that it was not possible to construct a suitable 
matched diet based on nuts alone because of the high percentage of fat. Adding lentils to 
the recipe provided more protein but disproportionately increased the carbohydrate level. 
In order to produce a nuts and legumes preload of the same composition as the other 
three, egg whites were added to the recipe. To provide consistency, they were then added 
to all preloads and the recipes were adjusted to equalise the macronutrient composition.
The preload meals were similar in appearance and presentation, each containing a protein 
and vegetable bake with potato topping. Ingredients other than the primary protein source 
were the same in each recipe with variation in specific quantities. Olive oil was used 
where additional fat was required in order to keep the acylated fatty acid content as even 
as possible, given the high amount of monounsaturated fat in the nuts and legumes 
preload. All ingredients were standard food items to ensure preloads resembled ordinary 
dishes. As far as possible ingredients were purchased in bulk for the entire study to limit 
variation in the food items used. The meals were prepared in the HNR volunteer suite 
kitchen following basic food hygiene standards. Meals were frozen, then defrosted and 
heated in the oven prior to each investigation day according to a standard protocol.
13One egg yolk was incorporated into all preloads as a vehicle for the C octanoic acid 
label to measure gastric emptying (see 3.2.3). The yolk was blended with the mashed 
potato topping so that an even amount of isotope would be eaten with each mouthful of 
food and measurement of gastric emptying would be consistent from the start of the meal.
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j Subjects were asked to eat the entire preload meal within 15 min at the start of the
t
experiment day. Many subjects commented that the preload meal was a large amount of 
food to eat in the morning and were not able to complete the preload in the requested 
time. Some were not able to complete the preload after 30 min at which time the plates 
and serving dishes were removed and the remaining food was weighed.
, An ad libitum test meal was provided at 180 min after the preload meal. Subjects were
offered a large plate of pizza (9.4 MJ) and a large bowl of yoghurt (3.8 MJ) from which 
they could serve their own meal. Both dishes were comprised of 15% protein, 34% fat, 
and 51% carbohydrate. The pizza had an homogenous cheese and tomato topping and 
was cut into 32 small even-sized slices. This serving arrangement reduced the likelihood 
of subjects knowing what proportion of the pizza they had consumed. Minimizing 
interaction between cognitive cues and innate appetite control mechanisms was important
!
as in a trial of the study design, one subject ate exactly half of one pizza while another ate 
a whole pizza, suggesting that eating patterns were strongly influenced by such habits, 
and would potentially be replicated in subsequent visits without following satiety cues. 
The yoghurt was full-fat strawberry yoghurt containing pureed fruit. The dishes were 
covertly weighed before and after the meal so that energy consumed could be calculated.
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3.2.3 Measurement of gastric emptying
13Gastric emptying was assessed by measuring enrichment of C in breath CO2 .
Isotopically labelled 13C is incorporated into the medium-chain fatty acid octanoate and
1 ^consumed as part of a study meal. C-octanoic acid remains bound to the solid phase of a 
meal, but after passing through the pylorus and into the small intestine is rapidly 
absorbed, released into the portal vein, transported to the liver where it is metabolised 
(Jackson & Bluck, 2005). Approximately half of the label is oxidized to 13CC>2 , which is 
released in the breath after passing through bicarbonate pools and can be measured by 
continuous flow isotope ratio mass spectrometry.
In this study 100 pi [ l -13C]-Octanoic acid was added to a beaten egg yolk, which was 
cooked until solid in a dry frying pan to ensure binding of the isotope to the yolk lipids. 
The yolk was then blended to a fine consistency so that it could be added to the preload 
and consumed at an even rate throughout the meal. To collect the breath samples subjects 
were asked to gently blow through a drinking straw into 2 x 10 ml tubes for a count of 10 
s or until water vapour appeared on the side of the tube. Breath samples were stored at 
room temperature until analysis by isotope ratio mass spectrometer.
3.2.4 Outcome measures
3.2.4.1 Energy Intake
Energy intake at the test meal was calculated from the weight of the food served minus 
that remaining.
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3.2.42 Hunger and Satiety scores
Visual analogue scales to assess hunger, feeling of fullness, nausea, and mood were 
completed immediately prior to the preload meal (-10 and -1  min) and at 30, 60, 90, 120, 
150 and 180 min, and 30, 60 and 120 min after the test meal. Participants were asked to 
place a vertical mark on a continuous 10 cm line to indicate their response to each 
question. (See Chapter 2 for detail and Appendix 1.2.7 for the questionnaire).
32.4.3 Palatability
Visual analogue scales to assess palatability of the meal were completed after the preload 
meal and the test meal (Appendix 1.2.8).
32.4.4 Blood markers o f metabolic risk and satiety
Three 10 ml baseline blood samples were taken at -10, -5 and -1 min and a further six 10 
ml post preload blood samples were taken at 30, 60, 90, 120, 150 and 180 min as 
indicated in Table 3.2.1. The samples were analysed for glucose, insulin, and non- 
esterified fatty acids.
32.4 .5  Gastric Emptying
Two 10 ml breath samples were taken 12 min and 1 min prior to the preload meal and at 
12-min intervals for the six-hour duration of the study.
32.4 .6  Data analysis
The primary outcome measure of energy intake at the test meal was compared between 
preload meal types and analysed relative to the control preload using a mixed effects 
linear regression model for a crossover study that accounts for unbalanced randomisation 
and missing data.
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Hunger and satiety ratings and palatability scores were plotted over time and were 
analysed for AUC to 300 min, AUC to 180 min (the test meal), peak score and time to 
peak score, minimum score and time to minimum score, and score at all timepoints. A 
mixed effect linear regression model was used to compare baseline and peak ratings and 
scores at 180 min. Area under the curve was plotted using two methods as discussed in 
Chapter 2 (model a included all area under the curve, model b subtracted any area below 
baseline from the area above the curve) and differences between groups was analysed 
using a mixed effect linear regression model.
Glucose, insulin, fatty acid data, were analysed for change from baseline and area under 
the curve using the same method for VAS scores.
13C enrichment values in the breath CO2 , were fitted to an established gastric emptying 
model to determine parameters for gastric emptying -  tlag, tl/2 , tlat tasc and Rmax. The 
percentage dose recovered (PDR) curves were presented to illustrate the standard 
enrichment after each preload. The time taken to reach maximal 13CC>2 excretion is the 
tlag, while the tl/2  is the time at which half of the label has been excreted in the breath. 
The latency time (tlat) is the initial delay in the cumulative 13C excretion curve and the 
ascension time (tasc) is the time between the latency time and the half excretion time. 
Rmax is the maximum rate of label excretion.
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3.3 Results
3.3.1 Subject characteristics
Thirty-two subjects were recruited from the general population. Two subjects withdrew 
from the study after completing only one visit: one withdrew due to time commitments 
and the other because of concerns raised by the media about the risks of participating in 
clinical research studies. These two subjects were replaced. Two subjects were excluded 
from the analysis after completing the procedures, one was found to have type 2 diabetes 
when the glucose samples were analysed and the other could not eat the entire preload 
meal and did not wish to eat the test meal. In total 28 subjects completed the study and 
met the eligibility criteria to be included in the analysis.
The characteristics of the study population are shown in Table 3.3.1. There were 19 
female subjects and 9 male subjects. The mean age was 43.5 y (SD 16.6, range 19 -  68) 
and mean BMI was 22.8 kg/m2 (SD 2.3, range 18 -  27.9 kg/m2). There was no difference 
between male and female subjects in age (p = 0.375) or BMI (p = 0.686) but female 
subjects had a lower systolic (p = 0.003) and diastolic blood pressure (p = 0.016) than 
male subjects. The subjects who withdrew from the study did not differ from those who 
completed.
Body mass was measured at each visit (Table 3.3.2) and there were no significant 
changes over time.
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T a b le  3 .3 .1  C h a ra c te r is t ic s  o f  th e  s tu d y  p o p u la t io n
n = 28 Unit Mean SD Range
Age y 43.5 16.6 1 9 -6 8
Body mass kg 66.3 8.65 4 5 .6 -8 5 .8
Height m 1.7 0.087 1 .51 -1 .85
BMI kg/m2 22.7 2.31 1 8 -2 7 .9
Systolic BP mmHg 113 12 83 - 135
Diastolic BP mmHg 66 10 4 7 -8 6
Table 3.3.2 Mean body mass of subjects at each visit (mean, 95% Cl)
None of the subjects changed in weight during the five visits (p=0.189).
Meal
Mean body mass 
(kg)
95% Cl
p value versus 
control
Control 67.0 63.8, 70.2
Meat 66.6 63.4, 69.8 0.105
Dairy 67.0 63.7, 70.1 0.846
Nuts / legumes 67.2 64.0, 70.4 0.442
Soy 66.9 63.7, 70.1 0.601
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3.3.2 Energy Intake
There was a significant difference in energy consumed at the test meal following the 
different preload meals (p <0.01) (Table 3.3.3). Energy intake at the test meal was 
significantly lower following the soy meal than the control meal (p = 0.02). Energy intake 
after the meat, dairy, or nuts and legumes preload was not significantly different to the 
control. Energy intake after the soy preload was significantly lower than after all other 
preloads (p = 0.005 compared to control, p = 0.02 compared to meat, p = 0.03 compared 
to dairy, p < 0.0001 compared to nuts and legumes). The highest energy intake occurred 
after the nuts and legumes preload, where energy intake was significantly higher than the 
dairy (p = 0.074) and soy (p = <0.0001) preload but was not different from the control (p 
= 0.2) or meat preload (p = 0.1) (Figure 3.3.1).
Table 3.3.3 Energy intake at the test meal after each of the preload meals
Preload meal
Mean energy 
intake at the 
test meal 
(kJ)
Mean 
difference in 
energy intake 
versus control 
(kJ)
95% Cl of mean 
difference versus 
control
p value for 
difference 
versus 
control
Control 4605 3823,5387
Meat 4706 107 -350, 563 0.647
Dairy 4560 -35 -491,422 0.882
Nuts / 
legumes
5012 381 -81, 843 0.106
Soy 4067 -540 -1000, -81 0.021*
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Four subjects did not finish the control preload, two the meat preload, two the dairy 
preload, eight the nuts and legumes preload, and four could not finish the soy preload. In 
most cases only a small amount of food was left (1 0 - 5 0  g) but for the nuts and legumes 
preload, and the soy preload, the amount of food left was, in some cases, larger. The 
mean energy intake at the preload meal is shown in Table 3.3.4. The mean intake at the 
nuts and legumes preload was significantly less than the control preload (p = 0.008) and 
the time taken to consume the preload was lower in the meat (p = 0.002) and dairy 
preloads (p = 0.004).
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T a b le  3 .3 .4  M e a n  e n e rg y  in ta k e  a t  th e  p re lo a d  m e a l a n d  th e  tim e  ta k e n  to  c o m p le te  th e  m ea l.
Preload Meal
Mean energy 
intake at the 
preload meal 
(kJ)
SD
Mean time to 
consume the 
preload meal 
(min)
SD
Control 2488 29 19.4 6.3
Meat 2491 39 16.5 3.5
Dairy 2487 49 16.7 4.1
Nuts / legumes 2410 229 19.3 6.6
Soy 2452 136 19.1 6.4
p value for 
difference 
between preload 
meals
0.02* <0.001*
When the total energy consumed at the preload and test meals was analysed (Table 3.3.5) 
energy consumed on the soy-preload day was significantly less than the control day and 
was significantly lower than all other days (p = 0.002 versus control, p = 0.04 versus 
meat, p = 0.01 versus dairy, p = 0.001 versus nuts and legumes). The highest energy 
intake on the nuts and legumes experiment day was significantly greater than the soy day 
(p = 0.001) but not the dairy (p = 0.4), control (p = 0.8) or meat days (p = 0.2). The lower 
energy intake of the nuts and legumes preload reduced the total energy intake for the day 
and reduced the difference in total daily energy intake between the protein types.
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One subject was observed packing some of the test meal to take home on the third visit 
and such confounding behaviour may have occurred on the previous two visits. When 
data from these visits was removed from the analysis there was no effect on the results 
and so this subject was kept in the group analysis.
Table 3.3.5 Mean total daily energy intake (preload meal plus test meal).
Preload Meal
Mean total 
energy intake 
(preload plus 
test meal) 
(kJ)
Mean 
difference in 
energy intake 
versus control 
(kJ)
95% Cl of mean 
difference 
versus control
p value 
versus 
control
Control 6931 6107,7756
Meat 7203 27.1 -261, 803 0.318
Dairy 7057 125 -407,658 0.644
Nuts / legumes 7275 344 -188,876 0.205
Soy 6374 -557 -1090, -25 0.040*
3.3.3 Palatability
Palatability scores differed for the preload meals although absolute differences were 
small. The control preload scored higher than all the high-protein preloads for ‘How 
sweet did you find the meal?’ (p=0.007), ‘How tasty did you find the meal?’ (pcO.OOl), 
and ‘How enjoyable did you find the meal?’ (pcO.OOl).
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The meat high-protein preload scored highest for ‘How savoury did you find the meal?’ 
(p<0.001), and ‘How satisfying did you find the meal?’ (p<0.001). The dairy preload 
scored lowest for ‘How filling did you find the meal?’ (p=0.01) and scores were slightly 
higher in response to the question ‘How much more of this food do you think you could 
eat?’. The nuts and legumes preload scored lowest for ‘How sweet did you find the 
meal?’ (p=0.007), and for ‘How savoury did you find the meal?’ (p<0.001). The soy 
preload scored highest for ‘How filling did you find the meal?’ (p=0.01). Both the nuts 
and legumes preload and the soy preload scored lower than the other preloads for ‘How 
tasty did you find the meal?’ (p<0.001), ‘How pleasant did you find the meal?’ (p = 
0.0001), ‘How satisfying did you find the meal?’ (p<0.001) and ‘How enjoyable did you 
find the meal?’ (p<0.001).
The test meal was perceived to be less sweet (p = 0.04) and more savoury (p = 0.02) after 
the nuts and legumes preload than after the other preload meals. The test meal did not 
differ in scores for ‘tasty’, ‘pleasant’, ‘filling’, ‘satisfying’, ‘enjoyable’ or how much 
more food could be eaten.
3.3.4 Hunger and satiety
Hunger was significantly lower at t = 30 min after the soy preload (p = 0.008) and at t =
90 min after the nuts and legumes preload (p = 0.045). At t = 180 there was a non­
significant reduction in hunger after the soy preload (p = 0.083). There was no difference 
between the groups in any other parameters for the question 'How hungry are you?' 
(Figure 3.3.2 and Figure 3.3.3). For the question ‘How full do you feel’ (Figure 3.3.4 and 
Figure 3.3.5) the score at t = 180 min after the soy preload was significantly higher than 
the other preloads (p = 0.018). The subsequent energy intake at the test meal after the soy
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preload was then significantly lower (Figure 3.3.1). There was no difference in any 
parameters for the question ‘How strong is your desire to eat?’ (Figure 3.3.6 and Figure 
3.3.7). In response to the question ‘How much food do you think you could eat?’ (Figure 
3.3.8 and Figure 3.3.9) scores were significantly lower at t = 90 min after the nuts and 
legumes preload and the soy preload (p = 0.0496) and the time to the minimum score was 
less after the nut and legumes preload (p = 0.015).
An appetite score was calculated as the mean response to ‘hunger’, ‘fullness’ (and 
reciprocal of the fullness score), ‘desire to eat’, and ‘amount that could be eaten’ (Bowen 
et al., 2006c). There was no difference in any parameters in the appetite score between 
study preloads.
Other factors were included in the questionnaire, mainly as a diversion from the appetite 
questions above. Some differences between preload meals were observed. In response to 
the question ‘How content are you?’ (Figure 3.3.10 and Figure 3.3.11) there were 
significant differences in scores during the investigation days. Subjects were more 
content at baseline prior to the nuts and legumes preload (p = 0.006) and meat preload (p 
= 0.012). At 30 min contentment remained high after the meat preload but had fallen after 
the nuts and legumes preload and was lower after the soy preload (p = 0.038). There was 
no difference in scores between 30 and 180 min but at 180 min there was a trend for 
lower scores after the nuts and legumes preload and higher for the meat preload (p = 
0.059). AUC for the entire investigation day (t = 0 - 300 min) was higher for the meat 
preload and lower for the nuts and legumes preload (p = 0.021) but there was no 
difference between the AUC for the groups between the preload and test meals (t = 0 -  
180 min).
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‘Irritability’ scores (Figure 3.3.12 and Figure 3.3.13) were generally low but were lower 
at baseline prior to the meat preload (p = 0.033) and the nuts and legumes preload (p = 
0.011) which were not affected by order of visit. Scores remained low after the meat 
preload at 150 min (p = 0.017) and were lower after the dairy preload than the control (p 
= 0.035). The maximum score after the meat preload was lower than after the other 
preloads (p = 0.035) and AUC after the meat preload was lower between the preload and 
test meals (p = 0.027) and throughout the entire investigation day (p = 0.034).
In response to the question ‘How depressed are you?’ (Figure 3.3.14 and Figure 3.3.15) 
the only difference in any of the parameters was the maximum score after the meat 
preload was higher than after the other preloads (p = 0.029). The scores for the question 
‘How alert are you?’ (Figure 3.3.16 and Figure 3.3.17 were lower after the nuts and 
legumes preloads (p = 0.004) and soy preload (p = 0.013) at 180 min but there were no 
differences for any other parameter.
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Figure 3.3.7 Mean AUC for VAS scores for the question ‘How strong is your desire to eat?’ from 
baseline until the test meal at 180 min
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Figure 3.3.9 Mean AUC for VAS scores for the question ‘How much food do you think you could 
eat?’ from baseline until the test meal at 180 min
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Figure 3.3.11 Mean AUC for VAS scores for the question ‘How content are you?’ from baseline until 
the test meal at 180 min
16000
14000
12000
10000
U 8000
D<
<  6000 
>
4000
2000
i
control meat dairy nuts and legumes
Preload meal
soy
178
12^^^03003026082216082681165221874^0078294
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Figure 3.3.13 Mean AUC for VAS scores for the question ‘How irritable are you?’ from baseline 
until the test meal at 180 min
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Figure 3.3.15 Mean AUC for VAS scores for the question ‘How depressed are you?’ from baseline 
until the test meal at 180 min
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3.3.5 Blood markers of metabolic risk and satiety
Mean blood glucose at baseline did not differ between preload meals, but curves 
following the preload were different at all time points (Figure 3.3.18). The glucose curve 
after the nuts and legumes preload was the flattest with the lowest peak at t = 30 min (p < 
0.001) and the smallest post-prandial dip at t = 90 min (p < 0.001). The highest peak was 
after the control preload followed by the dairy and meat preloads, then the soy and nuts 
and legumes preloads (p < 0.00001). The greatest post-prandial dip was after the dairy 
preload (p < 0.001) and glucose levels remained significantly lower throughout the whole 
post-prandial period. Prior to the test meal (t = 180 min) the glucose level was highest 
after the nuts and legumes preload, followed by the soy, meat, dairy and control preloads
(p <  0.001).
AUC was analysed using the two methods as discussed in Chapter 2. AUC was lowest 
after the dairy preload and highest after the nuts and legumes preload (p < 0.001) (Figure 
3.3.19). Given the large post-prandial dip, analysis of AUC was challenging, as the 
recommended methods ignore or remove parts of the curve below baseline (Brouns, 
2005) thus omitting any effects of post-prandial excursions on hunger and metabolic risk.
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Figure 3.3.19 Mean AUC for glucose concentration from baseline until the test meal at 180 min
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Figure 3.3.20 shows the blood insulin curves following the preload meals. There was no 
difference at baseline, then levels peaked between 30 and 60 min, with significantly 
higher levels after the dairy, control and meat preload, and low levels after the soy and 
nuts and legumes preloads (p < 0.001) (in the same order as the peak glucose 
concentration). By t = 180 min there was no difference between preloads although the 
insulin levels had not returned to baseline. AUC was significantly different between 
preloads, with the control having the highest AUC, followed by the dairy, meat, soy, and 
nuts and legumes preload (p<0.001) (Figure 3.3.21).
NEFA concentration did not differ at baseline and fell after all preloads following the 
same pattern (Figure 3.3.22). NEFA levels remained higher after the nuts and legumes 
preload at t = 60 (p < 0.00001), 90 (p = 0.0002), and 120 min (p = 0.022) but by t = 180 
min the highest NEFA concentration was after the soy preload followed by the nuts, 
meat, dairy and control preloads (p = 0.0263). AUC was significantly higher after the 
nuts and legumes preload using the first AUC model (p = 0.005) (Figure 3.3.23). The 
second model was not used as all the area below the baseline is subtracted from the area 
above the baseline, and so is not informative when concentrations fall from baseline and 
do not subsequently rise.
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Figure 3.3.21 Mean AUC for blood insulin concentration from baseline until the test meal at 180 min
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3.3.6 Gastric Emptying
The mean PDR (percentage dose recovered) was higher after the soy preload at 49 ± 11 
% compared with 45 ± 7% for the control and 45 ± 10 % for the other preloads. Figure 
3.3.24 shows the mean standard enrichment curve after each preload. Table 3.3.6 shows 
the mean direct gastric emptying parameters for the five preload meals.
Figure 3.3.24 13C-isotopic enrichment in breath C 02
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T a b le  3 .3 .6  G a s tr ic  e m p ty in g  d i r e c t  p a ra m e te r s  (m e a n  ±  sd)
Preload
Meal
Tlag (h) tl/2  (h) tla t (h) tasc (h)
Rmax(out)
(h-1)
Control 1.92 ±0.25 2.94 ± 0.43 0.68 ±0.10 2.26 ± 0.39 0.23 ± 0.04
M eat 2.00 ± 0.35 3.27 ±0.65 0.64 ±0.11 2.63 ±0.59 0.20 ± 0.05
Dairy 1.89 ±0.32 2.99 ± 0.47 0.64 ±0.14 2.35 ±0.38 0.22 ± 0.04
Nuts / 
legumes
1.94 ±0.36 3.10 ±0.52 0.64 ±0.15 2.46 ± 0.41 0.21 ± 0.04
Soy 2.10 ±0.34 3.47 ±0.66 0.65 ±0.12 2.81 ±0.61 0.19 ±0.06
p value 
between 
preload 
meals
p = 0.003 p < 0.001 p = 0.58 p < 0.001 p < 0.001
13Lag time (tlag), the time taken to reach maximal CO2 excretion, was significantly 
longer after the soy preload, at 2.10 ± 0.34 h (p = 0.002) than the other preloads. The half 
excretion time (tl/2), the time taken for 50 % of the total 13CC>2 excreted in the breath to 
appear, was significantly longer after the soy preload (3.47 ± 0.66 h, p < 0.0001) and 
meat preload (3.27 ± 0.65 h, p = 0.001), followed by the nuts and legumes preload (3.10 
± 0.52 h), dairy preload (2.99 ± 0.47 h), and control (2.94 ± 0.43 h). There was no
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difference between the preloads in the latency time (tlat) which represents the initial 
delay in the cumulative 13C excretion curve. The ascension time (tasc), the time between 
the latency time and the half excretion time during the period of high 13C excretion, was 
significantly different between all preloads (p < 0.00001). The longest times were after 
the soy and meat preloads, followed by the nuts and legumes preload, and then the dairy 
and control preloads. Similarly Rmax(out), the maximum rate of label excretion, was 
slowest after the soy preload (0.19 ± 0.06 h '1), followed by the meat (0.20 ± 0.05 h '1) and 
nut and legumes (0.21 ± 0.04 h 1) preloads, and the dairy (0.22 ± 0.04 h 1) and control 
(0.23 ± 0.04 h 1) preloads had similar rates.
The self-corrected analogs representing the input to the bicarbonate pool were also 
analysed (Table 3.3.7). tlag(in) was fastest after the soy and meat preloads, followed by 
the nuts and legumes and dairy preloads, with the longest time after the control preload (p 
= 0.0007). There was no difference between the preloads for tl/2(in) (p = 0.59). The 
tlat(in) followed the same pattern as the tlag(in), with soy and meat preloads having the 
fastest latency input time and the control preload the slowest (p = 0.003). The tasc(in), as 
in tasc(out) was slowest after the soy and meat preload, then the nuts and legumes 
preload, and the dairy and control preloads were similar with the fastest times (p < 
0.0001). There were no differences between preloads for Rmax(in), the maximum rate of 
label absorption (p = 0.55)
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T a b le  3 .3 .7  G a s tr ic  e m p ty in g  se lf  c o r r e c te d  p a ra m e te r s  (m e a n  ±  sd )
Preload
Meal
tlag in (h)
tl/2  in
(h)
tla t in
(h)
tasc in (h)
Rmax(in)
( h 1)
Control 0.50 ±0.18 1.14 ±0.15 0.11 ±0.06 0.28 ±0.46 0.53 ± 0.07
M eat 0.30 ± 0.22 1.10 ± 0.19 0.05 ± 0.06 3.22 ±0.68 0.56 ±0.12
Dairy 0.39 ± 0.23 1.08 ±0.22 0.07 ± 0.07 2.91 ± 0.46 0.57 ±0.12
Nuts/
legumes
0.37 ± 0.22 1.10 ±0.24 0.07 ± 0.57 3.03 ±0.51 0.57 ±0.19
Soy 0.28 ± 0.23 1.14 ±0.19 0.05 ± 0.06 3.43 ±0.69 0.54 ±0.10
p value 
between 
preload 
meals
p < 0.001 p = 0.6 p = 0.003 p < 0.001 p = 0.5
190
3.4 Discussion
In this study, four high-protein meals differing in protein type and a standard protein 
control meal were investigated for the short-term effects on the control of appetite, gastric 
emptying and post-prandial metabolism and subsequent energy intake in a classical 
preload design. The study was performed in a metabolic suite under standardised 
conditions to optimise investigation of the physiological effects of the meals.
The type of protein used in the study reflect typical dietary sources and were of topical 
interest given their epidemiological associations with cardiovascular and other health 
benefits, and the environmental advantage of consuming vegetable rather than animal 
protein. Soy is increasing in popularity in Western cultures because of benefits seen in 
relation to cardiovascular disease and bone density in Asian cultures with habitual high 
consumption, but little is known about the effect on energy intake. Nuts have been 
extensively studied for their cardiovascular benefits but concerns have been raised about 
the detrimental effect on energy intake and body mass of consuming such a high energy- 
dense food. Dairy products are of interest as recent concerns about their high saturated fat 
content have led to decreased consumption, which in turn may have led to inadequate 
calcium intake, yet dairy is claimed to aid weight loss. Meat was chosen for the standard 
protein and one of the high-protein preloads as the most common protein type habitually 
consumed which could therefore be a comparator to the other protein sources.
3.4.1 Effect of different protein types on satiety and energy intake
This study demonstrated that preload meals differing in protein type and quantity exert 
differential effects on satiety and subsequent energy intake. Energy intake after the soy 
high-protein preload was 11.7% lower than after the standard protein preload with a
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difference of 538 kJ. This finding is reinforced by subjective assessments of hunger and 
satiety in which the soy preload produced lower hunger scores immediately after the 
meal, higher fullness scores prior to the test meal and reduced prospective consumption 
of food scores midway between the preload and test meal.
Protein has traditionally been said to be the most satiating macronutrient. With the 
exception of the soy preload, energy intake after the high-protein preloads was no 
different to the standard protein preload. This finding is similar to previous studies 
investigating short-term energy intake after meals differing in the proportion of protein 
(Stubbs et al., 1996), (Raben et al., 2003) despite a number of studies demonstrating a 
reduction in energy intake after protein-rich meals (Poppitt et al., 1998), (Barkeling et al., 
1990), (Latner & Schwartz, 1999; Vozzo et al., 2003) (Porrini et al., 1997). The 
discrepancy in these data sets is possibly due to the proportion of energy from protein in 
the preload meals. With the exception of Vozzo et al, the proportion of energy from 
protein was between 43% and 72% in studies mentioned above which demonstrated 
enhanced satiety compared with other macronutrients. In comparison, the high-protein 
preload provided 31.8% of energy in a similarly designed study which did not 
demonstrate any difference in satiety or energy intake (Raben et al., 2003). 33% of 
energy from protein used in high-protein preloads in this study may therefore have been 
too low to distinguish differences between the preloads in subsequent energy intake and 
satiety but reflects a more realistic intake. Initially the intention was to prepare meals 
containing a higher percentage of energy from protein. However, in order to balance the 
protein and fat content (to keep the fat content constant across all preload meals), and 
prepare the preloads with whole foods, a high rather than very high proportion of energy 
from protein was required in the meals. The high-fat content of the main protein source of 
the nuts and legumes meal was particularly limiting.
It is possible that the energy content of the preloads limited the effect on energy intake. 
However, at 2.5 MJ the meals were designed to be adequate to demonstrate an effect of 
the components of the meals. A preload of less than 1 MJ is insufficient to produce 
changes in energy intake (Poppitt et al., 1998), whilst a saturating effect of larger meals 
(5 MJ) may exist (Lang et a l., 1998).
Although the preloads were designed with very similar ingredients and were visually very 
similar, the different protein types significantly affected palatability. The control preload, 
which had a composition close to habitual macronutrient composition, scored the highest 
for tastiness and was more enjoyable. Scores were significantly lower after the soy 
preload and the nuts and legumes preload for tastiness, pleasantness, and satisfaction and 
these preloads were less enjoyable. Palatability of the preload meal has been shown to 
affect energy intake at the test meal (Barkeling et al., 1990) but energy intake was lower 
after the soy preload only and not after the nuts and legumes preload. These two preloads 
contained ingredients that the study population may have rarely eaten and so the 
unfamiliarity could have reduced their palatability.
An effect of soy on short-term energy intake has not been identified previously, however, 
a reduction in energy intake is consistent with data from a six-month intervention in 
which 90 subjects were provided with an energy restricted diet with or without additional 
soy protein supplements, and those provided with the soy supplements showed greater 
weight loss (8.9 kg) than the standard diet (6.2 kg) (Deibert et al., 2004). While the effect 
size in the present study is small in the context of a specific hypoenergetic diet for the 
treatment of established obesity, it may be an important component of the overall diet for 
the prevention of weight gain. Hill et al (2003) suggested that decreasing energy intake
by approximately 420 kJ (100 kcal) per day is potentially useful for population-based 
weight management (Hill et al., 2003).
Energy intake after the nuts and legumes preload was 8.8% higher than after the control 
preload. This finding was surprising and is in contrast to longer-term studies where nuts 
consumed in addition to a standard diet did not increase total energy intake (Hollis & 
Mattes, 2007) or change in weight (Fraser et al., 2002a) (Sabate, 2003). More subjects 
were unable to finish the nuts and legumes preload than the other preloads, suggesting an 
immediate effect of increasing satiation. In keeping with this finding, the hunger scores 
after the nuts and legumes preload fell immediately after eating and were lower at 90 min 
than after the other preloads, and lower scores for prospective food consumption were 
also present. However, the resulting reduction in energy intake at the preload meal may 
have increased later energy consumption. When the total energy intake for the 
investigation day (preload and test meals) was calculated, excess consumption for the 
nuts and legumes investigation day was lower than the excess energy calculated at the 
test meal alone. Interpreting the impact of this diet is complicated since, because of 
difficulties in formulating this preload while maintaining the correct macronutrient 
proportions, the nuts and legumes preload was also higher in fibre (Table 3.2.2) and 
lower in glycaemic index (Figure 3.3.18) than the other high protein preloads. As high 
fibre, low glycaemic index meals are reported to increase satiety and energy intake 
(Hulshof et al., 1993) (Roberts, 2000), it was therefore unexpected that the energy intake 
at the test meal after this preload was the highest.
Bowen et al (2006c) introduced an appetite score which combines the four questions 
relating to hunger, fullness, desire to eat and prospective consumption of food (Bowen et
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al., 2006c). It might be expected that the integrated assessment would provide a more 
rounded approach but there were no differences in the scores after the preload meals.
Surprisingly, scores for contentment and alertness were lower after both the soy and nuts 
and legumes preload. The lower immediate contentment scores may have been due to the 
lower palatability scores but it is not clear why lower scores were obtained for alertness 
prior to the test meal after these two preload meals. It is unlikely that these low scores 
affected the energy intake at the test meals as energy intake was reduced after the soy but 
increased after the nuts and legumes preload. The meat preload produced higher scores 
for contentment, lower scores for irritability, and a higher score for depression. The meat 
preload was the preload most similar to a common UK recipe and the familiarity and 
increased palatability may have enhanced contentment and reduced irritability. The 
highest maximum score for depression after the meat preload is not consistent with these 
results and is unexplained. These questions were primarily added to the questionnaire to 
reduce the focus on appetite and allow for a covert analysis of satiety. It was not expected 
that significant differences would be found between the investigation days. The 
differences are however important as factors such as contentment after a meal, alertness, 
and irritability determine whether an alteration in meal composition is acceptable and 
may thus be included in habitual eating patterns.
3.4.2 Mechanisms for the effect of protein type on satiety, energy intake and
metabolic risk factors
A number of mechanisms for the effect on satiety and energy intake after preload meals 
differing in protein type were investigated in this study. Consistent with the finding of 
increased satiety and reduced energy intake after the soy preload, gastric emptying was
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slower after the soy preload than the other preloads. Delayed gastric emptying has been 
associated with increased satiety and reduced energy intake (Hall et al., 2003; Bowen et 
al., 2006c) and also with a reduction in post-prandial glycaemia (Ma et al., 2009). High- 
protein meals have previously been shown to have slower gastric emptying than high- 
carbohydrate meals (Ma et al., 2009) but the effect of protein type on gastric emptying 
has not been previously reported. A differential effect of protein type on gastric 
emptying, may therefore account for some of the differences in satiety and energy intake 
that were observed in this study.
Marked differences in post-prandial glucose and insulin concentrations were observed in 
this group of healthy, lean subjects despite similar carbohydrate content of the high 
protein preload meals. It appears that protein is a powerful modulator of glucose 
metabolism, particularly when the meal contains non-animal protein (nuts, legumes and 
soy) perhaps due to their higher fibre content or lower GI. As large fluxes in post-prandial 
glucose and insulin may increase hunger, particularly when the glucose level falls below 
baseline prior to the subsequent meal, this effect on glucose metabolism may be an 
important mechanism by which different protein types influence satiety. The effect on 
satiety of reducing glucose excursions has been investigated with carbohydrate meals 
differing in their glycaemic index (GI) - the area under the glycaemic response curve 
during a 2-hour period after consumption of 50 g carbohydrate from a test food (where 
values are expressed relative to the effect of either white bread or glucose). When meals 
of similar carbohydrate content but differing in GI are provided, a low GI meal results in 
lower glucose excursions and is associated with a reduction in post prandial satiety 
(Arumugam et al., 2008) and an increase in energy intake at a subsequent meal (Roberts, 
2000). Similarly the effect of different protein types on post-prandial glucose excursions 
may influence post-prandial satiety and subsequent energy intake.
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It is possible that the nature of the carbohydrate in the high protein preload meals in this 
study may have influenced post-prandial glucose metabolism, despite similar 
carbohydrate content. All the meals contained potato flakes, a high GI form of potato, 
however the nuts and legumes and soy preloads had very little potato in comparison to the 
other high protein preloads and the control preload. Carbohydrate in these two preload 
meals was comprised of ingredients substantially lower in GI -  lentils in the nuts and 
legumes meal and soy mince in the soy meal -  which may have lowered post-prandial 
glucose excursions. Additionally, fibre was higher in the nuts and legumes meal, further 
contributing to a reduction in glucose secretion.
The post-prandial peak concentrations of glucose and insulin were lowest after the nuts 
and legumes preload and the least post-prandial glucose dip was observed compared to the 
other preloads. This time period coincided with the lowest scores for prospective 
consumption of food, suggesting the larger post-prandial dip increased hunger. If food had 
been available between the two meals, the lower post-prandial blood glucose dip after the 
control and dairy preload may have contributed to increased food consumption. Glucose 
and insulin concentrations were similar prior to the test meal, suggesting that the influence 
on energy intake at this meal was not as pronounced.
An effect on post-prandial glucose and insulin levels of different protein meals may also 
provide metabolic benefits, and a reduction in cardiovascular risk is seen when glucose 
excursions are low (as discussed in Chapter 1). Nut consumption is associated with a 
reduction in cardiovascular disease (Hu et al., 1998; Albert et al., 2002) and developing 
diabetes (Jiang et a l, 2002) which may in part be explained by a reduction in post­
prandial glucose concentration. A similar effect of nuts on glycaemic excursions was
seen in 15 subjects who consumed meals based on rice, almonds or potatoes of the same 
macronutrient composition. Glucose and insulin concentrations were lowest after the rice 
and almond meals than the potato meal and, additionally, lower oxidative damage to 
proteins was observed, suggesting that cardiovascular disease risk may be reduced by 
lowering post-prandial glucose and thus oxidative damage (Jenkins et al., 2006).
Therefore, despite similar total carbohydrate content of the preload meals differences in 
protein types and associated changes in the nature of carbohydrates may exert a 
differential effect on glucose metabolism, which leads to changes in satiety and 
subsequent energy intake and may account for observed improvements in metabolic risk 
with certain protein types.
The post-prandial NEFA concentrations were similar after all meals except for the nuts 
and legumes meal. Higher levels of blood glucose and insulin levels promote the 
incorporation of free fatty acids into adipose tissue tri acyl glycerol so the delayed fall in 
NEFA may have been due to attenuation of the glucose increment after the nuts and 
legumes meal.
3.4.3 Strengths and limitations
This highly controlled crossover study conducted under standardised conditions allowed 
for consistent within-subject comparisons to investigate the physiological effects of the 
controlled preload meals of differing composition. Subjects were not aware of what was 
being investigated or in what ways the meals differed so this covert design reduced 
conscious alterations in eating behaviour.
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The preloads were well matched for macronutrient composition and energy intake, and 
used standard household ingredients, provided in a recognisable form similar to a 
standard meal. A control preload with protein composition similar to the habitual diet was 
provided to compare with the high-protein preloads, in contrast to many preload studies 
which lack a control. The proportion of energy from protein in the high-protein preloads 
was designed to be only slightly higher than recommended intake and whole foods were 
selected in order to make the meal manipulation sustainable long-term and capable of 
being translated into real life despite the experiments being performed within the confines 
of a metabolic suite. The preload meals were designed to be relatively low in fat (lower 
than standard UK intake) and fat was kept constant due to the large effect of fat on 
energy intake and satiety (Stubbs et al., 1995a). The variability in the type of 
carbohydrate between the control and the high-protein preloads did potentially affect the 
post-prandial glucose and insulin response but reflects the full consequence of 
manipulating the source of protein in the diet.
Meals were provided at times close to standard meal times in order to replicate habitual 
eating patterns and therefore extrapolate the results as far as possible to a free-living 
environment. An alternative method to investigate satiety is to record the time until 
subjects request a subsequent meal after a preload meal. A preload with higher satiating 
properties delays the time until the next meal, but consumption at the subsequent meal 
may not be affected. The objective of the present study was to assess energy intake at a 
second meal and so a set mealtime was selected.
The test meal provided choice of quantity of food with one savoury and one sweet dish. 
The nutritional composition of each dish was similar to that of the control meal to 
resemble habitual food consumption, and the meals were designed so that each mouthful
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would contain the same ingredients and composition. The pizza and yoghurt dishes were 
liked by all participants, and had high palatability ratings. Subjects’ consumption was 
determined by appetite as the pizza was provided in small slices which impeded 
calculation of their intake as a proportion of the whole, pre-empting habitual pizza eating 
-  eating a half or whole pizza. Subjects were able to serve their own portion of yoghurt 
from the large serving dish and to eat to satiety.
The main limitation of the preloads was that visual appearance differed slightly. Despite 
the basic ingredients being the same in all preloads the different protein type altered the 
appearance, size, texture and palatability of the preloads. When the preloads were 
designed, it was decided to prioritise the macronutrient composition and the use of 
standard ingredients with the consequence that the fibre content, energy density and fatty 
acid profile differed in meals containing the different protein types. An attempt was made 
to balance the high levels of monounsaturated fatty acids in nuts tri acyl glycerols by 
adding olive oil to preloads if any extra fat was required and therefore reduce the 
differences in fatty acid profile.
The preload meal was 2.5 MJ, which was lower than originally intended, comprising less 
than one third of habitual daily intake. However pilot testing of the preload meals 
suggested that larger meals might have been difficult to consume in entirety and indeed 
not all subjects could complete even the 2.5 MJ meal. As the preload was baked and 
contained ingredients more commonly eaten in the evening rather than after an overnight 
fast, some subjects found the unfamiliarity made consumption of the meal difficult. There 
is a suggestion that a larger size meal is necessary to produce full effects on satiation (de 
Graaf et al., 1992) and therefore the energy content of the preload meal may have been 
too low to observe the full satiating properties.
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Visual analogue scales are a well-validated method for analysing satiety sensations (as 
discussed in Chapter 2) however there are inherent problems in any such questionnaire. 
Because of the frequency and repetitiveness of the questions subjects may not read the 
question correctly or think carefully about their response. Some subjects provided low 
scores for both fullness and hunger or provided an inconsistent pattern of scores 
throughout the investigation day, which may have affected the satiety results.
3.4.4 Summary
After consuming a high-protein soy-based preload, subjects experienced a significant 
suppression of energy intake compared to a standard meal of lower protein. An associated 
increased satiety was also observed, mediated in part by delayed gastric emptying and 
reduced post-prandial glucose and insulin excursions. Moreover there was a significant 
reduction in energy intake following high soy protein relative to meals of similar absolute 
protein content but from meat, dairy, nut and legume sources. If the effect on energy 
intake is sustained beyond a single meal, consuming meals rich in soy protein may 
improve body-mass control.
High-protein meals are often associated with increased satiety and energy intake 
compared to a meal of standard protein composition. An effect on these factors was not 
clearly seen in this study, possibly due to meal size or that the 33% of energy provided by 
the high protein meals was not sufficient to maximally influence energy intake.
A similar increase in satiety was observed after a high-protein preload containing nuts 
and legumes, but it did not translate to a reduction in energy intake during ad libitum
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eating after the preload. However, the nuts and legumes meal appeared to be associated 
with increased meal satiation, an important factor in energy regulation in usual eating 
patterns, where meal size and timing are unrestricted. Additionally, the lower glucose and 
insulin excursions after the nuts and legumes preload have the potential to improve 
metabolic risk factors and cardiovascular disease.
This study highlights the differing effect of protein types on energy intake, satiety, gastric 
emptying and glucose and insulin concentrations after a meal, which may in part account 
for the discrepancies in previous studies of high protein meals reporting satiety and 
energy intake.
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4 Chapter 4 Measuring the effects on energy
metabolism of isoenergetic 
manipulation of the protein:non­
protein energy ratio under ad libitum- 
feeding conditions.
4.1 Introduction
Evidence presented in Chapter 1 (Section 1.5) suggests that diets with a high-protein:non­
protein energy ratio (P:E) may facilitate weight loss and enhance weight maintenance. 
Short-term experimental studies presented in Chapter 3 show that dietary protein can 
reduce immediate and subsequent food intake by early termination of eating, delaying 
eating and/or reducing intake at the next meal, suggesting that the action of protein on 
satiety may be a critical factor in the control of energy intake.
Evidence from longer well-controlled studies is limited. Westerterp-Plantenga et al (1999) 
demonstrated enhanced medium-term satiety in 8 subjects confined in a calorimeter, 
consuming an isoenergetic diet containing 29% or 9% of energy from protein at normal 
meal times over 24 hours (Westerterp-Plantenga et al., 1999). Reported satiety was higher 
during meals and over the 24 h period among subjects eating the high-protein diet 
compared to the low-protein diet, indicating that in a highly controlled setting with limited 
food choice and availability, increasing the proportion of energy from protein increases 
satiety, and the effect is maintained for many hours. In a subsequent study, 12 subjects ate 
an isoenergetic diet comprising 30% or 10% of energy from protein for 4 days. On the 
fourth day, while confined to a calorimeter, satiety scores among subjects on the high-
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protein diet were higher and hunger scores lower before and after dinner and for the whole 
24 h period (calculated by AUC) (Lejeune et al., 2006). These studies, performed in 
highly controlled settings with fixed food intake limits the translation of these 
observations to a free-choice setting.
In a detailed longer-term study, 19 subjects were placed on a weight-maintenance diet 
(15% P, 35% F, and 50% C) for 2 weeks, followed by an isoenergetic high-protein diet 
(30% P, 20% F, and 50% C) for 2 weeks, then an ad libitum high-protein diet (30% P,
20% F, and 50% C) for 12 weeks (Weigle et al., 2005). During the isoenergetic high- 
protein diet there was no change in weight but visual analogue scores of hunger were 
reduced and those of fullness were increased. When the high-protein diet was consumed 
ad libitum, subjects reduced their energy intake by 1.8 MJ/day and experienced an average 
decrease in body mass of 4.9 kg over the 12-week period. Despite the lack of a control 
group in this study, the enhanced satiety and reduced energy intake observed 
demonstrated a substantial effect of the high-protein diet.
4.1.1 Protein and energy intake: The protein leverage hypothesis
There is a substantial body of evidence that protein intake in animals is tightly regulated to 
reach a specific ‘intake target’. Experimental evidence comes from a range of herbivorous 
and carnivorous animals, including caterpillars (Lee et al., 2002), grasshoppers 
(Raubenheimer & Simpson, 2003), carnivorous ground beetles and spiders (Mayntz et al., 
2005), rats (Simpson & Raubenheimer, 1997) and mice (Sorensen et al., 2008). This 
intake target is chosen to maximise growth and reproductive capacity (Simpson & 
Raubenheimer, 1997). Simpson and Raubenheimer (2005) have developed the ‘protein 
leverage hypothesis’ which describes the prioritisation of protein over carbohydrate and
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fat, such that protein intake determines total energy intake (Simpson & Raubenheimer, 
2005). Animals select food that meets their nutrient requirements (the nutrient target) 
whilst providing for optimal growth or maintenance of body composition (the growth 
target). The ratio of protein to non-protein food that the animal eats in ideal conditions is 
termed the ‘intake target’ (Figure 4.1.1 (a)). When food availability is limited, animals 
prioritise absolute protein intake. If the proportion of protein in the food supply is limited 
animals over-eat carbohydrate and fat to ensure adequate protein is ingested (Figure 4.1.1 
(b)). If available food is high in protein, animals become satiated after consuming a 
sufficient amount of protein, resulting in under-eating carbohydrate and fat, and hence 
energy. Accordingly, small changes in the percentage of dietary protein can sunstantially 
effect total energy intake, as the absolute amount of protein is prioritised while 
carbohydrate and fat, the major energy providing nutrients, are secondary (Simpson & 
Raubenheimer, 1997).
It is uncertain whether a particular macronutrient drives a similarly regulated system in 
humans. If protein intake modulates total energy (and therefore carbohydrate and fat) 
intake, changes in food availability or meal patterns which alter protein intake, may 
influence total energy intake and thus provide a mechanism for long-term body mass 
regulation. If protein intake is diluted by carbohydrate and fat (as may occur when these 
nutrients are more affordable or accessible), carbohydrate and fat may be over-consumed 
to maintain absolute protein intake leading to an increase in total energy consumption.
Experiments reported by Stock, 1999, support the hypothesis that protein is important in 
regulating energy balance and investigated energy balance at different levels of protein 
intake. A diet comprising 20% of energy from protein produced the highest efficiency of 
energy utilisation. When the proportion of energy from protein in the diet was reduced to
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as low as 5% dietary induced thermogenesis increased. It was argued that this increase in 
heat production occurred in response to the need to increase consumption of fat and 
carbohydrate in response to the nutrient deficient low-protein diet, and was termed 
homeostatic waste. Likewise, an increase in protein increased DIT, due to the high 
metabolic cost of metabolising protein (Stock, 1999). For the purposes of this study the 
10%P, 15%P and 25%P diets were defined as low, medium and high protein.
Figure 4.1.1 Protein leverage hypothesis
a) the P:E intake target in ideal eating conditions and b) the change in carbohydrate and fat intake required 
when food availability alters in order to maintain protein intake (Simpson and Raubenheimer, 2005).
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As discussed in Chapter 1, energy intake and the onset of satiety in humans involve a 
complex system of sensory, cognitive and physiological responses to the presence of food. 
Regulation of this system is less likely to be driven by a single factor, such as dietary 
protein, as appears to occur in most animals studied to date. The increasing rates of 
overweight and obesity suggest that humans are not able to readily select their nutrient or 
growth targets. Archaeological evidence suggests that hunter-gatherer societies, who 
consumed a diet high in protein, were leaner and taller than subsequent societies who 
consumed grain-based diets (O'Keefe & Cordain, 2004). It is possible that hunter-gatherer
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populations may have had more physiologically regulated food consumption. As the 
available protein was high, individuals could eat to their intake target while maintaining 
optimal body mass. As food choice and availability increase, particularly food with added 
fat and sugar (such as sugar-sweetened beverages which now constitute 16% of total 
energy in the US (Malik et al., 2006)), the relationship between food consumption and 
physiological responses may lessen, resulting in weight gain and obesity. If, however, 
increased protein is available, humans may respond by eating to their appropriate intake 
target and reduce weight gain.
One preliminary study tested the protein leverage hypothesis in humans (Simpson et al., 
2003). Five female and five male white, health-conscious subjects aged 14 -  49 y were 
provided with all meals during a six-day residential experiment. Food selected from a 
buffet was consumed ad libitum, with a wide range of choice on days 1 and 2, and days 5 
and 6. On days 3 and 4, half of the subjects were provided with a variety of food high in 
protein, while the other half were provided with food low in protein. The results are 
presented in Figure 4.1.2.
When food high in protein was offered, subjects increased their protein intake by 16% and 
reduced their carbohydrate and fat intake by 62%. Total energy intake fell by 47%. On 
returning to a habitual diet protein intake was reduced, suggesting a compensatory 
response to the protein excess consumed over the previous 2 days (Figure 4.1.2a)). 
Subjects offered food low in protein on days 3 and 4 reduced protein intake by 20% and 
increased carbohydrate and fat intake by 45%. Total energy intake increased by 35%. 
There was no compensatory increase in protein intake or reduction in carbohydrate and fat 
intake on days 5 and 6 relative to consumption on days 3 and 4 (Figure 4.1.2(b)). Subjects 
appeared to regulate protein intake over and above carbohydrate and fat, and adjusted
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their total energy intake to maintain an absolute intake of protein. Therefore, protein may 
exert similar regulatory control over intake in humans as in wild and laboratory animals.
Figure 4.1.2 Mean (SEM) intake over each of the 2-day phases of the experiment to test the protein 
leverage hypothesis in humans.
(a) under-consumption of carbohydrate (C) and fat (F) for subjects offered food high in protein and (b) over­
consumption of C and F for subjects offered food low in protein on days 3 and 4. (Simpson et al, 2003)
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There were a number of limitations to this study. The study was a parallel design with 
few subjects not representative of the general population, and there was large inter­
individual variability in food intake. Food provided on days 3 and 4 was not controlled 
for a number of factors known to affect satiety and energy intake (as discussed in Chapter 
1) including palatability, energy density, fibre, variety and visual appearance. As subjects 
were only provided with one of the two protein-manipulated menus, the outcomes could 
not be compared within-subject, and food choices may have been affected by the
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communal nature of food selection and consumption. Further testing is required with a 
more controlled dietary manipulation with a within-subject design.
4.1.2 Dietary protein and metabolic risk
4.1.2.1 Body composition
Evidence suggests that diets with higher P:E ratio may promote weight loss, improve 
body composition and reduce fat deposition in adipose tissue, alter lipid metabolism, 
lower post-prandial blood glucose, enhance insulin sensitivity, and alter growth factors 
and hormones involved in glucose metabolism.
Fat mass, particularly abdominal fat, is a key component in the diagnosis of the metabolic 
syndrome and is associated with an increased risk of cardiovascular disease (Eckel et al., 
2005). Therefore reducing fat mass or improving the ratio of lean to fat mass is expected 
to have metabolic benefits. For example, in mice susceptible to weight gain, increasing 
the protein content of the diet over 10 weeks delayed weight gain and reduced the 
quantity of fat gained, from less than 1 g in the high-protein/low-fat diet, to 5 g in the 
low-protein/low-fat diet, to almost 8 g in the high-protein/high-fat diet (p < 0.05) (Klaus, 
2005).
In 617 adults reporting habitual high consumption of protein, in food frequency 
questionnaires, substituting protein for carbohydrate (but not fat) resulted in a lower 
WHR by 0.0005 for every gram per day increase in protein intake (Figure 4.1.3) 
(Merchant et al., 2005). Similarly, among 20,126 women there was an inverse 
relationship between protein intake and the change in waist circumference over five
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years. Interestingly no association between total energy or energy from fat and waist 
circumference was observed (Halkjaer et al., 2006).
Figure 4.1.3 The relationship between WHR and protein intake (g/d)
After multivariate adjustment in study participants (P for significance of overall spline < 0.001). 
Adjustments were made for age (y), total energy (kJ/d), height (cm), physical activity score (continuous 
variables), sex (dichotomous), BMI (kg/m2) (continuous), smoking (never, past, current), alcohol intake 
(never or <1 time/mo, 1 time/mo to 5 times/wk, >5 times/wk), and ethnicity (Aboriginal, South Asian, 
Chinese, European). (Merchant et al., 2005)
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During energy restriction, body mass is lost from both fat stores and from lean body 
mass. However, if whilst reducing body mass, partitioning of energy stores preserves lean 
mass, a higher proportion of fat tissue is lost. There is evidence to suggest that increasing 
the proportion of protein in the diet can maintain lean tissue during weight loss and 
thereby increase the amount of fat lost.
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Partitioning of energy stores was demonstrated in 48 overweight women, consuming an 
energy-restricted diet high in protein or carbohydrate over four months, in whom body 
mass was reduced by 9.3 kg (7.3 kg fat mass, 2 kg lean mass) in the high-protein group 
(30% of energy from protein) with relative preservation of lean mass compared to 7.6 kg 
body mass loss (p < 0.05) (5.0 kg fat mass, p < 0.05, 2.6 kg lean mass, p = 0.1) in the 
high-carbohydrate group (15% of energy from protein) (Layman et al., 2005).
Similarly, overweight women provided with a 10-week energy restricted diet, comprising 
30% or 16% of energy from protein, lost body mass (7.5 kg high-protein, 7.0 kg low- 
protein) comprising significantly more fat in the high-protein group than the lower- 
protein group (5.6 vs. 4.7 kg; p<0.05) and sparing of lean tissue (p <0.05). (Layman et 
al., 2003).
During ad libitum eating lean mass preservation was demonstrated in 148 subjects who 
consumed a weight-maintenance diet comprising 18% or 15% of energy from protein for 
three months, preceded by a four-week period of weight loss following a very low-energy 
diet (an additional 48.2 g/day of protein was consumed in the higher protein group) 
(Westerterp-Plantenga et al., 2004). After 6.4 kg of weight loss, weight regained over 
three months was 1 kg of lean mass in the additional protein group compared to 2 kg of 
lean and fat mass in the control group. It is notable that this study demonstrated a 
beneficial effect on both weight regain and body composition despite only a small 
increase in protein consumption over the control diet. It is possible that subjects in the 
additional protein group were consuming a diet closer to their intake target, as described 
in the protein leverage hypothesis, and so were not required to overeat carbohydrate and 
fat to reach optimal protein intake.
211
In a further study during an ad libitum 30% protein diet 19 lean subjects experienced a 
4.9 kg weight loss after 12 weeks, 76% of which was fat mass (Weigle et al., 2005). No 
control group was included, however this study illustrates that weight loss occurring 
during ad libitum consumption of a comparatively high-protein diet results in an 
improved lean-to-fat mass ratio.
Altering the ratio of lean to adipose tissue during weight loss or weight maintenance has 
significant long-term health benefits. The data from intervention studies during energy 
restriction or weight maintenance suggests that a positive protein balance produces a 
beneficial change in body composition and may be one mechanism by which protein 
modulates metabolic risk. However, a direct relationship between a positive protein 
balance leading to a change in body composition remains to be demonstrated.
4.1.2.2 Glucose metabolism
Abnormalities in glucose metabolism and insulin sensitivity are an important component 
of metabolic risk. Impaired glucose metabolism may be the first indicator of risk of more 
serious disease such as type 2 diabetes, and is associated with an increased risk for 
cardiovascular disease. Fluctuations in insulin levels and rebound hypoglycaemia 
following elevations in glucose also appear to stimulate hunger (Bray et al., 1998) 
leading to effects on satiety and weight regulation.
The post-prandial rise in glucose and insulin were lower after a protein-rich meal in 14 
lean healthy subjects provided with five meals of different macronutrient composition 
(Erdmann et al., 2004). Glucose decreased from 4.6 mmol/1 to 4.2 mmol/1 over 4 hours 
after a meal containing 86% of energy from protein, indicating significantly more
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efficient glucose clearance than after high-fat or high-carbohydrate meals. Protein intake 
was considerably higher than is usual in habitual diets, so translating these data to the 
general population is problematic.
A more realistic study used a randomised crossover design in 23 overweight, otherwise 
healthy women. Over nine hours subjects ate snacks high in protein (morning snack 
21.9% P, 19.4% F, 58.7% C, afternoon snack 39.7% P, 24.1% F, 36.2% C) or low in 
protein (<0.1% P, 35.5% F, 64.4% C). Glucose and insulin levels were lower when the 
high-protein snacks were eaten, particularly at 1 and 2-hour timepoints after the 
consumption of the snack bars (Williams et al., 2006). Energy intake at an ad libitum 
buffet lunch and throughout the day did not differ between groups presumably because 
manipulating the composition of only the snacks had a modest effect on daily 
macronutrient intake.
The short-term reduction in post-prandial glucose may be maintained when a high- 
protein diet is adopted over several weeks. Eight men with mild untreated type 2 diabetes 
were randomised to five weeks of a high (30% P, 50% F, 20% C) or standard protein 
(15% P, 30% F, 55% C) diet in a controlled crossover design, with a five-week washout 
between diets (Gannon & Nuttall, 2004). Mean fasting blood glucose concentration 
reduced from 9.3 mmol/L to 6.6 mmol/L during the high-protein diet, while fasting 
glucose concentration did not significantly reduce in the standard protein diet (10 mmol/L 
to 8.8 mmol/L). Mean glucose concentration over 24 h and the 24 h response curves for 
glucose and insulin were all significantly lower during the high-protein diet. 
Glycohaemoglobin was reduced from 9.8% to 7.6% during the high protein diet but 
remained unchanged during the standard protein diet. As these subjects had type 2 
diabetes the potential for improvement was greater than for healthy subjects, however the
reductions in glucose and glycohaemoglobin are remarkable over the short period 
studied.
4.1.3 Objective
The primary objective of this study was to determine the effect of dietary protein on 
energy intake by studying ad libitum energy intake on diets of varying P:E ratios (where 
protein provided 10%, 15% or 25% of energy) under standardised conditions, using a 
within-subject design. The secondary objective was to investigate the effect of changes in 
P:E ratio on body composition and various appetite control mechanisms, including 
circulating metabolites and appetite hormones.
4.2 Methods
This study was performed at MRC Human Nutrition Research (HNR) and the Wellcome 
Trust Clinical Research Facility (CRF) between March 2007 and December 2007. The 
study was approved by Cambridge Local Research Ethics Committee in November 2006 
(Ref No. 06/Q0108/181), by the Addenbrooke’s NHS Foundation Trust Research and 
Development Committee in January 2007 (Ref: A090877), and the Scientific Advisory 
Board for the Wellcome Trust Clinical Research Facility at Addenbrooke’s Hospital in 
November 2006.
4.2.1.1 Subjects
4.2.1.1.1 Sample size
There were no pre-existing data for studies on manipulation of the P:E ratio to estimate 
the sample size. Estimates were therefore based on the work of Stubbs et al., (1995a) 
where ad libitum food intake was measured on three occasions over 7 days in 6 men,
214
confined to a calorimeter (Stubbs et al., 1995a). Protein was held constant (13% of 
energy) but the proportion of dietary fat was manipulated so that the diets contained 20%, 
40%, or 60% fat with reciprocal changes in carbohydrate. Mean ± SEM energy intake on 
the different diets was: 20% fat - 9.03 ± 0.25 MJ/day; 40% fat - 10.22 ± 0.29 MJ/day; 
60% fat - 12.36 ± 0.41 MJ/day.
To detect a difference in energy intake of 0.5MJ/day using a crossover design, with a 
maximum SE of 0.41MJ/day, for 90% power at 5% significance, a sample size of 10 was 
required. It was therefore planned to study 10 completing subjects with any dropouts or 
non-completers replaced.
4.2.1.1.2 Recruitment
Subjects were recruited from the general population in a similar manner to the previous 
study (3.2.1.2). The HNR volunteer database was searched, and all potentially eligible 
subjects were sent a letter, approved by the ethics committee (see Appendix II.2.4), 
inviting them to participate in the study. An advertisement (see Appendix II.2.6) was 
placed on a university student email newsletter. Information sheets and advertisements 
were also placed in the volunteer suite lounge to alert subjects who had been involved in 
other research studies at HNR.
Interested individuals were contacted to discuss the study in more detail and complete a 
telephone-screening questionnaire (see Appendix II.2.3) to determine eligibility. Subjects 
were then invited to HNR for a screening visit (see 4.2.2.1).
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The general practitioner (GP) of subjects eligible to participate in the study was informed 
(see Appendix II.2.5) and asked to contact the chief investigator if there was any medical 
reason that would prevent participation in the study. All clinically relevant results were 
reported back to the GP with the consent of the subject.
4.2.1.1.3 Eligibility
Male and female subjects were eligible to participate in the study if they were aged 18-70 
years, with a BMI less than 25 kg/m2, were willing to eat all the study foods, were 
unrestrained eaters (scoring less than 20 on the EAT-26) and were able to live in the 
research facility for the duration of the study.
Subjects were excluded if they were pregnant or planning pregnancy, breastfeeding, had 
known chronic disease -  diabetes, cardiovascular disease, renal disease, liver disease, or 
untreated thyroid disease, unstable or untreated elevated blood pressure or cholesterol, 
chronic inflammatory conditions, were taking medications that might interfere with 
glucose metabolism or appetite, allergy or intolerance to any of the intervention foods, 
vegetarian, had previous history of an eating disorder, were following a weight-reducing 
diet or recently experienced significant weight change.
Subjects were asked not to alter lifestyle habits for the duration of the study visits, to 
continue their usual diet and exercise regimen and to not start or stop taking any dietary 
supplements during the four weeks prior to or for the duration of the study. 
Premenopausal women were studied in the same phase of their menstrual cycle to 
minimise the potential effects of reproductive hormones on appetite control (Buffenstein
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et al., 1995). To standardise the schedule the study aimed to measure all subjects 4 weeks 
apart.
4.2.2 Study design
Subjects completed the preliminary telephone questionnaire and attended HNR for a 
screening day. Those eligible to participate attended for 3 five-day periods of dietary 
manipulation, in random order, with approximately four weeks between each visit (see 
Table 4.2.1 for details of each experiment week). For the first three days of the five-day 
residential period, participants were provided with ad libitum food of fixed P:E ratio 
(10%, 15% or 25% protein). The days were spent at HNR and the nights at the Wellcome 
Trust Clinical Research Facility (CRF), Addenbrooke’s Hospital. The last 36 hours of 
each experiment week was spent in a room calorimeter at the CRF. This study is 
described in Chapter 5. Transport was provided to move between the two sites so that 
participants were continuously supervised.
Subjects were advised that they were participating in a study to investigate the effects of 
different foods on metabolism and body composition. They were unaware of the manner 
in which the food was manipulated or that energy intake was being measured.
4.2.2.1 Screening day
Potential participants were invited to HNR to discuss the study in detail. After a full 
explanation of all the requirements of the study, written consent was obtained (Appendix 
II.2.2). A medical history was taken and all medications and supplements used were 
recorded. Subjects were asked to record medications they used during the study period or 
any appointments with their GP. Measurements were taken of body mass, height, waist
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circumference, and blood pressure (as described in Chapter 2). BMI was calculated to 
ensure subjects met eligibility criteria. The Eating Attitudes Test (EAT-26) (Garfinkel & 
Newman, 2001)) (Appendix II.2.8) was completed to identify symptoms of an eating 
disorder and as a basis for excluding restrained eaters. The maximum score to be eligible 
for inclusion was 20 points. Participants also completed the International Physical 
Activity Questionnaire to assess habitual exercise (Appendix II.2.9). This questionnaire is 
designed for 15-69 year olds to record activity that has occurred over the previous 7 days 
(Craig et al., 2003).
Subjects were instructed on how to complete a 4-day food diary, including 2 weekdays 
and 2 weekend days. Food diaries were completed prior to each experiment week to 
provide an estimate of habitual food intake and to document any changes in the P:E ratio 
of the background diet over the course of the study.
A visit to inspect the facilities and calorimeters at the CRF was arranged. All procedures 
performed at HNR and the CRF were explained in detail to the subjects who were also 
provided with information leaflets for future reference. Dates for the study visits were 
arranged to ensure that subjects were studied in the same phase of their menstrual cycle, 
and were free of other social engagements during the study visits and immediately prior 
to their study weeks, to maintain standard eating and exercise behaviour during the study 
period. Subjects were asked to avoid strenuous activity and alcohol for the 24 hours prior 
to commencing the study.
218
T a b le  4.2 .1  S tu d y  sc h e d u le
Screening Experiment Week
Performed at CRF
Day 1 
(Mon)
Day 2 
(Tue) Day 3 (Wed)
Day 4 
(Thurs)
Day 5 
(Fri)
Protein manipulated ad lib.diet
Protein manipulated isoenergetic diet
Food diary 4 days X
24 hour urine X X
Medical history/exam X
Eating attitudes test X
Physical activity questionnaire X
Basal Metabolic Rate X X
Fasting blood analyses X X
Post-prandial blood analyses X
Height X
Body mass X X X
Blood Pressure X X X
Waist X X X
Whole Body DXA X X
Bod Pod X X
Visual Analogue Scale - Appetite hourly
Visual Analogue Scale - Palatability Post-prandial
Continuous glucose sensor
Calorimeter
Afternoon walk or exercise in calorimeter X X X X
4.2.22 Experiment Week
Day 0: Each subject arrived at the CRF at 6pm with their 4-day food diary. Subjects were 
admitted to the CRF and asked about recent illnesses or medication use that might 
prevent them from participating in a study visit. Subjects were provided with a standard 
meal providing 6.4 MJ (see Appendix II. 1 for details) and asked to eat to satiety. They 
were then requested to fast from midnight.
Day 1: Basal metabolic rate (BMR) was measured before rising using a GEM indirect 
calorimeter (see 2.4.2 for details). Body mass, waist circumference, and blood pressure
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were measured and a whole body DXA scan, and a Bod Pod Body Composition 
measurement was performed (as described in Chapter 2). Blood samples were taken for 
measuring fasting glucose, insulin, lipids, and hsCRP (section 4.2.3.4 and in 2.6.3).
Participants were transported to HNR once these investigations were completed. On 
arrival at HNR, subjects were advised that food was available ad libitum throughout the 
day but that no food from other sources could be consumed. Subjects were invited to 
request food at any stage and to consume sufficient food in order to be comfortably full 
after meals. All food was weighed before and any leftovers after eating. Meals were 
consumed in private booths and subjects were encouraged not to talk with other study 
participants whilst eating. Drinks were not limited but subjects were required to consume 
the same number of cups of tea or coffee each day. Subjects were provided with a flask 
containing 150 ml milk that could be used for hot drinks or added to the breakfast meal 
but had to be consumed within the day. A snack box was provided for consumption 
between meals whilst at HNR, and more snacks could be requested at any stage.
Participants spent an hour in the afternoon on a supervised walk. At other times they were 
confined to the metabolic suite. During this time, they had access to the internet, 
computers, television, reading material and desk space for craft activities, writing etc. 
After the evening meal, subjects were transported back to the CRF to spend the night. A 
snack box was provided for the evening which was removed at bedtime, or at midnight, 
sealed and returned to the investigators the next day.
Day 2: Participants were transported to HNR from the CRF after an overnight fast. Their 
snack boxes were emptied and remaining food weighed. Food and exercise was provided 
as day 1. A continuous glucose monitor was inserted in the afternoon (see 2.6.3.2).
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Subjects were given full instructions about the care of the monitor and how to measure 
comparison capillary blood glucose levels. Subjects were given sheets to record the time 
of all activities, meals, exercise and blood sampling, and advised to measure blood 
samples and enter the results into the glucose monitor before every meal and before bed 
each day until the morning of day 5.
Day 3: Food and exercise was provided as for day 2. Visual analogue scales for the 
measurement of subjective hunger and satiety were completed hourly throughout the day. 
Visual analogue scales for palatability were completed after each meal. Subjects were 
transported to the CRF with weighed and prepared food for day 4, their evening snack 
boxes, and the remaining VAS questionnaires.
On returning to the CRF subjects entered the whole body calorimeter. An intravenous 
cannula was inserted before the calorimeter door was closed. They continued to complete 
hourly VAS until 2200 h and were able to consume food ad libitum from their snack 
boxes until bedtime.
Day 4: Participants spent the day in the calorimeter. The protocol is detailed in Chapter 5. 
Subjects started a 24-hour urine collection from the second urine sample of the day. 
Fasting blood samples were taken for glucose, insulin, lipids, and hsCRP. Basal and post­
prandial measures of insulin, ghrelin, GLP-1, PYY, PP, IGF-I and IGF-BP3 were taken at 
30-minute intervals after the first fixed-energy meal of the day until the second meal.
Day 5: Participants completed the 24-hour urine collection and then left the calorimeter. 
Repeat measures of basal metabolic rate, body mass, waist circumference, blood 
pressure, a whole body DXA scan, and air plethysmography measurements were
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performed. The continuous glucose monitor was removed. Subjects were offered a free 
choice of breakfast and provided with transport to return home.
The same protocol was repeated for the two subsequent study visits.
4.2.23 Dietary Manipulation
All food provided was manipulated to comprise 10%, 15% or 25% of energy from 
protein (10%P, 15%P, 25%P) from mixed protein sources. Dietary fat was kept constant 
at 30% (in order to minimise changes in energy density) and the proportion of 
carbohydrate was adjusted to be 60, 55 or 45% of total energy. The 15%P diet was 
designed to be a control diet, most consistent with habitual diet in the UK population. 
The 10%P and 25%P diets were elected as low and high-protein diets respectively which 
were within the recommended minimum and maximum protein requirements, and to 
allow the preparation of diets that were palatable, able to be consumed over a long period 
of time, and which could be prepared using whole foods.
Each participant was studied on three occasions and on each occasion was provided with 
one of the three diets. The order of diets was randomised. There were six possible 
sequences for the order of diets and subjects were randomly allocated to one of these 
sequences (Table 4.2.2).
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T a b le  4 .2 .2  D ie t se q u e n c e s  fo llo w ed  by  s u b je c ts  sh o w in g  %  e n e rg y  f r o m  p ro te in
Subject Visit 1 Visit 2 Visit 3
1 25% 10% 15%
2 25% 15% 10%
3 10% 15% 25%
4 15% 10% 25%
5 15% 10% 25%
6 15% 25% 10%
7 25% 10% 15%
8 10% 15% 25%
9 15% 25% 10%
10 10% 25% 15%
The visual appearance of dishes for each macronutrient composition was matched as 
closely as possible to disguise the experimental manipulation of nutrient composition and 
all were informally pretested.
All meals were homogenous in nature to ensure that the dietary composition was correct 
irrespective of the total volume consumed. Each meal contained two different items -  one 
savoury, one sweet - and the recipes were adjusted to produce food of the appropriate 
macronutrient composition. As described in Chapter 2 standard tables (FSA, 2002) were 
used to calculate the composition of meals. Fibre and energy density were kept constant 
as far as possible for each macronutrient composition of the same meal. A summary of
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the composition of the meals is shown in Table 4.2.3 and Table 4.2.4. The meals are 
detailed in Appendix II. 1.
The meals were prepared in the HNR volunteer suite kitchen following good food 
hygiene standards. Where appropriate, meals were frozen, then defrosted and heated by 
microwave oven prior to each investigation day to an internal temperature of 80°C 
according to a standard protocol.
All meals were offered in large serving dishes from which participants could select their 
own serving size, to ensure ad libitum intake. Snacks of the appropriate composition were 
provided in a snack box from which subjects could eat freely. All food provided and all 
leftover food was weighed to calculate energy intake. This methodology is comparable to 
previous highly controlled appetite studies (e.g. (Stubbs et al., 1995a).
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T a b le  4 .2 .3  M a c r o n u tr i e n t  c o m p o s itio n , f ib re  a n d  e n e rg y  d e n s ity  o f  th e  s tu d y  m ea ls  p e r  se rv in g , d a y s  1 a n d  3.
Meal and Diet type Protein
%
Fat
%
Carbohydrate
%
Energy
kJ
Fibre
g
Energy Density 
kj/g
Breakfast
Bran flakes cereal
10%P 10.2 29.7 60.1 3491 24.5 7.9
15%P 14.8 30.1 55.1 3515 24.4 7.6
25 %P 24.6 30.3 45.1 3492 23.6 7.8
Lunch
Macaroni cheese
10%P 10.4 30.0 59.7 5008 6.5 5.0
15%P 15.1 30.1 54.8 4999 6.5 5.8
25%P 25.0 30.1 44.9 5014 6.4 5.9
Raspberry yoghurt
10%P 10.0 30.2 59.7 2496 8.0 5.4
15%P 15.4 30.3 54.3 2504 8.9 4.3
25 %P 24.6 30.2 45.2 2502 9.1 3.3
Dinner
Mushroom chicken and rice
10%P 9.9 30.0 60.1 5005 2.7 5.1
15%P 15.2 30.0 54.9 5008 2.5 5.3
25 %P 25.0 29.7 45.3 4984 2.2 5.4
Bread and butter pudding
10%P 10.0 30.1 60.0 2498 4.4 7.6
15%P. 14.9 30.3 54.7 2497 3.0 7.6
25 %P 24.7 30.3 45.1 2508 3.2 5.1
Snacks
Yoghurt muffins*
10%P 10.0 29.9 60.1 2491 2.3 12.9
15%P 15.1 30.3 54.6 2504 2.6 11.3
25 %P 25.1 30.7 44.3 2503 3.8 9.2
Cheese scones*
10%P 10.1 29.9 60.1 5000 6.6 14.3
15%P 15.1 29.9 55.0 4998 6.0 13.7
25 %P 25.0 30.0 45.0 5009 6.6 12.5
Tuna sandwiches*
10%P 11.8 29.5 58.7 2554 3.6 11.3
15%P 15.2 29.9 54.9 2504 3.3 10.9
25 %P 25.1 29.9 45.0 2501 10.5 9.5
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T a b le  4 .2 .4  M a c r o n u tr ie n t  co m p o s itio n , f ib re  a n d  e n e rg y  d e n s ity  o f  th e  s tu d y  m e a ls  p e r  se rv in g , d a y s  2 a n d  4
Meal and Diet type Protein
%
Fat
%
Carbohydrate
%
Energy
kj
Fibre
g
Energy Density 
kj/g
Breakfast
Porridge
10%P 9.9 30.3 59.7 3508 13.9 3.7
15%P 15.1 29.7 55.2 3499 13.6 3.7
25 %P 24.3 30.2 45.5 3511 12.6 4.7
Lunch
Vegetable and lentil curry
10%P 10.3 30.0 59.7 5018 24.5 2.6
15%P 15.2 30.0 54.9 5019 25.7 2.7
25 %P 24.8 29.7 45.4 4980 23.5 3.1
Strawberry yoghurt
10%P 10.1 30.0 59.9 2508 6.2 5.7
15%P 15.1 30.1 54.8 2517 7.1 4.6
25 %P 24.7 30.5 44.8 2515 6.3 3.5
Dinner
Bolognaise pasta
10%P 10.8 29.9 59.2 5019 10.4 5.3
15%P 15.0 29.9 55.1 4998 10.9 5.1
25 %P 25.1 29.7 45.2 4993 9.6 5.0
Rice pudding
10%P 9.8 29.9 60.2 2504 0.4 5.2
15%P 14.5 30.4 55.1 2500 0.4 5.7
25%P 24.5 30.5 45.0 2509 0.3 4.4
Snacks (day 2)
Peanut butter sandwiches *
10%P 11.5 30.4 58.1 2472 4.1 12.2
15%P 15.4 29.6 55.0 2500 10.6 11.8
25 %P 17.8 42.6 39.6 2871 13.8 11.9
* Snacks were provided during the day and in the evening. The snacks on day 1 were yoghurt muffins and 
cheese scones during the day and in the evening, with the addition of raspberry yoghurt in the evening. On 
day 2 peanut butter sandwiches were provided during the day, and the evening snack was peanut butter 
sandwiches, yoghurt muffins, cheese scones and strawberry yoghurt. On day 3 the daytime snack was tuna 
sandwiches and the evening snack was tuna sandwiches, yoghurt muffins, cheese scones and raspberry 
yoghurt. No snack was provided on day 4.
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4.2.3 Outcome measures
4.2.3.1 Energy Intake
Energy intake was calculated from the weight and composition of the food consumed.
4.2.3.2 Palatability
Visual analogue scales to assess palatability of the meal were completed after each meal 
and were completed separately for each course of the meal (Table 4.2.1).
4.2.3.3 Hunger and Satiety scores
Visual analogue scales to assess hunger, fullness, and mood were completed hourly on 
day 3 from 0900h to 2200h (Table 4.2.1). (See 2.3 for detail and Appendix 1.2.7 for the 
questionnaire).
4.2.3.4 Body composition
Body composition was measured using Dual Energy X-ray absorptiometry (DXA) and air 
plethysmography (Bod Pod).
42.3.5 Urine Samples
24-hour urine collections were collected between days 4 and 5 of the experiment weeks 
and were measured as a crosscheck on protein intake during the dietary manipulation. 
Subjects’ urine was measured and sampled from the time they entered the calorimeter 
until leaving the calorimeter 36 hours later. After each void, the urine volume was 
measured and 2 x 10 ml aliquots were collected in pre-labelled urine collection tubes
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(Sarstedt, Leicester, UK). From the first void after 0700 h (the second void of the day) on 
day 4 of the study until the first void on day 5 of the study all urine was collected for a 24 
h urine collection. The total volume was recorded and 2 x 25 ml aliquots were taken into 
a glass universal. Samples were stored in a refrigerator at -A  °C until analysis.
4.2.3.6 Blood markers o f metabolic risk and satiety
10 ml blood samples were taken on days 1 and 4 of each of the three study visits. The 
blood samples were analysed for markers of cardiovascular risk: glucose, insulin, lipids, 
and high-sensitivity c-reactive protein (hsCRP).
On day 4, 11 ml blood samples were taken at -1, 30, 60, 90, 120, 150, 180, 210 minutes 
after eating the meal to measure post-prandial levels of glucose, insulin, ghrelin, GLP-1, 
PYY, PP, IGF-I and IGF-BP3 (described in 2.6.3).
Interstitial glucose measurements were recorded every 20 minutes from the evening of 
day 2 until the morning of day 5 using continuous glucose monitoring (2.6.3.2). The 
CGMS was worn for a sufficient duration to provide data from two full 24-hour (0700 h -  
0700 h) periods, from 1600 h on day 2 until 0900 h on day 5.
4.2.3.7 Dietary assessment
Four-day food diaries, including 2 weekdays and 2 weekend days were collected prior to 
each experiment week. Instructions on how to complete the diary were provided at the 
screening visit.
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4.2.3.8 Data analysis
The primary outcome measure of total energy intake over the three ad libitum eating days 
was analysed using a random effects model for continuous normal data. Subjects were the 
only random effect to make the analysis within subject; the fixed effects were the 
percentage of protein (categorical). In addition, period effects and the linear trend for 
percentage of protein were investigated. The primary comparisons of interest, 25%P vs. 
15%P and 10%P vs. 15%P, were estimated with 95% confidence intervals.
Exploratory secondary endpoints were analysed using the same model. In addition, 
period-specific baseline measurements were used for body composition measurements to 
assess a carry-over effect. Appetite VAS scores and post-prandial blood concentrations 
were plotted over time. The area under the curve was calculated and analysed using the 
same random effects model.
Potential confounders were investigated by including them in the model as fixed effects 
and assessing whether the primary comparisons of interest remain qualitatively 
unchanged. All assumptions of the models were checked using Q-Q plot of residuals to 
check normality, residuals versus predicted values to check homogeneity of residual 
variance, residuals versus percentage protein to check for model fit.
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4.3 Results
4.3.1 Subject Characteristics
Subjects were recruited from the general population. Fifteen subjects appeared eligible to 
participate in the study after completing the telephone-screening questionnaire and 
attended MRC HNR for a screening visit. Of these, two were ineligible because they 
exceeded the upper limit of BMI, and three were unable to commit adequate time for the 
study. The ten remaining subjects were recruited, and all subjects completed the three 
study visits.
Baseline characteristics of the study population are shown in Table 4.3.1. There were 5 
male and 5 female subjects. The mean age was 43.4 y (SD 14.4, range 24-64) and mean 
BMI was 22.2 kg/m2 (SD 2.2, range 17.5 -  24.4 kg/m2). Mean waist circumference was 
78 cm (SD 10.9, range 58 -  94). Mean EAT-26 was 3.7 (SD 2.8, range 0 -  9). All 
subjects performed some physical activity, but only six subjects engaged in vigorous 
exercise, with maximum reported exercise time of 39 min/day. Subjects reported 
spending 30.7 min/d (SD 27.9) engaged in moderate exercise and 36.2 min/d (SD 34.9) 
performing light activity.
There was no difference between male and female subjects in age (p = 0.627), BMI (p = 
0.051), systolic (p = 0.055) or diastolic (p = 0.212) blood pressures, EAT-26 score (p = 
0.344) or physical activity (vigorous p = 0.46, moderate p = 0.74, light p = 0.64, none p = 
0.13). As would be expected, waist circumference was significantly lower in female 
(mean 69.8 cm, SD 6.9) than male (mean 86.2 cm, SD 7.2) subjects (p = 0.006). Given
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the similarities between male and female subjects, the data were analysed as a single
group.
Table 4.3.1 Characteristics of the study population
n = 10 Unit Mean SD Range
Age y 43.4 14.4 2 4 -6 4
Body Mass kg 65.8 12.6 38.9-82.1
Height m 1.71 0.10 1.49-1.84
BMI kg/mz 22.2 2.2 17.5 - 24.4
Systolic BP mm Hg 122 12 100 - 139
Diastolic BP mm Hg 71 10 5 9 -8 5
Waist
cm 78 10.9 5 8 - 9 4
Circumference
EAT-26 score 4 3 0 - 9
Physical Activity 
(from IPAQ)
- Vigorous
min/day
14.6 16.6 0 - 3 9
- Moderate 30.7 27.9 0 - 7 7
- Light 36.2 34.9 0 - 1 2 0
- None 785 450 120- 1680
4.3.2 Baseline diets
There was no evidence of a difference within subjects in recorded food intake, using a 
four-day food diary, prior to each visit for energy intake (p = 0.93), protein (p = 0.78), fat 
(p = 0.9), carbohydrate (p = 0.12), NSP (non-starch polysaccharide fibre) (p = 0.65) or
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alcohol (p = 0.06). There was no effect of visit order. Individual results are shown in 
Figure 4.3.1. Table 4.3.2 shows the mean energy intake prior to each study visit, and the 
percentage of energy consumed from protein, fat and carbohydrate.
Figure 4.3.1 Individual macronutrient intake (as a % of £1) prior to each study visit
C = carbohydrate intake, F = fat intake, P = protein intake
Subject and Experimental Diet
100%
£  80%
0 - 0 , 0 .  Cl.0 l.C l.  0 - O .O l. 0 - 0 , 0 ,  0 . 0 . 0 ,  0l. 0 l.C l,  0 . 0 . 0 .  0 . 0 . 0 .  0 . 0 . 0 .  Cl.C l.C l.
O Oiri m  O »ri<n Oirno O inn o  m iri o  ©</->>r> ovrn
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Table 4.3.2 Recorded food intake from four-day food diaries compiled prior to the experimental 
visits (Mean, Cl)
Food record 
p rio r to diet:
Energy 
Intake (MJ)
% of energy 
from  protein
% of energy 
from  fat
% of energy 
from
carbohydrate
10% P 8.4 (7.7, 9.7) 15.2(13.4, 17.0) 35.4 (31.6, 39.1) 50.0 (46, 53.6)
15% P 8.6 (7.6, 9.6) 15.4(13.6, 17.2) 37.7 (33.9,41.5) 47 (43.4, 50.8)
25% P 8.6 (7.6, 9.6) 14.4(12.6, 16.2) 37.5 (33.7,41.3) 47 (43.2, 50.6)
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4.3.3 Outcome measures
4.3.3.1 Study diets
Composition of the study diets was verified by measuring urine nitrogen, and palatability 
of the study diets was assessed to ensure the diets were of similar taste.
4.3.3.1.1 Palatability
There was little difference between subjects’ rating of palatability of the study diets and 
no difference between diets in the overall mean palatability scores for each question on 
the palatability questionnaire (Table 4.3.3).
The 25%P breakfast was rated more filling than the 10%P (p = 0.008) or 15%P (p = 
0.027) breakfasts but subjects found the 15%P breakfast more enjoyable than the 25%P 
(p = 0.03). The 25%P lunch main meal was rated tastier than the 10%P (p = 0.005) and 
more satisfying compared to the 10%P (p = 0.003) and 15%P (p = 0.02) diets. There was 
no difference in palatability ratings for the lunch dessert. The dinner main meal scored 
higher for tastiness with 15%P than 10%P (p = 0.011) and was more pleasant (p = 0.012). 
The 25%P (p = 0.008) and 15%P (p = 0.044) meals were more enjoyable than the 10%P 
meal. There were no differences in ratings for the dinner dessert.
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4.3.3.1.2 Urinary nitrogen
Nitrogen excretion during the 25%P diet (0.77% ± 0.07) was significantly higher than 
during the 15%P diet (0.49% ± 0.07) (P<0.0001) and the 10%P diet (0.40%±0.07) (P 
<0.0001) (Figure 4.3.2). The difference between the 10%P and 15%P diets was not 
significant (P = 0.18). Individual results are shown in Figure 4.3.3. There was no effect of 
visit order on nitrogen excretion rates. Unfortunately three of the samples were misplaced 
during storage at the CRF and were not able to be included in this analysis.
Figure 4.3.2 Mean (± SEM) urine nitrogen collected on day 4 of each study visit
■  10%P
15%P
Experimental diet
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F ig u re  4 .3 .3  U r in a ry  n itro g e n  e x c re tio n  o n  d a y  4  o f  e a c h  s tu d y  v is it f o r  in d iv id u a l su b je c ts .
10%P n = 8, 15%P n = 10, 25%P n = 9,
no data was available for subject 1, 25%P; subject 3, 10%P; and subject 9, 10%P
1.6
1.4
1.2
B 10%P
15%P
B 25 %P
1 2 3 4 5 6 7 8 9  10
Subject ID
4.3.3.2 Energy intake
Energy intake (El) was analysed by comparing the three study diets, and separated into 
energy intake per day, per meal, and eating occasion (meals versus snacks). All statistical 
analyses were performed twice, including and excluding subject 8, whose energy intake 
exceeded requirements by 52 -  84% on each treatment. Results reported include all 
subjects unless removing subject 8 changed the outcome of the analysis, where both 
results are included.
4.3.3.2.1 Total El per diet
Individual total El per treatment is shown in Figure 4.3.4. With all subjects included in the 
analysis the total energy intake was not significantly different between each study diet (p 
= 0.16). The mean total El during the three ad libitum days on the 10%P diet was 28.5
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MJ/3 days (SD 13.3), during the 15%P diet was 28.2 MJ/3 days (SD 11.1) and during the 
25%P diet was 27.0 MJ/3 days (SD 12.0) (Figure 4.3.4) When subject 8 was excluded 
from the analysis the mean total El during the 25%P diet (24.2 MJ/3 d, SD 8.7, 8.1MJ/d, 
SE 1.0) was significantly lower than the 15%P visit (26.1 MJ/3 d, SD 9.2, 8.7 MJ/d, SE 
1.0), (p = 0.001), with a mean of 25.3 MJ/3 days, SD 9.3, 8.4 MJ/d, SE 1.0) during the 
10%P diet (Figure 4.3.5). The difference was not affected by order of subjects’ visits. 
There was no difference in energy intake between the diets when analysed per meal or per 
day.
Figure 4.3.4 Total energy intake (El) over three experimental days for all subjects for each 
experimental diet
60 
50 
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m
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10%P
15%P
25%P
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F ig u re  4 .3 .5  M e a n  e n e rg y  in ta k e  fo r  a ll s u b je c ts  a n d  th e  c o h o r t  e x c lu d in g  s u b je c t  8 f o r  e a c h
e x p e r im e n ta l d ie t
■ 10%P
■ 25%P
Mean, all subjects Mean, excluding subject 8
Cumulative energy intake over the three days was plotted for each eating episode and the 
mean results are presented in Figure 4.3.6 and Figure 4.3.7. Figure 4.3.6 shows that food 
intake pattern was very similar for each day, with slightly lower intake during the 25%P 
diet throughout the entire three-day experiment, particularly towards the end of each day 
(dinner and the evening snacks). This effect was evident from day 1 of the study. Total 
cumulative energy intake is presented in Figure 4.3.7 for each study diet and demonstrates 
the similarity in the pattern of consumption for each day of the study visits.
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Figure 4.3.7 Mean cumulative energy intake for all subjects for the three experimental days of each 
study visit.
10%P 15%P 25%P
Diet type
H Day 3 
9  Day 2 
H  Day 1
4.3.3.2.2 El per diet per day
Data were separated into different time periods throughout the experimental week to look 
in greater detail at the pattern of El. The El per day of each study visit is shown in Figure 
4.3.8 for individual subjects and the mean is shown in Figure 4.3.9. There was a 
significant effect of diet and day on energy intake (p = 0.0015). On the 10%P diet, El was 
lower on day 2 than day 1 or 3 (p = 0.015). On the 15%P diet, El was lower on day 2 than 
day 1 (p < 0.0001) with the greatest intake on day 3 (p = 0.028). During the 25%P diet, 
El did not differ between day 1 and 2 but was marginally higher on day 3 than day 1 (p = 
0.05).
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F ig u re  4 .3 .8  E l  o n  ea c h  s tu d y  d a y  fo r  a ll su b je c ts  fo r  e a c h  e x p e r im e n ta l d ie t
■  25%P
Subject ID  and day o f study visit
Figure 4.3.9 Total Mean (SEM) El per day for the three ad libitum days of each study diet
■ 10%P
15%P
■ 25%P
Day of study visit
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4.3.3.2.3 El per meal per diet
El between diets was no different for breakfast (p = 0.29), lunch (p = 0.20), or evening 
snacks (p = 0.40). El at dinner was significantly reduced during the 25%P diet compared 
to the 10%P and 15%P diets (p = 0.0002). Day snacks (DS) were significantly increased 
during the 25%P diet compared to the 10%P and 15%P diets (p = 0.01). When subject 8 
was removed from the analysis, there was an additional difference in El at lunch which 
was significantly lower during the 10%P (p = 0.04) and 25%P diet (p = 0.015) compared 
to the 15%P diet. Individual El for each meal is shown in Figure 4.3.11. The mean total 
El for each meal is shown in Figure 4.3.10. Whilst El intake differed between meals (p < 
0.00001) there was no diet and meal interaction for El (p = 0.220).
Figure 4.3.10 Mean (SEM) total El per meal per diet over the 3 study days
a, 25%P < 15%P and 10%P
b, 25 %P > 15%P and 10%P
■ 10%P
15%P
■ 25% P
Daytime snack Evening snackDinnerBreakfast Lunch
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El was also analysed by separating food consumption into meals (including all food 
consumed at breakfast, lunch and dinner) or snacks (daytime and evening snacks). During 
the 25%P diet total energy intake from meals was reduced (20.9 MJ/3 d) (p = 0.0001) 
compared with the 15%P (23.7 MJ/3 d) and 10%P (23.5 MJ/3 d) diets. Conversely El 
from snacks was significantly increased during the 25%P diet (6.1 MJ/3d) compared with 
the 15%P (4.6 MJ/3d, p = 0.001) and 10%P (4.8 MJ/3d, p = 0.004) diets. El per meal 
type is shown in Figure 4.3.12 for individual subjects and the mean is shown in Figure 
4.3.13. As expected, El from meals was significantly higher than from snacks (p = 
0 .00001).
Figure 4.3.11 Total El per meal per diet for individual subjects 
B = Breakfast, L = Lunch, D = Dinner, DS = Day Snack, ES = Evening Snack
10%P
15%P
2 5 % P
1
0Q Lj O M M IqJujOQ Lj O M1 'q|uj nuQiSK PQ U Q 85 maa Lj q 83 m IB J Q cq U Q 85 &PQ U Q 85 £
Subject ID
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F ig u re  4 .3 .12  T o ta l  E l  p e r  m ea l ty p e  p e r  su b je c t , M  =  m ea l, S =  s n a c k
Subject and meal type
■  10%P 
O 15%P
■  25 %P
Figure 4.3.13 Mean (SEM) total El per meal type
■ 10%P 
0  15%P
■  25 %P
Meal type
Snack
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4.3.3.2.4 Ad libitum  El versus calculated energy requirements
Energy intake during the ad libitum eating days was compared to the energy of food 
provided during the fixed-eating day. As detailed in Chapter 5 the calculation was based 
on measured BMR, with an allowance for the two periods of exercise that were 
performed whilst in the calorimeter. The total exercise was similar to the one-hour walk 
that subjects performed each ad libitum day, so the calculated energy intake should 
approximate energy needs on all study days. Subjects were consistent in whether their El 
during the ad libitum days exceeded energy requirements or was below requirements 
(Figure 4.3.14).
Figure 4.3.14 El during the ad libitum El study days (day 1-3) and the calculated energy 
requirements (fixed El day 4).
Subjects 1, 3 ,4 , 9, 10 were female, subjects 2, 5 ,6 , 7, 8 were male
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It is evident in this figure that subject 8 exceeded energy requirements by 1 . 5 - 2  times. 
When subject 8 was excluded from the analysis the mean difference in energy intake 
between the ad libitum eating days and the calculated energy requirements was small 
(Table 4.3.4). Excluding subject 8, El was less than estimated energy needs during the 
25%P diet, and El was significantly lower during the 25%P diet than the 15%P diet (p = 
0.003). Of the subjects who overate all except one was male, while all female subjects 
under-ate except one. Mean El and the mean calculated energy requirement is shown in 
Figure 4.3.15.
Table 4.3.4 Mean difference in El between the ad libitum eating days and estimated energy 
requirements (excluding subject 8)
Diet Difference in energy 
intake (MJ)
SEM
10%P 0.03 0.7
15%P 0.4 0.7
25 %P -0.2 0.6
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Figure 4.3.15 Mean (SD) El during the ad libitum study days (El 123) and the calculated El 
requirements (El 4).
□  Ad libitum E l 
19 Fixed El
15%P 25%P10%P
4.33.3  Hunger and satiety
Fullness scores were significantly higher during the 25% P diet (p = 0.006) than the 
15%P diet. Figure 4.3.17 demonstrates that scores were higher during the 25%P diet at 
1100 h compared to the 10% P diet (p = 0.018), at 2000 h compared to the 10% P diet (p 
= 0.005), at 2100 h compared to the 10%P and 15%P diets (p = 0.019), and at 2200 h 
25%P compared to the 15%P diet (p = 0.01). The AUC fullness scores were significantly 
higher during the 25%P diet than the 15%P (p = 0.001) and 10%P diets (p = 0.018) 
(Table 4.3.5). There was no difference in the maximum score (p = 0.54), time to 
maximum score (p = 0.77), or the minimum score (p = 0.36), but the minimum score was 
earlier in the day during the 25%P diet (p = 0.017) with most subjects reporting their 
lowest scores before breakfast.
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There was no difference in self-reported hunger scores at any timepoint during the day 
(Figure 4.3.16) or for the AUC (Table 4.3.5).
The 15%P diet produced the highest scores for the question ‘How much food do you 
think you could eat?’ at 1100 h (compared to the 10%P and 25%P diets, p = 0.033), 1800 
h (compared to the 10%P and 25%P diets, p = 0.005), and 2100 h (compared to the 25%P 
diets, p = 0.04) (Figure 4.3.18). There was no difference in the AUC (Table 4.3.5) or any 
other parameters.
In response to the question ‘How strong is your desire to eat?’ there was no difference in 
scores between the diets (p = 0.89) or at any timepoint during the day (Figure 4.3.19). 
The AUC did not differ between the diets (Table 4.3.5).
Self-reported scores for ‘How content are you?’ did not differ at any timepoint (Figure 
4.3.20) or for the AUC (Table 4.3.5). Scores were higher for visit 2 (p = 0.018) and 3 (p = 
0.022) than for visit 1.
In response to the question ‘How irritable are you?’ mean VAS scores were lower with 
the 15%P diet than 10%P (p = 0.05) or 25%P diets (p = 0.006). Figure 4.3.21 
demonstrates that there was no difference in scores at specific timepoints during the day, 
and the AUC did not differ between diets (Table 4.3.5). Scores were lower during visits 2 
and 3 (p <  0.0001).
Mean VAS scores were lower during the 15%P and 25%P diets than the 10 %P diets (p < 
0.0001) for the question ‘How depressed are you?’. Scores were lower for visit 2 than
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visit 1 (p < 0.0001) but did not differ at any timepoint (Figure 4.3.22) or for the AUC 
(Table 4.3.5).
In response to the question ‘How alert are you?’ mean scores were higher during the 
25%P diet than 10%P or 15%P diets (p < 0.0001) with higher scores at 1100 h (p = 0.05) 
and at 2200 h (p = 0.04) (Figure 4.3.23). Scores were lower during visit 3 than visit 1 (p = 
0.005). There was no difference in the AUC (Table 4.3.5) or for any other parameter 
analysed.
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Figure 4.3.17 Mean ± SEM VAS score ‘How full do you feel?’
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Figure 4.3.19 Mean ± SEM VAS score ‘How strong is your desire to eat?’
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Figure 4.3.21 Mean ± SEM VAS score ‘How irritable are you?’
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Figure 4.3.23 Mean ± SEM VAS score ‘How mentally alert are you?
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Table 4.3.5 Mean ± SEM AUC for self-reported scores of hunger and satiety as assessed by VAS 
Vas detailed in page 248 and 4.3.3.3
VAS 10%P diet 
AUC score.h ± 
SEM
15%P diet 
AUC score.h 
± SEM
25%P diet 
AUC score.h 
± SEM
p value
Hunger 302 ± 49 347 ±49 302 ± 49 0.14
Full 810 ± 7 6 788 ± 76 871 ± 7 6 0.004*
Desire 290 ± 49 302 ± 49 286 ± 4 9 0.87
How much 328 ± 49 346 ±49 302 ± 49 0.21
Content 1006 ±71 1020 ±71 988 ±71 0.70
Irritable 193 ± 70 156 ± 70 214 ± 7 0 0.59
Depressed 239 ± 73 144 ±73 154 ± 73 0.30
Alert 1051 ± 6 9 1016 ±69 1110 ± 69 0.34
43.3.4 Body mass
Subjects were weighed at the start and end of each study visit. There was no evidence of 
a difference in body mass on day 1 (p = 0.30) or day 5 (p = 0.31) of each study visit. The 
body mass difference between day 1 and day 5 was -0.3 kg (SD 0.8) during the 10%P 
diet, -0.4 kg (SD 0.9) during the 15%P diet, and -0 .4  (SD 0.8) during the 25%P diet with 
no significant difference between each study diet (p = 0.94). Individual data are shown in 
Table 4.3.6 and Figure 4.3.24. The analysis was repeated excluding subject 8 whose food
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consumption significantly exceeded energy requirements on all ad libitum eating days. 
Excluding this subject did not materially change the mean body mass on day 5 (p = 0.06) 
or the change in body mass (p = 0.937) for any of the study diets.
Table 4.3.6 Body Mass (kg) of the study population -  measured at baseline and at the end of each 
study visit.
Subject 10% Protein 15% Protein 25% Protein
Day
1
Day
5
Difference Day
1
Day
5
Difference Day
1
Day
5
Difference
1 61.4 60.8 -0.6 60.7 60.2 -0.5 61.1 60.8 -0.3
2 83.2 83.2 0.0 84.5 83.4 -1.1 82.1 83.2 1.1
3 73.9 73.3 -0.6 74.1 72.3 -1.8 73.7 72.8 -0.9
4 61.6 61.1 -0.5 62.2 62.9 0.7 62.6 61.7 -0.9
5 65.6 64.9 -0.7 66.7 65.4 -1.3 66.4 64.9 -1.8
6 70.2 69.4 -0.8 71.1 70.4 -0.7 70.3 69.8 -0.5
7 71.5 71.6 0.1 72.0 72.1 0.1 70.2 70.2 0.0
8 78.0 79.7 1.7 78.6 79.9 1.3 81.2 81.9 0.7
9 38.5 37.4 -1.1 38.9 38.5 -0.4 38.7 37.7 -0.1
10 54.2 53.4 -0.1 54.7 54.2 -0.5 54.0 53.5 -0.5
Mean 65.8 65.5 -0.3 66.4 65.9 -0.4 66.0 65.6 -0.4
Mean 
(excluding 
subject 8)
64.5 63.9 -0.6 65.0 64.4 -0.6 64.3 63.8 -0.5
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4.33.5 Body Composition
Measurement of body composition by air displacement plethysmography is presented in 
Table 4.3.7. Measurements of total body mass, fat mass and lean mass by DXA are also 
presented for comparison.
Mean fat mass did not differ between diets on day 1 or day 5 of each study visit but was 
significantly reduced on day 5 compared to day 1 on the 10%P diet (p = 0.003) and the 
15%P diet (p < 0.0001). Mean fat-free mass was higher on day 5 on the 15%P diet than 
the 25%P diet (p = 0.013) and there was a significant increase in mean fat-free mass from 
day 1 to day 5 on the 15%P diet (p = 0.045).
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There was no evidence of a difference between treatments in the change over five days in 
body mass (25%P -0.40 kg, SE 0.26, 15%P -0.34 kg, SE 0.26, 10%P -0.34kg, SE 0.26) 
(p = 0.96), fat mass (25%P -0.09 kg, SE 0.26, 15%P -0.82 kg, SE 0.26, 10%P -0.52 kg, 
SE 0.26) (p = 0.06) (Figure 4.3.25), or fat free mass (25%P 0.15 kg, SE 0.28, 15%P 0.48 
kg, SE 0.27, 10%P -0.3 kg, SE 0.27) (p = 0.07) (Figure 4.3.26).
When body composition was measured by DXA, there was no evidence of a difference 
between diets in mean mass, fat mass or lean mass on day 1 or day 5 of each study diet. 
Fat mass was significantly lower on day 5 than day 1 on the 25%P diet (p = 0.0009) 
(Table 4.3.7).
There was no evidence of a difference between treatments in the change over five days in 
body mass (25%P -0.27 kg, SE 0.28, 15%P -0.27 kg, SE 0.28, 10%P -0.38kg, SE 0.28) 
(p = 0.87), or fat free mass (25%P 0.22 kg, SE 0.32, 15%P -0.36 kg, SE 0.32, 10%P -  
0.16 kg, SE 0.32) (p = 0.21) (Figure 4.3.28) when measured by DXA. Fat mass fell 
significantly more on the 25%P diet than the 15%P diet (25%P -0.48 kg, SE 0.26, 15%P 
0.071 kg, SE 0.13, 10%P -0.19 kg, SE 0.13) (p = 0.009) (Figure 4.3.27).
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Table 4.3.7 Mean (SEM) mass, fat mass, fat-free mass/lean mass measured by Bod Pod and DXA on 
day 1 and 5 of each diet
Testing the change in mass between day 1 and day 5 (p*) and the difference between mass on day 1 and day 
5 (p§).
Diet Total body mass (kg) Fat mass (kg) Fat-free mass (kg)
Day 1 Day 5 p* Day 1 Day 5 p* Day 1 Day 5 p*
Bod Pod
10%P 65.8±4.1 65.5±4.1 0.17 16.1±2.0 15.6±2.0 0.03 49.7±3.5 49.9±3.6 0.34
15%P 66.2±4.1 65.8±4.1 0.23 16.6±2.0 15.8±2.0 <0.001 49.6±3.6 50.0±3.6 0.04
25%P 66.1 ±4.2 65.7±4.2 0.11 16.5±2.2 16.4±2.2 0.8 49.6±3.5 49.3±3.6 0.43
P§ 0.51 0.45 0.44 0.17 0.94 0.04
DXA
10%P 65.9±4.2 65.5±4.2 0.10 16.6±2.3 16.4±2.3 0.14 46.4±3.4 46.3±3.4 0.58
15%P 66.2±4.2 65.9±4.2 0.38 16.7±2.3 16.8±2.3 0.5 46.7±3.4 46.3±3.4 0.23
25 %P 66.2±4.2 65.9±4.2 0.34 17.1± 2.4 16.6±2.4 0.0009 46.3±3.3 46.5±3.3 0.55
p§ 0.54 0.29 0.25 0.27 0.44 0.37
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Figure 4.3.26 Change in fat-free mass from day 1 to day 5 of each study diet measured by Bod Pod 
for individual subjects
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Figure 4.3.28 Change in lean mass from day 1 to day 5 of each study diet measured by DXA for 
individual subjects
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There was no evidence of a difference in waist circumference between visits on day 1 (p = 
0.34), day 5 (p = 0.76), or the change in waist circumference between day 1 and day 5 on 
each study visit (p = 0.88). Individual measurements are shown in Figure 4.3.29.
Figure 4.3.29 Waist circumference difference of all subjects at each visit
■ 10%P 
B 15%P 
H25%P
Subject ID
4.3.3.6 Metabolic Risk
Measurements of the change in systolic (SBP) and diastolic blood pressure (DBP) 
between day 1 and 5 of each study visit are shown in Figure 4.3.30 and Figure 4.3.31. 
There was no difference between the study visits for systolic blood pressure on day 1 (p = 
0.15), day 5 (p = 0.97), or the change in systolic blood pressure between day 1 and day 5 
(p = 0.46). Diastolic blood pressure was higher on day 1 of the 25%P visit (72.2 mmHg, 
SD 10.6) compared to day 1 on the 10%P visit (65.8 mmHg, SD 5.2) (p = 0.02). The day 
1 DBP on the 15%P visit was 70 mmHg (SD 11.2). The difference in DBP was no longer 
significant when visit order was added to the model (p = 0.08). There was no difference 
between visits for the DBP on day 5 (p = 0.88), or between day 1 and day 5 (p = 0.30).
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Figure 4.3.31 Diastolic blood pressure differences of all subjects at each visit
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43 .3 .7  Blood markers o f satiety
4.3.3.7.1 Ghrelin
After the fixed-energy breakfast there was no difference in subjects’ blood ghrelin 
concentration between diets at baseline or at any other timepoint (Figure 4.3.32). There 
was a marked trend towards higher mean AUC as the percentage of protein increased: 
10%P 18961 ± 12637 pg.min/ml, 15%P 28252 ± 12977 pg.min/ml, 25%P 35351 ± 12637 
pg.min/ml; although this difference was not significantly different (p = 0.2). There was 
no evidence of a difference between the diets in ghrelin concentration or time of the 
maximum and minimum values.
Figure 4.3.32 Mean ± SEM blood ghrelin after a fixed-energy breakfast eaten at time 0
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4 .3 .3 .7 .2  G L P -1
Subjects’ blood GLP-1 did not differ between the diets at baseline, but at 120 min GLP-1 
was significantly lower on the 10%P (2.6 ± 0.2 pM) diet compared to the 25%P diets (2.9 
± 0.2 pM), p = 0.018. (15%P 2.6 ± 0.2 pM). There was no difference between the diets at 
any other timepoint (Figure 4.3.33). The mean AUC increased as the percentage of protein 
increased, but the difference between the diets was not significant (p = 0.26). There was 
no evidence of a difference between the diets in concentration of GLP-1 or time of the 
maximum and minimum values.
Figure 4.3.33 Mean ± SEM blood GLP-1 after a fixed-energy breakfast eaten at time 0
* indicates significant difference between the 10%P and 25%P diets
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4.3.3.7.3 PYY
There was a difference in total PYY concentration at baseline between the 10%P (86 ± 17 
pg/ml) and the 15%P (111 ± 18 pg/ml) and 25%P (76 ±18  pg/ml) diets (p = 0.02). There 
was no difference at any other timepoint after the fixed-energy meal (Figure 4.3.34). The 
mean AUC did not differ between the diets (p = 0.28). There was a difference in the 
minimum concentration between the diets, corresponding to the difference in 
concentration at baseline. The time and concentration of the maximum PYY values were 
not different between the diets.
Figure 4.3.34 Mean ± SEM blood PYY after a fixed-energy breakfast eaten at time 0
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4.3.3.7.4 PP
There was no difference in subjects’ PP concentration between diets at baseline or at any 
timepoint after the fixed-energy meal (Figure 4.3.35). Mean AUC, lowest after the 10%P 
meal (153281 ± 38369 pg.min/ml), was significantly different to the 15%P meal (245269 
± 38859 pg.min/ml) and the 25%P meal (219920 ± 38369 pg.min/ml) (p < 0.0001). 
Similarly the maximum concentration of PP was lowest during the 10%P diet (1274 ± 
200 pg/ml) compared to the 15%P (1637 ± 203 pg/ml) and 25%P (1567 ± 200 pg/ml) (p 
= 0.018). The minimum concentration was during the 10%P diet (334 ± 194 pg/ml) 
which was significantly lower than during the 15%P (697 ± 196 pg/ml) and the 25%P 
diets (656 ± 194  pg/ml) (p < 0.0001). The mean time to the minimum concentration was 
shorter during the 10%P diet (90 ± 24 min) than the 15%P diet (125 ± 24 min) (p 
=0.003). The minimum concentration of PP during the 25%P diet was at 97 ± 24 min.
Figure 4.3.35 Mean ± SEM blood PP after a fixed-energy breakfast eaten at time 0
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4.33.8  Blood markers o f metabolic risk
4.3.3.8.1 Glucose
Figure 4.3.36 shows the change in individual fasting blood glucose between study day 1 
and study day 4 for each diet. Fasting glucose concentration did not change during the 
study visits or differ between diets (mean 5.3 mmol/1, SD 0.4).
After the fixed-energy breakfast on day 4 there was no difference in glucose curves at 
baseline or at any other timepoint (Figure 4.3.37). The AUC did not differ between the 
diets (p = 0.59) and there was no evidence of a difference in the time or value of the 
maximum and minimum points.
Figure 4.3.36 Change in fasting blood glucose between day 1 and day 4
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4.3.3.8.2 Continuous glucose monitoring
Interstitial blood glucose concentrations measured by the continuous glucose monitor 
were analysed during the final ad libitum-eating day and during the fixed-energy intake 
day spent in the calorimeter on day 4 of the study visit.
4.3.3.8.3 Ad libitum- eating day
Mean results for the ad libitum day are presented in Table 4.3.8 and Figure 4.3.38. 
Glucose concentrations were analysed for the whole 24 h period and the periods from 
waking to before breakfast (0700 -  0900), before breakfast to before lunch (0900 -  
1230), before lunch to before dinner (1230 -  1730), before dinner to bed time (1730 -  
2330), bedtime to waking (2330 -  0700). The time periods were selected to include the 
relevant meal for each subject within the time window. However, as subjects could elect 
to eat at any stage throughout the day, meals were consumed at different times within
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these time periods and extra snacks may have additionally been consumed. The afternoon 
walk at 1500 h is marked on Figure 4.3.38.
The mean glucose concentration and AUC were significantly lower during the 25%P diet 
than the 10%P and 15%P diets for the entire 24 h ad libitum day and in all time periods, 
except between waking and breakfast. There was no evidence of a difference in the mean 
AUC between the 10%P and 15%P diets at any time throughout the day.
There was no difference in mean glucose concentration at 0700 h, 0900 h, 1230 h, or 
1730 h. At 2330 h mean glucose concentration was significantly lower during the 25%P 
diet than the 10%P or 15%P (p = 0.03). At 0700 the following morning the mean glucose 
concentration was significantly lower during the 25%P diet than the 15%P (p = 0.03).
The maximum glucose concentration was lower between breakfast and lunch during the 
25%P diet (6.51 mmol/1 ± 0.46) than the 10%P (7.78 mmol/1 ± 0.47) (p = 0.013) and 
15%P diets (7.07 mmol/1 ± 0.47) (p = 0.045), and between lunch and dinner the 
concentration was lower during the 25%P diet (6.45 mmol/1 ± 0.42) than the 10%P (7.84 
mmol/1 ± 0.40) (P = 0.001) and 15%P diets (7.29 mmol/1 ± 0.41) (p = 0.044). There was 
no difference during other time periods or for the whole 24 h period.
The minimum glucose concentration was lower between breakfast and lunch during the 
25%P (4.67 mmol/1 ± 0.19) (p = 0.004) and 10%P diets (4.88 mmol/1 ± 0.19) (p = 0.03) 
than the 15%P diet (5.33 mmol/1 ± 0.19), and was lower overnight during the 25%P diet 
(4.65 mmol/1 ± 0.25) than the 15%P diet (5.47 mmol/1 ± 0.26) (p = 0.007). The glucose 
concentration during the 10%P diet was 5.06 mmol/1 ± 0.25 and did not differ from the 
other two diets.
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Table 4.3.8 Mean ± SEM interstitial glucose concentration and AUC during the 24 h ad libitum 
period and specific time periods throughout the day for all subjects
Time 10%P 15%P 25%P P
M ean interstitial glucose (mmol/1)
M ean over 24 h 5.90 ±0 .2 5.89 ± 0.2 5.44 ±0 .2 <0.0001*§
0700 - 0900 5.47 ± 0.2 5.29 ± 0.2 5.44 ±0 .2 0.01§#
0900 -1230 6.06 ± 0.2 6.01 ± 0.2 5.46 ± 0.2 <0.0001*§
1230-1730 5.94 ± 0.2 5.90 ± 0.2 5.38 ±0 .2 <0.0001 *§
1730-2330 6.22 ± 0.2 6.08 ± 0.2 5.55 ±0 .2 <0.0001*§#
2330 - 0700 5.65 ± 0.2 5.96 ±0.2 5.24 ± 0.2 <0.0001*§#
M ean AUC (mmol.min/1)
M ean over 24 h 8470 ± 337 8464 ± 347 7800 ± 337 0.04 *§
0700 - 0900 628 ± 30.9 606 ± 32.4 626 ± 30.9 0.8
0900 -1230 1241 ± 50.2 1241 ± 50.2 1120 ±48.2 0.03*§
1230-1730 1755 ± 72.6 1741 ±75.2 1574 ± 75.2 0.02* §
1730-2330 2208 ± 105.9 2157 ± 110.1 1969.7 ± 105.9 0.03*
2330 - 0700 2513 ±113.9 2652 ± 118.2 2333 ±113.9 0.03 §
§ 25%P diet different from 15%P, * 25%P diet different from 10%P, # 15%P diet 
different from 10%P
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4.3.3.8.4 Fixed-energy intake day
The results for the fixed-energy intake day are shown in Table 4.3.9 and Figure 4.3.39. 
As all activities and eating episodes occurred at the same time for all subjects, the day 
was separated into time periods dependent on meal times. Meals were eaten at 0930 h, 
1330 h and 1830 h and so the day was divided into waking to before breakfast (0700 -  
0930), before breakfast to before lunch (0930 -  1330), before lunch to before dinner 
(1330 -  1830), before dinner to bed time (1830 -  2330), bedtime to waking (2330 -  
0700). No snacks were provided and only decaffeinated drinks were served. Two periods 
of standardised exercise were performed at 1500 h and 2000 h marked on Figure 4.3.39.
There was no difference in mean glucose concentration at 0700, 1330, 1830, 2330, or 
0700 the following morning. Mean glucose was significantly higher at 0930 during the 
15%P diet (5.77 ± 0.23) than the 10%P (5.25 ± 0.23) and 25%P diets (5.18 ± 0.22) (p = 
0 .01).
Mean glucose concentration was significantly lower during the 25%P diet than the 10%P 
and 15%P during all time periods and for the entire 24 h period. During the 15%P diet 
mean glucose concentration was lower than the 10%P diet for the entire 24 h period and 
from lunch to dinner, dinner to bedtime, and overnight Table 4.3.9. The AUC was lower 
during the 25%P diet than the 15%P or 10%P between breakfast and lunch, and during 
the 25%P and 15%P diets compared to the 10%P diets between dinner and bedtime. 
There was no difference in the 24 h AUC.
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The maximum glucose concentration was lower for the whole 24 h period during the 
25%P diet (6.96 ± 0.56) than the 15%P (7.49 ± 0.58) (p <0.0001) and 10%P diets (9.32 ± 
0.62) (p <0.0001). The 15%P diet was lower than the 10%P diet (p = 0.007). The 
maximum glucose concentration was also lower between breakfast and lunch during the 
25%P diet (6.55 ± 0.47) than the 15%P diet (7.14 ± 0.47) which was lower than the 
10%P diet (8.05 ± 0.49) (p = 0.02), between lunch and dinner during the 25%P diet (6.06 
± 0.37) and the 15%P diet (6.47 ± 0.39) than the 10%P diet (7.75 ± 0.41) (p = 0.001), 
from dinner to bedtime during the 25%P (6.79 ± 0.60) and 15%P (6.88 ± 0.62) than the 
10%P diet (9.28 ± 0.70) (p = 0.002). There were no differences between diets in the 
period between waking and breakfast, or overnight.
The time to maximum glucose concentration was later during the 25 %P diet than the 10% 
and 15%P diets (p = 0.0001) between lunch and dinner and earlier during the 25%P diet 
and the 15%P diets than the 10%P diets (p = 0.04) overnight. There were no differences 
at other periods throughout the day.
The minimum glucose concentration was lower between waking and breakfast during the 
25%P (4.97 ± 0.22) and 10%P (5.14 ± 0.24) than the 15%P diets (5.58 ± 0.23) (p = 
0.007), and between breakfast and lunch during the 25%P diet (4.69 ± 0.19) than 15%P 
diet (5.23 ± 0.19) (p = 0.03). The 10%P diet did not differ from the other two (4.8 ± 0.2). 
There was no difference in the time to minimum concentration at any period throughout 
the day.
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Table 4.3.9 Mean ± SEM interstitial glucose concentration and AUC at specific time periods for all 
subjects eating the fixed-energy meals over 24 hours
Time 10%P 15%P 25%P P
Mean interstitial glucose (mmol/1)
Mean over 24 h 5.95 ±0.16 5.66 ±0.16 5.31 ±0.16 <0.0001*§#
0700 - 0930 5.52 ±0.21 5.91 ±0.21 5.32 ±0.21 <0.0001*§#
0930 - 1330 5.89 ±0.17 5.90 ±0.17 5.39 ±0.17 <0.0001*§
1330-1830 5.97 ±0.17 5.63 ±0.17 5.36 ±0.17 <0.0001*§#
1830-2330 6.69 ±0.21 5.79 ±0.21 5.48 ±0.21 <0.0001*§#
2330 - 0700 5.70 ±0.19 5.41 ±0.19 5.14 ±0.19 <0.0001*§#
Mean AUC (mmol.min/1)
Mean over 24 h 8205 ±447 8121 ± 424 7463 ±404 0.27
0700 - 0930 804 ± 37 859 ± 36 772 ± 35 0.01§
0930 -1330 1422 ± 50 1405 ± 48 1271 ±48 0.007* §
1330-1830 1758 ±78 1660 ± 74 1581 ±71 0.13
1830-2330 2021 ± 102 1706 ±91 1617 ± 87 0.002*#
2330 - 0700 2510 ±125 2377 ± 113 2318 ±113 0.37
* 25%P diet different from 10%P, § 25 %P diet different from 15%P, # 15%P diet 
different from 10%P
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The mean glucose concentrations and AUC for the entire 24 h period are presented in 
Table 4.3.10 for the ad libitum day and the fixed-energy day. The mean glucose 
concentration was lower during the fixed energy day for the 15%P and 25%P diets. There 
was no difference in mean AUC. The days differed by the number of eating episodes, 
with no snacks provided on the fixed-energy day, however energy intake did not differ 
significantly between the days (Figure 4.3.14).
Table 4.3.10 Mean interstitial glucose and AUC over 24 h during the ad libitum and fixed-energy 
intake days
Diet A d  libitum  day Fixed-energy day P
Mean interstitial glucose (mmol/1)
10%P 5.90 ±0 .2 5.95 ±0.16 0.003
15%P 5.89 ±0 .2 5.66 ±0.16 <0.0001
25 %P 5.44 ± 0.2 5.31 ±0.16 <0.0001
Mean AUC (mmol.min/1)
10%P 8470 ± 337 8205 ±447 0.51
15%P 8464 ± 347 8121 ±424 0.16
25 %P 7800 ± 337 7463 ±404 0.94
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4.3.3.8.5 Insulin
Subjects’ mean fasting blood insulin concentration was higher on day 4 than day 1 during 
each of the study diets (Figure 4.3.40), but there was no difference between diets in the 
change in insulin concentration during the study week (p = 0.28). The individual 
difference between day 1 and day 4 is shown in Figure 4.3.41. Fasting insulin 
concentrations did not differ when adjusted for day of the study week or diet.
Post-prandial insulin curves are shown in Figure 4.3.42. There was no difference in 
insulin concentration at baseline or at any other timepoint after the fixed-energy breakfast 
on day 4. The AUC did not differ between diets (p = 0.25), neither did the time and 
concentration of the maximum or minimum values.
Figure 4.3.40 Mean (SEM) fasting blood insulin concentrations on days 1 and 4 of each study diet for 
all subjects
Diet
Insulin
Concentration 
Day 1
mean±SEM
Insulin
Concentration 
Day 4 
mean±SEM
p for difference 
between day 1 
and day 4
10%P 27.9 ± 4 .6 44.4 ±4 .6 <0.0001
15%P 27.9 ±4.1 35.7 ±4.1 0.03
25 %P 22.8 ±4.3 38.2 ±4 .0 0.002
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Figure 4.3.42 Mean (SEM) blood insulin after a fixed-energy breakfast eaten at time 0
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4.3.3.8.6 HsCRP
Mean hsCRP at baseline was 1.13 mg/L (0.25 -  1.99) for the 10%P diet, 0.94 mg/L (0.15 
-  1.91) for the 15%P diet, and 1.11 mg/L for the 25%P diet (0.29 -  2.61) which are all 
within the normal range. There was no difference in hsCRP concentration between diets 
on day 1 or day 4 of the study. hsCRP was lower on day 4 than day 1 during the 10%P 
diet (1.1 ± 0 .2  mg/L versus 0.8 ± 0.2 mg/L, p = 0.048). This difference appears to be due 
to large individual differences in hsCRP as demonstrated in Figure 4.3.43. There was no 
difference in hsCRP between day 1 and day 4 of the study for the 15% P or the 25%P 
diets.
Figure 4.3.43 Change in plasma hsCRP levels between day 1 and day 4 of each diet
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4.3.3.8.7 IGF-I and IGF-BP3
IGF-I concentration in subject 6 was considerably higher than the other subjects. All 
analyses were performed including and excluding subject 6. Results reported include all 
subjects unless removing subject 6 significantly altered the outcome.
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There was no difference between the diets in subjects’ fasting blood IGF-I concentration 
on day 1 or day 4. IGF-I was significantly higher on day 4 (mean 153.8 ng/ml ± 20 SEM) 
than day 1 (148.5 ng/ml ± 23) during the 25%P diet (p = 0.03). When subject 6 was 
removed from the analysis, the difference was increased, and the concentration of IGF-I 
was also significantly higher on day 4 than day 1 during the 15%P diet (p = 0.02). 
Individual differences in plasma IGF-I concentration are shown in Figure 4.3.44. The 
differences between day 1 and day 4 did not differ between diets (p = 0.4).
Post-prandial IGF-I concentrations were higher at 60 min (p = 0.003), 90 min (p = 
0.0007), 120 min (p = 0.02) and 210 min (p = 0.008) during the 25% P diet as 
demonstrated in the post-prandial curves shown in Figure 4.3.45. AUC was significantly 
higher after the 25%P meal (27414 ng.min/ml ± 3959 SEM, p < 0.0001) and 15%P meal 
(26573 ng.min/ml ± 3970, p = 0.01) than the 10%P meal (24191 ng.min/ml ± 3959) when 
subject 6 was removed from the analysis, but there was no difference between diets with 
all subjects included (p = 0.12). The maximum concentration of IGF-I was higher after 
the 25%P meal (p = 0.01).
IGF-BP3 (IGF binding protein 3) was higher on day 4 than day 1 during the 10%P diet (p 
= 0.001) but the change in IGF-BP3 did not differ between diets (p = 0.64). Individual 
differences are shown in Figure 4.3.46. There was no difference in IGF-BP3 at any 
timepoint (Figure 4.3.47) after the test meal and the AUC did not differ between the diets 
(p = 0.82). There was no difference in IGF-BP3 for any other parameters analysed.
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Figure 4.3.45 Mean ± SEM blood IGF-I curves after a fixed energy breakfast eaten at time 0
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Figure 4.3.47 Mean (SEM) blood IGF-BP3 curves over 3.5 hours after a fixed energy breakfast eaten 
at time zero.
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4.3.3.8.8 Blood lipids
There was no difference between diets in the total cholesterol concentration in the 
subjects’ blood on day 1 or day 4 of the study visits. Total cholesterol was higher on day 
4 than day 1 for each diet (10%P diet p = 0.03, 15%P diet p = 0.005, 25%P p < 0.0001), 
but there was no difference between the diets for the change in concentration between 
day 1 and day 4 (Figure 4.3.48).
LDL cholesterol concentration did not differ on day 1 or day 4 of each diet, or between 
day 1 and day 4. The change in concentration is shown in Figure 4.3.49.
HDL cholesterol concentration for all subjects is presented in Figure 4.3.50. The 
concentration on day 4 increased during the 25 %P diet (0.25 mmol/1 ± 0.01) and was 
significantly different to the change in concentration during the 10%P (-0.08 ± 0.06) (p = 
0.01) and 15%P (-0.03 ± 0.06) (p = 0.004) diets.
Subjects’ blood triacylglycerol concentration was higher on day 4 than day 1 for each diet 
(10%P - p < 0.0001, 15%P - p = 0.001, 25%P - p < 0.0001) but was significantly lower 
on day 4 with the 15%P (1.2 mmol/1 ± 0.2, P = 0.009) and 25%P (1.2 mmol/1 ± 0.2, P = 
0.011) diets than the 10%P diet (1.5 nimol/1 ± 0.2). The rise in triacylglycerol levels was 
lower with 15%P (p = 0.012) compared to the 10%P. Individual differences are shown in 
Figure 4.3.51.
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Figure 4.3.49 Change in calculated LDL levels between day 1 and day 4 of each diet
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Figure 4.3.51 Change in blood triacylglycerol levels between day 1 and day 4 of each diet
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4.4 Discussion
This study investigated the effect of diets of varying P:E ratios on ad libitum energy 
intake and appetite control mechanisms. The study was a crossover design, conducted 
under standardised conditions, to allow for within-subject comparisons and increased 
statistical power to detect any effects relative to a parallel design. The study diets were 
carefully planned and prepared with similar palatability to provide the intended 
differences in the proportion of total energy as protein.
This study reveals that a diet containing 25% energy as protein is associated with earlier 
meal satiation, increased fullness and a reduction in energy intake over 3 days. There was 
also a reduction in glucose excursions, an increase in post-prandial IGF-I and 
improvements in blood lipids. Taken together these data imply that a diet containing an 
increased P:E ratio may aid weight control and reduce metabolic risk.
There was however no clear effect of reductions in the P:E ratio. On a diet containing 
10% energy as protein there was no effect on appetite sensations or energy intake, 
suggesting a non-linear relationship between P:E and the control of food intake or an 
inadequate decrease to detect a difference. However there was a clear deterioration in 
post-prandial glucose homeostasis with an increase in 24 h glycaemia with decreasing 
proportion of protein, indicative of an adverse effect on metabolic risk.
4.4.1 Effect of diets of varying P:E ratios on energy intake
This study demonstrated that when lean, healthy subjects were provided an ad libitum 
diet of varying P:E ratio over a three-day period, while confined to a metabolic suite, El 
was reduced when protein was increased to 25% of energy (25%P) compared to a
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‘control’ diet containing 15% energy as protein (15%P). The mean reduction in El was 
0.6 MJ/d, which, assuming no adaptation, equates to approximately 0.14 kg weight 
reduction per week or 3.7 kg over six months.
These values are broadly consistent with a previous study showing an immediate 
reduction in spontaneous consumption when participants were allowed to eat ad libitum 
on a diet containing 30% protein, following a 2 week period of controlled feeding to 
energy balance (Weigle et al., 2005). Together these studies extend the evidence from 
short-term preload studies, discussed in Chapter 3, which consistently show that test 
meals high in protein reduce El at a subsequent meal, compared to isoenergetic meals 
high in fat or carbohydrate. The present study, in which every meal was manipulated over 
3 days, shows that the effect is robust and persists over time, without prompting 
autoregulatory compensation mechanisms. It may thus be of physiological significance in 
the longer-term control of body weight.
4.4.1.1 The protein leverage hypothesis
The protein leverage hypothesis predicts that when protein availability changes such that 
the ratio of protein:non-protein energy increases or decreases absolute protein intake is 
preserved (Simpson & Raubenheimer, 2005). The hypothesis predicts that when the 
available diet contains a higher percentage of protein, absolute protein needs are met 
earlier, without the need to consume as much non-protein energy, and total energy intake 
is reduced. Conversely when the available diet is low in protein more food must be 
consumed to meet the target protein requirements, increasing the total energy consumed. 
Modelling of this hypothesis indicates that small changes in the available protein have 
significant changes in the total amount of energy consumed.
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The data from the present study support one component of the hypothesis, that an 
increase in the proportion of protein in the diet reduces total energy intake. It does not 
suggest that lowering available protein increases total energy intake, as no dose-response 
effect was demonstrated, in contrast to data from other animals, including mice (Sorensen 
et al., 2008), rats (Simpson & Raubenheimer, 1997), carnivorous ground beetles and 
spiders (Mayntz et al., 2005).
Humans may exert more conscious control over food intake than animals concealing their 
response to changes in the P:E ratio. It is also possible that the 10%P and 15%P diets 
were too similar in protein content to demonstrate a difference in El (as may be suggested 
by the lack of a difference in nitrogen excretion from subjects after eating the 10%P and 
the 15%P diets). The only study to investigate the protein leverage effect in humans 
provided an ad libitum high or low-protein diet for two days after a two-day control 
period to 10 subjects (Simpson et al., 2003). During the two investigation days, buffets of 
food high or low in protein were available at each meal. The five subjects in the high- 
protein group reduced their daily intake from 8.5 MJ/d to 5.6 MJ/d and consumed a diet 
that provided 45% of energy from protein. In the low-protein group subjects increased 
their intake from 7.5 MJ/d to 12 MJ/d and protein only provided 8.5% of total energy. 
The protein:non-protein energy ratios were of a much wider range than was used in the 
current study and the diets provided were unlikely to be sustainable for longer periods.
Diets comprised of 45% of protein or more have consistently been shown to reduce El 
and increase satiety (Barkeling et al., 1990; Poppitt et al., 1998; Latner & Schwartz, 
1999) (Porrini et al., 1997) while meals containing less than 30% of energy from protein 
have provided less consistent results (Raben et al., 2003; Vozzo et al., 2003). As a diet 
comprising less than 30% of energy as protein is more likely to be sustainable and safe in
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the long term, this area required further investigation and hence a 25%P diet was selected 
for the present investigations.
4.4.1.2 Factors influencing energy intake
In this study there was no effect on meal frequency. Instead the changes in energy intake 
occurred predominately within a meal, implying an effect on satiation. Prior research 
shows that satiation can be disrupted by the introduction of different foods (variety 
effect), the presence of others (social context) and competing tasks (distraction) 
(Hetherington, 2007). This study was highly controlled and took place in a metabolic 
suite to reduce the effects of these external influences on food consumption and to 
maximise the ability to detect physiological effects of satiety on energy intake at a meal 
and throughout the study visit. To limit the effects on food consumption of eating in the 
presence of others or with distractions, all meals were consumed in private booths with 
no other distracting events. Subjects were able to eat for as long as required, with dishes 
only removed once subjects indicated that they had completed their meal.
When a large variety of food is available, energy intake tends to increase (Hetherington, 
2007). For this reason, there was no choice provided at each meal although several 
different dishes were presented throughout the day. Intake may also increase in response 
to large portions (Rolls et al., 2006). However, the ad libitum nature of the study required 
a large amount of food to be offered at each meal to ensure that sufficient food was 
available for subjects to eat ad libitum and to discourage subjects from consuming the 
entire portion as it was presented, which may be habitual or perceived to be more socially 
acceptable. Similar portions were offered on each dietary treatment and subjects were 
broadly consistent in whether they over- or under-ate throughout the ad libitum eating
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days in comparison to their calculated energy requirements, reinforcing the value of a 
within subject design. There was a slight, but not significant, tendency towards weight 
loss during the study visits suggesting that most subjects were not over-consuming 
because of the availability of large portions of food, and potentially that the lack of 
variety may have inhibited consumption. Subject 8 was a notable exception, as he 
consistently over-ate in comparison to his estimated energy expenditure consuming 
almost the entire portion at each meal. Removing these data from the analysis 
significantly affected the El results and for this reason El data were presented including 
and excluding the results from subject 8.
In contrast to the changes in El observed when the P:E ratio of the diet was increased 
from 15%P to 25%P, El did not differ when protein was decreased from 15%P to 10%P. 
Similarly urine nitrogen excretion was 93% higher during the 25%P diet compared to the 
10%P diet and 57% higher than the 15%P diet but no difference was present between the 
10%P and 15%P diets (despite a trend towards greater urine nitrogen excretion during the 
15%P diet). This finding is somewhat surprising as, at lower intakes of protein, 
obligatory losses account for a greater proportion of nitrogen loss and urinary nitrogen 
excretion is anticipated to be lower than expected (Millward, 1997) rather than higher 
than predicted as demonstrated in this study. However Bingham et al, 1985, report that 
urinary nitrogen measurement underestimates dietary nitrogen at higher levels of protein. 
Whilst the mean urinary nitrogen (UN):dietary nitrogen (DN) ratio was 0.81 for 8 
subjects consuming their normal diet over 28 days, the range was 0.7 to 0.9. The inter­
individual and day-to-day variation accounted for a proportion of this range. However 
those subjects with the lowest protein intake were observed to have the highest UN:DN 
ratio (closer to 0.9) and subjects with greater protein intake produced a lower UN:DN
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(Bingham & Cummings, 1985). In the present study a higher UN:DN could account for 
the higher than expected urinary nitrogen measured during the 10%P diet.
The P:E ratios selected for this study (10%P, 15%P, and 25%P) were designed to 
investigate the hypothesis that small changes in the proportion of protein available in the 
diet lead to a compensatory inverse change in fat and carbohydrate consumption and 
therefore in total energy intake. The similarities in El and nitrogen excretion at the lower 
end of the normal range in this study, instead suggest a threshold effect where reducing 
protein intake has little effect on physiological mechanisms that regulate food intake. It is 
possible that greater reductions in protein availability may influence total energy intake. 
However, there would have been limited value in investigating the effects of a diet 
outside the range that could not be sustained from habitual foodstuffs.
The relatively short duration of this study may also have been a factor in control of El. 
Dietary regulation is dependent on the duration of effect of feedback mechanisms to 
influence subsequent eating patterns. In contrast to laboratory rats where food intake is 
regulated by adjusting the interval between meals, in humans food intake is regulated by 
adjusting meal size and is determined by the length of time since the last meal and the 
amount of food remaining in the stomach (de Castro, 1988). The time period over which 
energy intake is regulated is less clear. Individual energy balance was measured in 12 men 
in an armed forces training establishment by directly measuring energy expenditure 
(measuring expired air in a Douglas bag) and weighing and recording all food consumed. 
There was no correlation between the mean expenditure on any one day and the intake on 
that day. However mean energy intake and expenditure was balanced over weekly and 
fortnightly periods. In particular, it was observed that there was a significant correlation 
between the mean daily expenditure and mean daily intake two days later. (Edholm et al.,
1955). In a further study, detailed analysis of seven-day food diaries showed that food 
consumed on one day has a small negative feedback on intake on the subsequent day and 
a much larger effect two days later. The effect continues on the third day but disappears 
by the fourth day (de Castro, 1998). These observations suggest that the three day time- 
period of ad libitum eating in this study was sufficient to maintain mean energy balance, 
however it is possible that additional days of dietary manipulation may have provided a 
more consistent response.
It has been argued that the regulation of macronutrient balance is more precise than for 
energy, with macronutrient intake on one day affecting intake up to two days later but not 
beyond (de Castro, 1998), and so the three days of the present study would have been 
adequate to establish a stable eating pattern. Given the consistency in daily food intake in 
participants in this study, where the patterns of response to the diets was established 
within a day and no differences in intake were identified between day 1 and 3 of each 
study week (Figure 4.3.6), the short duration of the study does not appear to have 
compromised the final outcome.
Inevitably, habitual eating habits and food preferences would have had some influence on 
total food consumption during the study. Our aim was to limit these factors as much as 
possible so that the physiological effects of the diets on energy intake could be assessed. 
However, to try to establish whether other factors influenced food consumption energy 
intake was analysed on each study day and for each meal and type of meal.
4.4.1.3 E l per study day
There was no consistent trend in El over the three days for the three different diets, 
although there were differences in El between individual days of each study visit. One
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possible explanation relates to the energy density of the diets. The energy density of the 
food offered on day 2 was lower (5.4 kJ/g) than on day 1 (7.8 kJ/g) or day 3 (7.0 kJ/g). 
Increases in energy density are associated with an increased El, especially in short-term 
laboratory studies (Stubbs et al., 2000a) and may therefore account for the higher El on 
days 1 and 3.
Palatability is another factor that may have affected El on the different study days. 
Palatability questionnaires were only completed on day 3 of each visit (alongside the 
appetite questionnaires), in order not to overemphasise the importance of appetite and 
food intake. If subjects were aware that appetite and El were being measured eating 
patterns may have been affected by conscious control mechanisms. In retrospect, 
ensuring similar palatability across the menus rather than just between individual dishes 
might have produced more convincing data. However, reducing variability may have 
been unacceptable to the subjects and affected energy intake later in the study week. 
Providing the diets in random order may have reduced the differences apparent on 
different study days. But, in view of the controlled nature of the study and the 
physiological investigations performed, it was important that the same meals were 
consumed at the same points throughout the study so that meaningful comparisons could 
be made.
El increased on day 3 during the 15%P and 25 %P compared to day 1 despite the same 
menu being offered. One possible reason for this increase in El is that subjects may have 
been more comfortable with the metabolic suite environment by day 3 of the visit and so 
may have consumed more. The other possibility is that El increased on day 3 to 
compensate for the reduced El on day 2.
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4.4.1.4 E l per meal and per meal type
To clarify more precisely when differences in El were occurring, all meals and meal 
types were analysed separately. On the 25%P diet El was reduced during meals 
(suggesting increased satiation), though its full impact was offset by an increase in snacks 
consumed. The reduction in El at meals was apparent at both lunch and dinner and more 
snacks were consumed during both the daytime and the evening. Overall there was a 
reduction in El at meals of 0.9 MJ/d compared to the 10%P and 15%P diets, a 10% 
decrease in El which if sustained over a long period would lead to a substantial reduction 
in body mass. A 0.4 MJ/d increase in energy consumed as snacks lessened the effect of 
the 25%P diet to decrease El at meals. It is difficult to extrapolate this finding to a free- 
living scenario, since snacks were readily available and there were few distractions 
during this study. Frequent snacking is likely to be atypical for some participants, 
although it must also be recognised that food access and availability are relatively high in 
many modern environments.
The discrepancy in the effect of the higher-protein diet on El at meals and snacks may 
illustrate the difference between physiological signals of satiety and the influence of non- 
physiological factors that control eating behaviour. Meals were all consumed in private 
booths at discrete time periods whereas snacks were available throughout the day and 
were usually kept on the subject’s desk where they could be consumed while other 
distracting tasks were being performed. An evening snack box was provided and snacks 
may have been consumed during other activities such as reading, working on the 
computer or watching television.
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4.4.2 Effect of diets of varying P:E ratios on satiety
Satiety and satiation during a meal have an important role in energy balance. VAS 
questionnaires that record levels of satiety during and after a meal are a reliable indicator 
of the physiological response to eating (which may or may not translate to an effect on 
energy intake depending on environmental influences) (Flint et al., 2000). Results of the 
appetite questionnaires completed during an ad libitum eating day support the hypothesis 
that diets higher in protein enhance satiety, and that an increase in satiety may be a 
mechanism for reducing energy intake during a meal and throughout the day.
VAS scores for fullness were consistently higher throughout the day during the 25%P 
diet, with the AUC 10% higher than during the 15%P diet. Fullness scores were 
significantly higher at 1100 h (two hours after breakfast), and 2000 h to 2200 h (two to 
four hours after dinner) suggesting that the effect of protein on satiety lasts for some 
hours after a meal.
The effect of increasing protein on satiety evident in this study is supported by a number 
of previous studies that have demonstrated an increase in satiety during or immediately 
after a meal (Stubbs et al., 1996; Poppitt et al., 1998) (Porrini et al., 1995; Porrini et al., 
1997; Westerterp-Plantenga et al., 1999; Oesch et al., 2005; Harper et al., 2007), 
throughout a day (Stubbs et al., 1996) (Westerterp-Plantenga et al., 1999), or over longer 
periods (Weigle et al., 2005) (Westerterp-Plantenga et al., 2004) (Lejeune et al., 2005). 
Porrini et al, 1997 demonstrated that El was reduced by 42% while subjects were 
consuming a high-protein meal compared to a high-fat meal, indicating the satiating 
properties of protein (Porrini et al., 1997). El was also reduced at an ad libitum meal 
immediately after a high protein preload meal but when a high-protein snack was 
consumed 2 h prior to a meal subjects reported increased fullness and reduced hunger
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with no change in El at the subsequent meal. Stubbs et al, 1996 (Stubbs et al., 1996) and 
Harper et al, 2007 (Harper et al., 2007) also reported higher satiety scores after a high- 
protein meal but no effect on El at a test meal. The consistent reporting of higher satiety 
scores after high-protein meals (Porrini et al., 1995; Poppitt et al., 1998) (Latner & 
Schwartz, 1999) (Oesch et al., 2005) supports the hypothesis that higher protein meals 
increase satiety and therefore may have a significant affect on El when a high-protein 
meal is consumed.
The variation in the response to high-protein meals and subsequent eating patterns 
suggest that the physiological control of satiety may be overridden by external influences 
that affect the amount of energy consumed over an entire day. This hypothesis is 
supported by the results from this study that indicate that high-protein meals promote 
satiety during the meal. Although this diet reduced total El for the entire day, the effect 
was offset by the non-physiological factors that influence snacking or grazing (Gatenby, 
1997).
4.4.3 Dietary manipulation
The study diets were designed to be as consistent as possible in appearance, taste, energy 
density and fibre while maintaining the appropriate macronutrient composition. Food was 
selected that would be familiar to the UK population. Habitual diets of the subjects 
(comprising 15% of energy from protein, 36.9% from fat and 48% from carbohydrate) 
were broadly comparable in terms of macronutrients, to the standard UK diet (16.5% of 
energy from protein, 35.5% from fat and 48.1% from carbohydrate) (NDNS, 2003) and 
the ‘control’ diet used in the study was the same as habitual protein intake (15% of 
energy). Fat (30% of energy) was lower, consistent with dietary recommendations for
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good health, and consequently the proportion of energy provided as carbohydrate (55%) 
was higher than a standard UK diet.
Standard supermarket ingredients were used in the preparation of all food and unusual 
tastes such as spices were limited. The three meals (with lunch and dinner having two 
courses) and three to four snack options per day provided a variety of dishes on each 
study day to allow for different food preferences. However at each meal only one dish 
was available to prevent the effect of a larger variety of food stimulating energy intake 
(Rolls et al., 1981; Stubbs et al., 2001). All meals were eaten in a private booth to reduce 
any influence from other study subjects or metabolic suite staff.
Table 4.2.3 and Table 4.2.4 summarise the composition of each meal for the different P:E 
ratios. Energy density was within 1 kJ/g for all the main meal dishes. Where food was 
baked, such as the muffins and scones, or had few ingredients, such as the sandwiches, 
maintaining energy density proved to be more difficult. In these dishes the macronutrient 
composition was prioritised and was able to be kept within 1% of the intended 
composition in all dishes except the peanut butter sandwiches. The proportion of energy 
from main meals was significantly higher than from snacks (Figure 4.3.13) so is unlikely 
to have significantly altered total energy intake. Fibre was adjusted in all recipes by 
adding bran or altering ingredients and was constant for all main meals. Both fibre and 
energy density are important determinants of energy intake (Rolls et al., 2005) and satiety 
(Hulshof et al., 1993), therefore to attempt to isolate the effect of the macronutrients on 
these factors it was necessary to create meals that were as similar as possible except in 
their macronutrient content.
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The consistency of meals is demonstrated by the results from the palatability 
questionnaire. While there was no evidence of a difference in palatability between diets 
there were some individual differences between meals. This variation was difficult to 
avoid as standard grocery items were used to prepare the meals and not all differences in 
the ingredients could be removed. There did not appear to be a relationship between 
palatability scores and El. The 25%P breakfast meal was rated the most filling and the 
15%P meal was rated the most enjoyable, however El was slightly higher during the 
10%P meal (ns). At lunch, the 25%P meal was rated the tastiest and the most satisfying 
and El was the lowest perhaps reflecting the satiating properties of the higher-protein 
meal, as discussed in section 4.4.2. The dinner meal produced the largest differences. The 
15%P meal was tastier, more pleasant and more enjoyable than the 10%P meal and 
consistent with this El was highest. The 25%P meal was rated more enjoyable than the 
10%P meal but El was the lowest.
The 10%P meals were the least familiar to the subjects and palatability scores tended to 
be lower for the main meals. It may be that the slightly lower palatability at these meals 
reduced El and constrained any underlying drive to increase El as P:E ratio decreased. 
Conversely the 25%P diet had higher palatability ratings at the main meals but El was 
consistently lower. Higher palatability and familiarity with the study meals may have 
exaggerated El during the 15%P meals. In subsequent collaborative studies we have 
undertaken more formal pretesting of diets to reduce the effect of differences in 
palatability (Gosby et al., 2010).
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4.4.4 Effect of diets of varying P:E ratios on metabolic risk factors
4.4.4.1 Body mass
There was no difference in body mass between the treatments which is to be expected 
with such small differences in El over just three-days. Since subjects were confined to a 
calorimeter (see Chapter 5) on day 4 (the morning after their third ad libitum eating day) 
the final weight was not taken until the morning of day 5. A fixed-energy diet was 
provided on day 4  designed for weight maintenance. In practise some subjects ate less 
than the calculated energy requirements so the delay in making the final weight may have 
compromised the quality of this measure. Additionally there was the potential for 
changes in hydration to confound body mass measurements. Subjects were not 
accustomed to the drier atmosphere of the constantly air-conditioned metabolic suite 
environment and although fluid intake was ad libitum throughout the study, fluid 
replacement varied between subjects. Some subjects reported headaches that may have 
been attributable to inadequate fluid replacement and there was some evidence of 
inadequate fluid balance on clinical examination.
There was a trend towards a reduction in body mass on each of the study diets which is 
likely to be atypical but does indicate that subjects did not significantly overeat during the 
study despite the availability of a large amount of ad libitum food. There may be a 
number of explanations for this trend. It is possible that the 60 min daily walk was more 
activity than subjects were accustomed to, although all subjects reported performing 
some physical activity, with a mean of more than 60 min of moderate and light physical 
activity. Since the remainder of the day was entirely sedentary it seems unlikely that 
usual physical activity was exceeded. Instead it is perhaps more likely that subjects found
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the food less pleasant than their habitual diet or that intake was constrained by low 
variety of food offered.
4.4.42 Body composition
Changes in body composition over the short time-period of each study week were small 
and below the sensitivity of measurement techniques (Jebb et al., 1993). This may 
explain the discrepancies observed between the different methods. Changes in fat mass 
and fat-free mass measured by Bod Pod and DXA differed which probably relates to the 
different assumptions of these two methods.
Bod Pod measurements assume a constant hydration of lean mass but it is likely that 
hydration status and glycogen stores in this study changed over the course of the study 
week and possibly changed differentially with each study diet. DXA assumes that tissue 
consists of bone, fat and lean soft tissue. Lean soft tissue is calculated as the difference 
between body mass and fat and bone components. Changes in hydration have been 
demonstrated by modelling overhydration states. Water and saline were added to meat of 
known fat and lean composition and fat estimation errors were calculated after the 
resulting models were scanned using DXA (Pietrobelli et al., 1998). The results clearly 
show that DXA fat estimation errors occur with added fluid, however the direction of 
error depended on the type of fluid added. Additional normal saline predicted fat mass to 
be lower than actual fat mass while water added to the model predicted fat mass to be 
higher than actual fat mass. The error increased with a higher proportion of added fluid, 
however it is unlikely that in healthy subjects hydration states would change substantially 
to significantly affect measurements. When hydration changes by 1-5% as might be
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expected in healthy people the estimated error of measurement of fat mass is <1% 
(Pietrobelli et al., 1998).
The Bod Pod measured a significant decrease in fat mass during the 10%P and 15%P 
diets that did not occur during the 25%P diet. Contrary to these data, DXA measurements 
showed a reduction in fat mass only during the 25%P diet. Fat-free mass appeared to rise 
slightly during the 15%P diet as measured by Bod Pod but did not differ during any of 
the diets when measured by DXA.
When these discrepancies were examined further there was a clear difference in the 
relationship between measurements in fat mass and fat-free mass with changes in body 
mass which may reflect the manner in which the Bod Pod and DXA are able to measure 
changes in water flux and hydration status and changes in glycogen stores. A trend for 
change in fat mass versus change in body mass is evident when fat mass is measured by 
Bod Pod (Figure 4.4.1) but not when measured by DXA (Figure 4.4.2) reflecting the 
greater accuracy of the Bod Pod. The opposite occurs when fat-free mass is measured. 
There is only a weak relationship between fat-free mass and body mass measured by Bod 
Pod (Figure 4.4.3) but DXA shows a strong relationship between change in lean mass 
versus change in body mass (Figure 4.4.4). This increase seems implausible, since 
increase in lean tissue apparently exceeded the increase in body mass.
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The lack of a consistent and plausible measured effect of the diets on body composition 
in this study is due to the short duration of each diet and time between measurements. 
Over a longer period a higher percentage of protein in the diet has been reported to 
preserve lean mass and reduce fat mass in the context of weight loss (Layman et al., 
2003) (Farnsworth et al., 2003) (Brinkworth et al., 2004) or during weight maintenance 
after weight loss (Westerterp-Plantenga et al., 2004). It is possible that in the short term, 
a diet higher in protein and lower in carbohydrate appears to lower lean mass because of 
lower hydration of lean tissue. Lower carbohydrate intake lowers glycogen stores in 
muscle and liver. As glycogen is lost, fluid is also lost from these tissues (Kawamori, 
1999) increasing errors in the accurate measurement of fat and fat-free mass.
4.4.4.3 Blood pressure
There was no effect of the diets on BP during the study weeks. Blood pressures of 
individuals were variable throughout the study, possibly due to different stressors 
perceived by the subjects. Given the short duration of each diet it is not surprising that no 
significant change in blood pressure was identified but a longer-term effect of the protein 
content of the diet on blood pressure remains possible.
4.4.4.4 Lipids
Evidence is accumulating to suggest that diets with higher-protein:non-protein energy 
may improve the blood lipid profile in spite of initial concerns that diets higher in protein, 
particularly animal protein which is often associated with lipids rich in saturated fatty 
acids, may be detrimental. Higher total lipids and lipids with more saturated fatty acids 
are associated with earlier onset of atherosclerosis and an increased risk of heart disease, 
and may therefore counteract any benefit obtained from weight loss from a high-protein 
diet. However, prospective data from 80082 women in the Nurses Health Study supports
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the benefits of a diet higher in protein on ischaemic heart disease. The relative risk of 
heart disease was 0.74 in women who reported high intakes of protein compared to those 
who ate less protein (Hu et al., 1999).
During a 10-week weight loss study 24 women randomised to a 30% or 16% protein diet 
(with fat constant at 30%) reduced their serum cholesterol by 10% in both diets consistent 
with the 8% weight loss in both groups (Layman et al., 2003). The high-protein group 
also had significant reductions in triacylglycerols and the ratio of triacylglycerol:HDL. 
These reductions in lipids were obtained despite the high-protein diet containing more 
than twice the dietary cholesterol of the low-protein diet. A reduction in blood 
triacylglycerol concentration has been reported in similar long-term studies of high- 
protein and low-carbohydrate diets (Foster et al., 2003) (Samaha et al., 2003) but not 
over such a short period as in the present study.
Over the four-day period of each diet in this study, there was an unexpected rise in total 
blood cholesterol that was not diet dependent. A rise in serum cholesterol during periods 
of stress has been reported (Sane, 1978) and it is possible that the cholesterol levels in 
this study may have risen after having spending one night in a calorimeter and being 
confined to a metabolic suite for the previous three days. Despite this HDL cholesterol 
increased only during the 25%P diet, and the change in triacylglycerol concentration was 
significantly lower during the 15%P and 25%P diets. Elevated serum triacylglycerol 
concentration indicates the presence of triacylglycerol-rich lipoproteins which can 
penetrate the arterial intima, become trapped in the arterial wall and promote 
development of atherosclerosis. Recently two prospective cohort studies have identified a 
strong association between triacylglycerol levels and cardiovascular events (in 26509 
women in the Women’s Health Study followed for 11 y) (Bansal et al., 2007) risk of MI,
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IHD and death (in 7587 women and 6394 men followed for 26 y) (Nordestgaard et al., 
2007). Non-fasting triacylglycerol levels may be particularly important in the 
development of atherosclerosis and a stronger association was found when triacylglycerol 
levels were measured in the non-fasted state.
4.4A.5 Glucose
Hyperglycaemia is a central component of the metabolic syndrome, and elevations in 
post-prandial glucose concentrations are associated with a significantly increased risk of 
developing type 2 diabetes and cardiovascular disease. In this study two methods were 
used to investigate the effects of the dietary intervention on post-prandial and 24 h 
glucose patterns. First, interstitial glucose was measured using continuous glucose 
monitoring to investigate whether diets of different P:E ratio produced differing effects 
on 24 h glucose patterns when diets were consumed ad libitum in a similar manner to a 
free-living individual, and in the more controlled fixed-energy environment. Second, 
fasting blood glucose concentrations were measured at the start and end of each study 
week to identify whether the diets produced longer lasting effects on overnight glucose 
metabolism. Post-prandial blood glucose curves were also measured to investigate the 
effect of the meals and to compare results to that obtained with the continuous glucose 
monitor, as although this method of measuring glucose levels is commonly used in 
managing people with type 1 or type 2 diabetes, it has been used infrequently in healthy 
subjects with normal glucose levels.
Glucose levels recorded by the CGMS demonstrated a clear and sustained beneficial 
effect of a higher-protein diet on 24 h glucose levels and post-prandial glycaemic 
excursions, both important factors in reducing the risk of metabolic disease. During both 
the ad libitum and fixed energy intake days glucose levels were consistently lower in the
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pre and post-prandial periods with the 25%P diet than lower protein diets. The significant 
dose-response effect of the protein content of the diets on post-prandial maximum 
glucose concentration during the fixed-energy day is evident in Figure 4.3.39. The 
difference between the glucose curves is clearer than during the ad libitum eating day as 
all meals were eaten at the same time, no snacks were provided during the day, and each 
subject ate the same amount of energy on all three visits. In contrast, during the ad 
libitum eating day eating patterns were more variable and attenuated the subtle effect of 
diet composition. There was little difference between the glucose concentrations during 
the 10%P and 15%P for any period analysed. The unexpectedly lower El during the 
10%P than the 15%P diet may account for this lack of difference. Despite a lower El 
during the 10%P diet, glucose concentrations were the same as during the 15%P diet. If 
El had been similar during the 10%P and 15%P diets, or lower during the 15%P diet as 
predicted by the protein leverage hypothesis, glucose levels would be expected to have 
been higher during the 10%P diet in a similar pattern to the fixed-energy eating day.
There was no evidence of a difference in fasting blood glucose levels measured at the 
start and end of each study week, which is perhaps not surprising over such a short time- 
period period and in lean, non-diabetic subjects. Glucose concentration in the fasted state 
is maintained by the more complex process of hepatic gluconeogenesis, which is 
regulated by changes in glucose, insulin, free fatty acids, and glucagon (Kawamori, 
1999). Although hepatic glucose production is very responsive to changes in insulin 
concentrations, changing the whole system would expect to take longer than three days. 
The predominant mechanism for improving post-prandial glycaemia after a meal lower in 
carbohydrate and higher in protein is a reduction in the initial glucose load. Whether the 
effect on glucose levels is primarily due to the change in protein or the reciprocal changes 
in carbohydrate is uncertain and hence the effect of high-protein diets in a free-living state
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depends on the wider dietary context. It has been proposed that glucose homeostasis 
improves during a high-protein diet independent of carbohydrate intake and is mediated 
through up-regulation of liver gluconeogenesis during the fasted state and increased 
glycogen synthesis after a meal (Westerterp-Plantenga et al., 2006).
Surprisingly, little difference between the diets was demonstrated in post-prandial blood 
samples taken after the fixed-energy breakfast. This finding differs somewhat to the 
CGMS glucose concentration recorded at the same time and is most plausibly explained 
by the methods used to measure glucose. Firstly, the CGMS measures interstitial glucose 
at 5 min intervals. Blood glucose samples were taken at 30 min intervals to allow for the 
time required to collect and process a sample and to limit the total blood taken to an 
ethically acceptable quantity. It is therefore possible that the blood samples may not have 
been taken at the maximal peak or trough level and underestimate the post-prandial 
curve. Secondly, changes in interstitial glucose concentration lag behind those of blood 
glucose concentration by 4-10 min (Boyne et al., 2003) depending on insulin-mediated 
glucose uptake to peripheral tissues and peripheral sensitivity to insulin which differs at 
different sites and between subjects (Aussedat et al., 2000). The magnitude of an increase 
in interstitial glucose after a glucose load is reported to be 70% of that in plasma glucose 
suggesting that CGMS measurements may underestimate peak glucose values. During the 
subsequent decrease in glucose, interstitial glucose decreases faster than plasma glucose 
due to insulin stimulated peripheral glucose uptake. Differences between interstitial and 
plasma glucose are therefore greatest when glucose is rapidly increasing (Kulcu et al.,
2003). It is possible that in this study the CGMS results indicate a much larger difference 
in post-prandial glucose concentrations that may have been identified in the blood if 
plasma samples were taken at more frequent time intervals. It has been argued that 
interstitial glucose levels may be more clinically important as they more closely reflect
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cellular glucose concentrations, where most complications secondary to hyperglycaemia 
arise (Boyne et al., 2003).
The improvement in post-prandial and 24 h glucose concentration with a diet higher in 
protein demonstrated in this study is supported by a number of previous studies. 
Increasing protein to 30% of energy in 8 subjects with type 2 diabetes for five weeks in a 
crossover study resulted in a reduction in mean 24 h glucose and glycohaemoglobin 
(9.8% in the control 15%P diet compared to 7.6% in the high-protein diet) (Gannon & 
Nuttall, 2004). A further study in 10 obese subjects with type 2 diabetes demonstrated a 
normalisation of mean 24 h glucose levels and a reduction in HbAlc from 7.3% to 6.8% 
(Boden et al., 2005). In both of these cases, the experimental diets were high in protein 
but very low in carbohydrate. Blood glucose levels would therefore be expected to be 
lower after a period of a low-carbohydrate diet and the effect of the increased protein 
cannot be isolated from the change in carbohydrate. A more substantial effect would also 
be expected in subjects with type 2 diabetes, as blood glucose levels are higher and less 
tightly controlled at baseline.
An effect on blood glucose after a single meal has also been demonstrated. 23 
overweight to moderately obese women were provided with an isoenergetic high- 
carbohydrate or high-protein snack comprising 22% P, 59% C, 19% F and 750 kJ 
(Williams et al., 2006). Mean maximum blood glucose concentrations were 5.7 mmol/1 
after the high-protein snack and 6.8 mmol/1 after the high-carbohydrate snack. Similarly 
this study was performed in overweight subjects in whom a larger post-prandial blood 
glucose excursion may be expected. It is notable that in this study of lean subjects with 
no increased risk for diabetes or metabolic disease the post-prandial maximum blood
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glucose differed by 2.5 mmol/1 after dinner (6.8 mmol/1 during the 25%P diet and 9.3 
mmol/1 during the 10%P diet) and the mean 24 h glucose differed by 0.7 mmol/1.
The difference in 24 h glucose profiles during the ad libitum eating day is notable given 
that extensive research comparing the action of foods differing in glycaemic index on 
post-prandial glycaemia has produced mixed results. A previous crossover study 
investigating glucose profiles with diets differing in their glycaemic index in 19 
hyperinsulinaemic women was not able to identify any differences during ad libitum 
eating after 12 weeks of the intervention diet (Aston et al., 2010). In a shorter study 10 
healthy adults were given instructions to consume one low-glycaemic index food with 
each meal for seven days. CGMS glucose profiles were lower after the seven days of 
consuming low-glycaemic index foods than at baseline (Brynes et al., 2005). The 
difference in results was predominantly due to a lower overnight and fasting glucose in 
the latter study, with little difference observed between the two diets post-prandially. In 
contrast, in the present study, small changes in the P:E ratio produced significant 
differences in 24 h glucose profiles, suggesting that increases in the proportion of dietary 
protein may be a more effective strategy than altering glycaemic index to improve 
glycaemic control.
4.4.4.6 Insulin
The subjects’ post-prandial blood insulin concentrations were independent of the diets 
consumed, which is not surprising given that the samples were taken at the same 
timepoints as the blood glucose concentration which did not differ between diets. Insulin 
is secreted from the pancreas in response to dietary intake and blood glucose 
concentration. Protein eaten with glucose stimulates insulin secretion significantly more 
than similar quantities of protein or glucose eaten separately, resulting in a reduction in
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blood glucose (Nuttall et al., 1984) and protein may stimulate insulin secretion to assist in 
the control of blood glucose. Over a longer duration insulin sensitivity has been reported 
to increase, particularly insulin-mediated glucose uptake in skeletal muscle when lean 
body mass is preserved during weight loss (Westerterp-Plantenga et al., 2006). If it had 
been possible to measure insulin concentration throughout the day in this study, it is 
likely that a reduction in post-prandial and mean insulin concentrations in a similar 
pattern to the changes in glucose would have been observed.
4.4.4.7 Insulin-like Growth Factor-1 and IGF Binding Proteins
IGF-I is important in the regulation of growth. More than 90% of IGF-I in the blood is 
bound to IGF binding proteins, predominantly IGF-BP3. Epidemiological evidence 
suggests that IGF-I may increase the risk of prostate, colorectal and premenopausal breast 
cancers, all cancers linked to indices of growth such as body mass index, physical 
activity, and rapid growth in early life (Renehan et al., 2004), while a low IGF-I 
concentration is associated with the development of osteoporosis, heart disease and 
glucose intolerance (Larsson et al., 2005) (Sandhu et al., 2002).
IGF-I appears to have an intrinsic role in glucose metabolism. IGF-I is structurally 
similar to insulin, and the IGF-I receptor, through which the biological action of IGF-I is 
mediated, is a tetramer with two a and two P subunits similar to the insulin receptor 
(Ogawa, 1999). IGF-I production is primarily regulated by growth hormone but insulin 
enhances IGF-I production. Infusions of IGF-I reduce blood glucose and insulin 
concentrations (Dunger & Acerini, 1997) and, in animals, inactivation of the IGF-I gene, 
resulting in a marked decrease in circulating IGF-I, is associated with hyperinsulinaemia 
and insulin insensitivity. A longitudinal study of 615 normoglycaemic subjects measured 
IGF-I at baseline and after 4.5 y follow-up. The odds ratio for developing impaired
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glucose tolerance or type 2 diabetes with an IGF-I concentration >152 pg/L was 0.50 
compared to a concentration <152 pg/L (Sandhu et al., 2002).
IGF-I levels are predominantly determined by genetic factors and sex but physical 
activity and diet may also modify circulating IGF-I. Serum IGF-I levels are increased 
with higher-protein intake, particularly dairy protein (Norat et al., 2007) (Larsson et al., 
2005). IGF-I levels measured in 2109 women were positively related to protein intake but 
IGF-BP3 did not appear to be related to dietary factors (Norat et al., 2007). In another 
study of 226 men who undertook 14 dietary telephone questionnaires over one year 
reporting 24 h food intake to estimate long-term diet, increased consumption of protein 
was associated with higher IGF-I concentrations.
These epidemiological data support the results reported in this study. IGF-I increased 
during the 25%P study visit but not during the 10%P visit, and post-prandial IGF-I was 
higher after the higher-protein meal than the lower-protein meal, suggesting that protein 
affects IGF-I concentrations immediately after a meal and over a four-day period. In 
agreement with Norat et al (2007) there was no evidence of a change in IGF-BP3 with a 
change in dietary protein in the present study (Norat et al., 2007).
4.4.4.8 Gastrointestinal hormones
There is increasing recognition of the importance of gastrointestinal hormones in the 
control of satiety, energy intake and glucose metabolism. Altering the post-prandial 
secretion of gastrointestinal hormones may be one mechanism by which dietary protein 
exerts an effect on these factors. In this study, the analysis of these hormones may have 
been sub optimal, since new assays became available over the course of the study which 
required different processing schedules. When the blood sampling protocol was initially
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established, there was no ability to measure the active components of ghrelin, GLP-1 or 
PYY. The blood samples for hormone analyses were all stabilised immediately with 
aprotinin while subsequent assay development recommended the addition of a DPP-IV 
inhibitor to stabilise the active components of the hormones. This procedure was 
performed where necessary when the samples were defrosted to limit further degradation 
of the active hormones. There was a good post-prandial response for all the hormones 
measured, supporting the validity of this method.
Ghrelin levels rise before a meal and fall shortly after a meal, as observed in this study. 
Ghrelin increases appetite and food intake by increasing the number of meals initiated 
rather than increasing meal size. The response of ghrelin to changes in macronutrient 
intake is not clear, as previous investigations have led to contradictory results. In this 
study, ghrelin concentrations fell to a similar level after each of the study diets. The 
differences in concentrations at baseline were not significantly different but there 
appeared to be a larger fall after the 25%P meal, than after the 10%P meal, which 
followed a fairly flat profile. The higher concentrations of ghrelin at baseline would 
account for the trend to a larger AUC after the 25%P meal. Reports that carbohydrate 
intake is the most effective macronutrient at suppressing post-prandial ghrelin 
concentration (Karhunen et al., 2008) may explain the lowest ghrelin concentrations in 
the 10%P diet containing the highest carbohydrate content. However prolonged 
suppression of ghrelin after a high-protein breakfast compared to a breakfast high in 
carbohydrate has been observed (Bowen et al., 2006b; Bowen et al., 2007) as has no 
effect of protein intake on plasma ghrelin responses (Smeets et al., 2008) (Lephart et al.,
2004). One reason for the contradictory data on ghrelin measured in subjects eating meals 
differing in macronutrient composition may be that the most potent suppressor of ghrelin 
release is ingested energy rather than a specific macronutrient component of the meal.
Such mechanisms would account for the similar suppression observed after all of the 
(isoenergetic) meals in the present study.
Plasma GLP-1 concentrations rise rapidly after a meal and, while carbohydrates are a 
strong stimuli of GLP-1 release (consistent with the incretin role of GLP-1) protein 
appears to produce an even greater release of GLP-1 (Karhunen et al., 2008). When 19 
subjects consumed diets rich in protein (32% of energy), carbohydrate (12% of energy 
from protein) or fat (11% of energy from protein) the greatest post-prandial response and 
5 h AUC occurred after the high-protein meal (Raben et al., 2003). Similarly, in 28 obese 
men who were investigated for four hours after a test beverage, whey protein (85% of 
energy from protein) produced a higher and more sustained increase at 120 min in GLP-1 
than fructose or glucose (11% of energy from protein) (Bowen et al., 2007). In the 
present study there was a trend to a dose-response relationship in the maximal GLP-1 
concentration and the AUC. A sustained increase in GLP-1 at 120 min after the 25 %P 
meal suggests a greater effect of protein on GLP-1 release that may have been more 
apparent if a the meal had been higher in total energy or was comprised of a greater 
proportion of protein (as was used in the previous two studies). This dose-response 
relationship is logical given the incretin effect of GLP-1 and the reduction in plasma 
glucose that was evident in the 24 h glucose curves during the 25 %P diet.
PYY is released in response to food intake in the distal part of the GI tract and, while 
secretion is usually observed within 30 minutes of ingestion of a meal, the long period of 
elevated PYY release present in this study is consistent with previous investigations of 
post-prandial PYY release, due to a ongoing release of PYY from the gut. PYY 
concentration was lowest in the 25%P diet at baseline and remained lower throughout the 
post-prandial period, with a trend towards lower AUC compared to the 15%P and 10%P
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diets. Batterham et al (2006) demonstrated a greater PYY response to a high protein meal 
than high fat or high carbohydrate, but the high protein meal contained 65% of energy 
from protein and a larger response to the meal would therefore be expected (Batterham et 
al., 2006). In contrast, Smeets et al (2008) in a similar design to the present study, 
demonstrated no difference in PYY concentrations of 30 subjects who consumed a high- 
protein (25% of energy from protein) and a low-protein (10% of energy from protein) 
lunch (Smeets et al., 2008). Similarly the data in this study suggested a lower PYY 
response to the 25%P meal than the 10%P meal.
Food intake activates the parasympathetic nervous system and stimulates secretion of 
pancreatic polypeptide (PP) from the pancreas. Levels are low while fasting but increase 
throughout the phases of digestion (Karhunen et al., 2008) as was seen in the present 
study. The mean AUC and the maximum concentration was higher during the 25%P and 
15%P diets than the 10%P diet. Stimulation of PP by protein-rich meals has been 
observed in 19 obese children provided with a low-protein (0.2 g/kg) or high-protein (2.0 
g/kg) meal. Blood samples collected for three hours after the meal demonstrated a larger 
peak response to the high-protein meal (581 ± 127 pg/ml) than the low-protein meal (302 
± 93 pg/ml) (Zipf et al., 1983). Interestingly high-protein meals have been shown to 
stimulate PP secretion to a greater extent than low-protein, high-carbohydrate meals even 
during sham feeding (when subjects tasted the meals and then spat out the food) 
(Witteman et al., 1994). PP appears to have an important role in satiety and energy 
balance in the short and long term (Koska et al., 2004). 90-minute infusions of PP in 14 
lean subjects produced a reduction in energy intake (2.4 MJ) compared with saline (2.7 
MJ), and hunger scores were lower during the PP infusion (Jesudason et al., 2007). 
Therefore the greater stimulation of PP secretion with the 25%P and 15%P diet compared
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to the 10%P diet observed in the present study is likely to be one of the mechanisms that 
resulted in increased satiety and reduced energy intake in the higher-protein meals.
4.4.5 Summary
This study has shown that increasing the P:E ratio of the diet from 15% to 25% over a 
three-day period of ad libitum intake reduces total energy intake, particularly energy 
consumed during meal times and later in the day, suggesting an impact on satiation. The 
reduction in energy intake was supported by an increase in reported satiety during the 
25%P diet, particularly fullness scores and prospective consumption of food. Neither a 
change in energy intake or an effect on satiety was evident when the P:E ratio of the diet 
was reduced to 10%. Although predictions from the protein leverage hypothesis suggest 
that a change in P intake from 15%P to 10%P is sufficient to result in a subsequent 
increase in energy intake, it is possible that in humans the difference between the diets is 
too small to alter El significantly because habitual eating habits and non-physiological 
factors also influence eating habits and energy intake
The reduction in El on diets with higher P:E ratio may arise from the enhanced satiety 
and, although not seen in this study because of its short duration, promote weight loss.
This mechanism is supported by data showing enhanced secretion of gastrointestinal 
hormones. Higher PP secretion in response to the high-protein diet is consistent with an 
increase in satiety, and the trend to increased GLP-1 with increasing protein would 
promote glucose disposal and reduce post-prandial glycaemia.
317
There was a clear effect of modifying the P:E ratio on 24 h glucose profiles and post­
prandial glycaemic excursions. The lower, flatter glucose curves of the 25%P diet in 
comparison to the 15%P and 10%P diets are consistent with a reduction in metabolic risk 
if the diet was followed in the long term. IGF-I concentration increased over the duration 
of the study and when measured post-prandially, consistent with the change in glucose 
metabolism during the higher-protein diet. The intrinsic link between insulin and IGF-I 
also suggests that insulin action is likely to have been altered over the duration of the 
study, although such changes were not detected during the post-prandial measurements 
performed after breakfast. These changes, together with a reduction in triacylglycerols 
suggest that a modest increase in the P:E ratio may attenuate the development of 
atherosclerosis and cardiovascular disease.
By demonstrating a reduction in energy intake and enhanced satiety when consuming a 
diet of 25%P compared to a standard diet of 15%P, this study supports the increasing 
evidence that a higher P:E ratio reduces energy intake and improves weight control. The 
favourable effects of the higher-protein diet on markers of metabolic risk in addition to 
improved weight regulation may provide additional beneficial effect by reducing the risk 
of developing metabolic diseases and assist in the management of people with established 
glucose intolerance or type 2 diabetes.
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5 Chapter 5 Measuring the effect of manipulating 
the protein:non-protein energy ratio 
of the diet on energy expenditure and 
substrate oxidation.
5.1 Introduction
Manipulating the proteinmon-protein energy ratio of the diet over short and medium term 
time frames has been shown to promote weight loss and weight maintenance. Evidence 
presented in Chapter 4 suggests that increasing the P:E ratio may increase satiety and 
reduce hunger, and subsequently reduce energy intake. The degree to which energy intake 
is reduced over the long term, and the contribution of the enhanced satiating properties of 
protein to sustained weight maintenance are uncertain. It also remains possible that dietary 
protein influences energy balance by altering energy expenditure.
A high-protein meal increases diet-induced thermogenesis and may therefore lead to 
higher daily energy expenditure (see 1.5.4). Atkins (1998) argued that a diet high in 
protein confers a metabolic advantage: an increase in body mass reduction per kilojoule 
compared to diets of similar energy content with different macronutrient composition 
(Atkins, 1998). This metabolic advantage is hypothesised to be predominantly due to an 
increase in energy expenditure, which promotes weight loss (Feinman & Fine, 2003). In 
randomised controlled trials, weight loss was disproportionately greater in subjects 
following a high-protein, low-carbohydrate diet over six months compared to a high 
carbohydrate, low fat diet despite similar energy intake (Samaha et al., 2003) (Foster et 
al., 2003). If energy intake was indeed similar, another factor must contribute to the
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differences in weight loss between the diets. According to the energy balance equation, 
energy balance, and therefore weight maintenance, is the sum of energy intake and energy 
expenditure, so the weight loss observed in these studies must be due to increased energy 
expenditure, through increases in BMR, thermogenesis or voluntary physical activity.
Short-term studies of high-protein diets have suggested an increase in energy expenditure 
compared to low-protein diets. Energy expenditure was measured in a calorimeter at 
baseline and on day four of each intervention period in 12 overweight and obese men 
provided with four days of a diet rich in pork protein (29% of energy from protein), soy 
protein (28% of energy from protein) or carbohydrate (11% of energy from protein). 24 h 
EE was 3% higher with the pork protein diet than the high-carbohydrate diet and 2% 
higher with the soy protein than the high-carbohydrate diet. BMR, SMR and DIT were all 
higher after the pork diet than the carbohydrate diet. One limitation of this study was that 
the diet was consumed at home for three days before the subjects entered the calorimeter, 
reducing the ability of the investigators to monitor all food consumption. Additionally the 
diets were not equally matched for energy intake, energy density or fibre content, which 
may have influenced the final day of investigations (Mikkelsen et al., 2000).
A further study measured EE in a group of twelve lean women over 24 h in a calorimeter. 
The study diets were composed of 30% of energy from protein, 40% carbohydrate and 
30% fat or 10%, 60% and 30% respectively, and meals were provided at home for three 
days prior to the investigation days. This adaptation period reduces complications arising 
from sensory effects on DIT. While there was no difference in total EE during the 24 h 
period, DIT and SMR were greater during the high-protein diet than the low-protein diet 
(Lejeune et al., 2006).
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DIT is the component of energy expenditure that is most commonly associated with 
altering dietary protein. Eight lean and overweight women consumed isoenergetic diets 
high in protein (29% protein, 61% carbohydrate, 10% fat) or fat (9% protein, 30% 
carbohydrate, 61% fat) over 36 h whilst energy expenditure was measured in a room 
calorimeter. DIT was higher during the high-protein diet (1295 kJ/d) than the high-fat diet 
(931 kJ/d) (p > 0.05) (Westerterp et al., 1999) and was correlated with measures of satiety, 
perhaps suggesting that post-prandial increases in oxygen consumption and body 
temperature may regulate satiety (Westerterp-Plantenga et al., 1999). DIT may be affected 
by sensory stimulation and palatability of the meal as well as the familiarity of the meal 
(Westerterp-Plantenga et al., 1999) and it is possible that these factors contributed to the 
rise in DIT in this study in addition to a macronutrient effect. However, despite the 
increase in DIT, there was no difference in TEE or SMR, which questions whether there is 
any substantial effect of high-protein diets that may lead to increased EE in the long term.
The thermic effect of a food is the increase in energy expenditure above baseline 
following consumption of food and drink. It is dependent on the digestion, absorption and 
disposal of ingested nutrients, and therefore is influenced by the composition of food 
consumed. The body has limited storage capacity for protein and it must therefore be 
metabolically processed immediately following a meal. Whole-body protein synthesis 
increases after a meal and the high cost of peptide bond synthesis during this process leads 
to an increase in thermogenesis after a protein-rich meal which is greater than isoenergetic 
consumption of fat or carbohydrate. Robinson et al (1990) determined rates of energy 
expenditure and protein turnover in seven men who received hourly isoenergetic high- 
protein or high-carbohydrate meals over 9 hours. The thermic responses to the high- 
protein meals (9.6% of energy intake) were greater than to the high-carbohydrate meals 
(5.7%). Whole-body nitrogen turnover was higher during the high-protein meals and
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calculations based on ATP requirements were used to estimate the rate of protein 
synthesis. Robinson concluded that 68 ± 3% of the thermic response to a high-protein 
meal could be accounted for by increases in protein synthesis compared with the fasting 
state (Robinson et al., 1990).
Gluconeogenesis and ureogenesis have been proposed as additional mechanisms for the 
higher thermic effect of a protein-rich meal (Feinman & Fine, 2003). The production of 
glucose from non-carbohydrate precursors is energetically costly. A high-protein diet may 
stimulate gluconeogenesis, particularly when the carbohydrate content of the meal is very 
low, in order to ensure adequate glucose is present for brain, CNS and red blood cell 
function. In response to the utilization of protein stores to produce glucose, protein 
synthesis must occur to maintain nitrogen balance. The combined effect of greater 
gluconeogenesis to meet the obligate demand for glucose and the subsequent increase in 
protein turnover may therefore contribute to higher post-prandial energy expenditure after 
a high-protein diet.
Veldhorst et al (2009) investigated the effect of a high-protein, carbohydrate-free diet on 
gluconeogenesis in ten lean men. In a crossover design, subjects received an isoenergetic 
diet comprising 30% of energy from protein, 0% from carbohydrate and 70% from fat or 
12%, 55% and 33% of energy from protein, carbohydrate and fat for 1.5 days (Veldhorst 
et al., 2009). EE was measured in a room calorimeter and gluconeogenesis was calculated 
using an infusion of isotopically labelled glucose to determine endogenous glucose 
production and fractional gluconeogenesis. Fractional gluconeogenesis and therefore 
absolute gluconeogenesis was higher during the high-protein diet (171g/24 h) than the 
high-carbohydrate diet (145g/24 h) and the contribution of increased gluconeogenesis to 
increased EE was calculated at 42%. There were no difference in subjects’ blood insulin
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levels after the two diets to account for the increase in gluconeogenesis as has been 
previously observed (Veldhorst et al., 2009). Of the components of total EE, RMR was 
significantly higher in the high-protein diet at 8.46 MJ compared to 8.12 MJ during the 
high-carbohydrate diet, but there was no difference in TEE, SMR or DIT between the two 
diets.
In addition to total energy expenditure measured in a calorimeter, it is possible to use 
oxygen consumption and CO2 production, together with a measure of nitrogen loss, to 
calculate substrate oxidation - the contribution of individual fuels (protein, fat and 
carbohydrate) to energy expenditure and, if intakes are known, the partitioning of fuels 
over the period investigated (see 2.4.1 for details). The balance between food intake and 
the oxidation of the components of a meal may therefore predict whether energy balance 
is maintained or whether there is any imbalance. The oxidative hierarchy for 
macronutrients suggests that, because of the body’s requirements for glucose and the 
limited storage capacity of carbohydrate, the need to maintain carbohydrate balance is 
prioritised. Carbohydrate oxidation is therefore closely matched to intake. Protein follows 
in the hierarchy. Protein oxidation is well matched to intake and, in the short term, body 
protein mass is unchanged. Fat oxidation shows little relation to intake, as, in healthy 
metabolism, there is a large ability to store fat in adipose tissue. During positive energy 
balance fat oxidation is inversely proportional to the oxidation of other substrates, due to 
the prioritisation of carbohydrate and protein. Reduced fat oxidation may therefore result 
in an accumulation of body fat and long-term body mass gain (Jebb et al., 1996).
In two studies previously discussed, isoenergetic diets were provided in order to maintain 
body mass and substrate oxidation was measured while subjects were in the calorimeter 
(Westerterp et al., 1999), (Lejeune et a l,  2006). In the latter study during the high protein
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 ^ diet subjects were in a positive protein balance and a negative fat balance, which may 
indicate fat loss in the long term. The low protein diet was conversely associated with a 
positive fat balance (Lejeune et al., 2006).
Westerterp et al. (1999) reported significant differences in substrate utilization compared 
to intake of each substrate when subjects were fed in energy balance (Westerterp et al., 
1999). Energy expended on a high-protein diet (29% P, 61% C, 10% F) was derived 18% 
from protein, 70% from carbohydrate and 12% from fat, whereas during the high-fat diet 
(9% P, 30% C, 61% F) 11% of energy expended was derived from protein, 51% from 
carbohydrate and 38% from fat. There was therefore a positive protein balance during the 
high-protein diet and a large positive fat balance on the low-protein diet. A negative 
carbohydrate balance during the high-fat diet may have resulted from a high-carbohydrate 
meal provided the day prior to the investigation days. The lack of a close relationship 
between macronutrient intake and oxidation, observed in this study, demonstrates the 
difficulty in extrapolating data from the short-term experimental environment to the long­
term. The data indicates that time for adaptation to a diet is required before substrate 
utilization is adjusted to ingestion, suggesting that the effect of the diet on macronutrient 
oxidation persists to a certain extent.
Evidence therefore exists that a high-protein meal is associated with a greater thermic 
effect relative to isoenergetic fat or carbohydrate, due primarily to the high energy cost of 
increased protein turnover and gluconeogenesis. Whether this increase in post-prandial 
energy expenditure increases 24 h EE, or substrate oxidation to maintain body mass, is 
less clear. It has been argued that an increase in EE explains the observed beneficial 
effects of a high-protein diet on weight loss and maintenance. Investigations in a
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controlled setting of the longer-term effect of increasing the protein:energy ratio of the 
diet on EE and substrate oxidation are required in order to test this hypothesis.
5.1.1 Objective
The objective of this study was to measure the effect on energy expenditure of short-term 
changes in the P:E ratio (where protein provided 10%, 15% or 25% of energy) under 
isoenergetic conditions.
5.2 Methods
This study was performed at the Wellcome Trust Clinical Research Facility (CRF) 
between March 2007 and December 2007. The study was approved by Cambridge Local 
Research Ethics Committee in November 2006 (Ref No. 06/Q0108/181), by the 
Addenbrooke’s NHS Foundation Trust Research and Development Committee in January 
2007 (Ref: A090877), and the Scientific Advisory Board for the Wellcome Trust Clinical 
Research Facility at Addenbrooke’s Hospital in November 2006.
5.2.1 Subjects
The subjects who participated in this study also participated in the study described in 
Chapter 4. Details of the methods of recruitment of subjects and the eligibility criteria are 
discussed in 4.2.1.1.
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5.2.1.1 Sample size
Based on previous research in the calorimeters at the CRF a sample size of 10 was 
calculated to be sufficient to detect a change in 24-hour energy expenditure of 2%, when 
participants were studied on non-consecutive nights (Napolitano et al., 2011).
5.2.2 Study design
Energy expenditure was measured in a room calorimeter with subjects consuming a fixed 
El diet in which protein was 10%, 15% or 25% of energy from protein, 30% from fat and 
60%, 55% or 45% from carbohydrate. Each measurement period was preceded by a three- 
day period of ad libitum intake on a diet of matched P:E ratio.
All subjects had participated in the study discussed in Chapter 4, where for three days ad 
libitum food had been consumed, manipulated to provide 10, 15 or 25% of energy from 
protein. After the evening meal on day three, subjects returned to the CRF from HNR. A 
peripheral cannula was inserted into an antecubital vein according to the method discussed 
in Chapter 2 and flushed. The cannula was subsequently flushed prior to the subjects 
going to sleep, on waking, and after every blood sample.
Subjects entered the room calorimeter at 2000 h and the door was closed until the morning 
of day five (after 37 h). EE was measured throughout this entire time in the calorimeter.
Ad libitum eating conditions continued until 2230 h, when subjects were required to hand 
back their snack box to CRF staff. No food was subsequently available until the morning 
of day 4 when the fixed-intake day commenced. Subjects completed VAS questionnaires
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until 2200 h. Interstitial blood glucose measures were taken according to the protocol 
described in 4.2.3.5.
BMR measurements were recorded between 0800 h and 0900 h each day. Subjects were 
woken at 0700 h to pass urine, and returned to bed to rest. During the BMR measurement 
subjects were required to lie supine and still throughout the measurement time.
Fasting blood samples were taken at 0930 prior to the breakfast meal, and at half hour 
intervals after the breakfast meal until 1330. Samples were taken through the cannula that 
had been inserted the previous night. Subjects were asked to present their arm with the 
inserted cannula to study staff through a latex sleeve in the door of the calorimeter. The 
latex sleeve was adjusted to fit securely around the subject’s arm in order to maintain the 
seal of the calorimeter. Details of the samples taken and the analyses performed are 
discussed in 4.2.3.5. As these samples were designed to measure the effect of 
manipulations in P:E ratio on markers of satiety and metabolic risk these results are 
presented in Chapter 4.
All urine was collected whilst subjects were in the calorimeter. Two 5.5 ml aliquots of 
urine were stored from each sample and the volume of each sample was recorded. A 24 h 
collection was obtained from the second sample on day four until the first sample on day 
five.
Subjects completed two periods of exercise on day four, at 1500 and at 2000. Subjects 
cycled on the exercycle in the calorimetry room for 30 minutes at 50 watts with a 
pedalling speed between 40 and 60 rev per minute.
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EE was measured on the night of day 3, then from the morning of day 4 subjects were 
given a fixed energy diet with El based on BMR (measured by GEM) on day 1 of the 
study (BMR plus allowance for exercise). EE was measured until the morning of day 5.
5.2.2.1 Dietary Manipulation
On day 4, isoenergetic meals of fixed energy content were provided at 0930, 1330, and 
1830. The energy content of the meals was calculated for individual subjects based on 
BMR multiplied by 1.21 plus an allowance for two 30 min periods of exercise at 50 watts 
external work. BMR was measured by GEM calorimeter on day 1. Individual meals were 
prepared and weighed in advance, and subjects were encouraged to consume all food 
provided. Any remaining food was weighed and recorded. All food was of the same 
composition as during the ad libitum days 1-3 (comprising 10%, 15% or 25% of energy 
from protein with fat constant at 30% of energy) and used the same recipes as on day 2. 
Initially it was planned to provide total energy evenly distributed throughout the day, 
however during preliminary testing of the meals subjects experienced difficulty 
consuming 1/3 of the total energy for breakfast. To ensure that subjects were able to 
comfortably consume the total energy for the day 25% of energy was provided for 
breakfast, 35% for lunch (20% as the main course and 15% as the dessert), and 40% for 
dinner (25% as the main course and 15% as the dessert) (Table 5.2.1).
Meals were prepared for individual subjects in the kitchen at MRC HNR and transported 
to the CRF on the evening of day 3. Meals were either prepared specifically with recipes 
adjusted for the required amount of ingredients, or pre-prepared meals were used and a 
proportion of the meal removed to produce meals of the appropriate energy content. The
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meals were the same as those provided on day 2 and details of the recipes and nutritional 
content are presented in Table 4.2.4 and Appendix II.1.
Table 5.2.1 Proportion of fixed-energy intake that each dish provided for three meals
Meal
Proportion of daily 
energy intake that each 
meal provided (%)
Breakfast Porridge 25
Lunch
Vegetable Curry 20
Strawberry Yoghurt 15
Dinner
Pasta 25
Rice Pudding 15
5.2.3 Outcome measures
5.2.3.1 Energy expenditure
Energy expenditure was measured continuously from when subjects entered the 
calorimeter until leaving it 37 hours later. For analysis, measurements were divided into 
time periods of total daily EE, basal metabolic rate, EE during the night while sleeping (on 
the first night after ad libitum meals and on the second night after isoenergetic meals), and 
post-meal EE measured after breakfast. BMR was additionally measured using a 
ventilated-hood indirect calorimetry system at baseline for each study week (day 1) and 
after four days of the study diet (day 5).
329
5 2 3 2  Substrate oxidation
Oxidation of protein, fat, and carbohydrate were measured whilst in the calorimeter on 
day 4 of the study week. Measurements were divided into total 24h oxidation, BMR, and 
post-meal oxidation after the fixed-energy breakfast.
Methods for calculating EE and substrate oxidation are described in 2.4.1.
5 2 3 3  Data analysis
The primary outcome measure of total 24h EE was analysed using a random effect model 
for continuous normal data. Analysis was performed within-subject by making subject the 
only random effect. The fixed effects were the percentage of protein. The primary 
comparisons of interest - 25% vs. 15% protein and 10% vs. 15% protein - were estimated 
with 95% confidence intervals. Period-specific baseline measurements were used for 
analysis of BMR by ventilated-hood indirect calorimetry.
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5.3 Results
5.3.1 Subject Characteristics
The study population is described in Chapter 4 and baseline characteristics are presented 
in Table 4.3.1.
5.3.2 Meals
Two subjects were unable to consume their entire daily energy provision. Both subjects 
felt unwell during the stay in the calorimeter and ate very little of one meal. There was no 
difference between the diets in the mean energy that was not consumed (p = 0.48) and 
therefore there was no significant difference in the total energy intake on each study visit
(10%P 8584 ± 444, 15%P 8233 ± 444, 25%P 8350 ± 444, mean energy provided 8495
!
±384 kJ).
5.3.3 Urinary nitrogen
Urinary nitrogen excretion, collected on day 4 of the study visits, differed significantly 
between the diets (Figure 5.3.1). Nitrogen excretion during the 25%P diet (0.77 ± 0.07%) 
was significantly higher than during the 10%P diet (0.40 ± 0.07%) (P <0.0001) and the 
15%P diet (0.49 ± 0.07%) (P<0.0001). The difference between the 10% and 15%P diets 
was not significant (P = 0.184). Individual results are shown in Figure 5.3.2. There was no 
effect of visit order on nitrogen excretion rates.
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Figure 5.3.1 Mean (± SEM) urine nitrogen collected on day 4 of each study visit during which subjects 
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Figure 5.3.2 Urinary nitrogen excretion on day 4 of each study visit for individual subjects.
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5.3.4 Outcome measures
5.3.4.1 Energy expenditure and metabolic rate measured by whole-body calorimeter
Measurements of total energy expenditure and basal metabolic rate recorded during the 36 
h period in the calorimeter are presented in Table 5.3.1. There was no difference between 
dietary treatments in BMR on the first or second morning (Figure 5.3.3, Figure 5.3.4), 
DIT after breakfast on the first day in the calorimeter (Figure 5.3.5), SMR on the first or 
second night (Figure 5.3.6, Figure 5.3.7), or total energy expenditure (Figure 5.3.8).
Table 5.3.1 Energy expenditure and metabolic rate measured by calorimeter during specific time 
periods for each study visit (mean ± SEM)
EE (kj/min) 10%P 15%P 25%P P
BMR day 1 (kj/min) 4.5 ± 0.3 4.6 ± 0.3 4.4 ± 0.3 0.47
BMR day 2 (kj/min) 4.5 ± 0.3 4.7 ± 0.3 4.6 ± 0.3 0.26
DIT (kj/min) 6.1 ±0.3 6.2 ±0.3 6.3 ±0.3 0.38
DIT (MJ/3 h) 1.1 ±0 .6 1.1 ±0.6 1.1 ± 0 .6 0.38
SMR night 1 (kj/min) 4.2 ± 0.3 4.3 ± 0.3 4.4 ± 0.3 0.11
SMR night 2 (kj/min) 4.1 ±0 .2 4.1 ±0.2 4.1 ±0 .2 0.81
TEE (kj/min) 6.0 ± 0.3 6.1 ±0.3 6.1 ±0.3 0.47
TEE (MJ/24 h) 8.7 ± 0.4 8.8 ±0 .4 8.8 ± 0 .4 0.47
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Figure 5.3.4 Measure of BMR on the second morning of each study diet for individual subjects 
measured by calorimeter
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Figure 5.3.5 DIT, measured in the calorimeter over 3 h after a fixed-energy breakfast on each study 
diet
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Figure 5.3.6 Measure of SMR on night 1 of each study diet for individual subjects measured by 
calorimeter
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Figure 5.3.8 Measure of TEE of each study diet for individual subjects measured by calorimeter
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53.4.2 Basal metabolic rate measured by ventilated hood (GEM)
Resting Energy Expenditure (REE) did not differ between diet treatments on day 1 of the 
study week (P = 0.73) and there was no difference between day 1 and day 5 for any of the 
study diets (Table 5.3.2). On day 5 REE was higher after the 25%P diet (4.63 ± 0.3 
kJ/min, p = 0.045) than the 10%P diet (4.50 ± 0 .3  kJ/min). The mean difference between 
day 1 and day 5 did not differ between diets (10%P, -0.07 ± 0.42, 15%P, 0.08 ± 0.42, - 
0.98 ± 0.42) (P = 0.13). Individual differences in REE between day 1 and day 5 are 
presented in Table 5.3.3.
Table 5.3.2 Mean (SEM) REE measured by GEM on day 1 and 5 of each diet
Diet REE (kj/m in)
D1 D5 P
10%P 4.57 ± 0.2 4.50 ± 0.3 0.16
15%P 4.48 ± 0.2 4.55 ± 0.3 0.53
25%P 4.53 ± 0.2 4.63 ± 0.3 0.19
P 0.73 0.13
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53.4.3 Substrate oxidation measured by whole-body calorimeter
Oxidation of protein, fat and carbohydrate during the time spent in the calorimeter is 
presented in Table 5.3.3 separated into BMR, DIT and TEE.
During the one hour measurement of BMR on the first morning in the calorimeter (after 
three days of ad libitum  consumption of the study diet) protein oxidation was higher with 
the 25%P diet than the 15%P (p = 0.014) and 10%P diets (p = 0.001), but there was no 
difference in protein oxidation between the 15%P and the 10%P diets (p = 0.43). Fat 
oxidation was higher with the 25%P diet (p = 0.035) than the 10%P, but there was no 
evidence of a difference between the 25%P and the 15%P diets and the 15%P compared to 
the 10%P diet. Carbohydrate oxidation was lower during the 25%P diet compared to the
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10%P (p < 0.0001) and 15%P diets (p = 0.02). There was no difference between the 15%P 
and the 10%P diets (Figure 5.3.10).
Table 5.3.3 Oxidation of protein, fat and carbohydrate measured in kj for each study visit, during 
specific time periods in the calorimeter (mean ± SEM).
* 25 %P diet different from 10%P, § 25 %P diet different from 15%P, # 15%P diet different from 10%P
Energy
Expenditure
Diet Protein F at C arbohydrate
BMR day 1 10 %P 52.4 ±8.3 76.8 ±20 140.0 ± 26
k j/h 15 %P 59.2 ± 8.3 101.0 ± 20 114.0 ± 26
25 %P 81.2 ±8.6 115.7 ±21 67.0 ± 27
P 0.001*§ 0.035* *§
BMR day 2 10 %P 38.6 ±4.6 113.0 ±18 115.5 ± 20
k j/h 15 %P 56.3 ±4.6 150.0 ±18 78.6 ± 20
25 %P 87.7 ±4.8 134.2 ± 1 9 50 ±21
P <0.0001*§# 0.05 0.004*
DIT 10 %P 0.16 ±0.02 0.31 ±0.05 0.63 ± 0.07
M J/3 h 15 %P 0.22 ± 0.02 0.34 ±0.05 0.57 ± 0.07
25 %P 0.24 ± 0.02 0.39 ± 0.05 0.50 ± 0.07
P <0.001*# 0.06 0.002*
TEE 10 %P 1.14 ±0.08 2.85 ± 0.3 4.69 ± 0.47
M J/24 h 15 %P 1.56 ±0.08 2.87 ± 0.3 4.32 ±0.47
25 %P 2.22 ± 0.08 3.27 ± 0.3 3.32 ±0.47
P <0.001*§# 0.028*§ <0.001*§
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On the second day in the calorimeter during the measurement of BMR (after one day of 
fixed-energy intake of the study diet), there was a dose-response increase in protein 
oxidation with an increase in consumption, as illustrated in Figure 5.3.11. Protein 
oxidation during the 25%P diet was higher than during the 15%P (p < 0.0001) or the 
10%P diets (p < 0.0001), and was higher during the 15%P than 10%P diet (p = 0.006). 
There was no evidence of a difference in fat oxidation between any of the study diets. 
Carbohydrate oxidation was lower during the 25 %P than the 10%P diet (p = 0.004), 
however there was no difference between the 15%P and the 10%P diets or the 25%P and 
the 15%P diets.
DIT was measured on each dietary treatment, over a three-hour period after a fixed-energy 
breakfast. Protein oxidation was higher during the 25%P than the 10%P diet (p < 0.001) 
and during the 15%P than 10%P diet (p = 0.001). There was no evidence of a difference 
between the 25%P and the 15%P diets. No difference in fat oxidation was evident 
between the study diets. Carbohydrate oxidation was lower during the 25%P than the 
10%P diet (p = 0.002) but there was no difference between any of the other study diets 
(Figure 5.3.12).
Substrate oxidation during the 24 h measurement of TEE is presented in Figure 5.3.13. 
Protein oxidation was higher during the 25%P than the 15%P (p < 0.001) and the 10%P 
diets (p < 0.0001), and the 15%P diet produced greater protein oxidation than the 10%P 
diet (p <0.0001). Similarly fat oxidation was higher during the 25%P diet compared to the 
15%P (p = 0.038) and 10%P diets (p = 0.028), but there was no difference between the 
15%P and the 10%P diets. Carbohydrate oxidation was lower during the 25%P than the 
15%P (p < 0.001) or 10%P diets (p < 0.001). There was no evidence of a difference 
between the 15%P and the 10%P diet (p = 0.078).
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Figure 5.3.11 Mean ± SEM substrate oxidation for all subjects during measurement of BMR on day 2 
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Oxidation of fat, carbohydrate and protein was compared to intake for each substrate to 
calculate substrate balance. There was no difference between intake and oxidation of fat 
during the 10%P diet or 15%P diet, but fat oxidized during the 25%P diet (3286 ± 185 kJ) 
was significantly higher than fat intake (2504 ± 176 kJ) (p = 0.001) (Figure 5.3.14). 
Oxidation of carbohydrate did not differ from intake during the 10%P or 15%P diets but 
was significantly lower than intake during the 25%P diet (intake 3757 ± 289 kJ, oxidation 
3243 ± 298 kJ, p = 0.033) (Figure 5.3.15). Protein oxidation was higher than intake during 
the 10%P diet (intake 858 ± 53 kJ, oxidation 1140 ± 53 kJ, p <0.0001) and the 15%P diet 
(intake 1235 ± 76 kJ, oxidation 1560 ± 76 kJ, p <0.0001), but not during the 25%P diet 
(intake 2087 ± 105 kJ, oxidation 2231 ± 109 kJ, p = 0.163) (Figure 5.3.16). Total 24 h 
energy oxidized did not differ from intake during the 10%P diet (intake 8584 ± 465 kJ, 
oxidation 8682 ± 465 kJ, p = 0.163) but oxidation was higher than intake during the 15%P 
diet (intake 8233 ± 408 kJ, oxidation 8758 ± 408 kJ, p < 0.0001) and the 25%P diet 
(intake 8350 ± 428 kJ, oxidation 8835 ± 432 kJ, p = 0.02) (Figure 5.3.17).
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5.4 Discussion
This chapter reports the findings of a crossover study to investigate the effect of 
isoenergetic diets differing in their protein:energy ratio on energy expenditure. A major 
strength of this study was that experimental diets had been consumed for three days prior 
to the measurements of energy expenditure and substrate oxidation to allow time for 
adaptation. Additionally the intervention diets were designed to be representative of 
habitual diets, with the percentage of energy provided from protein within the acceptable 
limits of normal intake and the meals composed of commonly eaten dishes. In contrast to 
previous studies with more extreme dietary manipulations the findings from this study 
may be more easily translated to diets in the general population. Measurements were made 
in a whole body calorimeter and the conditions during the investigation periods were 
tightly standardised, to allow for consistent within-subject comparisons and increased 
power to detect any effects.
The findings of this study reveal that total energy expenditure is not affected by 
manipulating the P:E ratio of the diet over a four-day period. Measurements of substrate 
oxidation suggested that protein and carbohydrate oxidation follows or matches intake, 
but fat oxidation increases over intake when the diet is high in protein and lower in 
carbohydrate, leading to a small negative energy balance.
5.4.1 Effect of diets of varying P:E ratios on energy expenditure
This study demonstrated that energy expenditure does not differ between diets of varying 
P:E ratio when lean, healthy subjects are provided with isoenergetic diets over 24 h, while 
undertaking identical activities in a room calorimeter. Despite three days of adaptation to 
the study diets, during which all food was consumed ad libitum, there was no difference
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between diets composed of 10%, 15% or 25% of energy from protein on total energy 
expenditure, DIT, SMR or BMR. Likewise there was no difference in the change in BMR 
between the first day of each study week and the morning after the isoenergetic diet in the 
calorimeter.
As discussed in Chapter 4 (4.2.2.3) the meals were carefully designed and prepared to 
closely match individual energy requirements for each study visit with a different P:E 
ratio. The dishes were familiar to the subjects and were all made from standard household 
ingredients. Subjects were therefore readily able to consume their total energy provision 
without difficulty in all but two instances. On these two occasions subjects felt unwell 
whilst in the calorimeter and were unable to consume their entire meal. The difference in 
energy intake between these and dietary treatments was not significant (Section 5.3.2) and 
both subjects were able to complete their calorimeter stay and the remainder of the study. 
The difference in composition between the study diets was not large. The lower and 
higher proportions of total energy from protein in this study (10%P vs. 25%P) are both 
within the normal limits of recommended protein consumption as the study was 
specifically designed to investigate whether small changes in the proportion of energy 
from protein, which could be readily adopted by the general population, might affect 
energy expenditure. As illustrated by urine nitrogen excretion (Figure 5.3.1) there was a 
clear difference between nitrogen excretion, and therefore protein intake, on each of the 
study visits, confirming that food intake accurately reflected the planned diets.
While there has been uncertainty regarding the effect of protein on total energy 
expenditure, it has generally been believed that higher protein intake increases DIT. When 
12 women were provided with isoenergetic 4-day diets containing 10% or 30% of energy 
from protein, DIT was higher during the high-protein diet (0.91 MJ/d) than the low-
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protein diet (0.69 MJ/d), and there was a trend to higher 24h EE (Lejeune et al., 2006). 
Elevated DIT was also demonstrated in 36 subjects who consumed a high- or low-protein 
(32% or 10% of energy from protein) test meal as part of an energy restricted weight loss 
diet (Luscombe et al., 2003). DIT was 2% greater after the high-protein than the low- 
protein meal at baseline, but there was no difference in DIT after 16 weeks of energy 
restriction. It is possible that the higher proportion of energy from protein (above the 
recommended upper limit) in these studies, and the subsequent increase in protein 
metabolism, was sufficient to increase post-prandial EE. In the latter study TEE and RMR 
were measured at baseline and after 16 weeks of the study diet and did not differ between 
diets. There was however less of a difference between the diets during the 16 week 
intervention period (high-protein diet comprised 30% of energy as protein and the low- 
protein diet 15% of energy as protein) than on the test day (32% versus 10%). The small 
difference in DIT was not sufficient to explain the greater weight loss observed in the 
high-protein group over the whole intervention period.
The lack of an effect of diets varying in protein content on DIT demonstrated in this study 
is supported by Smeets et al, 2008 (Smeets et al., 2008), who provided a test lunch to 30 
subjects containing 10% or 25% of energy from protein, and comprising 35% of each 
subject’s daily energy requirements. They observed no difference in EE after the test 
lunch between the high and low-protein meals measured via a ventilated hood (although 
there was a non-significant increase in EE after the high-protein lunch). Similarly Raben 
et al, 2003 (Raben et a l,  2003) found no difference in EE measured over five hours in 19 
subjects after test meals containing 32% or 12% of energy from protein and 24% of 
energy requirements.
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One reason to explain why previous studies have suggested protein promotes DIT and 
leads to increased 24h EE compared with carbohydrate and fat is that the meals provided 
were more extreme than those used in this study. The thermic response to hourly meals 
containing 70% of energy from protein or 70% from carbohydrate found energy 
expenditure over nine hours greater after the high-protein meals (9.6% of energy intake) 
than after the carbohydrate meals (5.7%) (Robinson et al., 1990). These meals were 
prepared with protein powder and liquid formula and therefore could not be sustained in 
the long term.
These studies suggest that to demonstrate increased post-prandial energy expenditure after 
a high-protein meal the proportion of protein in the meal must be elevated above the 
recommended limit, and even in these circumstances greater DIT is insufficient to lead to 
a net increase in TEE.
Another factor that may have influenced EE in this study was that the proportion of total 
daily energy intake provided at the test meal was only 25%, with a mean of 2.1 ±0.1 MJ. 
While we intended to spread energy intake evenly throughout the day in the calorimeter, 
subjects had difficulty consuming the larger breakfasts. Prior to the study commencing the 
breakfast meal was reduced in size to maximise complete consumption of each meal 
hence mean difference in protein intake was only 12 g to 30 g at this meal.
One observation suggests that protein type may additionally influence energy expenditure. 
12 subjects consumed diets containing 29% of energy from protein, predominantly from 
pork or soy, or 11% of energy from protein. 24 h EE was higher with the pork diet than 
with the soy or carbohydrate diets (Mikkelsen et al., 2000). Limiting the meals to one 
protein type may therefore have been expected to produce a difference in EE between the
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study diets. However, in the current study the meals were purposefully designed to be of 
mixed protein source, to replicate a standard diet as much as possible.
5.4.2 Effect of diets of varying P:E ratios on substrate oxidation
Although EE did not differ between diets, this study demonstrates that the P:E ratio of the 
diet affects substrate oxidation. Protein and carbohydrate oxidation followed the same 
pattern as dietary intake suggesting autoregulation of substrate oxidation. The 24 h 
measurement demonstrated that fat oxidation was significantly higher during the 25%P 
diet than the 15%P or 10%P diets despite the proportion of fat in each diet being the same 
(30% of energy intake). Consequently, significantly more fat was oxidized during the 24 h 
period than was consumed (a difference of 782 kJ/24 h). Oxidation of carbohydrate was 
lower than intake during the 25%P diet; with a positive balance of 514 kJ/24 h. Total 24 h 
oxidation was therefore higher than intake during the 25%P protein diet.
The differences in oxidation observed are supported by a study in 12 women who 
consumed meals containing 10% or 30% of energy from protein and 30% from fat over 24 
h. During the high-protein diet subjects were in positive protein balance and negative fat 
balance, while during the low-protein diet subjects were in positive carbohydrate balance 
and additionally were in a small positive balance for protein and fat (Lejeune et al., 2006). 
In a further study, 26 women consumed meals either high in carbohydrate (15% of energy 
from protein) or high in protein (30% of energy) with fat intake constant at 30% of 
energy. Post-prandial oxidation measured over 6 h demonstrated greater fat oxidation after 
the high protein meal with no changes in carbohydrate oxidation or DIT (Labayen et al., 
2004). In a similar manner to the present study, there was no correlation between 
oxidative balance and measurement of energy expenditure, despite fat oxidation being
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greater than intake, which should lead to increased EE. This data suggests that changes in 
substrate oxidation may be identified with small changes in diet and perhaps with less 
extreme manipulations than is required to measure a difference in EE.
In contrast to the studies discussed above demonstrating greater fat oxidation with 
increasing protein, a study using diets of similar macronutrient composition to the present 
study, reported that substrate oxidation did not differ after a single test meal which 
provided 10% or 25% of energy from protein and 30 % of energy from fat (Smeets et al., 
2008). A period of 2 -  4 days of adaptation is required to establish an oxidative balance 
when intake of substrate changes (Jebb et al., 1993) (Westerterp et al., 1999). As the 
subjects in our study had consumed the study diet ad libitum for three days prior to their 
investigation period, the measurement of their substrate oxidation more accurately reflects 
changes in oxidation due to the study diets.
The increase in fat oxidation with the 25%P diet is most probably due to the reduction in 
carbohydrate intake. Jebb et al (1996) demonstrated the importance of carbohydrate in the 
oxidative hierarchy during studies of over- and under-feeding (Jebb et al., 1996). When 
dietary energy was present in excess, carbohydrate utilisation rates increased rapidly to 
match intake within a few days, while counterregulatory responses led to suppression of 
fat oxidation despite a substantial increase in fat intake. The converse occurred during 
underfeeding. While protein oxidation increased or decreased in response to intake, 
changes were small and balance between intake and oxidation was not achieved. There 
did not appear to be any autoregulation of fat oxidation, which was dependent on changes 
in carbohydrate and protein oxidation, predominantly that of carbohydrate.
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In our study, performed during energy balance, carbohydrate oxidation followed intake as 
expected but protein oxidation also appeared to be able to change in response to intake. A 
140% difference in protein intake between the low and high-protein diets produced a 96% 
difference in oxidation and there was no difference between intake and oxidation for the 
25%P diet, suggesting that some autoregulation of protein oxidation did occur. It is 
possible that during a state of energy balance, manipulation of the macronutrient 
composition of the diet may stimulate protein-induced regulation of oxidation.
There is evidence that cats are able to regulate protein oxidation dependent on intake, 
provided the minimum protein requirement is met (Green et al., 2008). In six women 
substrate oxidation was investigated by providing subjects with meals containing either 
3.9% or 11.4% of energy from protein, 35.4% or 27.8% of energy from carbohydrate and 
60% of energy from fat (Petzke & Klaus, 2008). During consumption of the low-protein 
diet exogenous post-prandial fat oxidation was significantly higher than during the 
adequate protein diet but total fat oxidation did not differ between the two, suggesting that 
a minimum intake may also be required in humans for autoregulation to occur.
Absolute fat intake did not differ between the diets but there was a substantially larger 
oxidation of fat during the 25%P diet -  782kJ during the 24 h period. The negative fat 
balance seen in the 25%P diet is likely to promote fat loss in the long term, and to have 
subsequent beneficial effects of a more favourable body composition for metabolic risk 
factors (as discussed in Section 1.7). Indeed, subjects with higher protein intake during 
weight maintenance after weight loss have a lower fat mass than subjects with lower 
protein intake (Westerterp-Plantenga et al., 2004; Lejeune et al., 2005). It appears that the 
ability to store dietary fat is critical to an individual’s susceptibility to increase body mass
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(Westerterp, 2009) and therefore any mechanism which promotes fat oxidation is 
advantageous to maintain or reduce body mass.
The importance of carbohydrate oxidation on food intake has been investigated in 112 
subjects, predominantly Pima Indians (Pannacciulli et al., 2007). Carbohydrate oxidation, 
measured in a calorimeter during energy balance, was a strong predictor of subsequent ad 
libitum food intake and short-term changes in body weight. The theoretical basis for this 
observation is that higher carbohydrate oxidation may deplete glycogen stores more 
readily and lead to an increase in hunger experienced, and subsequently greater food 
intake. Reducing carbohydrate intake may therefore reduce carbohydrate oxidation and 
subsequent hunger, leading to beneficial effects on body weight.
5.4.3 Summary
This study has shown that adjusting the P:E ratio of the diet from 10% to 25% of energy 
from protein, while maintaining fat at 30%, does not alter total energy expenditure, or any 
of the components of energy expenditure, when familiar meals are provided in energy 
balance in a calorimeter, after three days of ad libitum consumption of the study diet.
Additionally, these findings do not support previous evidence that increasing dietary 
protein increases DIT, although the effect on total energy expenditure has previously been 
less certain. Strengths of this study to support the data are that the investigations were 
performed in highly controlled conditions and yet the meals provided and the 
macronutrient manipulations were designed to be as close to habitual food consumption as 
possible. Additionally, three days of adaptation to each study diet was provided prior to 
investigation days. Providing less extreme manipulations of the diet may have reduced an
353
effect on DIT, which may explain the lack of consistency with previous studies which 
have demonstrated an increase in DIT with a high protein diet, however this study was 
specifically designed to utilise diets that may be able to be continued long-term.
In contrast, this study demonstrates that even relatively small manipulations in the P:E 
ratio of the diet alter substrate oxidation. Autoregulation of carbohydrate oxidation was 
evident and to a lesser extent for protein. Despite fat intake being equal in all three diets, 
fat oxidation was higher in the 25%P diet than the lower protein diets, and fat oxidation 
was higher than intake leading to a negative fat balance during the higher-protein diet, 
which may contribute to improvements in body composition.
The higher fat oxidation is probably due to lower intake of carbohydrate in the high- 
protein diet, whereby a reduction in carbohydrate oxidation produces a reciprocal increase 
in fat oxidation. The importance of carbohydrate oxidation in controlling hunger and food 
intake is also of interest when macronutrient intake is manipulated and may be important 
for long-term energy balance. Therefore increasing dietary protein in exchange for 
carbohydrate may not only reduce hunger by reducing carbohydrate oxidation. There may 
also be an increase in fat oxidation and reduction in fat storage, leading to long-term 
reductions in weight gain.
354
6 Chapter 6 Discussion
6.1 The need for strategies to reduce energy imbalance
In describing the normal mechanisms that regulate energy balance, the introductory 
Chapter 1 of this thesis demonstrates that, while complex physiological processes 
maintain energy balance, these biological systems may be overridden by environmental 
and psychological factors and lead to under- or overnutrition. The worldwide increase in 
obesity is caused by energy imbalance and is leading to a rapid rise in morbidity and 
mortality from metabolic diseases; particularly type 2 diabetes and cardiovascular 
disease. Furthermore it was argued that there is a pressing need to identify targets in the 
energy balance equation that can lead to acceptable strategies to prevent the development 
of obesity in the general population and promote weight loss in those currently obese, and 
additionally to attempt to reduce risk factors for metabolic diseases.
Dietary strategies are the foundation of any approach to alterations in energy balance 
because of their widespread applicability, and have been extensively studied to develop 
guidelines for the management of energy imbalance, particularly obesity. The increasing 
prevalence of popular diets has additionally led researchers to investigate the success and 
underlying mechanisms of novel regimes for weight loss. In part because of the 
widespread popularity of diets high in protein and the recognition that high-protein meals 
enhance satiety, protein has been recently recognised as a potentially important 
component in dietary strategies, where previously the macronutrients that comprise a 
much larger proportion of a standard diet (carbohydrate and fat) have received more 
attention.
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The role of protein in energy regulation is presented in Chapter 1, with a number of 
potential targets in the energy balance equation identified, notably enhancement of satiety 
and energy intake, possibly through an effect on gastric emptying, gastrointestinal 
hormone release and glucose metabolism, and an increase in energy expenditure and 
alteration of substrate oxidation rates. The potential benefit of protein on metabolic risk 
factors is also presented.
6.2 Satiety and energy intake
The work presented in Chapter 3 described a classic preload design study which 
investigated short term satiety and energy intake after high-protein meals of different 
protein type and a control, taking into account the benefits and restrictions of this type of 
study performed in a metabolic suite setting. The study identified that when high-protein 
meals differing in protein type but designed to be as familiar as possible, are provided 
with the percentage of protein just above the recommended upper limit of daily intake, soy 
protein stimulates satiety and inhibits food intake, while nuts and legumes enhance meal 
satiation.
In the longer term study presented in Chapter 4 a high-protein diet over 3 days containing 
protein at the upper limit of the recommended range, increased meal satiation, enhanced 
fullness and reduced energy intake by 0.6 MJ/d. In contrast, a reduction in dietary protein 
to the lower limit of the recommended range did not alter appetite sensations or energy 
intake when compared to a diet of standard protein content, despite predictions from the 
protein leverage hypothesis, described in Chapter 4, that lower availability of protein 
would lead to a compensatory increase in carbohydrate and fat consumption to reach a 
specific protein intake target.
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The effect of protein to increase satiety and reduce energy intake was investigated further 
to identify whether plausible mechanisms exist to account for such an effect and to predict 
whether consumption of high-protein diets in the long term may produce a sustained 
physiological suppression of energy intake. As presented in Chapter 3, a slower rate of 
gastric emptying seen after the soy protein diet may be a mechanism by which soy protein 
increases satiety and reduces energy intake. Gastrointestinal hormones slow gastric 
emptying, and while these hormones were not measured simultaneously with gastric 
emptying, measurements after high and low-protein meals in Chapter 4 demonstrated 
greater secretion of PP and the trend to greater GLP-1 secretion after a high-protein diet. 
Infusions of gastrointestinal hormones increase satiety and the ability of diets high in 
protein to alter their release may be one of the predominant mechanisms by which protein 
influences satiety and energy intake.
In Chapters 3 and 4 measurement of post-prandial glucose, which is known to stimulate 
hunger when concentrations increase and decrease rapidly, suggested that diets high in 
protein have an important role in regulating post-prandial glucose measurements 
particularly when the protein type is from plant source (for example, soy or nuts and 
legumes). The reduction in post-prandial glucose concentration coincided with an increase 
in satiety and a reduction in energy intake and provides further evidence that plausible 
physiological mechanisms exist to account for the reduction in El with an increase in the 
proportion of dietary protein.
Whether the observed reduction in energy intake would persist in the long term is 
debatable and requires further clarification. The studies reported in this thesis were 
performed under highly controlled conditions, which demonstrate the physiological 
effects of the alteration in diet, but is an environment distinctly different to usual eating
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habits. The reduction in daily energy intake of 0.6 MJ/d equating to a loss of body mass of 
3.7 kg over six months is equivalent to some weight loss intervention trials (Samaha et al., 
2003). This degree of loss of body mass compares favourably to ad libitum low fat, high 
carbohydrate diets (Astrup et al., 2000) and indeed is greater than in some studies that 
have manipulated the fat and carbohydrate content and source during ad libitum diets 
(Saris et al.). However, providing evidenced based dietary guidelines is limited by lack of 
long term effects, with initial loss in body mass, usually over six months, rarely persisting 
past one year (Sacks et al., 2009).
A change in habitual eating patterns must therefore be acceptable and sustainable. The 
DiOGenes study is the only UK trial to focus specifically on weight maintenance (after a 
period of weight loss) with high or low protein diets in overweight adults. Fewer dropouts 
occurred during the high protein groups and together with a reduction in weight regain 
(Larsen et al., in press) these data suggest that a moderate increase in protein may be 
acceptable long term and may be important in the prevention of weight gain. Additionally 
this study demonstrates that the satiating properties of protein exist in overweight subjects, 
suggesting that the results of the studies in this thesis performed in lean subjects may be 
extrapolated to the overweight or obese.
6.3 Energy expenditure and substrate oxidation
Chapter 5 describes a highly standardised study investigating energy expenditure during 
diets differing in their protein:energy ratio. Providing meals of 10%, 15% or 25% of 
energy from protein demonstrated that there was no difference in any parameter of energy 
expenditure, and clearly shows that any observed reduction in body mass during diets of 
moderately high-protein is not explained by alterations in energy expenditure.
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However, the percentage of protein in the diet has a significant impact on substrate 
oxidation rates. This study confirmed that protein and carbohydrate oxidation is 
autoregulated, while that of fat, as the lowest macronutrient in the oxidation hierarchy, is 
dependent on the oxidation of the other two substrates. Fat oxidation is greater when 
protein intake is higher (and carbohydrate intake lower) than when the same fat intake 
occurs in a diet low in protein, a finding which could have positive long-term benefits on 
loss of body mass and in particular a reduction in fat storage. While reduction in 
carbohydrate has been recognised as a critical factor in regulating fat oxidation, especially 
during over- or under-feeding, it is worthwhile exploring further whether protein per se 
may alter fat oxidation, enabling higher-protein diets to reduce fat mass and preserve lean 
mass during weight loss.
6.4 Body mass and composition
Despite greater fat oxidation observed during the high-protein diet there was no 
consistent reduction in body mass or the measurements that reflect fat mass - waist 
circumference, air displacement plethysmography or DXA scanning - in the studies 
reported in Chapters 4 and 5. The treatment periods and time between measurements 
were short and it was therefore not unexpected to find that these parameters remained 
unaltered. Most of the previous work investigating changes in body composition with a 
high-protein diet has occurred over longer periods of time, usually during weight 
reduction and applied a higher percentage of energy from protein than was used in this 
study. Chapter 5 suggests a plausible mechanism for a dose dependent increase in fat 
oxidation with increasing protein consumption. Whether moderate increases in protein 
consumption over a longer time period would lead to a dose-dependent reduction in fat
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mass or body mass is of interest, given the potential metabolic benefits of reducing fat 
mass by adopting a simple and acceptable dietary change.
6.5 Energy balance and appetite control mechanisms
These studies indicate that dietary protein regulates energy balance by altering energy 
intake but has no effect on energy expenditure. In contrast it appears that small changes in 
protein intake (and indeed in protein type) can alter energy intake and do so through a 
combination of changes in satiety and metabolic factors that influence appetite. The 
relative importance of the factors observed in these studies that reduce appetite -  slowing 
of gastric emptying, increased secretion of anorexigenic gastrointestinal hormones, and 
reduced glycaemic excursions -  is difficult to ascertain, not least because these factors are 
intrinsically intertwined. A slow rate of gastric emptying increases satiety and additionally 
may reduce the rate at which glucose appears in the blood after a meal. Gastrointestinal 
hormones (amongst other functions) stimulate anorexigenic centres in the brain to reduce 
energy intake, act locally to reduce the rate of gastric emptying, and, in the case of GLP-1, 
stimulate insulin secretion in the pancreas to reduce blood glucose levels.
6.6 Metabolic risk
The relationships between protein quantity and type and markers of metabolic risk were 
explored in the studies reported in Chapters 3 and 4. In Chapter 3, the action of protein 
type on glucose and insulin metabolism was clearly demonstrated. In particular, beneficial 
post-prandial effects of nuts and legumes and soy were observed on blood glucose. This 
finding provides a mechanism for the metabolic and cardiovascular benefits observed with
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habitual diets high in nuts or soy, and suggests that dietary recommendations to alter 
protein intake should also involve guidance on optimal protein composition.
The relationship between dose-dependent changes in protein and glucose and insulin 
metabolism was explored further. In Chapters 4 and 5, the post-breakfast glucose and 
insulin curves did not differ between the diets, possibly due to the mixed protein source of 
the breakfast meal, particularly the use of dairy proteins which were found to have greater 
post prandial glucose concentrations in Chapter 3, and because the breakfast meal was 
lower than one third of the daily energy content. The results reported in Chapter 4 show 
clear dose-dependent differences in 24 h glucose profiles with changes in the protein 
composition of the diet. The importance of glucose concentrations in the development of 
the metabolic syndrome, as described in Chapter 1, imply that altering protein intake may 
be advantageous in the long-term modification of metabolic risk.
That relatively small change in dietary protein can produce clear and clinically significant 
changes in glucose concentrations, in lean healthy subjects, is important. The relationship 
between elevated glucose and metabolic risk factors appears to occur in a continuous 
manner, rather than a specific cutoff value existing which prevents the development of 
metabolic disease. The ability to reduce glucose concentrations, even within the normal 
range, is therefore valuable and may be the most clinically significant finding of these 
studies. Whether these improvements in metabolic risk factors, due to moderate changes 
in dietary protein, lead to reductions in morbidity and mortality from metabolic diseases 
needs to be explored further in larger, long-term trials.
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6.7 Future directions
The search for appropriate strategies to reduce the ever-increasing burden of obesity has 
led to a considerable amount of research into dietary approaches that may prevent the 
development of overweight and obesity, assist in regimes to reduce body mass in those 
currently overweight, and prevent the development of weight-related metabolic disease. 
The challenge is to identify a dietary strategy that can be implemented easily and is 
sustainable.
An aspect that remains unclear from the work presented in this thesis is whether the 
beneficial effects observed from a moderate increase in protein is due primarily to the 
protein per se or because of a reciprocal reduction in carbohydrate. Fat was deliberately 
kept constant in these studies, leading to subjects consuming differing levels of 
carbohydrate, a factor which is known to affect post-prandial glucose excursions and fat 
oxidation. Simply reversing the diets to keep carbohydrate constant instead of fat would 
not solve this problem as increasing fat is associated with hyperphagia, changes in gastric 
emptying, and deterioration in lipid profiles. An approach would be to design a study 
based on low- or high- protein and include diets both high and low in fat and 
carbohydrate for each protein level. This larger study would require more subjects and 
ideally be of longer duration.
One way to clarify whether differing dietary protein leads to long-term changes in energy 
regulation is to compare changes in body mass in subjects whose protein intake can be 
objectively measured. Urinary nitrogen excretion reliably reflects protein intake and so 
could be used to identify whether changes in body mass are due to actual protein 
consumed (rather than a randomised intervention group which may not have complete 
adoption of the study diet). This information is available in the long-term intervention
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study DiOGenes where an analysis of change in body mass relative to urine nitrogen 
excretion is planned.
Long-term interventions are important to determine whether any of the effects of altering 
dietary protein observed in a metabolic suite environment translates to similar results in 
free-living subjects. Greater longevity of the study can more easily clarify whether the 
intervention diets are acceptable, sustainable and produce positive outcomes. Such 
comparisons require large sample sizes necessitating multi-centre projects, carefully 
standardised study design and monitoring.
The work presented in this thesis suggests that small increases in dietary protein may be 
an appropriate approach to assist in maintaining energy regulation. Moderately high 
protein meals are straightforward to prepare with standard ingredients, are palatable and 
acceptable and could therefore be predicted to be able to be adopted in the long term. The 
question remains as to whether this is indeed feasible in the wider population and whether 
a widespread recommendation to increase protein would have any deleterious effects in 
the community. Experience has shown us that changing habitual diet is challenging. The 
general understanding of nutrition in the community is limited, and therefore advice to 
alter protein intake would require education about what constitutes dietary protein and 
how to assess the quantities that need to be consumed. Expecting individuals to ‘count’ 
protein grams would be untenable and a simpler message would need to be provided. In 
an experimental setting, advice to alter the proportion of protein in the diet has been 
successful, even when used across eight European countries (Moore et al., 2010). The 
strategy used in this setting required subjects to work closely with a dietitian to understand 
protein exchanges, however it is feasible that a simpler version could be developed to 
provide relatively straightforward messages for the wider population.
Alongside an increase in education regarding a change in protein intake individuals may 
be assisted by the food industry providing high protein meals. Interestingly Marks and 
Spencer have recently introduced a high protein range, marketed to increase satiety for use 
as a weight loss strategy, with protein consumption recommended to be 30% of total 
energy. Slimfast have a similar approach for their rapid weight loss meal replacement 
plans with recommendations for high protein consumption. It is foreseeable that other 
food manufacturers will follow this approach and include high protein meals in their 
standard ranges for weight control, rather than just targeted for weight loss.
However, relying on manufactured products to alter eating habits provides two major 
problems. Firstly, education regarding ideal diet composition would not improve and 
people become more reliant on ready-made meals, further limiting the ability to cook and 
use fresh ingredients. There already exists a substantial problem with poor food 
preparation skills and complicating the dietary recommendations would undoubtedly 
worsen this. Secondly, ready-made meals are costly and are less accessible to low-income 
groups - the groups that are most vulnerable to developing obesity and metabolic diseases. 
Indeed it could be argued that adopting a high protein diet, whether relying on pre­
prepared meals or fresh produce, may be too expensive for many people in the 
community. This is undoubtedly true if the source of protein is of animal origin, however 
non-animal sources of protein -  beans, legumes, seeds, nuts, soy, etc -  are generally 
affordable and, as was presented in this thesis, are associated with lower risk factors for 
metabolic disease. A simple recommendation to increase consumption of these non­
animal sources of protein may have significant health benefits.
Further issues exist when considering widespread increases in protein consumption. It is 
likely that protein of animal origin would increase, leading to increased demand for
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animal production and the cereal production to feed these animals, with consequences for 
scarce resources. The humane treatment of farmed animals has come under debate 
recently with current farming practices already causing concern. Increasing the demand 
for animal products would likely pose further ethical dilemmas for the farming industry. 
Additionally, there are significant concerns about deforestation and the environmental 
effects of the need for an increase in farmland. At a local level converting forested areas to 
farmland may seem economically beneficial, however on a large scale further destruction 
of forests would produce disastrous environmental consequences.
The problem of obesity is large and calls for a concerted response and comprehensive 
recommendations for appropriate dietary strategies. It is hoped that the work presented in 
this thesis may contribute to the development of such strategies.
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Appendices
Appendix 1: The effect of protein type on short-term appetite 
and energy intake
1.1 Preload Meals
1.2 Study questionnaires and forms
1.2.1 Information Sheet
1.2.2 Consent Form
1.2.3 Telephone Screening Questionnaire
1.2.4 Approach letter to participants
1.2.5 Letter to participant’s GP
1.2.6 Advertisement
1.2.7 Appetite Questionnaire
1.2.8 Palatability Questionnaire
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Metabolic Response to different Meal Types
CONSENT FORM
LREC Reference Number: 0 5 / Q 0 1 0 6 / 3 7  
Name of Lead Investigator: Dr Rosemary Hall
P lease initial box
1. I confirm  t h a t  I h av e  read  a n d  u n d e r s ta n d  th e  in fo rm ation  s h e e t
d a t e d  A u g u s t  2 0 0 5  (ve rs ion  03) fo r  th e  a b o v e  s tu d y  an d  h a v e  h ad  th e  ________
o p p o r tu n i ty  to  a sk  q u e s t io n s .
2. I u n d e r s ta n d  t h a t  m y  par tic ipa tion  is v o lu n ta ry  an d  t h a t  I a m  f ree  to  
w i th d raw  a t  a n y  t im e ,  w ith o u t  giving a n y  re a s o n ,  a n d  w ith o u t  m y 
legal r ig h ts  being  a ffec ted .
3. I c o n s e n t  to  m y  g e n e ra l  p ra c t i t io n e r  be ing  notified o f m y  partic ipa tion  
in th is  r e s e a rc h .
4. I c o n s e n t  to  m y g e n e ra l  p ra c t i t io n e r  be ing  notified of m y  s tu d y  re su l t s  
a n d  an y  a b n o rm a l i t ie s  found  d u ring  th is  re s e a rc h .
5. I u n d e r s ta n d  t h a t  s a m p le s  ta k e n  a s  p a r t  o f  t h e  protocol of th is  s tu d y  
m a y  be s to re d  for up  to  10 y e a r s  a n d  u s e d  in fu r th e r  re s e a rc h  s tu d ie s .  
S a m p le s  will only  be u sed  in s tu d ie s  t h a t  h a v e  b ee n  ap p ro v e d  by th e  
a p p r o p r ia te  Ethics C o m m it tee .
6. I u n d e r s ta n d  t h a t  s a m p le s  ta k e n  a s  p a r t  o f  th is  s tu d y  m ay  be a n a ly s e d  
in a n o t h e r  lab o ra to ry  o u ts id e  of MRC H u m an  Nutrition R esea rch .
All s a m p le s  will be  m a d e  a n o n y m o u s ,  a n d  no p e rso n a l  in fo rm ation  will be  
s e n t  to  a n o t h e r  labo ra to ry .
7. I u n d e r s ta n d  t h a t  I c a n n o t  p a r t ic ip a te  in th is  re s e a rc h  if I a m  p re g n a n t .
I a m  n o t  p r e g n a n t  a n d  will inform th e  r e s e a rc h  t e a m  if I b e c o m e  p re g n a n t .
8. I a g r e e  to  t a k e  p a r t  in th e  a b o v e  s tu d y .
Name of Volunteer Date Signature
(Please p rin t)
Name of Research Team Member Date Signature
(Please p rin t)
Name of Researcher Date Signature
(Please p rin t)
3 copies required: top copy for researcher; one copy for volunteer; one copy to be kept with research subject's notes.
Metabolic Response to different Meal Types
Telephone Screening Q uestionnaire
N am p  ...........................................................................................................................
A d d re ss  ...........................
Age ........................... D a te  of B i r t h .................................
P hone  N um ber:  D a y ..... ................................................. E v e n i n g .............................................................
B es t  t im e  to  p h o n e  ....
G en era l  P r a c t i t i o n e r .......
Of (m edica l  p ra c t ic e ) ......
GP t e le p h o n e  n u m b e r .....
How did you h e a r  a b o u t  t h e  S tudy? (Advertisement/Database/etc)..................................................
Are you  cu rren t ly  in a n y  o th e r  re s e a rc h  s tu d ie s ,  o r  h a v e  you  b e e n  in an y  in t h e  las t  y e a r?
Health
Do you h av e  o r  h av e  you  had  a n y  of t h e  following cond it ions?
(i) D iab e te s
YES
□
NO
□
(ii) S to m a c h  o r bowel p ro b le m s □ □
(iii) A s th m a /E c z e m a /H a y f e v e r □ □
(iv) High C holes tero l □ □
(v) Chronic m edica l  co n d it io n s □ □
(vi) A n aem ia □ □
(vii) C an ce r □ □
(viii) Food /D rug  a l le rg ie s □ □
(ix) Eating D isorder □ □
(viii) Are you P re g n a n t  (o r  p lann ing ) o r B rea s tfeed in g □ □
(ix) Are you p r e m e n o p a u s a l □ □
P lease  list a n y  o th e r s
P lease  list an y  m e d ic a t io n s  (pills, t a b le t s ,  c o n t ra c e p t iv e s ,  in h a le rs  e tc . )  t h a t  you a r e  tak in g ,  
e i th e r  p re sc r ib ed  by y o u r  d o c to r  o r  p u rc h a s e d  o v e r  t h e  c o u n te r .
C u r re n t  W e i a h t ................. H e i a h t ..................... E s t im a te d  BMI
YES NO
Do y o u  s m o k e ? □ □
If y e s ,  how  m a n y  c ig a r e t te s  p e r  d a y ? .....................................
YES NO
Do y o u  d rink  alcohol? □ □
If y e s ,  how  m a n y  u n i ts  of alcohol w ould you c o n s u m e  in an  a v e r a g e  w e ek ?
(1 un it  = 1 m e a s u r e  o f sp iri ts  /  1 sm all  g la ss  o f  w ine /  1 half p in t o f  b ee r )
Availability and Transport
YES NO
Would you h a v e  a n y  difficulty in:
1. A ttend ing  MRC-HNR on five o cc as io n s? □ □
2. Eating all ty p e s  o f food? □ □
3. Having a blood s a m p le  ta k e n ? □ □
4. Fasting  o v e rn ig h t?
□ □
□ □
5. B rea th ing  into a t u b e  th ro u g h  a s t raw ?
YES NO
Would you h a v e  a n y  an t ic ip a ted  difficulties w ith  y o u r  availability □ □
o r t r a n s p o r t  a r r a n g e m e n t s  to  a t t e n d  e a c h  o f t h e s e  s e s s io n s?
YES NO
Do you h a v e  a n y  p re fe r red  d a y s  to  a t t e n d  t h e  unit? □ □
If y e s ,  p le a s e  g ive  d ay s .
Name of Research Team Member Date Signature
(Please p rin t)
Eligible for  th is  s tu d y YES NO
If YES: S e n d  In fo rm a tio n  S h e e t ....................................... YES NO
D iscussed  s u p p le m e n t  u se YES NO
D iscussed  m a in te n a n c e  of lifestyle fa c to rs YES NO
If p re -m e n o p a u s a l  d iscu ssed  m e n s t ru a l  p h a s e YES NO
A p p o in tm e n ts  Visit 1 ...................................................
Visit 2 ...................................................
Visit 3 ...................................................
Visit 4 ...................................................
Visit 5 ...................................................
If NO: Would you like in fo rm ation  a b o u t  o th e r  s tu d ie s  a t  MRC-HNR o r  c o n s id e r  placing y o u r
n a m e  on o u r  V o lu n tee r  D a ta b a s e ?  YES NO
Q u e s t io n n a i re  S e n t ...............................................................................  YES NO
Version 01 March 2005
Address
Date
D ear
Re: M etabolic R esponse to  d ifferent Meal Types
We a r e  cu r ren t ly  rec ru i t ing  v o lu n te e r s  for a nu tri t ion  s tu d y  a t  MRC H um an  Nutrition R esea rch .  
We h a v e  looked a t  t h e  in fo rm ation  t h a t  w e h a v e  on o u r  v o lu n te e r  d a t a b a s e  an d  found  t h a t  you 
m ay  be  ab le  to  be  involved.
This s tu d y  will in v e s t ig a te  th e  w ay  o u r  body re s p o n d s  to  d if fe ren t  ty p e s  of food.
We a r e  looking for a to ta l  of 30  h ea l th y  v o lu n te e r s  fo r  th is  s tu d y .  Each v o lu n te e r  w ould  be  
req u ired  to  a t t e n d  MRC H u m an  Nutrition R esea rch  for six  h o u rs  on  five d iffe ren t  o ccas io n s .  You 
w ould be g iven  d if fe ren t  m e a ls  an d  w e will m e a s u r e  w h a t  h a p p e n s  to  h o rm o n e s  an d  m e tab o l ic  
fa c to rs  in y o u r  blood a f te r  th e  m ea ls .
In recogn ition  of y o u r  t im e  c o m m itm e n t ,  you  will re ce iv e  a n  h o n o ra r iu m  of £ 1 0  for e a c h  visit. 
R easo n a b le  t rav e l  e x p e n s e s  will a lso  be  re im b u rse d .
P lease  read  t h e  en c lo se d  v o lu n te e r  in fo rm ation  s h e e t  for  m o re  de ta i ls ,  an d  if you a r e  in te re s te d  
in tak in g  p a r t ,  o r  if you  h a v e  a n y  q u e s t io n s ,  p le a s e  c o n ta c t  m e  on 0 1 2 2 3  4 2 6 3 5 6 .
Kind re g a rd s
Dr R o sem ary  Hall 
Clinical S c ien t is t
Version 01 March 2005
Dr...............
GP Address
Date
D ear  D r  ,
Re: M etabolic R esponse to different Meal Types
Your p a t i e n t  Name, DOB & Address o f Volunteer, h a s  v o lu n te e re d  to  t a k e  p a r t  in a re s e a rc h  
s tu d y  a t  MRC H u m an  Nutrition R e se a rc h  (HNR). He/She  h a s  g iven  u s  p e rm is s io n  to  c o n ta c t  you .
T he  s tu d y  is d e s ig n e d  to  in v e s t ig a te  m e ta b o l ic  r e s p o n se ,  s a t ie ty  h o rm o n e s  levels ,  an d  gas tr ic  
em p ty in g  e f fec ts  from  ea t in g  v ar io u s  m ea l  ty p e s .  (For m o re  in fo rm ation  s e e  t h e  a t ta c h e d  
v o lu n te e r  in fo rm ation  s h e e t ) .  P a r t ic ip an ts  will n eed  to  a t t e n d  MRC H u m an  Nutrition R esea rch  on 
five o c c a s io n s  a n d  will be  prov ided  with d iffe ren t  m e a ls  on  each  occas io n .  A ca n n u la  will be 
in se r ted  for b lood sam p lin g  an d  p a r t ic ip a n ts  will be  requ ired  to  p e r fo rm  f r e q u e n t  b re a th  t e s t s  
t h r o u g h o u t  t h e  t e s t  d ay s .
Your p a t i e n t  h a s  b ee n  a s k e d  to  p ro v id e  us  w ith  th e i r  m edica l  history . P a r t ic ip an ts  will be 
ex c lu d ed  if th e y  h a v e  a n y  a c u te  o r  ch ron ic  d i s e a s e ,  a r e  p re g n a n t ,  b re a s t f e e d in g  o r  p lann ing  
p re g n a n c y ,  o r  a r e  tak ing  a n y  m ed ica t io n  o th e r  t h a n  an  oral c o n tra c e p t iv e  pill.
We will inform  you  if a n y  a b n o rm a l  re su l ts  a r e  o b ta in ed  which m ay  be  of clinical s ignificance.
If you fee l th at there is a medical reason w hich should prevent their participation in 
th is study or if you need further deta ils p lease  contact m e on 0 1 2 2 3  - 4 2 6 3 5 6 .
Yours s in cere ly
Dr R o s e m a ry  Hall 
Clinical S c ien t is t
Human
Nutrition
Research
Are You Interested in 
Nutrition Research?
We are running a study to 
investigate how our body 
responds to different meals
Are you:
Aged 18-70 years
Healthy, non smoker, and a normal weight 
Willing to ea t different types of food 
- including meat and nuts 
Able to attend MRC HNR five times 
Willing to give blood samples
If you would like more information please 
contact Rosemary Hall on (01223) 437611
rosemary.hall@mrc-hnr.cam.ac.uk
You will be reimbursed for participation in the study and 
for reasonable travel expenses
Version 02, 25 April 2005
A ppetite Q uestionnaire
D ate
P ar t ic ip an t  ID □ □□
Visit No: TimeDOint: min
• P le a se  a n s w e r  th e  following q u e s t io n s  by placing a  vertica l m a rk  th ro u g h  th e  line.
• R eg ard  th e  e n d s  of e a ch  line a s  indicating  th e  m o s t  e x t r e m e  s e n s a t io n  you  h a v e  e v e r  felt.
1. How hungry a r e  you?
Not a t  all Very
h u n g ry h u n g ry
2. How full do you feel?
Not a t  all Verv
full full
3. How s t ro n g  is y o u r  desire to eat?
Not a t  all Very
s t ro n g s t ro n g
4. How much food do  you th in k  you  could  e a t?
N one A la rge
a t  ail a m o u n t
5. How contented  a re  you?
Not a t  all Very
c o n te n te d c o n te n te d
6. How irritable a r e  you?
Not a t  all Very
irri tab le ir r i tab le
7. How d ep ressed  a r e  you?
Not a t  all Very
d e p r e s s e d d e p r e s s e d
8. How m entally alert a r e  y ou?
Not a t  all Very
Alert Alert
Meal Q uestionnaire
D ate
P art ic ipan t  ID □ □□□ .
Visit No: TimeDOint: min
P lease  a n s w e r  th e  following q u e s t io n s  by placing a ve r tica l  m a rk  th ro u g h  th e  line.
R egard  th e  e n d s  of e a c h  line a s  indicating th e  m o s t  e x t r e m e  s e n s a t io n  you h a v e  e v e r  felt.
1. How sw eet did you find the meal? 
Not a t  all 
sweet
Extremely
sweet
2. How savoury did you find the meal? 
Not a t  all 
savoury
Extremely
savoury
3. How tasty did you find the meal? 
Not a t  all 
tasty
Extremely
tasty
4. How pleasant did you find the meal?
Not a t  all 
pleasant
Extremely
pleasant
5. How filling did you find the meal?
Not a t  all 
Filling
Extremely
filling
6. How satisfying did you find the meal? 
Not a t  all 
satisfying
Extremely
satisfying
7. How much more of this food do you think you could eat? 
A small 
amount
A large 
amount
8. How enjoyable did you find the meal? 
Not a t  all 
tasty
Extremely
tasty
Appendix II: Study 2 Measuring the effect of manipulating the P:E ratio on
energy metabolism.
11.1 Meals
11.2 Study questionnaires and forms 
77.2.7 Information Sheet
112.2 Consent Form
11.2.3 Telephone screening questionnaire
11.2.4 Approach Letter to Participants
11.2.5 Letter to participant’s GP
11.2.6 Advertisement
11.2.7 Three Factor Eating Questionnaire
11.2.8 Eating Attitude Test
11.2.9 International Physical Activity Questionnaire
11.2.10 Instructions for wearing the CGMS
*0 Vi5u  9
sa ^© rg
«
6  »
I  "C e  
w - c S
u
b
V)
©
a
9
U
3
9£
Hrr
>>9
Q
-a
£
<*>
>>9
Q
V9
H
N
>>9
Q
9
Q
99C/5
>>9
Q
9
O
"9©
00I*Vs
■
'Oa>
.H
«
^3
<3
ooin
cn
UiP6
u
. 9
*9 ^  3 CC
V, p
D x
©
00•a
o
C l.
cd
U
C D
00T3
OCU
CD
U
X9
£PQ
o  o  o  o  m in 
CN CN
3
X)
<DX
c d
3  ' I
§  ■§
S 9O .  c/3
<DX
cd
£T3
3
9VI
9
C3
3
IS<+H
3
t;
3
X
00
o>L
u
C Dx
c d
X©99
VI
©
s
'-3
9
Q
ooo
in
•ac
9
>  d
©
CD
JZ
cd
'S
2
9
o
9
T3
3
9
>  d
C D
CD
X
CD
’S
ol.
9
CD
9
U99
J
O
Oin
CN
a
3
X
00
o
k.
k.
CD
X
£
9k.
DO
a
3
X
00
o
?nk.
k.
CD
X
Q.
c/3
9
C<
a
3
X
00
o
>L
( D
X
£
9k.
o n
3x
00
o
>->
>>
k.
k.
( D
X
a ,
C/5
9
Ptf
O
o
o
in
o
©in
CN
9a.
9
3
00
o
3
P Q
3
CD
J4
CD
X
CD
£
o
o
3  "2 
s  §
00
3
'”3
T3
3
Q.
3
X
■o
3
9
00
3
3
T3
3
D.
i2
Vi
9a.
9
3
00
o
o
P Q
3
( D
J*
CD
X
CD
B
o
3  T3
00
3
3T3
3a,
06
3x
T339
T3
9
( D
T3
- a
3
Q.
< D3
3
3
■aU-cd
TD
C
i2
o
oin
CN
vo
CN
CD
.2 t;
* J"O -9 
3  00
9  OC/3 >->
3
£CkH
3
3
X
00
o
;n
■e
3x
00
o
X
CD99C/5
00
a9
*9
©
►
Sunday standard dinner
Energy provided kj
Tescos Steam Chicken in mild coconut curry sauce 450 g 1820
Tescos Baby Leaf Salad with purple basil 85 g 31
Pudz Sticky Toffee Pudding 210 g 3303
5154
Evening Snack (optional)
Duchy Originals lemon biscuits 1293
6447
Porridge
Ingredients Protein
(g) (g)
Fat
(g)
Carbohydrate Energy 
(g) (kj)
Fibre
(g)
Meal A
porridge, Jordan’s porridge oats 130 15.2 12.1 75.9 1996 11.7
sugar, demerara 19 0.1 0.0 19.9 319 0.0
dried skimmed milk 13 4.7 0.1 6.9 192 0.0
raisins 32 0.4 0.2 20.5 360 2.2
butter 20 0.1 16.4 0.1 612 0.0
water
Sum g 20.5 28.8 123.3 13.9
Sum kj 348 1064 2096 3508
% energy 9.9 30.3 59.7 100
Meal B
porridge, jordans porridge oats 130 15.2 12.1 75.9 1996 11.7
sugar, demerara 20 0.1 0.0 20.9 336 0.0
dried skimmed milk 28 10.1 0.2 14.8 415 0.0
Almonds 25 5.3 14.0 1.7 634 1.9
cream, single 10 0.3 1.9 0.2 80
water
Sum g 31.0 28.1 113.6 13.6
Sum kj 527 1040 1931 3499
% energy 15.1 29.7 55.2 100
Meal C
porridge, jordans porridge oats 65 7.6 6.1 38.0 998 5.9
sugar, demerara 5 0.0 0.0 5.2 84 0.0
milk, skimmed, 550 18.7 1.1 24.2 748 0.0
dried skimmed milk 40 14.4 0.2 21.2 593 0.0
Almonds 37 7.8 20.7 2.6 938 2.7
wheat bran 11 1.6 0.6 3.0 96 4.0
Sum g 50.1 28.6 94.1 12.59
Sum kj 852 1060 1599 3510
% energy 24.3 30.2 45.5 100
Cereal
Ingredients
(g)
Protein
(g)
Fat
(g)
Carbohydrate
(g)
Energy
(kJ)
Fibre
(g)
Meal A
Kellogg’s All-bran bran flakes 135 13.5 2.7 90.5 1867 20.3
Almonds 15.5 3.3 8.6 1.1 393 1.1
raisins 45 0.5 0.2 28.8 507 3.1
cream, single 80 2.6 15.3 1.8 638
whole milk 30 1.0 1.1 1.4 82.
water to make 250 ml fluid
Sum g 20.9 28.0 123.5 24.5
Sum kj 355 1037 2099 3491
% energy 10.2 29.7 60.1 100
Meal B
kellogs all bran bran flakes 100 10 2 67 1383 15
kellogs all bran original 12 1.7 0.4 5.8 142.1 3.2
milk, skimmed, 100 3.4 0.2 4.4 136 0
dried skimmed milk 15 5.4 0.1 8.0 222 0
Almonds 46 9.7 25.7 3.2 1166 3.4
raisins 40 0.44 0.2 25.64 450.8 2.7
Sum g 30.6 28.6 113.9 24.4
Sum kj 521 1057 1936 3515
% energy 14.8 30.1 55.1 100
Meal C
kellogs all bran bran flakes 35 3.5 0.7 23.5 484 5.3
kellogs all bran original 42 5.9 1.5 20.2 497 11.3
milk, skimmed, 200 6.8 0.4 8.8 272 0
dried skimmed milk 65 23.5 0.4 34.4 963 0
Almonds 45 9.5 25.1 3.1 1140 3.3
wheat bran 10 1.4 0.6 2.7 87 3.6
water to make 250 ml fluid
Sum g 50.6 28.6 92.6 23.56
Sum kj 859 1059 1574 3492
% energy 24.6 30.3 45.1 100
Yoghurt Muffins
Ingredients
(g)
Ingredients Protein 
(number) (g)
Fat
(g)
Carbohydrate
(g)
Energy
(kJ)
Fibre
(g)
Meal A
egg whole 25 0.5 3.1 2.7 0.0 157 0.0
raspberry Yeo
Valley yoghurt 50 2.1 2.0 6.2 212.5 0.0
flour white 75 7.1 1.0 58.3 1088 2.3
baking powder 2.5 0.1 0.0 1.0 17.3 0.0
butter 18 0.1 14.4 0.1 535 0.0
sugar, white 19 0.1 0.0 19.9 319 0.0
milk, skimmed, 61 2.1 0.1 2.7 83 0.0
Sum g 14.7 20.1 88.0 2.3
Sum kj 250 745 1496 2491
% energy 10 30 60 100
Meal B
egg white 64 2 5.8 0.0 0.0 97.9 0.0
raspberry Yeo
Valley yoghurt 50 2.1 2.0 6.2 212.5 0.0
almonds 13 2.6 7.0 0.9 316.8 0.9
flour white 55 5.2 0.7 42.7 798 1.7
baking powder 2.5 0.1 0.0 1.0 17 0.0
butter 13 0.1 10.7 0.1 398 0.0
sugar, white 20 0.1 0.0 20.9 336 0.0
milk, skimmed, 50 1.7 0.1 2.2 68 0.0
dried skimmed milk 13 4.5 0.1 6.6 185 0.0
Sum g 22.2 20.5 80.5 2.6
Sum kj 377.2 758.5 1368.2 2504
% energy 15 30 55 100
Meal C
egg white 128 4 11.5 0.0 0.0 196 0.0
raspberry Yeo
Valley yoghurt 25 1.1 1.0 3.1 106 0.0
natural Yeo Valley
yoghurt 50 2.3 2.1 3.3 172 0.0
almonds 30 6.3 16.7 2.1 760 2.2
flour white 52 4.9 0.7 40.4 754 1.6
baking powder 2.5 0.1 0.0 1.0 17.3 0.0
milk, skimmed, 206 50 1.7 0.1 2.2 68.0 0.0
dried skimmed milk
229 25 9.0 0.2 13.2 371 0.0
Sum g 36.9 20.7 65.2 3.8
Sum kj 627 767 1109 2503
% energy 25 31 44 100
Scones
Ingredients
(g)
Protein
(g)
Fat
(g)
Carbohydrate
(g)
Energy
(kJ)
Fibre
(g)
Meal A
cheddar full fat 20 5.1 7.0 0.0 345 0.0
flour white 214 20.1 2.8 166.3 3103 6.6
baking powder 15 0.8 0.0 5.7 104 0.0
butter 37 0.2 30.4 0.2 1132 0.0
milk, skimmed, 100 3.4 0.2 4.4 136 0.0
Sum g 29.6 40.4 177 6.6
Sum kj 503 1494 3002 4999
% energy 10 30 60 100
Meal B
Cheddar half fat 64 20.9 10.1 0.0 730 0.0
flour white 193 18.1 2.5 150.0 2799 6.0
baking powder 15 0.8 0.0 5.7 104 0.0
butter 351 34 0.2 27.5 0.2 1025 0.0
milk, skimmed, 206 130 4.4 0.3 5.7 177 0.0
Sum g 44.5 40.4 161.5 6.0
Sum kj 756 1495 2746 4998
% energy 15 30 55 100
Meal C
Cheddar half fat 163 53.3 25.8 0.0 1860 0.0
flour white 154 14.5 2.0 120.0 2233 4.8
baking powder 15 0.8 0.0 5.7 104 0.0
wheat bran 5 0.7 0.3 1.3 44 1.8
butter 351 15 0.1 12.3 0.1 459 0.0
milk, skimmed, 206 130 4.4 0.3 5.7 177 0.0
Sum g 73.8 40.6 132.5 6.6
Sum kj 1254 1503 2252 5009
% energy 25 30 45 100
Tuna sandwiches
Ingredients
(g)
Protein
(g)
Fat
(g)
Carbohydrate
(g)
Energy
(kj)
Fibre
(g)
Meal A
white bread 191 15.1 3.1 88.1 1778.2 3.6
butter 21 0.1 17.3 0.1 642.4 0.0
tuna 10 2.5 0.1 0.0 44.4 0.0
Sum g 17.7 20.4 88.2 3.6
Sum kj 301 754 1499 2465
% energy 12 30 59 100
Meal B
white bread 175 13.8 2.8 80.7 1629.3 3.3
butter 21 0.1 17.3 0.1 642.4 0.0
tuna 34 8.5 0.2 0.0 151.0 0.0
Sum g 22.5 20.2 80.8 3.3
Sum kj 382 749 1374 2504
% energy 15 30 55 100
Meal C
warburtons wholemeal 167 17.0 5.9 66.1 1629.9 10.5
butter 351 17 0.1 14.0 0.1 520.0 0.0
tuna 79 19.8 0.4 0.0 350.8 0.0
Sum g 36.9 20.2 66.2 10.5
Sum kj 627 748 1126 2501
% energy 25 30 45 100
Peanut Butter Sandwiches
Ingredients
(g)
Protein
(g)
Fat
(g)
Carbohydrate
(g)
Energy
(kj)
Fibre
(g)
Meal A
white bread 180 14.2 2.9 83.0 1676 3.4
butter 15 0.1 12.3 0.1 459 0.0
peanut butter tescos 
crunchy 10 2.4 5.1 1.5 255 0.6
Sum g 16.7 20.3 84.5 4.1
Sum kj 283 752 1437 2472
% energy 11 30 58 100
Meal B
wholemeal bread 1.85 17.4 4.6 77.7 1706 9.3
butter 5 0.0 4.1 0.0 153 0.0
peanut butter tescos 22 5.2 11.3 3.2 560 1.4
Sum g 22.6 20.0 80.9 10.6
Sum kj 384 740 1376 2500
% energy 15 30 55 100
Meal C
warburtons wholemeal 155 15.8 5.4 61.4 1513 9.8
peanut butter whole 
earth 55 14.3 27.6 5.6 1349 4.0
Sum g 30.1 33.0 66.9 13.8
Sum kj 511 1222 1138 2871
% energy 18 43 40 100
M acaroni Cheese
Ingredients Protein
(g) (g)
Fat
(g)
Carbohydrate Energy 
(g) (kj)
Fibre
(g)
Meal A
Macaroni, raw 150 18.0 2.7 111.2 2184 4.4
Onions, raw 150 1.8 0.3 11.9 225 2.1
cheddar full fat 20 5.1 7.0 0.0 345
cornflour 50 0.3 0.4 46.0 754 0.1
butter 36.4 0.2 29.9 0.2 1113 0.0
milk, skimmed, 150 5.1 0.3 6.6 204 0.0
Sum g 30.5 40.6 175.8 6.5
Sum kj 518 1500 2989 5008
% energy 10 30 60 100
Meal B
Macaroni, raw 165 19.8 3.0 122.3 2402 4.8
Onions, raw 50 0.6 0.1 4.0 75 0.7
Cheddar half fat 40 13.1 6.3 0.0 456 0.0
flour white 31.5 3.0 0.4 24.5 457 1.0
butter 37 0.2 30.4 0.2 1132 0.0
milk, skimmed, 230 7.8 0.5 10.1 313 0.0
Sum g 44.5 40.7 161.0 6.5
Sum kj 756 1505 2738 4999
% energy 15 30 55 100
Meal C
Macaroni, raw 128 15.4 2.3 94.9 1864 3.7
Onions, raw 50 0.6 0.1 4.0 75 0.7
Cheddar half fat 143 46.8 22.6 0.0 1632 0.0
flour white 29 2.7 0.4 22.5 421 0.9
wheat bran 3 0.4 0.2 0.8 26 1.1
butter 18 0.1 14.8 0.1 551 0.0
milk, skimmed, 230 7.8 0.5 10.1 313 0.0
Sum g 73.8 40.8 132.4 6.4
Sum kj 1255 1509 2250 5014
% energy 25 30 45 100
Vegetable Curry
Ingredients
(g)
Protein
(g)
Fat
(g)
Carbohydrate
(g)
Energy
(kJ)
Fibre
(g)
Meal A
lentils, green and brown, raw 40 9.7 0.8 19.5 506 3.6
Onions, raw 150 1.8 0.3 11.9 225 2.1
potatoes, new, raw 590 10.0 1.8 95.0 1758 5.9
Olive oil 34 0.0 34.0 0.0 1257 0.0
Green pepper 200 1.6 0.6 5.2 130 0.0
bacon rashers, back, raw 10 1.7 1.7 0.0 7 0.0
Carrots 450 2.7 1.4 35.6 657 10.8
Tomatoes canned 300 3.0 0.3 9.0 207 2.1
Sum g 30.5 40.7 176.1 24.5
Sum kj 519 1506 2994 5018
% energy 10 30 60 100
Meal B
lentils, green and brown, raw 110 26.7 2.1 53.7 1390 9.8
Onions, raw 100 1.2 0.2 7.9 150 1.4
potatoes, new, raw 350 6.0 1.1 56.4 1043 3.5
Olive oil 32 0.0 32.0 0.0 1183 0.0
Green pepper 200 1.6 0.6 5.2 130 0.0
bacon rashers, back, raw 20 3.3 3.3 0.0 13 0.0
Carrots 340 2.0 1.0 26.9 496 8.2
Tomatoes canned 400 4.0 0.4 12.0 276 2.8
Sum g 44.8 40.6 162.0 25.7
Sum kj 762 1503 2754 5019
% energy 15 30 55 100
Meal C
lentils, green and brown, raw 200 48.6 3.8 97.6 2528 17.8
Onions, raw 50 0.6 0.1 4.0 75 0.7
potatoes, new, raw 90 1.5 0.3 14.5 268 0.9
Olive oil 17 0.0 17.0 0.0 628 0.0
Green pepper 51 0.4 0.2 1.3 33 0.0
bacon rashers, back, raw 110 18.2 18.2 0.0 72 0.0
Carrots 85 0.5 0.3 6.7 124 2.0
Tomatoes canned 300 3.0 0.3 9.0 207 2.1
Sum g 72.8 40.0 133.1 23.5
Sum kj 1238 1480 2262 4980
% energy 25 30 45 100
Raspberry Yoghurt
Ingredients Protein
(g) (g)
Fat
(g)
Carbohydrate Energy 
(g) (kj)
Fibre
(g)
Meal A
danone 400 14.0 11.2 46.4 1440 8.0
sugar, white 39 0.2 0.0 40.8 656 0.0
creme fraiche 23 0.5 9.2 0.6 358 0.0
Sum g 14.7 20.4 87.7 8.0
Sum kj 250 755 1491 2496
% energy 10 30 60 100
Meal B
danone 440 15.4 12.3 51.0 1584 8.8
Tofu blue dragon 90 6.2 2.4 2.2 232 0.1
sugar, white 25 0.1 0.0 26.1 420 0.0
cream, single 30 1.0 5.7 0.7 239 0.0
Sum g 22.7 20.5 80.0 8.9
Sum kj 386 758 1360 2504
% energy 15 30 54 100
Meal C
danone 440 15.4 12.3 51.0 1584 8.8
sugar, white 8 0.0 0.0 8.4 134 0.0
Tofu blue dragon 300 20.7 8.1 7.2 774 0.3
Sum g 36.1 20.4 66.6 9.1
Sum kj 614 756 1132 2502
% energy 25 30 45 100
Straw berry Y oghurt
Ingredients Protein
(g) (g)
Fat
(g)
Carbohydrate Energy 
(g) (kj)
Fibre
(g)
Meal A
danone 385 14.3 12.3 49.3 1536 6.2
sugar, white 37 0.2 0.0 38.7 622 0.0
creme fraiche 20 0.4 8.0 0.5 311 0.0
Sum g 14.9 20.3 88.4 6.2
Sum kj 253 752 1503 2508
% energy 10 30 60 100
Meal B
danone 440 16.3 14.1 56.3 1756 7.0
Tofu blue dragon 75 5.2 2.0 1.8 194 0.1
sugar, white 21.5 0.1 0.0 22.5 361 0.0
cream, single 23 0.8 4.4 0.5 184 0.0
Sum g 22.3 20.5 81.1 19.4
Sum kj 379 758 1379 2516
% energy 15 30 55 100
Meal C
danone 370 13.7 11.8 47.4 1476 5.9
sugar, white 10.5 0.1 0.0 11.0 177 0.0
Tofu blue dragon 330 22.8 8.9 7.9 851 0.3
Sum g 36.5 20.8 66.3 6.3
Sum kj 621 768 1126 2515
% energy 25 31 45 100
Pasta Bolognaise
Ingredients Protein
(g) (g)
Fat
(g)
Carbohydrate
(g)
Energy
(kJ)
Fibre
(g)
Meal A
Pasta shells 175 21.0 3.2 129.7 2548 5.1
Olive oil 31 0.0 31.0 0.0 1146 0.0
Beef lean raw 17 3.8 0.7 0.0 92 0.0
dolmio med veg sauce 480 7.2 5.8 45.1 1118 5.3
Sum g 32.0 40.6 174.8 10.4
Sum kj 544 1503 2972 5019
% energy 11 30 59 100
Meal B
Pasta shells 140 16.8 2.5 103.7 2038 4.1
Olive oil 27 0.0 27.0 0.0 998 0.0
Beef lean raw 80 18.0 3.4 0.0 434 0.0
dolmio med veg sauce 620 9.3 7.4 58.3 1445 6.8
Sum g 44.1 40.4 162.0 10.9
Sum kj 750 1494 2754 4998
% energy 15 30 55 100
Meal C
Pasta shells 103 12.4 1.9 76.3 1500 3.0
Olive oil 21 0.0 21.0 0.0 776 0.0
Beef lean raw 233 52.4 10.0 0.0 1263 0.0
dolmio med veg sauce 600 9.0 7.2 56.4 1398 6.6
Sum g 73.8 40.1 132.7 9.6
Sum kj 1254 1482 2256 4993
% energy 25 30 45 100
Chicken and Rice
Ingredients
(g)
Protein
(g)
Fat
(g)
Carbohydrate
(g)
Energy
(kj)
Fibre
(g)
Meal A
Chicken, light meat raw 50 12.0 0.6 0.0 225 0.0
Chicken tonight 
mushroom 400 3.2 21.6 25.2 1348 0.8
Rice basmati,raw 190 14.1 1.0 151.6 2854 1.9
Olive oil 17.5 0.0 17.5 0.0 647 0.0
Sum g 29.3 40.6 176.8 2.7
Sum kj 497 1502 3006 5005
% energy 10 30 60 100
Meal B
Chicken, light meat raw 120 28.8 1.3 0.0 539 0.0
Chicken tonight 
mushroom 400 3.2 21.6 25.2 1348 0.8
Rice basmati,raw 171 12.7 0.9 136.5 2568 1.7
Olive oil 16.8 0.0 16.8 0.0 621 0.0
Sum g 44.7 40.6 161.7 2.5
Sum kj 759 1501 2748 5008
% energy 15 30 55 100
Meal C
Chicken, light meat raw 250 60.0 2.8 0.0 1123 0.0
Chicken tonight 
mushroom 400 3.2 21.6 25.2 1348 0.8
Rice basmati,raw 135 10.0 0.7 107.7 2028 1.4
Olive oil 15 0.0 15.0 0.0 554 0.0
Sum g 73.2 40.0 132.9 2.2
Sum kj 1244 1480 2260 4984
% energy 25 30 45 100
Bread and Butter Pudding
Ingredients Ingredients Protein 
(g) (number) (g)
Fat
(g)
Carbohydrate Energy 
(g) (kJ)
Fibre
(g)
Meal A
Egg whole 50 1 6.3 5.4 0.0 313.5 0.0
white bread 55 4.4 0.9 25.4 512.1 1.1
raisins 50 0.6 0.3 32.1 563.5 3.4
butter 12 0.1 9.9 0.1 367.1 0.0
sugar, white 25 0.1 0.0 26.1 420.3 0.0
whole milk 100 3.3 3.9 4.5 274.0
Sum g 14.6 20.3 88.1 4.5
Sum kj 249 751 1498 2498
% energy 10 30 60 100
Meal B
Egg whole 100 2 12.5 10.8 0.0 627.0 0.0
white bread 50 4.0 0.8 23.1 465.5 1.0
raisins 30 0.3 0.2 19.2 338.1 2.0
butter 3.5 0.0 2.9 0.0 107.1 0.0
sugar, white 30 0.2 0.0 31.4 504.3 0.0
whole milk 150 5.0 5.9 6.8 411.0
Sum g 21.9 20.5 80.4 3.0
Sum kj 372 758 1367 2497
% energy 15 30 55 100
Meal C
Egg whole 100 2 12.5 10.8 0.0 627.0 0.0
Egg white 128 4 11.5 0.0 0.0 195.8 0.0
white bread 50 4.0 0.8 23.1 465.5 1.0
raisins 22 0.2 0.1 14.1 247.9 1.5
Almonds 10 2.1 5.6 0.7 253.4 0.7
butter 3.5 0.0 2.9 0.0 107.1 0.0
sugar, white 20 0.1 0.0 20.9 336.2 0.0
milk, skimmed, 175 159.08 6.0 0.4 7.7 238.0 0.0
Sum g 36.4 20.5 66.5 3.2
Sum kj 619 759 1130 2508
% energy 25 30 45 100
Rice Pudding
Ingredients Ingredients Protein 
(g) (num ber) (g)
Fat
(g)
C arbohydrate  Energy 
(g) (k j)
Fibre
(g)
M eal A
flaked pudding rice 60 0.1 0.5 51.3 891 0.4
Egg whole 50 1 6.3 5.4 0.0 314 0.0
Egg white 32 1 2.9 0.0 0.0 49 0.0
butter 10 0.1 8.2 0.1 306 0.0
sugar, white 30 0.2 0.0 31.4 504 0.0
milk, skimmed, 120 4.1 0.2 5.3 163 0.0
cream, single 31 1.0 5.9 0.7 247
Sum  g 14.5 20.3 88.7 0.4
Sum  k j 247 750 1507 2504
% energy 10 30 60 100
M eal B
flaked pudding rice 55 0.1 0.4 47.0 817 0.4
Egg whole 150 3 18.8 16.2 0.0 941 0.0
sugar, white 30 0.2 0.0 31.4 504 0.0
milk, skimmed, 50 1.7 0.1 2.2 68 0.0
cream, single 20 0.7 3.8 0.4 160
Sum  g 21.3 20.6 81.0 0.4
Sum  k j 362 761 1377 2500
% energy (from H) 14 30 55 100
M eal C
flaked pudding rice 45 0.1 0.4 38.5 668 0.3
Egg whole 150 3 18.8 16.2 0.0 941 0.0
Egg white 128 4 11.5 0.0 0.0 196 0.0
sugar, white 20 0.1 0.0 20.9 336 0.0
milk, skimmed, 150 5.1 0.3 6.6 204 0.0
cream, single 20 0.7 3.8 0.4 160
Sum  g 36.2 20.7 66.4 0.3
Sum  k j 615 765 1129 2509
% energy 24.5 30.5 45.0 100
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MRC
Human
N u t r i t io n
Research
Diet and Energy Metabolism - Consent Form
LREC Reference Number: 0 6 /Q 0 1 0 8 /1 8 1
Nam e of Principal Investigator: Dr R osem ary Hall
P lease initial box
1. I confirm  t h a t  I h a v e  read  an d  u n d e r s ta n d  th e  in fo rm ation  s h e e t
d a te d  12  April 2 0 0 6  (vers ion  01) for  t h e  a b o v e  s tu d y  an d  h av e  had  th e ___________ ________
o p p o r tu n i ty  to  a s k  q u e s t io n s .
2. I u n d e r s ta n d  t h a t  m y partic ipa tion  is v o lu n ta ry  an d  t h a t  I a m  f ree  to  ------------
w ith d raw  a t  a n y  t im e ,  w ith o u t  giving a n y  r e a s o n ,  a n d  w ith o u t  m y
m edica l c a re  o r  legal r igh ts  being a ffec ted .
3. I c o n s e n t  to  m y  g e n e ra l  p ra c t i t io n e r  be ing  notified o f m y partic ipa tion  
in th is  r e s e a rc h .
4. I c o n s e n t  to  m y  g e n e ra l  p rac t i t io n e r  be ing  notified o f m y s tu d y  re su lts  
an d  a n y  a b n o rm a l i t ie s  found  during  th is  re s e a rc h .
5. I u n d e r s ta n d  t h a t  s a m p le s  ta k e n  a s  p a r t  o f  t h e  protocol o f  th is  s tu d y  
m a y  be s to re d  for up  to  10 y e a r s  an d  u s e d  in fu r th e r  re s e a rc h  s tu d ie s .  
S a m p le s  will on ly  be u sed  in s tu d ie s  t h a t  h a v e  b e e n  a p p ro v e d  by th e  
a p p r o p r ia te  Ethics C o m m it tee .
6. I u n d e r s ta n d  t h a t  s a m p le s  ta k e n  a s  p a r t  o f  th is  s tu d y  m ay  be  an a ly se d  
in a n o th e r  lab o ra to ry  o u ts id e  of MRC H u m an  Nutrition R esea rch .
All s a m p le s  will be  m a d e  a n o n y m o u s ,  a n d  no p e r so n a l  in fo rm ation  will be 
s e n t  to  a n o t h e r  lab o ra to ry .
7. I h a v e  re a d  t h e  DXA In fo rm ation  Leaflet an d  will inform th e  re se a rc h  t e a m  
if I a m  p re g n a n t .
8. I u n d e r s ta n d  t h a t  I c a n n o t  p a r t ic ip a te  in th is  r e s e a rc h  if I a m  p re g n a n t .
I a m  n o t  p r e g n a n t  an d  will inform th e  r e s e a rc h  t e a m  if I b e c o m e  p re g n a n t .
9. I a g r e e  to  t a k e  p a r t  in th e  ab o v e  s tu d y .
Name of Volunteer Date Signature
(Please print)
Name of Research Team Member Date Signature
(Please print)
Name of Researcher Date Signature
(Please print)
3 copies required: top copy for researcher; one copy for volunteer; one copy to be kept with research subject's notes.
Version 01 12 April 2006
Diet and Energy Metabolism
Telephone Screening Q uestionnaire
N am p .................................................................................................................................
A d d re ss  ...........................
Age ........................... D a te  of B i r t h .................................
P hone  N um ber:  D ay .... ................................................. E v e n i n g .............................................................
B es t  t im e  to  p h o n e  ....
G enera l  P r a c t i t i o n e r ......
Of (m edica l  p ra c t ic e ) ......
GP te le p h o n e  n u m b e r .  ..
How did you h e a r  a b o u t  t h e  s tu d y ?  (Advertisement/Database/etc)..................................................
Are you cu r ren t ly  in a n y  o th e r  re s e a rc h  s tu d ie s ,  o r  h a v e  you  b e e n  in a n y  in th e  las t  y e a r?
Health
C u rre n t  w e ia h t  ka H eiah t m E s t im a te d  BMI k g /m 2
Do you h av e  o r  h a v e  you  had  a n y  of t h e  following cond it ions?
YES NO
(x) D iab e tes □ □
(xi) High Blood P re s s u re □ □
(xii) S to m a c h  o r  bowel p ro b le m s □ □
(xiii) A s th m a /E c z e m a /H a y fe v e r □ □
(xiv) High C holes tero l □ □
(xv) Chronic m edica l  co n d i t io n s  (h e a r t ,  k idney , liver, th y ro id ) □ □
(xvi) A naem ia □ □
(xvii) Food/D rug  a l le rg ie s □ □
(xviii) Eating D iso rde r □ □
(xix) Are you P re g n a n t  o r  B rea s tfeed in g  (o r  p lann ing  p re g n a n c y ) □ □
(xx) Do you h a v e  a p a c e m a k e r  o r  m e ta l  im p lan ts □ □
Pleasp list anv o th ers ..................................................... .......................
Please  list an y  m e d ic a t io n s  (pills, t a b le ts ,  c o n t ra c e p t iv e s ,  in h a le rs  e tc . )  t h a t  you a r e  tak in g ,  e i th e r  
p resc r ib ed  by y o u r  d o c to r  o r  p u rc h a s e d  o v e r  th e  c o u n te r .
Do you  sm o k e ?
If y e s ,  how m a n y  c ig a r e t te s  p e r  d a y ? .....................................
YES
□
NO
□
YES NO
Do you  drink  alcohol? □ □
If y e s ,  how m a n y  u n its  of alcohol w ould  you c o n s u m e  in an  a v e r a g e  w e ek ?
(1 u n i t  = 1 m e a s u r e  o f sp ir i ts  /  1 sm all  g la ss  of w ine /  1 half  p in t  of b ee r )
Availability and Transport
W ould you  h av e  a n y  difficulty in:
YES NO
6. Living in for five d a y s  on  th r e e  o cc as io n s  th r e e  
w e e k s  a p a r t?
7. Eating all ty p e s  of food?
8. Having a blood s a m p le  ta k e n ?
9. S p en d in g  t im e  in a ro o m  ca lo r im e te r?
10. Having a DXA, MRI, BOD POD m e a s u r e m e n t?
□ □
□ □
□ □
□ □
□ □
n n
W ould you  h a v e  a n y  a n t ic ip a ted  difficulties with y o u r  availability  
o r  t r a n s p o r t  a r r a n g e m e n ts  to  a t t e n d  e a c h  o f t h e s e  s e s s io n s?
YES
□
NO
□
Do y o u  h a v e  a n y  p re fe rred  d a y s  to  a t t e n d  th e  unit?  
If y e s ,  p lea se  g ive d ay s .
YES
□
NO
□
Name of Research Team member Date Signature
(Please print)
Eligible for  th is  s tu d y  YES NO
If YES: S en d  In fo rm a tio n  S h e e t   YES NO
Next A p p o in tm e n t ..................................................
If NO: Would you like in fo rm atio n  a b o u t  o th e r  s tu d ie s  a t  MRC HNR o r  c o n s id e r  placing y o u r
n a m e  on o u r  V o lu n tee r  D a ta b a s e ?  YES NO
Q u es t io n n a ire  S e n t   YES NO
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Address
Date
D ear
Re: Diet and Energy Metabolism
We a r e  cu r ren t ly  recru it ing  v o lu n te e r s  for a nu tr i t ion  s tu d y  a t  MRC H u m an  Nutrition R esea rch .  We 
h av e  looked a t  t h e  in fo rm ation  t h a t  w e h a v e  on o u r  v o lu n te e r  d a t a b a s e  an d  found  t h a t  you m ay  
be eligible to  be  involved.
This s tu d y  will in v e s t ig a te  th e  e ffec t  o f  d if fe ren t  d ie ts  on  e n e rg y  ba lan ce .
We a r e  looking fo r  a to ta l  of 20  v o lu n te e r s  for  th is  s tu d y .  Each v o lu n te e r  will be  req u ired  to 
sp e n d  five d a y s  (a n d  n igh ts )  a t  MRC H u m an  N utrition R esea rch  a n d  th e  W ellcom e T ru s t  Clinical 
R esea rch  Facility on  th r e e  o ccas ions .  We will p rov ide  you  with all of y o u r  food an d  m e a s u r e  th e  
e f fec ts  of d if fe ren t  d ie ts  on t h e  h o rm o n e s  a n d  m e tab o l ic  fac to rs  p ro d u c ed  a f te r  e a t in g ,  yo u r  
e n e rg y  e x p e n d i tu r e ,  an d  y o u r  body co m p o s it io n .  In  b e tw e e n  t e s t s  you  will be  ab le  to  re lax , re ad ,  
work, a c c e s s  th e  in te rn e t ,  w a tch  TV, e t c  a n d  will h a v e  a period of ex e rc ise  e a c h  day .
In recogn it ion  of y o u r  t im e  c o m m itm e n t ,  you  will rece ive  a n  h o n o ra r iu m  of £ 2 0 0 .  R easo n a b le  
trave l  e x p e n s e s  will a lso  be  re im b u rse d .
P lease  re ad  t h e  en c lo se d  v o lu n te e r  in fo rm atio n  s h e e t  for m o re  de ta i ls ,  a n d  if you a r e  in te re s te d  in 
tak in g  p a r t ,  o r  if you  h a v e  an y  q u e s t io n s ,  p le a s e  c o n ta c t  m e  on 0 1 2 2 3  4 2 6 3 5 6 .
Kind r e g a rd s
Dr R o s e m a ry  Hall 
Clinical S c ien t is t
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D r...............
GP Address
Date
D e ar  D r  ,
Re: Diet and Energy M etabolism
Your p a t ie n t  Name, DOB & Address o f Volunteer, h a s  v o lu n te e r e d  to  t a k e  p a r t  in a re s e a rc h  s tu d y  
a t  MRC H u m an  Nutrition R e se a rc h  (HNR). He/She  h a s  g iven  us  p e rm iss io n  to  c o n ta c t  you.
T h e  s tu d y  is d e s ig n e d  to  in v e s t ig a te  t h e  e ffec t of d if fe ren t  d ie ts  on  e n e rg y  in tak e  an d  
e x p e n d i tu re .  On t h r e e  o c c a s io n s  p a r t ic ip a n ts  will b e  req u ired  to  s p e n d  five d a y s  a t  MRC HNR a n d  
th e  W elcom e T ru s t  Clinical R esea rch  Facility, A d d e n b ro o k e 's  H ospital.  T hey  will be  p rov ided  with 
all th e i r  food an d  w e  will m e a s u r e  m e tab o lic  fa c to rs  an d  s a t i e ty  h o rm o n e s  a s s o c ia te d  with 
a p p e t i t e  an d  th e  p o s tp ra n d ia l  r e s p o n s e  to  e a t in g ,  e n e rg y  e x p e n d i tu r e  an d  body co m p o s i t io n .  Part  
o f th is  t im e  will be s p e n t  in a room  ca lo r im e te r .  (For m o re  in fo rm ation  s e e  t h e  a t t a c h e d  v o lu n te e r  
in fo rm ation  s h e e t ) .  We will h a v e  tw o g ro u p s  -  lean  (BMI < 2 5 )  an d  o b e s e  (BMI 3 0 - 4 0 k g /m 2 )
Your p a t ie n t  h a s  b e e n  a s k e d  to  p rov ide  us  with  th e i r  m edica l  h istory . V o lu n tee rs  will be  ex c lu d ed  
if t h e y  a re  s m o k e r s ,  a r e  p r e g n a n t  or p lann ing  p re g n a n c y ,  h a v e  a n y  know n chron ic  d i s e a s e ,  a r e  
re s t r a in e d  e a te r s ,  o r  a r e  u n a b le  to  e a t  an y  o f th e  s tu d y  foods.
We will inform you if a n y  a b n o rm a l  re su lts  a r e  o b ta in ed  w hich m a y  be of clinical s ign ificance.
If you feel that th ere is a m edical reason w hich should prevent their participation in 
th is study or if you need  further details p lease  contact our clinician on 012 2 3  - 4 2 6 3 5 6 .
Yours s incere ly
Dr R o sem ary  Hall 
Clinical S c ien tis t
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Volunteers Wanted
For Nutrition Research
We are running a study to 
investigate how different diets 
affect energy balance.
Are you:
Healthy
Aged 18-70 years
Willing to spend 5 days and nights living at 
MRC HNR and Wellcome Trust Clinical 
Research Facility on 3 occasions 
Able to eat all kinds of food
If you would like more information please 
contact Rosemary Hall on (01223) 426356 
rosemary.hall@mrc-hnr.cam.ac.uk
You will be reimbursed for participation in the study and for 
reasonable travel expenses
Version 01 14/04/06
APPENDIX: THREE-FACTOR EATING QUESTIONNAIRE
One point is given for each item in Fart I and for each item (numbered question) in Pan 11. The comet 
answer for the trite/ false ttems is underlined and beside it is the number of the factor ibai ft SfteiisUSes. The 
direction of the question in Part II is determined by splitting the responses at the middle. If the item is 
labelled ! + ', those response above the middle are given a zero. Vice versa for those with a For 
example, anyone scoring 3 or 4 on the first item in Part ll (item No. 37} would receive one point. 
Anyone scoring I or 2 would receive a zero.
Part I
Factor
Number
1 When I smell a sizzling steak or sec a juicy piece of meat , 1 find it very difficult 
to keep from eating, even if I have just finished a meal. T F 2
2. i  usually eat too much at social occasions, like parties and picnics. T F 2
3. I am usually so hungry that 1 eat more than three times a day. T F 3
4, When I have eaten my quota of calories. 1 am usually good about not eating 
any more. T F 1
5, Dieting is so hard for the because I jus! get too hungry. T F 3
6. 1 deliberately take small helpings as a means of controlling my weight. I F 1
7, Sometimes things just taste so good that I keep on eating even when 1 am no 
longer hungry. T F 2
3. Since I am often hungry, I sometimes wish that while I am eating, an expert 
would tell me that I have had enough or that 1 can have something more 
to eat.. T F 3
9. When I feel anxious, I find myself eating . T F 2
10. Life is too short to worry about dieting. T F 1
11. Since my weight goes up and down, 1 have gone on redwing diets more than 
once. T F 2
12. I often feel so hungry that l just have to eat something. T P 3
13- When 1 am with someone who is overeating, 1 usually overeat too. I F 2
14. 1 have a pretty good idea of the number of calories In common food. T F 1
15. Sometimes when t start eating^ 1 just can’t seem to stop: T F 2
16. It is not difficult for me to leave something on my plate. f F 2
17. At certain times of the day, I get hungry because 1 have gotten used to eating 
them. T F 3
Id. While on a diet, if 1 eat food that is not allowed, I consciously eat less for a 
period of time to make up for it, I F 8
19, Being with someone who is eating often makes me hungry enough to eat also. T F 3
20. When I feel blue, I often overeat. T F 2
21. I enjoy eating too much to spoil it by counting calories or watching my weight. T F 1
22. When I see a real rMteacy, T often gel so hungry that  0 have to eat right auvay. 1 F %
23. I often stop eating when I am not really full as a conscious means of limiting 
the amount that i eat. T F 1
24. 1 get so hungry that my stomach often seems like a bottomless pit. T F 3
25. My wdght has hardly changed at all in the last ten years. T F 2
26. 1 Urn always hungry so it is hard for me to stop eating before I finish the 
food on my plate. 1 F 3
27. When 1 feel lonely, 1 console myself by eating. T F 2
23. I consciously hold back at meats in order not to gain weight. I F 1
29. 1 sometimes get very hungry late in the evening or at might. T F 3
30. I  eat anything I want, any time 1 want. T F 3
31. Without even thinking about it, 1 take a long time to eat. T F 2
32. I count calories as a conscious means of oontrolling my weight. T F 1
33. I do not cat some food* because they make me fat. T F 1
34. 1 am always hungry enough to eat at any time. T F 3
35. ! pay a  great deal of attention to changes in my figure. T P 1
36. While on a diet, if 1 eat a food that Is not allowed, I often then splurge and 
eat other high calorie foods. I F 2
Fart II
Directions Please answer the following questions by circling the ntimber above the response that 
appropriate to yon.
57, H ow  often are you dieting in  a  conscious effort to control! your weight?
1 2  5 4
rardy sometime* usually always ■+ 1
36. Would a weight fluctuation of 5 Ihs affect the way you live your life?
39.
40.
41.
1
not at all
2
slightly
How often do you feel! hungry?
1 2
only at sometimes
mealtimes between meals
moderately
often between 
meals
very much 
4
almost
always
Do your feelings of guilt about overeating help you to control your food intake?
1 2  3 4
never rarely often always
How difficult would it be for you to stop eating halfway through dinner and not eat for the 
next four hours?
+ l
i
easy
2
slightly
difficult
moderately
d if f ic u lt
42, How conscious are you of what you are eating?
1 2 3
not at all slightly moderately
43. How frequently do you avoid ‘stocking up* on tempting foods?
1 2 3
almost never seldom usually
very
difficult
4
extremely
almost always
+ 3
4  1
4  I
44. How likely are you to shop for low calorie foods?
I
unlikely slightly unlikely moderately likely very likely
45. Do you eat sensibly in front of others and splurge alone?
1 2 3 4
never rarely often always + 2
46, How likely are you to consciously eat slowly in order to cut down on how much you eat? 
1 2  3 4
unlikely slightly likely moderately likely v e ry fik d y  4 I
47. How frequently do you skip dessert because you are no longer hungry?
1 2  3 4
almost never seldom at least onee a week almost every day - 3
48. How likely are you to consciously eat less than you want?
I 2 3 4
unlikely slightly likely moderately likely very likely ■+ li
4?; Do you go on eating binges though you arc not hungry?
1 2  3 4
never rarely sometimes at least once a week + 2
SO. On a scale of 0 to 5, where 0 means no restraint in eating (eating whatever you want, whenever you 
want it) and 5 means total restraint (constantly limiting food intake and never 'giving in'), what 
number would you give yourself?
0
eat whatever you want, whenever you want it + 1
1
usually eat whatever you want, whenever you want it
2
often eat whatever you wane, whenever you want it
3
often limit food intake, but often ‘give in’
4
usually limit food intake, rarely ‘give in’
5
constantly limiting food intake, never ‘giving in’
31. To what extent does this statement describe your eating behavior? *1 start dieting in the morning, 
hut because of any number of things that happen rfittrmg the day, by evening I have given up and eai 
what I wont, promising myself to start dieting again tomorrow.’
1 2  3 4
not like me little like me pretty good describes me
description o f me perfectly +  2
Diet and Energy M etabolism  
Visit 1 Q uestionnaire (EAT-26)
P ar t ic ip an t  ID
Please respond to  how  each of th e  following sta tem en ts  apply to  you:
Always Usually Often Som etim es Rarely Never Score
1. Am terrif ied  a b o u t  being  
o v e rw e ig h t 0 0 0 0 0
0
2. Avoid ea tin g  w h e n  I a m  h u n g ry 0 0 0 0 0 0
3. Find m yse lf  p re o ccu p ied  with food 0 0 0 0 0 0
4. Have g o n e  on e a t in g  b in g es  w h e re  
I feel t h a t  I m ay  n o t  be  ab le  to  s to p 0 0 0 0 0 0
5. C ut m y food in to  sm all  p ieces 0 0 0 0 0 0
6. A w are of th e  ca lo r ie  c o n te n t  of 
fo o d s  t h a t  I e a t
7. Particularly  avoid  food with a  high
0 0 0 0 0 0
c a rb o h y d ra te  c o n te n t  (i .e . b re a d ,  
rice, p o ta to e s ,  e tc . )
0 0 0 0 0 0
8. Feel t h a t  o th e r s  w ould p re fe r  if I 
a t e  m o re
0 0 0 0 0 0
9. Vomit a f te r  I h a v e  e a t e n 0 0 0 0 0 0
10. Feel e x t re m e ly  guilty  a f te r  e a t in g 0 0 0 0 0 0
11. Am p reo ccu p ied  with a  d e s i re  to  
be  th in n e r 0 0 0
0 0 0
12. Think a b o u t  b u rn ing  up  ca lo r ies  
w h e n  I ex e rc ise 0 0
0 0 0 0
13. O th e r  peop le  th in k  t h a t  I a m  too  
th in 0 0
0 0 0 0
14. Am p reoccup ied  with t h e  th o u g h t  
of having  fa t  on m y  body 0 0 0 0
0 0
15. T ake  longer  t h a n  o th e r s  to  e a t  
m y  m ea ls 0 0 0
0 0 0
16. Avoid foods with s u g a r  in th e m 0 0 0 0 0 0
17. Eat d ie t  foods 0 0 0 0 0 0
18. Feel t h a t  food co n tro ls  m y  life 0 0 0 0 0 0
19. D isplay se lf-contro l  a ro u n d  food
20. Feel t h a t  o th e r s  p r e s s u r e  m e  to  
e a t
21. Give to o  m uch  t im e  a n d  th o u g h t  
to  food
22. Feel u n co m fo r ta b le  a f te r  e a t in g  
s w e e t s
23. E n g a g e  in d ie ting  b eh a v io r
24. Like m y s to m a c h  to  be  e m p ty
25. Enjoy try ing  new  rich foods
26. H ave  th e  im pu lse  to  v o m it  
a f te r  m ea ls
Total S co re  ( s e e  below for sco r ing  in s tru c t io n s )
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
P le ase  re sp o n d  to  each  of t h e  following q u e s t io n s :
1) H ave  you g o n e  on ea t in g  b in g es  w h e re  you  feel t h a t  you m a y  n o t  be  ab le  to  s to p ?  (Eating 
m u ch  m o re  th a n  m o s t  p eo p le  w ould  e a t  u n d e r  th e  s a m e  c i rc u m s ta n c e s )
No O Yes O O H o w  m a n y  t im e s  in t h e  las t  6 m o n t h s ? __________
2) H ave  you e v e r  m a d e  y o u rse lf  sick (v o m ite d )  to  contro l y o u r  w e ig h t  o r  s h a p e ?
No O Yes O O H o w  m a n y  t im e s  in t h e  las t  6 m o n t h s ? __________
3) H ave  you e v e r  u sed  lax a tiv es ,  d ie t  pills o r  d iu re t ics  ( w a te r  pills) to  contro l  y o u r  w e ig h t  or 
s h a p e ?  No 0  Yes O O H o w  m a n y  t im e s  in t h e  las t  6 m o n t h s ? __________
4) H av e  you e v e r  b ee n  t r e a t e d  fo r  an  e a t in g  d iso rd e r?
No O Yes 0  o w h e n ? __________
5) H ave  you recen tly  th o u g h t  of o r  a t t e m p t e d  su ic ide?
No 0  Yes 0  o w h e n ? __________
Scoring System
Always Usually Often Som etim es Rarely Never
All q u e s t io n s  e x c e p t  25. 3 2 1 0 0 0
Q u e s t io n  25 0 0 0 1 2 3
S c o re s  a b o v e  20  requ ire  fu r th e r  in v es t ig a t io n .
F u r th e r  inves t iga t ion  is a lso  req u ired  if t h e  r e s p o n s e  to  o n e  of t h e  final 5 beh av io u ra l  q u e s t io n s  is 
'Yes'.
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE
W e  a r e  in te re s ted  in finding out ab o u t  th e  kinds of physical activities th a t  p eo p le  do  a s  part  of 
their e v e ry d a y  lives. T h e  q u e s t io n s  will a s k  you ab o u t  the  t im e you s p e n t  being  physically active 
in th e  last 7 days. P le a s e  a n s w e r  e a c h  q u es t io n  e v e n  if you do  not co n s id e r  yourself to b e  an  
ac tive  p e rso n .  P le a s e  think ab o u t  the  activities you do  at work, a s  par t  of your h o u s e  an d  yard 
work, to g e t  from p lace  to p lace , an d  in your s p a r e  time for recreation , e x e rc ise  o r  sport.
Think ab o u t  all th e  vigorous an d  moderate activities tha t  you did in th e  last 7 days. Vigorous 
physical activities refer to activities tha t  ta k e  hard  physical effort an d  m a k e  you b re a th e  m uch 
h a rd e r  th an  normal. Moderate activities refer to activities th a t  ta k e  m o d e ra te  physical effort an d  
m a k e  you b re a th e  so m e w h a t  h a rd e r  th a n  normal.
PART 1: JOB-RELATED PHYSICAL ACTIVITY
T h e  first sec tio n  is ab o u t  your work. This  includes paid jobs, farming, vo lun teer  work, c o u r s e  
work, an d  a n y  o th er  unpaid  work th a t  you did o u ts id e  your hom e. Do not include unpaid  work 
you might do  a ro u n d  your hom e, like h ousew ork ,  yard  work, g en e ra l  m a in te n a n c e ,  a n d  caring 
for your family. T h e s e  a re  a s k e d  in P art  3.
1. Do you currently  h av e  a  job or do an y  unpaid  work ou ts ide  your h o m e ?
Y es
No
Skip to PART2: TRANSPORTATION
T h e  nex t  q u e s t io n s  a re  ab o u t  all th e  physical activity you did in th e  last 7 days a s  par t  of your 
paid o r  unpaid  work. This d o e s  not include traveling to an d  from work.
2. During th e  last 7 days, o n  how  m an y  d a y s  did you do vigorous physical activities like 
h ea v y  lifting, digging, h eav y  construction, or climbing up s ta irs  as part of your work?
Think ab o u t  only th o s e  physical activities th a t  you did for a t leas t  10 m inu tes  a t  a  time.
 days per week
No v igorous  job -re la ted  physical activity Skip to question 4
3. How  m u ch  tim e did you usually s p e n d  on  o n e  of th o s e  d a y s  doing vigorous physical 
activities a s  par t  of your w ork?
 hours per day 
 minutes per day
4. Again, think ab o u t  only th o s e  physical activities th a t  you did for a t le a s t  10 m in u te s  a t  a  
time. During th e  last 7 days, on how  m an y  d a y s  did you do  moderate physical activities 
like carrying light loads  as part of your work? P le a s e  do  not include walking.
 days per week
No m o d e ra te  job -re la ted  physical activity Skip to question 6
5. How m uch  tim e did you usually  s p e n d  on  o n e  of th o s e  d a y s  doing moderate physical 
activities a s  par t  of your work?
hours per day 
minutes per day
6. During th e  last 7 days, o n  how m an y  d a y s  did you walk for a t  leas t  10 m inu tes  a t  a  t im e 
as part of your work? P le a s e  do not coun t an y  walking you did to travel to or from
work.
 days per week
No job-re la ted  walking Skip to PART2: TRANSPORTATION
7. How m u ch  tim e did you usually  s p e n d  on o n e  of th o s e  d a y s  walking a s  part  of your 
w ork?
 hours per day
 minutes per day
PART2: TRANSPORTATION PHYSICAL ACTIVITY
T h e s e  q u e s t io n s  a r e  ab o u t  how  you trave led  from p lace  to p lace , including to p la c e s  like work, 
s to re s ,  m ovies,  an d  s o  on.
8. During th e  last 7 days, on  how m an y  d a y s  did you travel in a motor vehicle like a  train, 
bus ,  car, or t r a m ?
 days per week
No traveling in a  m otor vehicle  Skip to question 10
9. How m u ch  tim e did you usually  s p e n d  on o n e  of th o s e  d a y s  traveling in a  train, bus , 
car, tram, or o th e r  kind of m otor veh ic le?
 hours per day
 minutes per day
Now think only a b o u t  th e  bicycling an d  walking you might h a v e  d o n e  to travel to a n d  from 
work, to do  e r ran d s ,  or to g o  from p lace  to p lace .
10. During th e  last 7 days, on how  m an y  d a y s  did you bicycle for at leas t  10 m in u te s  a t a  
time to g o  from place to place?
 days per week
No bicycling from p lace  to p lace  Skip to question 12
11. How m uch  tim e did you usually  s p e n d  on  o n e  of th o s e  d a y s  to bicycle from p lace  to 
p lace?
 hours per day
 minutes per day
12. During th e  last 7 days, on how  m an y  d a y s  did you walk for a t  leas t  10 m in u te s  a t  a  time 
to go from place to place?
 days per week
No walking from p lace  to p lace  Skip to PART 3: HOUSEWORK,
HOUSE MAINTENANCE, AND 
CARING FOR FAMILY
13. How m uch  tim e did you usually sp e n d  o n  o n e  of th o s e  d a y s  walking from p lace  to 
p lace?
 hours per day
 minutes per day
PART3: HOUSEWORKf HOUSE MAINTENANCE, AND CARING FOR FAMILY
T his  sec tion  is a b o u t  s o m e  of th e  physical activities you might h a v e  d o n e  in th e  last 7 days in 
a n d  a ro u n d  your hom e, like h ousew ork ,  garden ing ,  yard  work, g e n e ra l  m a in te n a n c e  work, and  
caring  for your family.
14. Think ab o u t  only th o s e  physical activities th a t  you did for a t  le a s t  10 m inu tes  a t  a  time.
During th e  last 7 days, on  how  m an y  d a y s  did you do  vigorous physical activities like 
h e a v y  lifting, chopping  w ood, shoveling  snow, or digging in the garden or yard?
 days per week
No vigorous activity in g a rd e n  or yard  Skip to question 16
15. How m uch  tim e did you usually  s p e n d  on  o n e  of th o s e  d a y s  doing vigorous physical 
activities in th e  g a rd e n  or y a rd ?
 hours per day
 minutes per day
16. Again, think a b o u t  only th o s e  physical activities th a t  you did for a t  leas t  10 m inu tes  a t  a  
time. During the  last 7 days, on  how  m an y  d a y s  did you do  moderate activities like 
carrying light loads, sw eep in g ,  w ash in g  windows, a n d  raking in the garden or yard?
 days per week
No m o d e ra te  activity in g a rd e n  or yard  Skip to question 18
17. How m u ch  tim e did you usually  s p e n d  on o n e  of th o s e  d a y s  doing moderate physical 
activities in th e  g a rd e n  or y a rd ?
 hours per day
 minutes per day
18. O n c e  again , think ab o u t  only th o s e  physical activities th a t  you did for a t leas t  10 m inu tes  
a t  a  time. During th e  last 7 days, on  how  m an y  d a y s  did you do  moderate activities like 
carrying light loads, w ash ing  window s, scrubb ing  floors a n d  sw ee p in g  inside your 
home?
 days per week
No m o d e ra te  activity inside h o m e  Skip to PART 4: RECREATION,
SPORT AND LEISURE-TIME PHYSICAL ACTIVITY
19. How m u ch  time did you usually  s p e n d  on  o n e  of th o s e  d a y s  doing moderate physical 
activities inside your h o m e ?
 hours per day
 minutes per day
PART4: RECREATION, SPORT, AND LEISURE-TIME PHYSICAL ACTIVITY
This  sec tion  is ab o u t  all th e  physical activities th a t  you did in th e  last 7 days solely for 
recreation , sport, e x e rc ise  o r  leisure. P le a s e  do  no t  include a n y  activities you h av e  a lready  
m en tioned .
20. Not counting a n y  walking you h a v e  a lready  m entioned , during th e  last 7 days, on how
m an y  d a y s  did you walk for a t le a s t  10 m in u te s  at a  time in your leisure time?
 days per week
No walking in le isure time Skip to question 22
21. How  m uch  time did you usually  s p e n d  on o n e  of th o s e  d a y s  walking in your leisure 
t im e?
 hours per day
 minutes per day
22. Think ab o u t  only th o s e  physical activities th a t  you did for a t  le a s t  10 m in u tes  a t  a  time. 
During th e  last 7 days, on  how  m a n y  d a y s  did you do  vigorous physical activities like 
ae ro b ics ,  running, fa s t  bicycling, o r  fa s t  sw im m ing in your leisure time?
 days per week
No v igorous  activity in le isure t im e Skip to question 24
23. How  m uch  time did you usually  s p e n d  on o n e  of th o s e  d a y s  doing vigorous physical 
activities in your leisure t im e?
 hours per day
 minutes per day
24. Again, think ab o u t  only th o s e  physical activities th a t  you did for a t  le a s t  10 m inu tes  a t  a  
time. During th e  last 7 days, on how  m a n y  d a y s  did you do  moderate physical activities 
like bicycling a t  a  regular p a c e ,  sw im m ing a t a  regular  p ace ,  an d  d o u b le s  ten n is  in your 
leisure time?
 days per week
No m o d e ra te  activity in le isure tim e Skip to PART 5: TIME SPENT
SITTING
25. H ow m uch  time did you usually  s p e n d  on  o n e  of th o s e  d a y s  doing moderate physical 
activities in your leisure t im e?
 hours per day
 minutes per day
PART 5: TIME SPENT SITTING
T h e  las t  q u es t io n s  a re  ab o u t  th e  t im e you  s p e n d  sitting while a t  work, a t  h o m e, while doing 
c o u r s e  work a n d  during leisure time. T h is  m ay  include time s p e n t  sitting a t  a  d esk ,  visiting 
friends, read ing  or sitting o r lying dow n to  w atch  television. Do not include an y  tim e s p e n t  sitting 
in a  m o to r  vehicle th a t  you h av e  a lre ad y  told m e  about.
26. During th e  last 7 days, how m u ch  tim e did you usually  s p e n d  sitting on  a  weekday?
 hours per day
 minutes per day
27. During th e  last 7 days, how m u ch  tim e did you usually s p e n d  sitting on a  weekend 
day?
 hours per day
 minutes per day
This is the end of the questionnaire, thank you for participating.
WEARING THE 
24-HOUR BLOOD 
GLUCOSE MONITOR
If you experience any problems or have any 
questions at any time whilst wearing the 
monitor, please contact:
Rosemary on 
01223 426356  
(07738 597193 out of hours)
or
Medtronic on 01923212213
ENTERING BLOOD GLUCOSE VALUES
You must enter a t  least 4 blood glucose readings into the monitor 
each day. Blood glucose readings can be taken at any time, but 
avoid taking them immediately following food or exercise.
To take a fingerstick glucose reading:
- Insert a tes t  strip into the fingerstick meter, with the yellow 
window facing up -  the meter will turn on automatically.
- When the blood drop symbol flashes the meter is ready.
- Obtain a blood sample using the lancet -  press the end of the 
'pen' so that the button on the side becomes yellow, and then 
hold the end of the 'pen' firmly against the side of your finger. 
Press the yellow button to perform the finger prick.
- Obtain a small drop of blood on your finger, and then touch and 
hold this drop of blood to the edge of the yellow window on the 
test  strip, within the curve. Hold your finger to the edge of the 
strip until the yellow window is completely filled with blood.
- The blood will be drawn automatically into the strip, and the 
meter will beep when the test  is beginning, a box will then 
rotate on the screen until the m easurem ent is completed.
- The result will then appear on the screen.
This result should be entered into the blood glucose monitor within 5 
minutes. To do this:
- Press SEL once -  "METER BG" will show
- Press ACT once -  the monitor screen will then change to " 
and "ENTER BG"
- Use the UP arrow  to enter your glucose reading, and then press 
ACT to enter this.
If an incorrect glucose meter value is entered into the monitor, it 
cannot be removed -  don't worry! Just enter  the correct value within 
5 minutes
RECORDING EVENTS
Every tim e you eat or take  exercise, please record this in the  
m onitor.
To do this:
- From the home screen, press SEL twice -  "EVENT" will show
- Press ACT once -  the display will flash
- Use the UP arrow to scroll through the options until you reach 
the appropriate one -  "FOOD", "MEDS", "EXERCISE" or "OTHER"
- Press ACT to enter the appropriate event
- You are most likely to use only "FOOD" and "EXERCISE". Enter 
"MEDS" if you take any medication, and "OTHER" for any other 
event you feel may be important. Please make a note detailing 
any exercise, medication or other event on the log sheet 
provided (see below for example). Details of meals or snacks 
will be recorded in your food diary.
EVENT DETAIL
Exercise 30 minutes walking the dog
Other Felt unwell with a migraine
ALARMS
This is unlikely to happen, but the monitor may alarm. The most 
likely reasons for this are tha t  the sensor has become disconnected or 
tha t  a calibration error has occurred.
Sensor Disconnected
This can occur if the sensor becomes disconnected from the monitor, 
or if the sensor is pulled out of the insertion site.
The alarm will beep every 15 seconds and "DISCONN-" will appear on 
the screen.
- Turn off the alarm by pressing SEL and then ACT
- Check the sensor-to-cable and cable-to-monitor connections, to 
make sure they are tight.
- Make sure the sensor is inserted and secure. If it has come out, 
don't worry or try to reinsert it, just contact Rosemary.
- If the glucose monitor has been disconnected, reconnect it, wait 
30 minutes, and then recalibrate the monitor with a fingerstick 
blood glucose reading.
Calibration error
This can occur if the blood glucose value entered into the monitor 
does not agree with that being recorded, or if an initial blood glucose 
reading is not entered into the monitor.
The alarm will beep every 15 seconds and "CAL ERROR" will appear 
on the screen.
- Turn off the alarm by pressing SEL and then ACT. The screen 
will change back to the home screen.
- Press SEL once to go to the "METER BG" screen -  check to make 
sure that the most recently entered blood glucose value is 
correct.
If an incorrect value was entered by mistake, take another blood 
glucose reading and enter the correct value as soon as possible.
